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Summary 
Ergothioneine (EGT) is a tri-N-methylated and sulphurised histidine derivative which exhibits 
antioxidant properties. EGT was first identified in Aspergillus fumigatus, in work pertaining to 
gliotoxin biosynthesis. Compared to wild-type, EGT levels were elevated in the absence of GliK, 
a gliotoxin biosynthetic enzyme. The work presented in this thesis demonstrates that deletion of 
A. fumigatus egtA (AFUA_2G15650), which encodes a trimodular enzyme, abrogated EGT 
biosynthesis in this opportunistic pathogen. A second EGT biosynthetic enzyme, egtB 
(AFUA_2G13295), was also identified. EgtB, a pyridoxal phosphate (PLP)-dependant cysteine 
desulphurase, contributed to, but was not essential for, EGT biosynthesis. EGT absence in A. 
fumigatus ΔegtA significantly reduced resistance to elevated concentrations of H2O2 and 
menadione, impaired gliotoxin production, increased glutathione biosynthesis, resulted in 
attenuated conidiation and affected cell wall integrity. EGT deficiency specifically decreased 
resistance to high H2O2 levels, which strongly infers functionality as an auxiliary, high-level, 
antioxidant. Quantitative proteomic analysis revealed significant proteomic remodelling in ΔegtA 
compared to wild-type under both basal and ROS conditions, whereby the abundance of 290 
proteins was altered. Specifically, the reciprocal differential abundance of cystathionine γ-
synthase and β-lyase, respectively, influenced cystathionine availability to affect EGT 
biosynthesis. Quantitative proteomic analysis also identified VipC (AFUA_8G01930), a putative 
methyltransferase which may be involved in the A. fumigatus response to EGT absence. A vipC 
deletion mutant was thus generated to further investigate VipC function in A. fumigatus. ΔvipC 
demonstrated significantly altered growth, development and metabolism compared to wild-type. 
Glutathione levels and abundance of related biosynthetic enzymes were significantly decreased 
in ΔvipC. Additionally, enzymes involved in the methionine cycle also had decreased abundance. 
These data indicate that VipC plays a significant role in coordinating the metabolic response to 
EGT absence in A. fumigatus. As a sulphur-containing metabolite, EGT therefore plays a key 
role in redox homeostasis and requires essential consideration in future oxidative stress studies in 
A. fumigatus. 
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1.1 Preamble 
This Chapter will begin with a general introduction to Aspergillus fumigatus (Section 1.2), with 
particular focus on asexual development (Section 1.3) and the cell wall (Section 1.4). This will 
highlight important aspects of A. fumiagtus biology that are of interest in this study. Discussion 
of oxidative stress will follow (Section 1.5), which will cover sources of reactive oxygen species 
(ROS), ROS toxicity, oxidative stress defence and conclude with a section on the interactions 
between secondary metabolism and oxidative stress in fungi. This will set the scene for 
discussion of gliotoxin: a double thiolated, redox-active secondary metabolite produced by A. 
fumigatus (Section 1.6). The biosynthesis of gliotoxin and its toxicity in the cell will be 
reviewed, followed by focus on the gliotoxin null mutant ΔgliK, which provided the first 
identification of ergothioneine (EGT) in A. fumigatus. Subsequently, the importance of sulphur 
metabolism in A. fumigatus will be examined (Section 1.7), with emphasis on sulphur 
assimilation and biosynthesis of sulphurised metabolites. This section will conclude with 
discussion on S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH) and their role in 
methylation. This is followed by a detailed description of EGT, a sulphurised and tri-N-
methylated histidine derivative with antioxidant properties and the main focus of this study 
(Section 1.8). Firstly, EGT function in animals and plants will be discussed briefly. Then the 
biosynthetic pathways of EGT in bacteria and fungi will be outlined, followed by a review of the 
current data on EGT functionality, highlighting areas where there are gaps in knowledge. This 
Chapter will then conclude with an outline of the rationale and objectives of this thesis (Section 
1.9). 
1.2  General Characteristics of Aspergillus fumigatus 
Aspergillus fumigatus is an opportunistic human pathogen of the phylum Ascomycota (Dagenais 
and Keller, 2009). A saprophytic filamentous fungus, A. fumigatus plays an important ecological 
role in its natural habitat in the soil by recycling environmental carbon and nitrogen by feeding 
on decaying organic matter (Latgé, 1999). A. fumigatus grows optimally at 37 
o
C and can survive 
anywhere in the range of 12 
o
C – 65 oC (Kwon-Chung and Sugui, 2013), temperatures it 
encounters naturally in self-heating compost piles. In the laboratory, A. fumigatus can grow 
rapidly on minimal agar plates containing a carbon source (e.g. glucose), a nitrogen source (e.g. 
nitrate), and trace elements (Brakhage and Langfelder, 2002). 
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A. fumigatus predominantly reproduces asexually, producing small grey-green haploid spores 
called conidia (Rokas, 2013). These conidia are 2-3.5 µm in diameter and have a hydrophobic 
surface. Due to this hydrophobicity, A. fumigatus conidia are incredibly buoyant in the air and 
thus easily disperse in the environment (O’Gorman, 2011). As a result, A. fumigatus conidia are 
ubiquitous in the atmosphere and are estimated to be present at concentrations of 1 – 100 conidia 
per m
3
 (Kwon-Chung and Sugui, 2013). 
The life cycle of A. fumigatus can be summarised as follows: (i) conidia are produced from 
conidiophores and released into the atmosphere (ii) conidia germinate and form septate mycelia 
(iii) mycelia produce conidiophores and the cycle continues (Ward et al., 2005). A. fumigatus has 
also been demonstrated to reproduce sexually, however only under very specific conditions 
(O’Gorman et al., 2009). 
As an opportunistic human pathogen, the primary route of A. fumigatus infection is inhalation via 
the lungs. Due to the ubiquitous nature of A. fumigatus conidia, humans are estimated to inhale 
several hundred of these spores every day (Latgé, 1999). The small size of the conidia enables 
them to penetrate into the pulmonary alveoli (Ben-Ami et al., 2010). In immunocompetent 
individuals, invading conidia are cleared rapidly from the lungs by mucociliary clearance and the 
innate immune system via alveolar macrophages and neutrophils (Dagenais and Keller, 2009). 
Conidia that escape clearance and germinate to form hyphae are targeted by neutrophils that 
release microbicidal molecules, reactive oxygen species (ROS) and neutrophil extracellular traps 
(McCormick et al., 2010; Hohl and Feldmesser, 2007; Bruns et al., 2010). 
In immunocompromised individuals however, conidia can germinate and cause infection. 
Depending on the site of infection, four different categories of disease can occur: allergic 
bronchopulmonary aspergillosis, chronic necrotising Aspergillus pneumonia, aspergilloma and 
invasive aspergillosis (Pathak et al., 2011). Invasive aspergillosis is the most serious and most 
prevalent of these diseases and is characterised by germination of the conidia and rapid hyphal 
growth to colonise the surrounding tissue. This leads to thrombosis, haemorrhage and 
dissemination to other organs via the bloodstream (McCormick et al., 2010; Dagenais and Keller, 
2009; Latge, 1999). Mortality of invasive aspergillosis ranges from 40% - 90% in high risk 
populations (Dagenais and Keller, 2009). 
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A. fumigatus produces a range of secondary metabolites, low molecular mass molecules 
produced separately to primary metabolism. While generally they are not essential for viability, 
secondary metabolites often have potent physiological activity that confer a competitive 
advantage on the producer (Keller et al., 2005; Macheleidt et al., 2016). A. fumigatus produces a 
range of secondary metabolites that can be separated into the following four categories: (i) non-
ribosomal peptides (ii) alkaloids (iii) terpenes (iv) polyketides (Keller et al., 2005). Secondary 
metabolites are encoded in clusters that are dispersed throughout the genome, towards telomeric 
regions of chromosomes (Fedorova et al., 2008). Secondary metabolism in Aspergilli is regulated 
by the methyltransferase LaeA (Bok and Keller, 2004), with deletion of laeA associated with 
absence of secondary metabolite cluster expression. Many of the secondary metabolites produced 
by A. fumigatus contribute towards pathogenesis, as demonstrated by Bok et al. (2005) who 
demonstrated reduced virulence in ΔlaeA in comparison to wild-type. Some of the secondary 
metabolites from A. fumigatus which are implicated in virulence include fumagillin, the 
fumitremorgins, fumitoxin and the fumigaclavines (Latgé, 1999). Siderophores, iron-chelating 
molecules that are used to sequester iron in the iron-starved environment of the host, have also 
been demonstrated to play an important role in virulence (Schrettl et al., 2007; Hissen et al., 
2005; Schrettl et al., 2004). Gliotoxin has also been demonstrated to contribute towards virulence 
and will be described in more detail in Section 1.6. 
1.3  Asexual Development in A. fumigatus 
As discussed in the previous section, conidia are essential for the dispersal, infection, and 
proliferation of A. fumigatus (Latgé, 1999). Asexual development begins with the formation of 
aerial hyphae that grow away from the mycelia. The top of the aerial hyphae swell to form a 
multinucleated vesicle, containing elongated cells called phialides. The phialides undergo a 
series of mitotic divisions, resulting in a chain of haploid conidia. The overall structure is called 
a conidiophore (Adams et al., 1998; Mullins et al., 1976, 1984; Ni et al., 2010; Rhodes & Askew, 
2010). 
Conidiation in A. fumigatus is controlled by a central regulatory pathway consisting of BrlA, 
AbaA and WetA (Alkhayyat et al., 2015). BrlA is transcriptional activator with two C2H2 zinc 
finger motifs essential for conidiation. BrlA is essential for development of the multinucleated 
vesicles and deletion of brlA results in elongated aerial hyphae with no conidiophores (Adams et 
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al., 1988, 1998; Mah & Yu, 2006). AbaA is necessary for correct differentiation of the phialides 
and deletion of abaA results in conidiophores lacking chains of conidia. AbaA is predicted to be 
a transcriptional activator which induces transcription of genes involved in mid-to-late phases of 
conidiation (Adams et al., 1998; Andrianopoulos & Timberlake, 1994; Tao & Yu, 2011). WetA 
functions to complete conidial development and is important for conidial maturity, integrity and 
viability. Deletion of wetA results in development of colourless conidia with defective spore 
walls (Andrianopoulos & Timberlake, 1994; Tao & Yu, 2011).  
Expression of brlA is required for activation of the asexual central regulatory pathway. Deletion 
of brlA results in abrogated expression of abaA and wetA. Additionally, expression of abaA is 
also required for wetA activation. This results in the expression cascade: expression of brlA, 
followed by abaA, followed by wetA (Figure 1.1). This ensures appropriate expression of genes 
depending on the developmental stage of the conidiophore. wetA deletion resulted in increased 
accumulation of brlA and abaA transcripts. This suggests negative feedback regulation involving 
wetA inhibition of brlA and abaA (Figure 1.1). brlA and abaA also regulate the expression of 
rodA. RodA forms part of the hydrophobic rodlet layer on the surface of the conidia, important 
for the aerial buoyancy of the conidia. brlA is essential for rodA expression, while deletion of 
abaA results in reduced expression of rodA (Figure 1.1) (Tao & Yu, 2011).  . 
Upstream regulation of conidiation is controlled by a variety of transcriptional regulators, 
including SomA, StuA, FluG, FlbB, FlbD and FlbE (Yu and Keller, 2005; Sheppard et al., 2005;  
Lin et al., 2015). These have been demonstrated to regulate expression of brlA, and thus 
activation of conidiation. The interactions between these proteins is outlined in Figure 1.1. 
Deletion mutants for these transcription factors result in a variety of defects to conidiation. 
Asexual development is also regulated by the velvet family of proteins, which consists of VeA, 
VelB, VelC, and VosA. These proteins all contain a novel velvet DNA binding domain, which 
functions in their role as transcriptional regulators (Bayram and Braus, 2012). Deletion of veA, 
velB or vosA in A. fumigatus results in increased conidiation, elevated numbers of conidiophores, 
increased conidial germination and increased levels of brlA mRNA (Park et al., 2012a). VeA, 
VelB and VosA therefore appear to negatively regulate conidiation in A. fumigatus (Figure 1.1). 
VosA and VelB were demonstrated to play a role in conidial viability, with ΔvosA and ΔvelB 
mutants associated with significant reduction in conidial viability compared to wild-type 
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(Fillinger et al., 2001; Park et al., 2012a, 2012b). AbaA has been demonstrated to regulate 
expression of VelB and VosA (Tao & Yu, 2011).  
 
Figure 1.1. Schematic representing the regulation of asexual development in A. fumigatus. The 
central regulatory pathway is displayed in red. The central regulatory pathway is influence by a 
variety of upstream transcription factors, velvet proteins and G-proteins. Image adapted from 
Mah and Yu (2005), Sheppard et al. (2005) and Alkhayyat et al. ( 2015). 
The heterotrimeric G-protein system has also been demonstrated to influence asexual 
development in A. fumigatus. Mah and Yu (2006) investigated two key components of the G-
protein signaling system, GpaA and FlbA.  Deletion of flbA or dominant activating GpaA 
mutations results in reduced conidiation with increased hyphal growth (Figure 1.1). The role of 
Gβγ heterodimer, SfaD (Gβ), and GpgA (Gγ), was analysed through deletion mutants for the two 
genes, sfaD and gpgA. Both mutants displayed impaired vegetative growth, conidial germination, 
and reduced conidial trehalose content (Shin et al., 2009).  
1.4  The cell wall of A. fumigatus 
The fungal cell wall provides structural integrity and protection to the cell and represents the first 
line of defence against external stresses. A dynamic structure, the cell wall is constantly 
undergoing modification in response to the growth environment (Bowman and Free, 2006). The 
cell wall is an important factor in considering the pathogenesis of A. fumigatus, as it plays an 
active role in infection and contains the majority of antigens detected by the host defence system 
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(Mouyna and Fontaine, 2009; Latgé, 1999). Due to its importance and because animal cells lack 
a cell wall, the cell wall of fungi represents a target for anti-fungal drug treatment. This is 
demonstrated by the echinocandins (e.g. caspofungin) which inhibit β(1,3)-glucan biosynthesis 
(Bowman et al., 2002).  
The cell wall of A. fumigatus is comprised mainly of polysaccharides, interlaced and coated with 
glycoproteins. Of the polysaccharides present in the cell wall, the most abundant are: α(1,3)-
glucans (35 – 46 %), β(1,3)-glucans (20 – 35 %), galactomannans (20 – 25 %), chitin (7 – 15 %) 
and β(1,6)-branched oligosaccharides (~4 %) (Fontaine et al., 2000). The fibrillar layer is 
composed of β(1,6)branched β(1,3) glucan linked to chitin, galactomannan and β(1,3;1,4)-
glucan. The fibrillar layer is embedded in the amorphous layer, which consists mostly of α(1,3)-
glucans and galactomannan. Glycoproteins are found embedded within the fibrillar layer and on 
the cell wall surface (Bernard and Latgé, 2001) (Figure 1.2). The polysaccharides of the cell wall 
are synthesised by membrane bound enzymes such as chitin synthases, β(1,3)-glucan synthases, 
mannosyltransferases and α(1,3)-glucan synthases. This is followed by transportation to the cell 
wall space where they undergo modification and crosslinking (Gastebois et al., 2009). 
 
Figure 1.2. Organisation of the A. fumigatus cell wall. Image obtained from Gastebois et al. 
(2009). 
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Cell wall maintenance is regulated by the cell wall integrity (CWI) signalling pathway. The CWI 
pathway consists of three MAP kinases (MAPK): Bck1 (MAPK kinase kinase), Mkk2 (MAPK 
kinase), and MpkA (MAPK). These form a signal cascade which results in MpkA localising to 
the nucleus where it is predicted to activate transcriptional regulators (Valiente et al., 2015) 
(Figure 1.3). Gene deletion of any of these three MAPKs results in the failure of MpkA to 
localise to the nucleus and a block on the signalling cascade (Valiante et al., 2008, 2009). 
Studies in Saccharomyces cerevisiae indicate that important upstream signals for the CWI 
pathway originate from WSC (CWI Stress Components) receptors, which are predicted to detect 
environmental stresses (Nanduri and Tartakoff, 2001; Dupres et al., 2009). These membrane 
bound proteins also contain a carbohydrate domain, leading to speculation they may act as a 
“bridge” between the cell wall and cytoplasmic membrane. A. fumigatus has four genes encoding 
WSC receptors: wsc1, wsc2, wsc3, and midA. Wsc1 is required for resistance to echinocandin 
antifungal drugs, while MidA was demonstrated to protect against elevated temperature and the 
cell wall perturbing agents congo red and calcofluor white. No function in the CWI pathway was 
demonstrated for Wsc2, and Wsc1, Wsc3 and MidA all displayed some redundancy in function 
(Dichtl et al., 2012). G protein coupled receptors are also predicted to partake in signalling 
upstream of the CWI in A. fumigatus. Deletion of gprC and gprD genes resulted in defects in cell 
wall related stress response (Gehrke et al., 2010). It has been demonstrated in S. cerevisiae that 
the WSC receptors are linked to the CWI pathway through different signalling elements (Figure 
1.2). Two of these are conserved in A. fumigatus: Rho1 and PkcA (Rispail et al., 2009). PkcA, 
protein kinase A, has not been characterised in A. fumigatus, however Rho1 is known to localise 
to the hyphal tip and has been demonstrated to participate in CWI signalling (Ditchl et al., 2010). 
While the CWI pathway is predicted to activate transcriptional regulators following localisation 
of MpkA to the nucleus, it has not been demonstrated which transcription factors are induced. 
Orthologs of transcription factors induced by the CWI pathway in S. cerevisiae have been 
identified in A. fumigatus (Rispail et al., 2009; Levin, 2011). Gene deletion studies for two of 
these genes, dvrA and ace2, demonstrated altered cell wall phenotypes (Ejzykowicz et al., 2009, 
2010; Verwer et al., 2012). However, further study is required to elucidate the targets of the CWI 
pathway. 
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Figure 1.3. The CWI signalling pathway in A. fumigatus. Stress receptors (Wsc1, Wsc3, MidA) 
activate the MAPK cascade via Rho1 and PkcA. The phosphorylation of MpkA causes it to 
localise to the nucleus, resulting in the activation of specific transcription factors. Image adapted 
from Valiente et al. (2015). 
1.5  Oxidative Stress 
Oxidative stress occurs when levels of reactive oxygen species (ROS) in a cell rise above 
tolerable levels, leading to deleterious effects on cellular metabolism and signalling (Lushchak, 
2011). ROS comprise of superoxide (
•
O2¯), the hydroxyl radical (
•
OH) and hydrogen peroxide 
(H2O2) (Turrens et al., 2003). Oxidative stress is of particular concern for aerobic organisms, as 
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approximately 90 % of ROS is produced by the electron transport chain (Starkov, 2008). This is 
due to “leakage” of ROS from the mitochondria in the normal process of aerobic respiration (Ott 
et al., 2007). Intracellular ROS are also produced from other metabolic processes and enzymes 
such as NADPH oxidase, lipoxygenases, cyclooxygenases, and xanthine oxidase have been 
demonstrated to contribute to ROS levels in the cell (Puddu et al., 2008). Furthermore, ROS can 
be introduced from exogenous sources. For a human pathogen such as A. fumigtaus, this is 
perhaps most relevant in interactions with the host immune system. As an anti-microbial 
strategy, human neutrophils will produce ROS to damage pathogens in a process known as 
“respiratory burst”. This is catalysed by an NADPH oxidase that generates superoxide (•O2¯) and 
H2O2 (Dahlgren and Karlsson, 1999). 
Elevated ROS can lead to damage to DNA, proteins and lipids. ROS can directly modify 
nucleotide bases in DNA; guanine in particular is vulnerable to modification by ROS, due to its 
low reduction potential. Modification of guanine by hydroxyl radicals can lead to the formation 
of 8-hydroxyguanosine. 8-hydroxyguanosine can pair with adenosine, leading to erroneous base 
pairing (Cooke et al., 2003). DNA damage also occurs in the form of single strand breakage, or 
less commonly, double strand breakage. This occurs when hydroxyl radicals interact with 
deoxyribose, resulting in the generation of peroxy radicals. These peroxy radicals can then nick 
the phosphodiester bonds in the backbone of the DNA strand, resulting in strand breakage 
(Dedon, 2008).  Oxidative damage to proteins can result in fragmentation, formation of protein-
protein cross-linkages and loss of function through oxidation of the protein backbone. Damage to 
proteins involved in intracellular signalling pathways and inhibition of correct proteolytic 
function can lead to severe disruption to cellular metabolism (Berlett and Stadtman, 1997). 
Protein thiol groups are particularly vulnerable to oxidative stress. Protein thiols can be modified 
by ROS to form sulfenic acid derivatives. While this modification is reversible, further oxidative 
attack can result in the formation of sulfinic acid or sulfonic acid derivatives. These 
modifications generally result in irreversible damage to the proteins, which then must be 
degraded by proteolytic enzymes (Biswas et al., 2006). Oxidative damage to lipids is best 
characterised by peroxidation of lipids in the cell membrane. This can result in loss of membrane 
fluidity and elasticity, impaired cellular functioning, and even cell rupture. Furthermore, lipid 
peroxidation results in the production of reactive aldehyde products, such as malondialdehyde 
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and 4-hydroxynonenal, which contribute towards DNA damage via formation of DNA adducts 
(Niki, 2009).  
It is therefore important that the levels of cellular ROS are managed in order to avoid these toxic 
effects. The oxidative stress defence system metabolises ROS in order to ensure they do not rise 
above tolerable levels. A number of enzymes partake in oxidative stress defence; foremost 
amongst these are superoxide dismutase (SOD) and catalase. SODs are a family of antioxidant 
enzymes that catalyse the dismutation of superoxide into either water or H2O2 by adding or 
removing an electron from the superoxide molecule. SODs typically require either copper and 
zinc together or manganese as co-factors (Sheng et al., 2014). Lambou et al. (2010) characterised 
four SODs in A. fumigatus. Deletion mutants for the genes encoding each SOD revealed 
sensitivity to induced ROS stress via menadione, sensitivity to macrophages, sensitivity to heat, 
reduced conidial survival and delayed conidiation. Catalase is a tetrameric enzyme consisting of 
four identical subunits with a heme group and NADPH contained in the centre (Chelikani et al., 
2004). Catalase converts two H2O2 molecules into water and O2 via a two-stage reaction. Stage 1 
involves the reaction of H2O2 with the heme group of catalase to form a high-valent iron 
intermediate. This high-valent iron intermediate then reacts rapidly with a second molecule of 
H2O2 to form O2 and water (Alfonso-Prieto et al,. 2009). A. fumigatus produces three catalases, 
two produced in mycelia and one in conidia. Gene deletion studies demonstrated that these are 
required for protection from H2O2 (Paris et al., 2003b; Calera et al., 1997). Other enzymes which 
contribute to oxidative stress defence in A. fumigatus are glutathione peroxidases (Burns et al., 
2005), thioredoxins (Kniemeyer et al., 2009) and peroxiredoxins (Hillmann et al., 2016). 
The activity of these enzymes is complemented by small molecules which also contribute 
towards ROS detoxification. The most important of these is glutathione (GSH), a tripeptide of 
glutamate, cysteine and glycine (Lu, 2009). In cells, glutathione is found in a reduced (GSH) and 
oxidised (GSSG) form. In healthy cells, 90% of the total glutathione content is comprised of 
GSH and a decrease in the GSH/GSSG ratio is indicative of oxidative stress (Anderson et al., 
1999; López-Mirabal and Winther, 2008). GSH is an efficient scavenger of free radicals and also 
functions to protect protein thiols from oxidative attack via glutathionylation (Galano and 
Alvarez-Idaboy, 2011; Dalle-Donne et al., 2009). Furthermore, GSH is required for the function 
of glutathione peroxidises (Brigelius-Flohé and Maiorino, 2013).  
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Regulation of the oxidative stress response occurs primarily at the genetic level. The 
transcription factor Yap1 is at the centre of the oxidative stress response in A. fumigatus. Lessing 
et al. (2007) demonstrated that under normal reduced conditions, Yap1 is located in the 
cytoplasm. However when stressed with ROS inducing agents, Yap1 localises to the nucleus to 
activate transcription of oxidative stress defence genes. Lessing et al. identified 29 proteins 
controlled directly or indirectly by Yap1, including catalase 2, thioredoxin peroxidase (AspF3) 
and cytochrome peroxidase. Deletion of yap1 in A. fumigatus resulted in sensitivity to elevated 
ROS induced by H2O2 and mendione. 
Another important aspect of the oxidative stress defence system is the CCAAT-binding complex 
(CBC). The CBC has been well characterised in A. nidulans and consists of three subunits: 
HapB, HapC and HapE. HapC senses the redox state of the cell through modifications of thiol 
groups within its histone fold motif (Thon et al., 2010). Under normal reduced conditions in the 
cell, HapC and HapE form a stable heterodimer, which is subsequently bound by HapB and 
transported to the nucleus. In the nucleus, the CBC prevents full expression of napA (A. nidulans 
yap1 ortholog). When levels of intracellular ROS are elevated however, the thiol groups of HapC 
form disulphide bridges, preventing the formation of the heterodimer with HapE. Thus, the CBC 
does not localise to the nucleus and napA is expressed fully (Figure 1.4) (Thon et al., 2010). 
It has been observed that much cross-talk occurs between oxidative stress and secondary 
metabolism in fungi (Sheridan et al., 2015). The expression of many secondary metabolites has 
been demonstrated to be induced by oxidative stress. Levels of type B trichothecenes, 
deoxynivalenol, and 15-acetyl-deoxynivalenol in Fusarium graminearum are increased and 
decreased in the presence of H2O2 and catalases respectively (Ponts et al., 2006, 2007). Similarly, 
levels of aflatoxin in Aspergillus parisiticus were demonstrated to be influenced by addition of 
H2O2 and antioxidants to culture media (Reverberi et al., 2005, 2008). 
Several secondary metabolites function to induce oxidative stress. This is best studied in the 
epipolythiodioxopiperazine (ETP) class of metabolites. ETP metabolites are a class of fungal 
toxins characterised by a disulphide bridge. This disulphide bridge is essential for the activity of 
ETPs as it facilitates ROS generation by redox cycling and interaction with protein thiol groups 
(Gardiner et al., 2005). This can be seen in the mycotoxin sporidesmin A, which is known to 
cause to facial eczema and liver injury in livestock when produced by the saprophytic fungus 
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Pithomyces chartarum (Menna et al., 2009). Sporidesmin A has been demonstrated to induce 
injury via redox cycling to produce superoxide, hydroxyl radicals and H2O2 (Munday, 1982, 
1984, 1987). 
 
Figure 1.4. Coordination of the oxidative stress defence in A. nidulans via regulation of napA by 
the CBC. Image adapted from Thon et al. (2010). (A) Under reducing conditions, HapC forms a 
stable heterodimer with HapE, which is then subsequently bound by HapB to form the CBC. The 
CBC is then transported to the nucleus where it represses napA expression. (B) Under oxidising 
conditions, the thiol groups of HapC form disulphide bridges, preventing formation of the CBC 
and thus does not localise to the nucleus. napA is then expressed fully. 
Gliotoxin is the best studied of the ETP metabolites and functions in a similar manner, which 
will be discussed further in Section 1.6. The naphthoquinones are another family of secondary 
metabolites that function through redox activity. Produced by a range of filamentous fungi, these 
metabolites have been demonstrated to interfere with the respiratory system of bacteria, yeast, 
fungi, and plant cells by accepting the reducing equivalents from redox enzymes and transferring 
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directly to oxygen, resulting in the respiratory chain being bypassed. Naphthoquinones have also 
been demonstrated to generate superoxide and interfere with glutathione reductase (Medentsev 
and Akimenko, 1998). 
Secondary metabolites also function in management of ROS levels. Siderophores contribute to 
oxidative stress defence via management of iron homeostasis. Siderophores are non-ribosomal 
peptides that scavange iron, both intra- and extra-cellularly. Intracellular siderophores (e.g 
ferricrocin) function in iron storage, while extracellular siderophores (e.g. fusarinine C) function 
in iron uptake in iron starved environments (e.g. host infection)(Haas, 2012). Iron is an important 
element in oxidative stress defence, as heme groups are required for the function of many 
antioxidant enzymes (Conesa et al., 2002), however over abundance of iron can lead to oxidative 
stress through Fenton reaction (Papanikolaou and Pantopoulos, 2005). Siderophores therefore 
contribute to oxidative stress defence via regulation of iron homeostasis. This is underlined in A. 
fumigatus and A. nidulans by the demonstration that siderophore encoding genes are upregulated 
by exposure to ROS inducing agents, while deletion of siderophore encoding genes leads to 
sensitivity to ROS inducing agents (Eisendle et al., 2006; Schrettl et al., 2007)). Ergothioneine, a 
trimethylated and sulphurised histidine derivative also contributes to oxidative stress defence and 
will be discussed in Section 1.8. 
1.6   Gliotoxin 
Gliotoxin in a non-ribosomally synthesised ETP metabolite produced by many fungal species, 
including A. fumigatus. As with every other ETP toxin, the activity of gliotoxin comes from its 
disulphide bridge which facilitates redox cycling (Figure 1.5). Gliotoxin has many toxic effects 
in the cell, including generation of ROS through redox cycling, depletion of GSH levels and 
forming disulphide bridges with protein thiols (Gardiner et al., 2005). Through these toxic 
effects, gliotoxin acts as an anti-microbial agent, as well as contributing to A. fumigatus 
pathogenicity in humans (De Carvalho and Abraham, 2012; Sugui et al., 2007). 
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Figure 1.5. Gliotoxin redox cycling, between the reduced (Dithiol) and oxidised (Disulphide) 
forms. Image obtained from Gardiner et al. (2005). 
1.6.1  Gliotoxin biosynthesis 
Gliotoxin is biosynthesised by a series of enzymatic reactions (Figure 1.6). The genes encoding 
these enzymes are located in a 13 gene cluster known as the gli cluster (Gardiner and Howlett, 
2005) (Figure 1.6). gli cluster activity is regulated by the transcription factor GliZ. Deletion of 
gliZ results in abrogation of the expression of key gliotoxin biosynthetic genes and gliotoxin 
biosynthesis (Bok et al., 2006). Gliotoxin biosynthesis is initiated by the non-ribosomal peptide 
synthetase GliP, which catalyses the conversion of serine and phenylalanine into cyclo-
phenylalanyl-serine (Balibar and Walsh, 2006). The α-carbon of the phenylalanine in cyclo-
phenylalanyl-serine is then hydroxylated by GliC to form an acyl imine intermediate (Chang et 
al., 2013). This acyl imine intermediate undergoes bis-glutathionylation, catalysed by GliG 
(Davis et al., 2011; Scharf et al., 2011), which introduces the thiol groups essential for gliotoxin 
activity. Bis-glutathionylation is followed by γ-glutamyl cyclotransferase activity, to remove 
both γ-glutamyl moieties. This is catalysed by GliK. (Gallagher et al., 2012; Scharf et al., 2013). 
GliJ then catalyses the removal of the two glycine fragments (Scharf et al., 2013), followed by 
processing by GliI, a pyridoxal phosphate (PLP)-dependant C-S lyase (Scharf et al., 2012). 
Methylation by GliN then follows to yield dithiol gliotoxin (Scharf et al., 2014).  
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Figure 1.6. (A) Biosynthesis of gliotoxin and bis-methylgliotoxin and their subsequent secretion. 
(B) Gliotoxin biosynthetic gene (gli) cluster. Image obtained from Dolan et al. (2015). 
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GliT catalyses the final step in gliotoxin biosynthesis, closure of the disulphide bridge (Scharf et 
al., 2010, 2013; Schrettl et al., 2010). Gliotoxin is then secreted from the cell via the major 
facilitator superfamily (MFS) transporter GliA (Wang et al., 2014; Owens et al., 2015). Dithiol 
gliotoxin can also be processed by the S-adenosylmethionine (SAM)-dependant 
methyltransferase GtmA, which is not encoded in the gli cluster. GtmA catalyses the S-
methylation of the gliotoxin thiol groups to form bis-methylgliotoxin. The method of secretion 
for bis-methylgliotoxin is unknown (Figure 1.6) (Dolan et al., 2014). 
In addition to GliZ, gliotoxin biosyntheiss is regulated by many other factors (Dolan et al., 
2015). LaeA, the master regulator of secondary metabolism, regulates gliotoxin biosynthesis. 
This was demonstrated in a ΔlaeA muatant which had severely reduced levels of gliotoxin (Bok 
and Keller, 2004). Related to this, deletion of veA, which interacts with LaeA in the nucleus, also 
resulted in reduced gliotoxin production (Dhingra et al., 2012). LaeA and the velvet proteins are 
involved in asexual development as discussed previously, in addition to regulating secondary 
metabolism. The developmental regulators FlbB and FlbE, and the transcription factor StuA, 
which regulates abaA transcription, positively influence gliotoxin biosynthesis, further 
emphasising the link between asexual development and gliotoxin biosynthesis (Kim and Shin, 
2013; Xiao et al., 2010; Kwon et al., 2010; Twumasi-Boateng et al., 2009). The MAP kinase 
MpkA, which also has a role in CWI signalling, positively regulates gliotoxin biosynthesis (Jain 
et al., 2011). The class 2 histone deacetylase HdaA and the histone methyltransferase CclA 
positively and negatively regulate gliotoxin biosynthesis respectively (Lee et al., 2009; Palmer et 
al., 2013). Gliotoxin is therefore regulated by a variety of factors and linked with metabolic 
processes such as asexual development. 
Dolan et al. (2014) demonstrated that bis-methylated gliotoxin formation acts to attenuate 
gliotoxin biosynthesis. Dolan et al. identified GtmA, the SAM-dependent gliotoxin bis-
thiomethyltransferase which is encoded outside the gli cluster, as responsible for gliotoxin bis-
methylation. Deletion of gtmA resulted in abrogation of bis-methylgliotoxin production, 
increased gliotoxin production and a concurrent increased abundance of gli cluster proteins. 
GtmA acts to bis-methylate dithiol gliotoxin to form bis-methylgliotoxin, in place of GliT 
mediated disulphide bridge closure. In this way bis-methylgliotoxin is formed as an alternative to 
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gliotoxin (Figure 1.6). This novel post-biosynthetic regulation of nonribosomal peptide synthesis 
had never been observed previously. 
1.6.2  Gliotoxin toxicity 
One of the most important properties of ETP toxins is their ability to redox cycle to produce 
ROS.  In the presence of an appropriate reducing agent (e.g. glutathione), gliotoxin can switch 
between a reduced and oxidised form, producing ROS (Figure 1.5). This leads to a decrease in 
intracellular reductants and an increase in ROS (Bernardo et al., 2003). Eichner et al. (1988) 
demonstrated DNA damage due to gliotoxin redox cycling, resulting in single and double 
stranded breaks in the DNA. Gliotoxin can also cause the formation of mixed disulphides by 
reacting with protein thiols. In this manner, gliotoxin can inhibit protein function, resulting in 
defective cellular metabolism. It has been demonstrated that gliotoxin can inhibit alcohol 
dehydrogenase, due to formation of a disulphide bridge in the co-factor binding region (Waring 
et al., 1995). It was however noticed, that gliotoxin could still inhibit alcohol dehydrogenase in 
the presence of a reductant, which prevented disulphide formation. This was due to generation of 
ROS by redox cycling of gliotoxin with the added reductant. Thus, gliotoxin inhibition of 
enzymes can occur through two mechanisms. Gliotoxin has also been noted to induce apoptosis 
in cells. This occurs through the activation of the pore-forming proapoptotic Bcl-2 family 
member Bak to elicit ROS generation, the mitochondrial release of apoptogenic factors, and 
caspase-3 activation (Hacker et al., 2013; Geissler et al., 2013).  
Through these actions, gliotoxin can modulate the host immune system, making it an important 
factor in A. fumigatus pathogenesis. It has been demonstrated that gliotoxin can inhibit 
macrophage phagocytosis (Eichner et al., 1986), NADPH oxidase (Yoshida et al., 2000), 
mitogen-activated T-cell proliferation (Mullbacher and Eichner, 1984), mast cell activation 
(Niide et al., 2006) and cytotoxic T-cell responses (Yamada et al., 2000). 
Because of these cytotoxic effects, it is important that A. fumigatus protects itself from the 
harmful actions of gliotoxin. It has been demonstrated that GliT is essential for self-protection 
against gliotoxin, with deletion of gliT resulting in severe sensitivity to exogenous gliotoxin 
compared to wild-type. Furthermore, strains of A. nidulans and S. cerevisiae transformed with 
gliT demonstrated increased resistance to exogenous gliotoxin compared to wild-type. 
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Relevantly, gliT was demonstrated to be regulated independently of gliZ, indicating gliotoxin 
self-protection can function autonomously of gliotoxin biosynthesis (Schrettl et al., 2010). GliA, 
the MFS transporter responsible for gliotoxin secretion, has also been demonstrated to contribute 
to gliotoxin self-protection, as the mutant ΔgliA had increased sensitivity to exogenous gliotoxin 
compared to wild-type. This indicates that efficient efflux of gliotoxin from the cell is required 
for gliotoxin self-protection in A. fumigatus (Wang et al., 2014; Owens et al., 2015). 
1.6.3  A. fumigatus ΔgliK 
Deletion mutants were utilised to study many of the genes in the gli cluster, including ΔgliP, 
ΔgliT, ΔgliG, ΔgliZ and ΔgliA (Kupfahl et al., 2006; Schrettl et al., 2010; Davis et al., 2011; Bok 
et al., 2006; Wang et al., 2014). This same strategy was used for investigating GliK function, 
using the ΔgliK mutant (Gallagher et al., 2012). GliK was demonstrated to be essential for 
gliotoxin biosynthesis, with gliotoxin production abrogated in ΔgliK. However, several other 
phenotypes were detected in addition to this. ΔgliK demonstrated sensitivity to exogenous 
gliotoxin and H2O2. It was observed that exogenous gliotoxin was exported from the cell at a 
reduced rate in ΔgliK compared to wild-type. RP-HPLC and LC-MS/MS analysis revealed 
increased levels of metabolites with a m/z between 394 and 396. These were later revealed to be 
members of the fumitremorgin family of secondary metabolites (Dr. Rebecca Owens and 
Professor Sean Doyle, personal communication). Additionally, ΔgliK led to the discovery of 
ergothioneine (EGT) in A. fumigatus and levels of the putative antioxidant were revealed to be 
significantly increased in ΔgliK compared to ATCC26933. 
Absence of GliK in A. fumigatus therefore results in a number of phenotypes, for which the 
reasons have yet to be fully elucidated. Owens et al. (2015) demonstrated that ΔgliK has reduced 
GliT induction following exposure to exogenous gliotoxin, which would result in sensitivity to 
exogenous gliotoxin as observed. Oxidative stress sensitivity has been speculated to be caused by 
a “GSH sink” resulting from abrogation of gliotoxin biosynthesis directly following the 
glutathionylation step (Professor Sean Doyle, personal communication). Gallagher et al. (2012) 
speculated that gliotoxin reduction due to increased EGT levels may have led to inhibited 
gliotoxin efflux. Further study is required to elucidate the reasons behind the many phenotypes 
observed in ΔgliK and the implications they have for gliotoxin biosynthesis and self-protection in 
A. fumigatus. 
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1.7  Sulphur Metabolism 
Sulphur is an essential element that is incorporated into various metabolic processes in A. 
fumigatus. This includes the proteinogenic amino acids cysteine and methionine, oxidative stress 
defence (GSH)(Lin, 2009), iron metabolism (Fe-S clusters)(Amich et al., 2013), ETP toxins 
(gliotoxin)(Davis et al., 2011) and methylation (S-adenosylmethionine)(Struck et al., 2012). A. 
fumigatus can acquire sulphur either through inorganic or organic sources (Amich et al., 2013). 
Sulphur availability is an important consideration in the pathogenesis of A. fumigatus, as it must 
source sulphur from the host environment to survive (Amich et al., 2016). 
1.7.1  Assimilation of sulphur 
Inorganic sources of sulphur that can be utilised by filamentous fungi include sulphate (SO4
2-
), 
sulphite (SO3
2−
) and sulphide (S
2-
) (Paszewski et al., 1994). Sulphate is widespread in nature and 
its assimilation pathway has been well characterised in filamentous fungi. Sulphate is first 
transported into the cell by a sulphate permease (SB). Following transport into the cell, sulphate 
is reduced to adenosine 5’-phosphosulphate (APS) by an ATP sulphurylase (SC). APS is then 
phosphorylated by an APS kinase (SD) to form 3’-phosphoadenosine 5’-phosphosulphate 
(PAPS). Sulphite is then released from PAPS via the PAPS reductase SA. Sulphite is reduced to 
sulphide by a sulphite reductase (AFUA_6G08920, α-subunit; SF: β-subunit). Sulphide can then 
be incorporated into cysteine or homocysteine via cysteine synthase (CysB) and O-acetylserine 
or homocysteine synthase (CysD) and O-acetylhomoserine respectively (Figure 1.7) (Marzluf, 
1997).  
Amich et al. (2016) demonstrated that SB is essential for sulphate assimilation in A. fumigatus. 
Deletion of sB resulted in abrogation of growth on media containing sulphate as a sole sulphur 
source. This indicates that SB function in A. fumigatus as a sulphate permease is non-redundant. 
ΔsB also had reduced growth on sulphite and thiosulphite, indicating that SB contributes to the 
transport of other inorganic sulphur sources. Amich et al. (2016) also studied the sulphite 
reductase, responsible for converting sulphite into sulphide. The gene encoding the β subunit of 
sulphite reductase, sF, was deleted. ΔsF was incapable of growing on any inorganic sulphur 
source, with the exception of sulphide. Sulphite redudctase is therefore essential for assimilation 
of inorganic sulphur sources, apart for sulphide. 
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Figure 1.7. Assimilation of inorganic sulphur (sulphate) in filamentous fungi. Abbreviations: 
SB, sulphate permease; SC, ATP sulphurylase; SD, adenosine 5′-phosphosulphate (APS) kinase; 
SA, 3′-phosphoadenosine-5′-phosphosulphate (PAPS) reductase; CysB, cysteine synthase; CysD, 
homocysteine synthase (Amich et al., 2016). 
The transcription factor MetR has been demonstrated to regulate inorganic sulphur assimilation 
in A. fumigatus (Amich et al., 2013). MetR is a leucine zipper (bZIP) transcription factor and 
orthlogs in A. nidulans (MetR) and N. crassa (CYS-3) have been demonstrated to regulate 
sulphur assimilation in their respective organisms (Natorff et al., 2003; Fu et al., 1989). Deletion 
of metR resulted in a complete absence of growth on media with inorganic sulphur as a sole 
sulphur source. Under sulphur rich conditions, MetR was demonstrated to be uniformly 
distributed throughout the cytoplasm, however under sulphur-depleted conditions, MetR 
localised strongly to the nucleus. MetR localisation to the nucleus was followed by upregulation 
of genes involved in the inorganic sulphur assimilation pathway: sB, sC, sD, sA and sulphite 
reductase. MetR was also demonstrated to bind to the promoter regions of sB, sC and sD. 
Deletion of metR resulted in decreased transcript of sB, sC, sD, sA and sulphite reductase relative 
to wild-type levels. MetR was therefore demonstrated to regulate inorganic sulphur assimilation. 
A. fumigatus can also utilise organic sulphur sources such as methionine, cysteine, homocysteine 
and taurine (a cysteine derivative). Regulation of the assimilation of organic sources is 
independent of MetR, which is required for assimilation of inorganic sulphur sources. This is 
demonstrated by the ΔmetR mutant, which matched wild-type growth on media with methionine 
or homocysteine as a sole sulphur source (Amich et al., 2013). Conversely, ΔmetR had severely 
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reduced growth on media with cysteine as a sole sulphur source compared to wild-type and could 
not grow at all on media with glutathione or taurine as a sole sulphur source. However, it was 
noted that ΔmetR could utilise GSH and cysteine as a sole sulphur source when simultaneously 
starved of nitrogen, indicating a link between sulphur and nitrogen utilisation. Taurine could not 
be utilised by ΔmetR regardless of nitrogen availability. Amich et al. (2016) demonstrated that 
sulphite reductase, of the inorganic sulphur assimilation pathway, is also required for taurine 
assimilation. This is because taurine catabolism releases sulphite, which must then be reduced to 
sulphide via sulphite reductase. As sulphite reducase is under MetR regulation, it follows that 
taurine cannot be utilised as a sulphur source in ΔmetR. 
Analysis of genes involved in methionine uptake and catabolism revealed that their expression is 
mostly independent of MetR. Analysis of the genes encoding for the putative methionine uptake 
proteins mupA and mupC revealed that mupC expression was not altered by deletion of metR, 
while mupA expression was reduced in ΔmetR compared to wild-type. The gene metAT, 
encoding for a methionine aminotransferase, had increased expression in ΔmetR compared to 
wild-type under sulphur-limiting conditions. metAT is predicted to carry out catabolism of 
methionine, essential for utilisation of methionine as a sulphur source. Upregulation of metAT in 
ΔmetR under sulphur limiting conditions indicates that not only is methionine utilisation 
independent of MetR, but can be increased in order to compensate for loss of inorganic sulphur 
utilisation. The question of cysteine utilisation could not be properly addressed as the 
mechanisms of cysteine catabolism have not been elucidated, However, cynA, encoding a 
putative cysteine permease, and cysD (cysteine synthase) appear to be regulated in a MetR 
dependant manner, indicating cystine uptake and assimilation may be regulated by MetR (Amich 
et al., 2013). 
While MetR positively regulates sulphur assimilation, a set of 4 genes (sconA, sconB, sconC and 
sconD) act to negatively regulate sulphur assimilation. In A. nidulans, deletion of scon genes 
results in excessive accumulation of sulphur containing amino acids. Notably, exposure to Met 
had no affect on sulphate assimilation in scon deletion mutants, while in wild-type Met exposure 
almost eliminated inorganic sulphur assimilation (Natorff et al., 1993). metR transcript is 
increased in scon deletion mutants, particularly sconB2, indicating interaction between the 
positive and negative elements of sulphur regulation (Nartorff et al., 2003). 
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Amich et al. (2013, 2016) investigated the impact of sulphur utilisation in the pathogenesis of A. 
fumigatus. The importance of efficient sulphur utilisation in virulence was demonstrated by 
ΔmetR, which had decreased virulence in Galleria mellonella compared to wild-type, indicating 
that sulphur assimilation can be a limiting factor in the pathogenesis of A. fumigatus. Deletion of 
sB and sF in A. fumigatus did not result in reduced virulence in a murine model, indicating 
inorganic sulphur sources nor taurine serve as an essential sulphur source during infection. 
Furthermore, a cysteine auxotroph mutant displayed reduced virulence in a murine model, 
indicating that cysteine levels in the murine lung are insufficient to act as a sulphur source during 
infection. 
1.7.2  Biosynthesis of sulphur containing amino acids and metabolites 
Cysteine (Cys) and methionine (Met) are sulphur-containing proteogenic amino acids. Cys can 
be formed directly from assimilated inorganic sulphur, as the enzyme cysteine synthase (CysB) 
converts sulphide and O-acetylserine into cysteine. Met can be converted from inorganic sulphur 
via homocysteine. Homocysteine synthase (CysD) catalyses the formation of homocysteine from 
sulphide and O-acetylhomoserine. A cobalamin-independent methionine synthase (MetH) then 
catalyses the transfer of a methyl group from methyltetrahydrofolate to homocysteine to form 
Met (Figure 1.8) (Brzywczy et al., 2007; Saint-Macary et al., 2015) 
Cys and homocysteine can be interconverted through transsulphuration pathway, via the 
intermediate cystathionine. The forward transsulphuration pathway converts Cys into 
cystathionine by the enzyme cystathionine γ-synthase (CGS; MetB). Cystathionine is then 
converted into homocysteine by cystathionine β-lyase (CBL; MetG). The reverse 
transsulphuration pathway sees homocysteine converted into cystathionine by cystathionine β-
synthase (CBS; MecA) and cystathionine converted into Cys by cystathionine γ-lyase (CGL; 
MecB). Through this pathway, the thiol group can be transferred between Cys and homocysteine 
(Figure 1.8) (Sieńko et al., 2009; Sohn et al., 2014). 
Met and homocysteine are two components of the “Met cycle”, which also includes SAM and S-
adenosylhomocysteine (SAH). Met is converted into SAM by the enzyme SAM synthetase 
(SasA). SAM is the universal methyl donor, as will be discussed in Section 1.7.3, and donation 
of the methyl group from SAM leads to the formation of SAH. SAH can then be converted into 
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homocysteine via a hydrolysis reaction catalysed by adenosylhomocysteinease (Sah1). As 
before, homocysteine is converted to Met by methionine synthase (MetH) to complete the cycle 
(Figure 1.8) (Saint-Macary et al., 2015; Owens et al., 2015).  
Met can be also recovered from SAM via the Met salvage cycle. In the Met salvage pathway, 
SAM is decarboxylated to form decarboxylated SAM (dcSAM). In a reaction catalysed by 
spermidine synthase, dcSAM donates aminopropyl groups to putrescine to form spermidine and 
5’-methylthioadenosine (MTA). MTA is then converted through a series of intermediates back to 
Met (Sauter et al., 2013). This pathway helps balance cellular Met and SAM levels (Figure 1.8). 
To date, it is known that Cys provides the thiol group for two important redox active metabolites 
in A. fumigatus: GSH and gliotoxin. Cys is converted into GSH via a two step pathway. The first 
step is likely catalysed by glutamate–cysteine ligase (Gcs1), which catalyses the condensation of 
Cys and glutamate to form γ-glutamylcysteine. γ-glutamylcysteine is then converted to GSH by 
the addition of a glycine to the C-terminal of γ-glutamylcysteine by glutathione synthase (Gsh2) 
(Lin, 2009). In gliotoxin biosynthesis, the two thiol groups originate from the addition of two 
GSH molecules. This reaction is catalysed by the glutathione-S-transferase GliG (Figure 1.8) 
(Davis et al., 2011).  
1.7.3  SAM, SAH and Methylation 
Methylation is the process of transferring a methyl group (CH3) to a substrate in place of a 
hydrogen atom. Methylation reactions are catalysed by methyltransferases, which can be 
categorised as C-, N-, O- or S-methyltransferases depending on their target. Targets of 
methylation include proteins, DNA, RNA and secondary metabolites. Functionally, methylation 
is involved in signal transduction, protein repair, chromatin regulation, gene silencing and 
secondary metabolite biosynthesis (Schubert et al., 2003; Liscombe et al., 2012).  
SAM donates the methyl group for methylation in the majority of methylation reactions, across 
all branches of life. For this reason it is known as the universal methyl donor (Struck et al., 
2012). Donation of the methyl group from SAM results in the formation of SAH, which can be 
hydrolysed to homocysteine as part of the Met cycle (Figure 1.8). SAH is a potent inhibitor of 
methylation (Caudill et al, 2001) and thus levels of SAH are an important factor in methylation  
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Figure 1.8. Sulphur metabolism in A. fumigatus, demonstrating the biosynthesis of sulphur containing amino acids and metabolites. 
Enzymes are shown in blue.
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levels. For this reason the ratio of SAM/SAH is considered a useful indicator of cellular 
methylation potential.  
The effects of perturbing SAM/SAH ratios have been studied through the disruption of 
adenosylhomocysteinase activity. As adenosylhomocysteinase catalyses the hydrolysis of SAH, 
any disruption to its activity would be expected to increase SAH levels, and reduce the 
SAM/SAH ratio. This would therefore be expected to inhibit methylation (Caudill et al., 2001). 
Fulneček et al. (2011) demonstrated that inhibition of adenosylhomocysteinase using 9-(S)-(2,3-
dihydroxypropyl)-adenine (DHPA) in tobacco seeds resulted in global hypomethylation of DNA. 
Phenotypically this resulted in dosage dependant developmental defects, linked to increased 
expression of floral organ identity genes. The authors concluded that tobacco seeds were 
particularly sensitive to accurate SAM/SAH levels at critical developmental periods.  
In fungi, Liao et al. (2012) investigated the effect of perturbed SAM/SAH ratios in 
Cryphonectria parasitica. Deletion of the gene encoding adenosylhomocysteinase resulted in a 
near 10-fold increase in SAH levels, and a 2-fold increase in SAM levels. This reduced the 
intraceullular SAM/SAH ratio from 2.63 to 0.53. Phenotypically, this resulted in reduced radial 
growth, decreased asexual development and loss of pigment. This was predicted to be due to a 
decrease in DNA methylation. Regulation of intracellular SAM/SAH levels are therefore 
important to regulate as disruption can result perturbation can effect tightly regulated gene 
expression. 
As discussed previously, bis-thiomethylation of gliotoxin via the methytransferase GtmA is an 
important factor in negative regulation of gliotoxin biosynthesis in A. fumigatus (Dolan et al., 
2014). While bis-methylation is not required for gliotoxin self-protection, disruption of the 
SAM/SAH ratio has been associated with gliotoxin sensitivity (Owens et al., 2015). ΔgliT, which 
demonstrates severe sensitivity to exogenous gliotoxin, had decreased levels of SAM and 
increased levels of SAH. Absence of GliT results in increased GtmA methyltransferase activity 
due to increased availability of dithiol gliotoxin. This leads to increased production of bis-
methylgliotoxin and a concurrent shift in SAM/SAH ratio. ΔgliK, which is also sensitive to 
gliotoxin and has attenuated GliT induction following exogenous gliotoxin exposure, also 
displayed altered SAM/SAH ratio in a similar manner to ΔgliT. GliT therefore plays an 
important role in maintaining SAM/SAH homeostasis following exposure to exogenous gliotoxin 
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in A. fumigatus and absence of GliT leads to decreased SAM/SAH ratio, which contributes to 
gliotoxin toxicity in ΔgliT and ΔgliK (Owens et al., 2015).  
1.8   Ergothioneine 
Ergothioneine (2-mercaptohistidine trimethylbetaine; EGT) is a sulphurised and tri-N-methylated 
histidine derivative. In the cell, it exists in a tautomeric state between both the thione and thiol 
forms (Figure 1.9) and has demonstrable antioxidant properties. EGT exhibits a higher redox 
potential (E’0 = -0.06 V) than GSH (E’0 = -0.25 V), which means that EGT is less susceptible to 
auto-oxidation, and consequently more stable in an aerated aqueous solution (Hand et al., 2005; 
Hartman, 1990). EGT is produced by fungi (excepting members of the Saccharomycotina 
subphylum) and select bacteria, particularly members of Actinobacterial and Cyanobacterial 
phyla (Jones et al., 2014). While animals or plants cannot produce EGT, they can obtain it from 
dietary sources or from symbiotic microorganisms (Ey et al., 2007).  
 
Figure 1.9. EGT structure in its thiol and thione form (Sheridan et al., 2016). 
1.8.1  EGT in animals and plants 
Humans acquire EGT from dietary sources. Rich sources of dietary EGT include mushrooms, 
oats, beans and red meat (Ey et al, 2007). Gründemann et al. (2005) identified a human EGT 
transporter, named OCTN1. OCTN1 is required for EGT transport into cells, as the plasma 
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membrane is otherwise impenetrable for EGT. Thus OCTN1 abundance correlates with cellular 
EGT content. Increased OCTN1 abundance has been demonstrated in erythrocyte progenitor 
cells, in fetal liver and bone marrow, ileum, trachea, kidney, cerebellum and lung, which have 
been associated with high intracellular EGT concentration. Thus, OCTN1 expression is a reliable 
indicator of EGT activity in human cells (Gründemann, 2012). 
Various studies have been carried out on the antioxidant effects of EGT in animal cells. Aruoma 
et al. (1999) demonstrated that EGT protected against H2O2 induced cell death and peroxynitrite 
(ONOO
−
) induced DNA damage in a human neuronal hybridoma cell line (N-18-RE-105). 
Deiana et al. (2004) reported that oral administration of EGT to rats protected against ferric-
nitrilotriacetate induced peroxidation of fatty acids in the kidney and liver. Furthermore, 
administration of EGT conserved the concentrations of α-tocopherol and glutathione in the 
kidney and liver. Markova et al. (2009) demonstrated that skin cells are capable of internalising 
and accumulating EGT via the OCTN1 transporter. Cells with accumulated EGT had reduced 
levels ROS and resistance to UV mediated oxidative stress. Disruption of the OCTN1 transporter 
in a HeLa cell line resulted in increased mitochondrial DNA damage, protein oxidation and lipid 
peroxidation  (Paul and Snyder, 2010). EGT has also been demonstrated to protect against the 
effects of cisplatin in neuronal cells (Song et al., 2010). EGT has therefore been demonstrated to 
be capable of protecting animal cells from oxidative damage. 
EGT also has potential as a biomarker for human disease. Hatano et al. (2014) reported that 
levels of EGT are significantly decreased in the serum of patients with Parkinson’s disease 
compared to healthy controls. Decreased EGT levels in blood are also associated with the onset 
of dementia (Cheah et al., 2016). Conversely, increased levels of EGT were detected in the 
brains of infants who died from sudden infant death syndrome (Graham et al., 2016). 
EGT has been reported to be present in a variety of plants (Ey et al., 2007). EGT has been 
demonstrated to accumulate in plants from EGT producing symbiotic microorganisms. In 
Gastrodia elata, EGT concentrations were found to correlate with the levels of EGT biosynthesis 
in the symbiotic fungus Armillaria mellea. EGT levels in G. elata were increased in actively 
growing tissues, indicating EGT is actively transported within the plant to specific tissues where 
it is needed (Park et al., 2010). An unusual function for EGT was demonstrated in G. elata by 
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Guo et al. (2016). It was shown that the biosynthesis of the secondary metabolite 
gastrolatathioneine uses EGT as a precursor. Thus, symbiotic fungi produce EGT, where it is 
taken up by G. elata and modified into the final product, gastrolatathioneine. Gastrolatathioneine 
can therefore be said to be co-produced by plant and fungus and represents the first EGT 
derivative isolated from plant or animal. 
1.8.2  EGT biosynthesis in bacteria 
The first demonstration of EGT biosynthesis was made by Seebeck (2010), who identified a five 
gene cluster (egtA-E) which encoded genes for EGT production in Mycobacteria smegmatis. 
EGT biosynthesis in M. smegmatis is initiated by trimethylation of the NH2 group of histidine by 
EgtD, a SAM-dependant histidine methyltransferase, to yield hercynine. Hercynine is then 
processed by EgtB, a sulphoxide synthase, which catalyses iron(II)-dependant oxidative 
sulphurisation to conjugate γ-glutamylcysteine to the imidazole side chain of hercynine. The 
product of this sulpurisation step, γ-glutamylhercynylcysteine sulphoxide, is processed by EgtC, 
a glutamine amindotransferase, which cleaves the γ-glutamyl residue to yield hercynylcysteine 
sulphoxide. Hercynylcysteine sulphoxide is then processed by a cysteine desulphurase (EgtE) to 
produce EGT (Figure 1.10). egtA encodes for a γ-glutamylcysteine synthase, which is predicted 
to provide the substrate for EgtB mediated sulphurisation.  
The crystal structures of EgtD, EgtB and EgtC have all been elucidated (Vit et al., 2014, 2015; 
Goncharenko et al., 2015), furthering the understanding of the EGT biosynthetic process. EgtD 
catalyses the first step in EGT biosynthesis, the tri-N-methylation of histidine. While 
methyltransferases are a well characterised class of enzymes, methyltransferases like EgtD that 
catalyze the transfer of three methyl groups to the same substrate are less well understood. 
Diphthine synthases are an example of a well characterised methyltransferase which catalyse 
trimethylation (Kishishita et al., 2008). However diphthine synthases trimethylate proteins and 
have no discernible sequence homology with EgtD. Furthermore, diphthine synthases elute from 
size-exclusion chromatography as homodimers, while EgtB elutes as a monomer. The closest 
EgtD homologue with known function is EasF (24% sequence identity to EgtD), which catalyses 
the N(α)-methylation of dimethylallyl tryptophan in ergot alkaloid biosynthesis in Claviceps 
species. However, the crystal structure of EasF has not been determined. The closest homolog 
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(16 % sequence identity) to EgtD with a resolved crystal structure is human methyltransferase 
Ad-003, which catalyses the dimethylation of ribosomal proteins at N-terminal proline residues 
(Webb et al., 2010; Vit et al., 2014). EgtD therefore appears to be quite unique in structure, 
indicating the tri-N-methylation of histidine is a specialised enzymatic reaction. 
 
Figure 1.10. EGT biosynthesis in bacteria as elucidated from M. smegmatis (Seebeck, 2010). 
EgtB catalyses O2-dependent C-S bond formation between γ-glutamylcysteine and hercynine in 
EGT biosynthesis. The catalytic activity and the architecture of EgtB are distinct from known 
sulphur transferases or thiol dioxygenases. Together with OvoA, an enzyme involved in ovothiol 
biosynthesis (Song et al., 2014), EgtB represents a distinct class of C-S bond forming catalysts 
known as sulphoxide synthases. The crystal structure of EgtB in complex with γ-glutamyl 
cysteine and hercynine revealed that the two substrates and three histidine residues serve as 
ligands in an octahedral iron binding site. This active site geometry is consistent with a catalytic 
mechanism in which C-S bond formation is initiated by an iron(III)-complexed thiol radical 
attacking the imidazole ring of hercynine (Goncharenko et al., 2015). 
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EgtC catalyses the cleavage of the γ-glutamyl tail from γ-glutamyl hercynylcysteine sulphoxide. 
The set of active site residues that define substrate specificity in EgtC are highly conserved, even 
in homologs that are not involved in EGT production. This suggests that these homologs 
transform substrates with significant similarity to γ-glutamyl hercynylcysteine sulphoxide. This 
indicates that the common ancestor of EgtC may have developed for a purpose other than EGT 
production (Vit et al., 2015).  
EgtE, a PLP-dependant cysteine desulphurase, catalyses the final step of EGT biosynthesis: 
conversion of hercynylcysteine sulphoxide in EGT. This reaction involves the cleavage of the 
hercynylcysteine sulphoxide cysteine residue at the sulphur atom. In the original in vitro 
reconstitution of EGT biosynthesis, Seebeck (2010) could not use EgtE to catalyse the final step 
due to solubility issues with the recombinant protein. As egtA was predicted to code for a PLP-
dependant β-lyase, an unrelated β-lyase from Erwinia tasmaniensis was substituted for EgtE. 
This unrelated β-lyase was capable of completing EGT biosynthesis, indicating that the final step 
of EGT can be carried out by non-specific PLP-binding β-lyases. Song et al. (2015) confirmed 
that M. smegmatis EgtE could catalyse the final step of EGT biosynthesis. 
egtA encodes for a γ-glutamylcysteine synthase and is predicted to contribute to EGT 
biosynthesis by biosynthesising the γ-glutamyl cysteine needed for iron(II)-dependant oxidative 
sulphurisation catalysed by EgtB. However, whether EgtA is necessary for EGT biosynthesis 
appears to vary between species. Deletion of egtA in Mycobacterium tuberculosis and M. 
smegmatis resulted in abrogation of EGT biosynthesis (Saini et al., 2016; Singh et al., 2016). 
However, a ΔegtA mutant in Streptomyces coelicolor A3(2) retained EGT production, albeit at a 
reduced level (Nakajima et al., 2015). Thus some bacterial species may be able to compensate 
for EgtA absence and complete EGT biosynthesis. This may be through an unrelated γ-
glutamylcysteine synthase or through the use of cysteine as a sulphur donor. 
In a study of the evolutionary history of EGT biosynthetic genes, Jones et al. (2014) reported that 
the 5 gene egtA-E cluster is specific for the Actinobacteria. However, EgtD and EgtB were found 
in a number of diverse phyla. Cyanobacteria are known producers of EGT (Pfeiffer et al., 2011), 
however they lack EgtA, EgtC and EgtE. This suggests that EgtD and EgtB are essential for EGT 
production in bacteria, while EgtA, EgtC and EgtE are dispensable. Presumably the activity of 
EgtA, EgtC and EgtE can be carried out by other enzymes, as demonstrated by the substitution of 
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an unrelated PLP-binding β-lyase for EgtE (Seebeck, 2010) and the observation that EGT 
biosynthesis proceeds in the absence in EgtA in S. coelicolor A3(2) (Nakajima et al., 2015).  The 
importance of EgtD in bacterial EGT biosynthesis is underlined by the many studies which have 
targeted egtD for deletion or disruption in order to create an EGT null mutant (Saini et al. 2016; 
Nakajima et al., 2015; Alamgir et al., 2015; Sao Emani et al., 2013). 
1.8.3  EGT biosynthesis in fungi 
EGT biosynthesis in fungi has been studied by Bello et al. (2012) and Pluskal et al. (2014) in 
Neurospora crassa and Schizosaccharomyces pombe, respectively. Bello et al. (2012) identified 
the first fungal EGT biosynthetic enzyme in N. crassa. Through bioinformatic anaylsis, they 
determined the gene NCU04343 contain domains from both bacterial EgtB and EgtD. This was 
consistent with previous observations of a fusion gene in fungal homologs of EGT biosynthetic 
genes (Seebeck, 2010). To determine if this gene was responsible for EGT biosynthesis in N. 
crassa, a gene deletion mutant was obtained from the Fungal Genetics Stock Centre (Kansas 
City, USA). HPLC analysis determined that the N. crassa NCU04343 mutant was incapable of 
producing EGT. NCU04343 was thus determined to be the first biosynthetic gene in EGT 
biosynthesis and was renamed egt-1. Pluskal et al. (2014) demonstrated that deletion of the egt-1 
homolog in S. pombe, egt1, also abrogated EGT production. This was further confirmation of the 
importance of egt-1 orthologs in fungal EGT biosynthesis.  
Work by Ishikawa et al. (1974) demonstrated that cysteine is the sulphur donor for EGT 
biosynthesis in fungi, as opposed to γ-glutamylcysteine utilised by bacteria (Seebeck, 2010). It 
has been reported that fungi do not contain orthlogs of bacterial EgtA or EgtC (Jones et al., 
2014). This would indicate that there is no γ-glutamylcysteine synthase to produce γ-
glutamylcysteine, or a glutamate aminotransferase to cleave the γ-glutamyl residue. This 
supports the data from Ishikawa et al. (1974) and indicates that fungal production of 
hercynylcysteine sulphoxide is catalysed by egt-1 using cysteine as a sulphur donor, without the 
need for the intermediate γ-glutamyl hercynylcysteine sulphoxide (Figure 1.11). 
As egt-1 catalyses the formation of hercynylcysteine sulphoxide, this indicated that only one 
other enzyme was required to complete EGT biosynthesis in fungi. Pluskal et al. (2014) 
investigated candidates for this second EGT biosynthetic enzyme by identifying genes encoding 
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PLP-dependant cysteine desulphurases. Four putative cysteine desulphurases were identified and 
deletion mutants for these were obtained from the Bioneer haploid deletion library (Kim et al., 
2010). Only one of the four genes deletions, ΔSPBC660.12c, demonstrated a significant decrease 
in EGT levels. Concurrently, ΔSPBC660.12c displayed an increase in the intermediate 
hercynylcysteine sulphoxide. This demonstrated that SPBC660.12c catalyses the final step in 
EGT biosynthesis and was renamed egt2. Importantly, deletion of egt2 did not abrogate EGT 
production; instead Δegt2 retained trace amounts of EGT. This demonstrates that, unlike egt1, 
egt2 is not essential for EGT biosynthesis, which agrees with findings from Seebeck (2010) who 
demonstrated that EgtE activity could be substituted by a non-specific enzyme.  
 
Figure 1.11. EGT biosynthesis in fungi and bacteria. Fungal enzymes are shown in red, bacterial 
enzymes are shown in blue. The fungal EGT pathway contains two enzymes, uses cysteine as a 
sulphur source and does not produce the intermediate γ-glutamyl hercynylcysteine sulphoxide.  
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Thus EGT bioynthesis in fungi was demonstrated to be carried out by 2 enzymes. The first, Egt-
1, is a fusion protein of bacterial EgtB and EgtD and catalyses the tri-N-methylation of histidine 
to form hercynine, followed by iron(II)-dependant oxidative sulphurisation to conjugate cysteine 
to the imidazole side chain of hercynine. Egt-1 yields hercynylcysteine sulphoxide, which is then 
processed by the second enzyme, Egt2. Egt2 is a PLP-dependant cysteine desulphurase that 
catalyses the cleavage of the cysteine residue of hercynylcysteine sulphoxide at the sulphur atom 
to yield EGT (Figure 1.11). 
Jones et al. (2014) investigated the evolutionary origins and distribution of EGT biosynthetic 
genes in fungi. Orthologs of N. crassa Egt-1 were identified in 73 fungal species. Egt-1 was 
absent in all members of Saccharomycotina analysed, indicating loss of Egt-1 occured before 
speciation occurred. Egt-1 was also absent in two members of the basidiomycetes: 
Moniliophthora perniciosa and Malassezia globosa. Due to the phylogenetic distance between 
M. perniciosa and M. globosa it is suggested that Egt-1 was lost independently in the two 
species. An Egt-1 ortholog was detected in all other members of the Basidiomycetes analysed, 
and in all members of the Ascomycetes, excepting members of Saccharomycotina.  
All EgtB and EgtD domains in fungi were found in the form of the fusion protein Egt-1. 
However, Jones et al. (2014) reported that two independent fusions EgtB and EgtD have 
occurred in bacteria. Jones et al. were unable to determine if an interkingdom horizontal gene 
transfer event happened and thus were unable to unambiguously determine the evolutionary 
origins of EGT biosynthetic genes. Three possible scenarios for the origin of EGT biosynthesis 
were thus proposed. First, that EGT biosynthesis evolved in fungi originally and Egt-1 was 
transferred to bacteria, followed by gene fission to form EgtB and EgtD. Second, that EGT 
biosynthesis evolved in bacteria first and transferred to the last fungal ancestor in a gene fusion 
event to form Egt-1. Finally, EGT biosynthesis may have evolved independently in bacteria and 
fungi. This last option is considered unlikely however, given the similarity in the gene sequences 
and pathways involved in fungal and bacterial EGT biosynthesis. 
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1.8.4  EGT function in bacteria and fungi 
EGT functionality in bacteria and fungi capable of producing it has been investigated by gene 
deletion or gene disruption studies. By targeting egtD in bacteria and egt-1 fungi, EGT 
biosynthesis can be abolished and EGT function can be inferred from any phenotypes observed.  
A Streptomyces coelicolor A3(2) ΔegtD mutant displayed abrogation of EGT production and 
was sensitive to the exogenous ROS inducers, H2O2 and cumene hydroperoxide. Abrogation of 
EGT in S. coelicolor A3(2) ΔegtD resulted in a concurrent increase in the levels of another low 
molecular mass thiol, mycothiol. Abrogation of mycothiol production had no effect on EGT 
production in Streptomyces coelicolor A3(2) (Nakajima et al., 2015). This indicates cross-talk 
between the two low molecular mass ROS scavengers. In M. smegmatis, egtD deletion also 
results in sensitivity to exogenous ROS. However, abrogation of EGT did not result in an 
increase in mycothiol (Sao Emani et al., 2013). Instead, a mycothiol deficient mutant 
demonstrated an increase in EGT (Ta et al., 2011). Once again cross-talk of low molecular mass 
thiols is demonstrated; however the priority appears to be reversed in M. smegmatis. 
Interestingly, Sao Emani et al. (2013) also reported that EGT is secreted into the culture medium 
in large quantities by M. smegmatis, indicating a possibly extracellular role for EGT. Saini et al. 
(2016) reported a similar EGT-mycothiol cross-talk in Mycobacterium tuberculosis, whereby 
EGT levels are increased in a mycothiol null mutant, but mycothiol is unaffected by absence of 
EGT. EGT protects M. tuberculosis against exogenous ROS inducing agents (H2O2, paraquat, 
menadione and cumene hydroperoxide) as observed elsewhere. EGT also contributed to 
antibacterial drug resistance in M. tuberculosis. 
Richard-Greenblatt et al. (2015) demonstrated that EGT is important for M. tuberculosis viability 
during starvation. EGT levels were demonstrated to increase significantly in M. tuberculosis 
when grown under starvation conditions. An M. tuberculosis ΔegtD strain demonstrated 
decreased viability under starvation conditions compared to wild-type and complemented strains. 
EGT was also demonstrated to contribute to the virulence of M. tuberculosis (Richard-Greenblatt 
et al., 2015; Saini et al., 2016). In Methylobacterium aquaticum, abrogated EGT production 
resulted in sensitivity to heat shock, UV radiation and sunlight. Curiously, the M. aquaticum null 
mutant showed increased resistance to H2O2 compared to wild-type. Levels of GSH were 
demonstrated to be increased in the EGT null mutant compared to wild-type and it was 
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speculated that this may explain the observed increase in resistance (Alamgir et al., 2015). Zhao 
et al. (2015) demonstrated a particularly novel role for EGT in Streptomyces lincolnensis. EGT, 
in conjunction with mycothiol, was demonstrated to be involved with the biosynthesis of the 
antibiotic lincomycin A. EGT serves as a carrier, via S-glycosylation, for the lincomycin A 
precursor lincosamine and mediates its condensation with a N -methylated 4-propyl- L –proline 
moiety. Mycothiol then associates with this newly formed intermediate via a second S-
glycosylation step to act as a sulphur donor. This represents the first biochemical evidence of 
EGT use in enzymatic reactions. 
To date, EGT function in fungi has been best analysed in N. crassa. Bello et al. (2012, 2014) 
used a Δegt-1 mutant to investigate EGT functionality in N. crassa. Analysis of conidial 
germination and viability following exposure to cupric oxide, menadione and UV light (254 nm) 
showed no significant differences between the wild-type and Δegt-1 strains. EGT was also 
demonstrated to play no role in protecting mycelia from cupric oxide toxicity. However, Δegt-1 
conidia showed a significant reduction in germination compared to wild-type when exposed to 
tert-butyl hydroperoxide. EGT was also demonstrated to contribute to N. crassa conidial 
longevity. Furthermore, the Δegt-1 mutant produced significantly less conidia compared to wild-
type. EGT therefore appears to play an important role in conidiation and conidial health in N. 
crassa. However no role for EGT in the mycelia of N. crassa was detected. 
Pluskal et al. (2014) generated an EGT null mutant (Δegt1) and a strain producing trace amounts 
of EGT (Δegt2) in S. pombe. Phenotypic analysis of these strains revealed no differences 
between the mutants and wild-type. EGT was demonstrated to play no role in protecting S. 
pombe from H2O2 and tert-butyl hydroperoxide. Metabolic analysis revealed no changes in the 
levels of metabolites in either strains, except for EGT itself and hercynylcysteine sulphoxide in 
Δegt2. Thus, no role for EGT in S. pombe has been characterised. 
The physiological function of EGT therefore appears to be both varied and ill-defined. There is 
strong evidence that EGT functions as an antioxidant, as many of the EGT null mutants display 
sensitivity to exogenous sources of ROS. However, as demonstrated in S. pombe, this is not 
always the case. Additionally, Bello et al. (2012, 2014) demonstrated that EGT only functions as 
an antioxidant in conidia, suggesting EGT function is required at specific stages of the N. crassa 
life cycle. EGT also demonstrated protection against antibacterial drugs, heat shock and UV light 
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(In M. aquaticum, but not N. crassa). EGT also appears to contribute to the virulence and 
starvation response of M. tuberculosis, while a novel role for EGT in contributing to lincomycin 
A biosynthesis in S. lincolnensis was also described. EGT function therefore appears to vary 
between species, while information of EGT function in filamentous fungi is limited to the studies 
from Bello et al. (2012, 2014). 
1.9   Thesis rationale and objectives 
EGT is a low molecular mass thiol produced by fungi and select bacteria that is utilised by plants 
and animals. EGT function has been investigated in bacteria and fungi and appears to play a 
variety of roles, oxidative stress defence the most prominent amongst them (Cheah and 
Halliwell, 2012). Two genes have been demonstrated to be responsible for EGT biosynthesis in 
fungi. The first, egt-1 in N. crassa, encodes for a fusion protein with methylation and sulphoxide 
synthase domains (Bello et al., 2012). The second, egt2 in S. pombe, encodes for a PLP-
dependant cysteine desulphurase (Pluskal et al., 2014). 
EGT was first identified in A. fumigatus by Gallagher et al. (2012) in the gliotoxin null mutant 
ΔgliK and its function in A. fumigatus has yet to be characterised. ΔgliK, in addition to abrogated 
gliotoxin biosynthesis demonstrated a range of phenotypes including: gliotoxin sensitivity, H2O2 
sensitivity, decreased gliotoxin efflux, increased levels of fumitremorgins and increased levels of 
EGT. Owens et al. (2015) later added to this knowledge, demonstrating that ΔgliK had reduced 
induction of GliT and perturbed SAM/SAH levels following gliotoxin exposure.  
The observed increase of EGT levels in ΔgliK was of considerable interest as EGT functionality 
in A. fumigatus was not characterised. ΔgliK demonstrated perturbations in oxidative stress 
defence, SAM/SAH levels and gliotoxin biosynthesis. Potentially, through SAM-dependant 
trimethylation and sulphurisation, EGT biosynthesis is linked metabolically with the same 
systems affected in ΔgliK. Additionally, the putative role of EGT as an antioxidant could be 
linked to H2O2 stress observed in ΔgliK. Thus EGT could be speculated to have a significant role 
in A. fumigatus adaption to gliK deletion. As such, further study of EGT function in A. fumigatus 
was required. 
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Therefore, the objectives of the work presented in this thesis were as follows: 
(i) Identify and delete the genes responsible for EGT biosynthesis in A. fumigatus. 
(ii) Characterise the function of EGT in A. fumigatus through the use of an EGT null 
mutant. 
(iii) Investigate the global systems affected by EGT absence in A. fumigatus through 
phenotypic and metabolomic analysis of the EGT null mutant. 
(iv) Investigate the impact of EGT absence on the A. fumigatus proteome through label-
free quantitative proteomic analysis. 
 
 
 
 
  
 
 
 
 
 
 
 
 
Chapter 2 
Materials and Methods 
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2.1  Materials 
All chemicals were purchased from Sigma-Aldrich Chemical Co. Ltd. (U.K.), unless otherwise 
stated. 
2.1.1  A. fumigatus Agars and Media 
2.1.1.1  Aspergillus Minimal Media 
2.1.1.1.1 Aspergillus Trace Elements 
Na2B4O7.10H2O (0.04 g), CuSO4.5H2O (0.4 g), FeSO4.7H2O (0.8 g), Na2MoO4.H2O (0.8 g) and 
ZnSO4.7H2 (8 g) were dissolved in deionised H2O (800 ml) in the order listed. The solution was 
made up to 1 L with deionised H2O. The solution was filter sterilised into 50 ml aliquots and 
stored at -20 °C.  
2.1.1.1.2 50 X Aspergillus Salt Solution 
KCl (26 g), MgSO4.7H2O (26 g) and KH2PO4 (76 g) were dissolved in 800 ml dH2O. The 
solution was made up to 1 L with dH2O and autoclaved at 121 °C for 15 min. The solution was 
then stored at room temperature. 
2.1.1.1.3 100 X Ammonium Tartrate 
Ammonium Tartrate (92 g) was dissolved in 1 L of dH2O and autoclaved at 121 °C for 15 min. 
The solution was stored at room temperature.  
2.1.1.1.4 Aspergillus Minimal Media (AMM) Liquid 
100 X ammonium tartrate (10 ml) (Section 2.1.1.1.3), 50 X Aspergillus salt solution (20 ml) 
(Section 2.1.1.1.2), 1 ml Aspergillus Trace elements (Section 2.1.1.1.1) and glucose (10 g) were 
added to 800 ml dH2O. The pH was adjusted to 6.8 and the solution was made up to 1 L with 
dH2O. The solution was autoclaved at 105 °C for 30 min and stored at room temperature. 
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2.1.1.1.5 Aspergillus Minimal Media (AMM) Agar 
100 X ammonium tartrate (10 ml) (Section 2.1.1.1.3), 50 X Aspergillus salt solution (20 ml) 
(Section 2.1.1.1.2), 1 ml Aspergillus Trace elements (Section 2.1.1.1.1) and glucose (10 g) were 
added to 800 ml dH2O. The pH was adjusted to 6.8. Agar (18 g) (Fischer Scientific, UK) was 
added to the solution and made up to 1 L with dH2O.  The solution was autoclaved at 105 °C for 
30 min and allowed to cool to ~50 °C before being poured into 90 mm petri dishes under sterile 
conditions. The plates were allowed to set and stored at 4 °C. 
2.1.1.2  Malt Extract Agar (MEA) 
Malt extract agar powder (50 g) (Oxoid Ltd, Hants., England) was dissolved in 1 L of dH2O and 
autoclaved at 115 °C for 10 min and allowed to cool to ~50 °C before being poured into 90 mm 
petri dishes under sterile conditions. The plates were allowed to set and stored at 4 °C. 
2.1.1.3  Sabouraud Dextrose Broth 
Sabouraud Dextrose broth powder (35 g) (Oxoid Ltd, Hants., England) was dissolved in 1 L of 
dH2O and autoclaved at 121 °C for 15 min. The media was stored at room temperature. 
2.1.1.4  Czapek-Dox Broth 
Czapek-Dox powder (35 g) (BD biosciences) was dissolved in 1 L of dH2O and autoclaved at 
121 °C for 15 min. The media was stored at room temperature. 
2.1.1.5  Regeneration Agar 
2.1.1.5.1 1.8 % (w/v) Regeneration Agar 
100 X ammonium tartrate (10 ml) (Section 2.1.1.1.3), 50 X Aspergillus salt solution (20 ml) 
(Section 2.1.1.1.2), 1 ml Aspergillus Trace elements (Section 2.1.1.1.1), sucrose (342 g) and 
glucose (10 g) were added to 800 ml dH2O. The pH was adjusted to 6.8. Agar (18 g) (Fischer 
Scientific, UK) was added to the solution and made up to 1 L with dH2O. The solution was 
autoclaved at 105 °C for 30 min and allowed to cool to ~50 °C before being poured into 90 mm 
petri dishes under sterile conditions. The plates were allowed to set and stored at 4 °C. 
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2.1.1.5.2 0.7 % (w/v) Regeneration Agar 
100 X ammonium tartrate (10 ml) (Section 2.1.1.1.3), 50 X Aspergillus salt solution (20 ml) 
(Section 2.1.1.1.2), 1 ml Aspergillus Trace elements (Section 2.1.1.1.1), sucrose (342 g) and 
glucose (10 g) were added to 800 ml dH2O. The pH was adjusted to 6.8. Agar (7 g) (Fischer 
Scientific, UK) was added to the solution and made up to 1 L with dH2O.  The solution was 
autoclaved at 105 °C for 30 min and allowed to cool to ~50 °C before being poured into 90 mm 
petri dishes under sterile conditions. The plates were allowed to set and stored at 4 °C. 
2.1.2  Escherichia coli Agars and Media 
2.1.2.1  Luria-Bertani Broth (LB broth) 
LB broth powder (25 g) (Difco, Maryland, USA) was dissolved in 1 L dH2O and autoclaved at 
121 °C for 15 min. The media was stored at room temperature. 
2.1.2.2  Luria-Bertani Agar (LB agar) 
LB broth powder (25 g) (Difco, Maryland, USA) was dissolved in 800 L dH2O. 18 g agar (Fisher 
Scientific, UK) was dissolved in the solution and the volume made up to 1 L with dH2O. The 
solution was autoclaved at 121 °C for 15 min and allowed to cool to ~50 °C before being poured 
into 90 mm petri dishes under sterile conditions. The plates were allowed to set and stored at 4 
°C. 
2.1.2.3  Super Optimal Catabolite repression (SOC) media 
SOC media was supplied with the One Shot® TOP10 Chemically Competent E. coli kit 
(Invitrogen). 
2.1.3  Solutions for pH Adjustment 
2.1.3.1  5 M Hydrochloric Acid (HCl) 
HCl (43.64 ml) was added to 56.36 ml dH2O, the solution was then stored at room temperature. 
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2.1.3.2  5 M Sodium Hydroxide (NaOH) 
NaOH pellets (20 g) were dissolved in 100 ml dH2O, the solution was then stored at room 
temperature. 
2.1.4  Phosphate Buffered Saline (PBS) 
10 PBS tablets (Oxoid, Cambridge, UK) were dissolved in 1 L dH2O. The solution was 
autoclaved at 121 
o
C for 15 min and stored at room temperature. 
2.1.5  Phosphate Buffered Saline-Tween 20 (PBST) 
Tween-20 (500 µl) was added to 1 L PBS (Section 2.1.4). The solution was autoclaved at 121 
o
C 
for 15 min and stored at room temperature. 
2.1.6  Antibiotics and Supplements 
All antibiotics and supplements were prepared as stock solutions in water or methanol and filter 
sterilised. All were stored at – 20 °C. Further information is provided in Table 2.1. 
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Table 2.1. Antibiotics and supplements used during this study. 
Condition Tested Reagent Used Stock Concentration Tested Concentration 
Oxidative Stress H2O2 1 M (in H2O) 1 – 4 mM 
Oxidative Stress Menadione 1 mM (in MeOH) 20 – 80 µM 
Oxidative Stress Diamide 100 mM (in H2O) 1.25 – 1.75 mM 
Gliotoxin Sensitivity Gliotoxin 1 mg/ml (in MeOH) 5 – 20 µg/ml 
Cell Wall Stress Congo Red 5 mg/ml (in H2O) 10 – 50 µg/ml 
Cell Wall Stress Calcofluor White 1 mg/ml (in H2O) 20 – 100 µg/ml 
Histidine Sensitivity Histidine 200 mM (in Molten AMM Agar) 200 mM 
Phenylalanine Sensitivity  Phenylalanine 150 mM (in Molten AMM Agar) 150 mM 
Pyrithiamine Resistance Pyrithiamine hydrobromide 0.1 mg/ml (in H2O) 0.1 µg/ml 
Hygromycin Resistance Hygromycin B 100 mg/ml (in H2O) 100 µg/ml 
Ampicillin Resistance Ampicillin 100 mg/ml (in H2O) 100 µg/ml 
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2.1.7  Molecular Biology Reagents 
2.1.7.1  50 X Tris-Acetate Buffer (TAE) 
Trizma base (242 g) and Ethylenediaminetetraacetic acid (EDTA) disodium salt dihydrate (18.61 
g) was added to 57.1 ml glacial acetic acid. The volume was adjusted to 1 L with dH2O. The 
solution was stored at room temperature. 
2.1.7.2  1 X Tris-Acetate Buffer (TAE) 
50 X TAE (20 ml) (Section 2.1.7.1) was added to dH2O (980 ml). The solution was stored at 
room temperature. 
2.1.7.3  Ethidium Bromide 
Ethidium Bromide (Sigma-Aldrich) was supplied at 1 mg/ml of which 2.5 µl was used per 100 
ml agarose gel. 
2.1.7.4  6 X DNA Loading Dye 
Loading dye (Promega, Southampton, UK) was used at the concentration supplied. 
2.1.7.5  Agarose Gels 
2.1.7.5.1 1 % (w/v) Agarose Gel 
Agarose powder (1 g) was dissolved into 100 ml 1 X TAE (Section 2.1.7.2). This mixture was 
heated in a microwave oven until the agarose had dissolved and the mixture was molten. 
Ethidium Bromide solution (Section 2.1.7.3) was added after pouring the molten solution into a 
cast. The gel was left to set for at least 30 min. 
2.1.7.5.2 0.7 % (w/v) Agarose Gel 
Agarose powder (0.7 g) was dissolved into 100 ml 1 X TAE (Section 2.1.7.2). This mixture was 
heated in a microwave oven until the agarose had dissolved and the mixture was molten. 
Ethidium Bromide solution (Section 2.1.7.3) was added after pouring the molten solution into a 
cast. The gel was left to set for at least 30 min. 
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2.1.7.6  Molecular Weight Ladders for Agarose Gel Electrophoresis  
Molecular weight ladders used in agarose gel electrophoresis are displayed in Figure 2.1. 
 
Figure 2.1. Molecular weight ladders used during this study. (A) New England Biolabs (NEB) 1 
kb DNA ladder. (B) Sigma 50 bp DNA Step Ladder. (C) Roche Molecular Weight Ladder VII, 
Digoxigenin (DIG) labeled. 
2.1.8  Aspergillus Transformation Reagents 
2.1.8.1  0.7 M Potassium Chloride 
KCl (13.05 g) was dissolved in 250 ml dH2O. The solution was autoclaved at 121
 o
C for 15 min 
and stored at room temperature. 
2.1.8.2  25 mM Potassium Phosphate Monobasic 
KH2PO4 (1.7 g) was dissolved in 500 ml dH2O. 
2.1.8.3  25 mM Potassium Phosphate Dibasic 
K2HPO4 (0.87 g) was dissolved in 200 ml dH2O. 
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2.1.8.4  Lysis Buffer 
KCl (26.1 g) was dissolved in 25 mM KH2PO4 (350 ml) (Section 2.1.8.2). The pH was adjusted 
to pH 5.8 with 25 mM K2HPO4 (Section 2.1.8.3). The solution was brought to 500 ml with 
dH2O. The solution was autoclaved at 121 
o
C for 15 min and stored at room temperature. 
2.1.8.5  Lytic Enzymes solution for protoplast generation 
Lytic enzymes from Trichoderma harzianum (0.9 g) were added to 30 ml lysis buffer (Section 
2.1.8.4) and filter sterilised with a 0.2 μm filter. 
2.1.8.6  Buffer L6 
Tris-HCl (0.484 g), sorbitol (72.88 g) and CaCl2.6H2O (0.876 g) were dissolved in dH2O. The 
pH was adjusted to pH 7.5 and the final volume adjusted to 400 ml with dH2O. The solution was 
autoclaved at 121 
o
C for 15 min and stored at room temperature. 
2.1.8.7  Buffer L7 
Polyethylene glycol (PEG) 6,000 (60 g) was dissolved in dH2O (40 ml) under gentle heat. Tris-
HCl (0.157 g) and CaCl2.6H2O (0.219 g) were then dissolved in the solution. The solution was 
removed from heat and pH adjusted to 7.5. The solution was autoclaved at 121 
o
C for 15 min and 
stored at room temperature.  
2.1.9  Southern Blot Reagents 
2.1.9.1  Southern Transfer Buffer 
NaOH (16 g) and NaCl (35.07 g) were dissolved in 1 L of dH2O.  
2.1.9.2  20 x SSC 
NaCl (175.3) and sodium citrate (88.2 g) were dissolved in dH2O. The pH was adjusted to pH 7 
and the final volume made up to 1 L. 
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2.1.9.3  2 x SSC 
20 X SSC (100 ml) (Section 2.1.9.2) was added to 900 ml dH2O and was stored at room 
temperature. 
2.1.9.4  10 % (w/v) SDS  
SDS (10 g) was dissolved in 1 L dH2O. The solution was stored at room temperature.  
2.1.9.5   0.1 % (w/v) SDS / 1 X SSC 
20 X SSC (50 ml) (Section 2.1.9.2) and 10 % (w/v) SDS (10 ml) (Section 2.1.9.4) were 
dissolved in 1 L dH2O. The solution was stored at room temperature.  
2.1.9.6  Digoxigenin (DIG) Detection Buffers  
2.1.9.6.1 10 % (w/v) Lauroylsarcosine 
Lauroylsarcosine (1 g) was dissolved in 10 ml dH2O. 
2.1.9.6.2 Membrane Pre-hybridization Buffer 
SDS (35 g), formamide (250 ml), blocking reagent (10 g) (Roche Applied Bioscience, 
Mannheim, Germany) and 10 % Lauroylsarcosine (w/v) (5 ml) (Section 2.1.9.6.1) were 
dissolved in 500 ml dH2O and stored at 4 
o
C. The solution was pre-heated at 65 
o
C for 15 min 
before use.  
2.1.9.6.3 DIG Buffer 1 (10 X) 
Maleic Acid (58 g) and NaCl (43.75 g) were dissolved in 400 ml dH2O. The pH was adjusted to 
pH 7.5 before the final volume was adjusted to 500 ml. The solution was autoclaved at 121 
o
C 
for 15 min and stored at room temperature.  
2.1.9.6.4 DIG Buffer 1 (1 X) 
100 ml 10 X DIG buffer 1 (Section 2.1.9.6.3) was added to 900 ml dH2O and stored at room 
temperature. 
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2.1.9.6.5 DIG Buffer 2 
Blocking reagent (0.4 g) (Roche Applied Bioscience, Mannheim, Germany) was dissolved in 40 
ml 1 X DIG buffer 1 (Section 2.1.9.6.4) under gentle heat. The solution was prepared fresh on 
the day. 
2.1.9.6.6 DIG Buffer 3 
Tris-HCl (1.58 g), NaCl (0.58 g) and MgCl2.6H2O (1.02 g) were dissolved in dH2O. The pH was 
adjusted to pH 9.5 and the final volume adjusted 100 ml. The solution was filter sterilized 
through a 0.2 µm filter and stored at room temperature. 
2.1.9.6.7 DIG Wash Buffer 
Tween 20 (600 µl) was dissolved in 1X DIG buffer 1 (200 ml), filter sterilized through a 0.2 µm 
filter and stored at room temperature.  
2.1.9.6.8 Anti-Digoxigenin-Alkaline Phosphatase (AP), Fab fragment conjugate 
Anti-Digoxigenin-AP, Fab fragments (Roche, Mannheim, Germany) (2 µl) was added to 20 ml 
DIG buffer 2 (Section 2.1.9.6.5). 
2.1.9.6.9 Chemiluminescent substrate phosphatase detection (CSPD) Substrate 
CSPD (50 μl) (Roche, Mannheim, Germany) was added to 5 ml DIG Buffer 3 (Section 
2.1.9.6.6). 
2.1.9.6.10 DIG-labelled deoxynucleotide Triphosphates (dNTPs) 
Pre-mixed DIG-labelled dNTPs were purchased from Roche and used according to the 
manufacturers guidelines for the generation of DIG-labelled probes for Southern detection 
probes. 
2.1.9.6.11 Developer Solution 
Developer (Kodak) was diluted 1/4 in dH2O and stored in a tinfoil covered Duran in a dark room. 
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2.1.9.6.12 Fixer Solution 
The fixer solution (Kodak) was diluted 1/5 in dH2O and stored in a tinfoil covered Duran in a 
dark room. 
2.1.10 Reverse-Phase High Performance Liquid Chromatography (RP-HPLC) 
Solvents 
2.1.10.1 HPLC Grade Water with 0.1 % (v/v) Trifluoroacetic Acid (TFA) 
TFA (1 ml) was added to 1 L HPLC Grade water. 
2.1.10.2 HPLC Grade Acetonitrile with 0.1 % (v/v) Trifluoroacetic Acid (TFA) 
TFA (1 ml) was added to 1 L HPLC Grade acetonitrile. 
2.1.11  5’ Iodoacetamidofluorescein (5’-IAF) 
2.1.11.1 20 mg/ml 5’ Iodoacetamidofluorescein (5’-IAF) 
5’-IAF (25 mg) was dissolved in DMSO (1.25 ml). The solution was aliquoted into 200 µl tubes, 
wrapped in tinfoil and stored at -20 
o
C. 
2.1.11.2 3 mg/ml 5’ Iodoacetamidofluorescein (5’-IAF) 
20 mg/ml 5’-IAF (15 µl) (Section 2.1.11.1) was added to DMSO (85 µl) in a 1.5 ml tube covered 
in tinfoil. The tube was kept in the dark at room temperature until needed. 
2.1.12  Protein Analysis Reagents 
2.1.12.1 Whole Protein Lysate Extraction Buffer 
100 mM Tris-HCl (15.7 g), 50 mM NaCl (2.92 g), 20 mM EDTA (5.85 g), 10% (v/v) Glycerol 
(100 ml) was added to 800 ml dH2O and brought into solution. The pH of the solution was 
adjusted to 7.5 and the volume made up to 1 L with dH2O. The solution was autoclaved at 121 
o
C for 15 min and stored at 4 
o
C. PMSF (1 mM) (Section 2.1.12.3) and Pepstatin A (1 µg/ml) 
(Section 2.1.12.4) were added immediately before use. 
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2.1.12.2 A. fumigatus Phosphate Lysis Buffer 
Sodium Phosphate monobasic (1.13 g), Sodium Phosphate dibasic (5.76 g), NaCl (2.92 g), 
EDTA (5.85 g), 10% (v/v) Glycerol (100 ml) was added to 800 ml dH2O and brought into 
solution. The pH of the solution was adjusted to 7.5 and the volume made up to 1 L with dH2O. 
The solution was autoclaved at 121 
o
C for 15 min and stored at 4 
o
C. PMSF (1 mM) (Section 
2.1.12.3) and Pepstatin A (1 µg/ml) (Section 2.1.12.4) were added immediately before use. 
2.1.12.3 100 mM Phenylmethylsulfonyl fluoride (PMSF) 
PMSF (174 mg) was dissolved in 10 ml methanol. The solution was stored at -20 
o
C. 
2.1.12.4 Pepstatin A (1 mg/ml) 
 Pepstatin A (5 mg) was brought to 5 ml with ethanol. The solution was stored at -20 
o
C. 
2.1.12.5 Bradford Solution 
Bradford Reagent (BioRad) was diluted 1/5 in PBS. This was stored at 4 ºC for up to one week. 
2.1.13  Mass Spectrometry Reagents 
2.1.13.1 100 % (w/v) Trichloroacetic acid (TCA) 
Trichloroacetic acid (100 g) was added to 45.5 ml dH2O and dissolved. The solution was stored 
in the dark at 4 
o
C. 
2.1.13.2 50 mM Ammonium bicarbonate  
Ammonium bicarbonate (395 mg) was dissolved in 100 ml of deionised H2O. The solution was 
prepared fresh on day of use. 
2.1.13.3 Protein Resuspension Buffer 
Tris-HCl (1.21 g) was dissolved in 50 ml deionised H2O. 36 g Urea (6 M) and 15.2 g Thiourea (2 
M) were then dissolved. The pH was adjusted to 8.0 and the volume was brought to 100 ml with 
deionised H2O. The solution was filtered with a 0.2 μm filter and stored at room temperature. 
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2.1.13.4 0.5 M Dithiontreitol (DTT) 
DTT (77 mg) was dissolved in 100 mM ammonium bicarbonate (1 ml) (Section 2.1.13.2). The 
solution was prepared fresh on the day of use. 
2.1.13.5 0.55 M Iodoacetamide  
Iodoacetamide (IAA) (50.8 mg) was dissolved in 100 mM ammonium bicarbonate (0.5 ml) 
(Section 2.1.13.2). The solution was prepared fresh on the day of use. 
2.1.13.6 Trypsin 
Immediately before use a vial containing 20 µg sequence grade modified trypsin (Promega) was 
resuspended in 20 µl trypsin resuspension buffer (Promega). The vial was kept on ice before use. 
Remaining trypsin was snap frozen and stored at -20 
o
C.  
2.1.13.7 0.1 % (v/v) Formic Acid 
Formic acid (1 ml) was added to 1 L deionised H2O. 
2.1.13.8 ProteaseMax Sufactant Trypsin Enhancer  
Immediately before use, a vial containing 1 mg ProteaseMax (Promega) was resuspended in 100 
µl of 50 mM ammonium bicarbonate (Section 2.1.13.2). The vial was kept on ice until use. 
Remaining ProteaseMax was snap frozen and stored at -20 
o
C.  
2.1.13.9 Q-Exactive Loading Buffer 
TFA (1 ml) was added to 1 L deionised H2O. 
2.1.14  ZipTip ® Pipette Tip Solutions 
2.1.14.1 Resuspension Buffer 
TFA (5 µl) was added to 995 µl deionised H2O in a 1.5 ml tube. Solution was made fresh on day 
of use. 
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2.1.14.2 Equilibration and Washing Solution 
TFA (1 µl) was added to 999 µl deionised H2O in a 1.5 ml tube. Solution was made fresh on day 
of use. 
2.1.14.3 Wetting Solution 
Acetonitrile (800 µl) and TFA (1 µl) was added to 199 µl deionised H2O in a 1.5 ml tube. 
Solution was made fresh on day of use. 
2.1.14.4 Elution Solution 
Acetonitrile (600 µl) and TFA (1 µl) was added to 399 µl deionised H2O in a 1.5 ml tube. 
Solution was made fresh on day of use. 
2.1.15  Reagents for Measurement of Intracellular GSH and GSSG 
2.1.15.1 125 mM Sodium Phosphate monobasic  
Sodium Phosphate Monobasic (1.5 g) was dissolved in 100 ml dH2O. It was stored at 4 °C until 
required for use.  
2.1.15.2 125 mM Sodium Phosphate dibasic  
Sodium Phosphate dibasic (1.77 g) was dissolved in 100 ml dH2O. It was stored at 4 °C until 
required for use. 
2.1.15.3 Assay Buffer 
125 mM sodium phosphate monobasic (Section 2.1.15.1) was added, dropwise, to 125 mM 
sodium  phosphate dibasic (Section 2.1.15.2), until the pH was adjusted to pH 7.5. EDTA 
(0.2345 g) was then dissolved in the solution. The solution was made up to 100 ml with dH2O. 
The solution was stored at 4 °C. 
2.1.15.4 5 % (w/v) 5’5-sulfosalicylic Acid (5 % (w/v) (SSA) 
SSA (0.5 g) was dissolved in assay buffer (10 ml) (Section 2.1.15.3) and stored on ice. 
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2.1.15.5 50 % (v/v) Triethanolamine 
Triethanolamine (250 µl) was added to assay buffer (250 µl) (Section 2.1.13.2). 
2.1.15.6 20 % (v/v) 2-vinylpyridine 
2-vinylpyridine (20 µl) was added to assay buffer (80 µl) (Section 2.1.13.2). This was carried out 
in the fumehood. 
2.1.15.7 10 mM 5,5’-dithio-bis(2-nitrobenzoic acid) (DTNB) 
DTNB (10.89 mg) was dissolved in assay buffer (3 ml) (Section 2.1.13.2). This was covered in 
tinfoil and stored on ice. 
2.1.15.8 DTNB containing 1 U Glutathione Reductase 
For every well to be assayed 1 U of glutathione reductase was added to 42 µl of 10 mM DTNB 
(Section 2.1.15.7). 
2.1.15.9 β-nicotinamide adenine dinucleotide 2’-phosphate reduced tetrasodium salt 
hydrate (NADPH)  
2.1.15.9.1 30 mM NADPH 
NADPH (25 mg) was dissolved in assay buffer (1 ml) (Section 2.1.13.2). This was aliquoted into 
smaller volumes, covered in tinfoil and stored at -20 
o
C. 
2.1.15.9.2 5 mM NADPH 
1 volume of 30 mM NADPH (Section 2.1.15.9.1) was added to 5 volumes of assay buffer 
(Section 2.1.13.2). This was covered in tinfoil and stored on ice. 
2.1.15.10 1 mg/ml Glutathione (GSH) 
GSH (1 mg) was dissolved in assay buffer (1 ml) (Section 2.1.13.2). This was covered in tinfoil 
and stored on ice. 
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2.1.15.11 2 mg/ml Glutathione disulfide (GSSG) 
GSSG (2 mg) was dissolved in assay buffer (1 ml) (Section 2.1.13.2). This was covered in tinfoil 
and stored on ice. 
2.1.16  2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA) 
H2DCFDA dessicate (100 mg) (Invitrogen) was resuspended in 2 ml DMSO creating a 50 mg/ml 
stock which was stored at -20 
o
C. 
2.2  Methods 
2.2.1  Microbiological Methods – Strain Storage and Growth 
Fungal and bacterial strains used in this study are listed in Table 2.2. Plasmids used in this study 
are listed in Table 2.3. 
Table 2.2. Fungal and bacterial strains used in this study, including antibiotics used. 
Species Strain Antibiotics Reference 
A. fumigatus  ATCC26933 N/A http://www.atcc.org 
A. fumigatus AfS77 N/A Hartmann et al., 2010 
A. fumigatus ΔegtA26933 Pyrithiamine (100 ng/ml This work 
A. fumigatus ΔegtA26933::egtA (egtAC26933) Hygromycin (200 µg/ml) This work 
A. fumigatus ΔegtAAfS77 Pyrithiamine (100 ng/ml) Sheridan et al., 2016 
A. fumigatus ΔvipC26933 Pyrithiamine (100 ng/ml) This work 
A. fumigatus ΔpalA26933 Pyrithiamine (100 ng/ml) This work 
E. coli TOP10 Ampicillin (100 µg/ml) N/A 
Table 2.3. List of Plasmids used in this study, including antibiotics used. 
Plasmid Encoded Antibiotic Resistance  
pCR®2.1-TOPO Ampicillin 
pSK275 Pyrithiamine 
pAN7.1 Hygromycin 
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2.2.1.1  A. fumigatus Growth, Maintenance and Storage 
A. fumigatus strains were maintained on MEA (Section 2.1.1.2). A single inoculation loop of 
spores from a stock spore solution was streaked onto a plate and incubated at 37 
o
C in a static 
incubator for 5 days. Conidia were harvested from the plate by adding sterile PBST (10 ml) 
(Section 2.1.5) to the conidia and rubbing the surface with a sterile inoculation loop to dislodge 
the spores. The spore solution was centrifuged at 2000 x g for 5 min. The supernatant was 
removed and the spore pellet was resuspended in sterile PBS (5 ml) (Section 2.1.4). The spores 
were counted using a haemocytometer to determine the spore density (spores/ml). The spore 
solution was stored at 4 
o
C until required. 
2.2.1.2  E. coli Growth, Maintenance and Storage 
E. coli strains were grown on LB agar (Section 2.1.2.2) overnight at 37 
o
C or in LB broth 
(Section 2.1.2.1) overnight at 37 
o
C, shaking at 200 rpm. Where appropriate, media was 
supplemented with suitable antibiotics. 
2.2.2  Plant Strains used in this study 
Plant strains used in this study are listed in Table 2.4. 
Table 2.4. Plant Strains used in this study. 
Species Strain 
Nicotiana tabacum L. cv. Petit Havana 
Nicotiana tabacum L. cv. Petit Havana:egtA:nfs1 
2.2.3  Molecular Biology Methods 
2.2.3.1  Isolation of Genomic DNA from A. fumigatus 
A. fumigatus conidia were harvested as described in Section 2.2.1.1. 100 µl of these suspensions 
were used to inoculate 50 ml cultures of Sabouraud Dextrose broth (Section 2.1.1.3). These 
cultures were incubated at 37 
o
C overnight, rotating at 200 rpm. The cultures were then filtered 
through miracloth and the mycelia were collected, flash frozen in liquid N2 and ground using a 
mortar and pestle. The DNA extractions were carried out using the ZR Fungal/Bacterial DNA kit 
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(Zymo Research, California, U.S.A.). DNA extraction was carried out according to the product 
protocol.   
2.2.3.2  Polymerase Chain Reaction (PCR) 
PCR was used to amplify fragments of DNA for cloning, transformation constructs, DIG-
labelled probes and colony PCR. Reactions were carried out using AccuTaq LA polymerase. 
Annealing temperatures were estimated as ca. 4 
o
C below the melting temperature (Tm) of the 
primers used. Extension times were ca. 1 min/kb of DNA to be synthesised. Reactions were 
carried out using the G-storm PCR system (Roche). Primers used in this study are listed in Table 
2.5.  
The general reaction constituents for AccuTaq LA polymerase used were as follows: 
10 X reaction buffer 2 µl 
dNTP mix (10 mM) 2 µl 
Forward Primer  (l0 µM) 1 µl 
Reverse Primer (10 µM) 1 µl 
DMSO 0.8 µl 
DNA template 10 – 100 ng 
AccuTaq 0.2 µl 
Molecular grade H2O to a total of 20 µl 
The following reaction cycle was used unless otherwise stated: 
95 
o
C (denaturing) 5 min 
95 
o
C (denaturing) 1 min 
56 
o
C (annealing) 1.5 min 
68 
o
C (extending) 1 min 
68 
o
C (extending) 10 min 
 
 
x 30 – 35 cycles 
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Table 2.5. Oligonucleotide primers used in this study. Restriction sites are underlined 
Primer Name Sequence (5’ – 3’) 
oAoPtrA1 GAGGACCTGGACAAGTAC 
oAoPtrA2 CATCGTGACCAGTGGTAC 
HYoptrA1 GCTCCATACAAGCCAACCAC      
YGoptrA2 GTCCTGCGGGTAAATAGCTG     
egtA1 GATCCACAAGATACGGGC 
egtA2 GGTGGGCAATGATCTTGG 
egtA3 CCGTCTTTGGACCTGTTC 
egtA4 GATAGTCTCCGCCGAAAG 
egtA5 TCATCCATCTCGCCTCTG 
egtA6 CAGGGTACATCCAGGTAC 
QPCR egtA F CTATGATGATGCCCTTGCCT 
QPCR egtA R GCATTCGCATGTAATAGCCC 
egtB1 ATCTACTAGTGAATCAGAGGGAATGGCA 
egtB2 GGAGATTCAAGAGGCGGAGG 
egtB3 GCCGAGCAGGAGCGTTTG 
egtB4 CACCAAGCTTCCATCAAAGTATGTCTCG 
egtB5 TGTCTCCCTCATTCATCTGTTCAA 
egtB6 CCCTCTCCGACATCCGCTCT 
QPCR egtB F TTTGCCGTGTCTGGTAGTGA 
QPCR egtB R GCAAACACAGGCACAAAGGT 
vipC1 AGCGGTGATGTGATTGACTAGTGGAG 
vipC2 GAGATGAGACGCCAGTGT 
vipC3 CAGGAGGAACTGGTGGAGAG 
vipC4 GTGCGGGCATAACATAAAGCTTCGGT 
vipC5 AGATGATGGCGAATACGATGT 
vipC6 GGGATGCCACTGGATTACC 
QPCR vipC F CGTTAGTCGCCTCTCTGTCG 
QPCR vipC R TCCAGGCGGTCTTGTTCTTG 
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palA1 CCGTCTCAAGATGGGCACTAGTATTA 
palA2 ACTTTGGGAGCAGTGGTAGAG 
palA3 CCAACAACAGGTTCCATCG 
palA4 CACTGGTACCTGGCAAACGGAAACTG 
palA5 TTTGCCCAATCCATCACAC 
palA6 GGACGGTAGGCTATGGCA 
QPCR palA F CGCATCAACTGGCTGTCCTA 
QPCR palA R GCGGAGATGAACGGATGGAA 
egtA_HYG_1  GCAGTCGACTGGGCAATGATCTTGG 
egtA_HYG_2 CCGTCTTTGGACCTGTGGATCCTGA 
gliK_HYG_1 GCGCATGCGCTTTCCCCATGTTGCTTG 
gliK_HYG_2 GCATACTGTAGTCGCGGTAGA 
gliK_HYG_3 ACGCCTCTAACATGCCATAC 
gliK_HYG_4 AGCGGATCCTGAAGATGCTGCGGC 
gliK_HYG_5 GCATTGGAAGAAGAGGACG 
gliK_HYG_6 GTAGTAGCCGATGATGCCG 
NFS1.1 ATAGGCGGCCGCACAGCAAAGGAGGGAG 
NFS1.2 GGCTTCGTATTCCTCGCA 
NFS1.3 CAATGGTGTATGTGCTGGG 
NFS1.4 CATTAAAGCTTCCCTTATTATCTGCCTCG 
NFS1.5 ATTTTGGTAAACTCTGCTCCG 
NFS1.6 AAGGCTTGAGAAACAACTGATT 
QPCR calm F CCGAGTACAAGGAAGCTTTCTC 
QPCR calm R GAATCATCTCGTCAACTTCGTCGTCAGT 
2.2.3.3  Colony PCR 
PCR screening of bacterial colonies were carried out by colony PCR.  An isolated colony was 
aseptically removed using a sterile tip and placed into a 0.2 ml tube containing PCR mastermix 
(Section 2.2.3.2) and also streaked onto a reference plate. PCR was carried out as per Section 
2.2.3.2 and genomic DNA and negative controls were included. 
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2.2.3.4  Restriction Enzyme Digest 
Restriction enzymes, 10 X reaction buffers and bovine serum albumin (BSA) were obtained from 
Promega. Reactions were carried out according to the manufacturer’s instructions as follows: 
DNA 1- 5 µg 
Enzyme 1 µl 
10 X Buffer 2.5 µl 
10 X BSA 2.5 µl 
Sterile Molecular Grade  H2O to a total of 25 µl 
Restriction digests were carried out at 37 
o
C for 2 h. 
2.2.3.5  Ligation of DNA Fragments 
Ligation of DNA was used for the generation of gene disruption constructs and plasmids for 
gene complementation. Ligation was carried out using the Ligafast Rapid DNA Ligation System 
(Promega), as per the manufacturer’s instructions. DNA fragments containing either a cohesive 
end (a single stranded overhang) or a blunt end (no overhang) were produced by restriction 
digest (Section 2.2.3.5). The preferred molecular ratio of insert to backbone for all ligations was 
3:1, this was estimated based off the size of the DNA fragment using the following formula: 
                                  
                 
   
 
 
              
Ligations were carried out using 50 – 200 ng of vector DNA, T4 DNA ligase (1 µl) and 2 X 
rapid ligation buffer.  
2.2.3.6  TOPO TA Cloning 
One step cloning of PCR products were carried out using the TOPO TA Cloning kit from 
Invitrogen, according to the manufacturer’s instructions. Prior to cloning, TOP10 cells were 
thawed on ice and LB agar plates (Section 2.1.2.2) containing 100 μg/ml ampicillin (Section 
2.1.6) were pre-warmed in a 37 
oC incubator. Genomic DNA PCR product (4 μl), Salt solution (1 
μl) and pCR®2.1-TOPO vector (1 μl) were added to a sterile 0.2 ml tube and left at room 
temperature for 30 min. A 2 μl aliquot of this reaction mixture was added to a vial of TOP10 E. 
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coli cells and placed on ice for 30 min. Cells were heat shocked at 42 
o
C for 30 s in a water bath 
and room temperature Super Optimal Catabolite repression (SOC) media  (250 μl) (Section 
2.1.2.3) was added to the vial. The vial was then incubated at 37 
o
C for 1 h, shaking at 200 rpm. 
During this incubation period, 32 μl of 5-bromo-4-chloro-3-indolyl-beta-D-galactopyranoside 
(X-gal) (Promega, UK) (40 mg/ml) was spread over the pre-warmed agar plates using a sterile 
spreader and the plates were returned to the incubator. A 50 μl aliquot of the cell suspension was 
spread on the selection plates using a sterile disposable spreader and the plates were incubated 
overnight at 37 °C. White colonies were selected and sub-cultured on to LB agar plates (Section 
2.1.2.2) with ampicillin (100 μg/ml). Potential colonies were screen by colony PCR (Section 
2.2.3.3) and restriction digestion (Section 2.2.3.4). 
2.2.3.7  Plasmid Purification from E. Coli  
Plasmid purification was carried out according to the Qiagen Plasmid purification manual using 
the QIA prep Mini-prep kit. All buffers and columns were supplied with the kit. An isolated 
colony was picked aseptically and used to inoculated 10 ml LB broth (Section 2.1.2.1) 
containing 100 µg/ml ampicillin. Cultures were grown overnight at 37 
o
C and the cells harvested 
by centrifugation at 13,000 x g for 10 min. Procedures were then carried out according to the 
manufacturers guidelines. Purified plasmids were subsequently analysed by restriction digestion 
(Section 2.2.3.4) followed by DNA gel electrophoresis (Section 2.2.3.8). 
2.2.3.8  DNA Gel Electrophoresis 
2.2.3.8.1 Preparation of Agarose Gel 
Agarose gel electrophoresis was used to visualise restriction digests, to separate DNA for 
Southern analysis, to separate differently sized DNA fragments prior to purification, for ensuring 
accuracy of PCR reactions and for estimation of DNA yield. Agarose gels were cast and run 
using Bio-Rad electrophoresis equipment. Agarose gels between 0.7 – 1 % (w/v) (Section 
2.1.7.5) were prepared in 1 X TAE buffer (Section 2.1.7.2) depending on the expected size of 
DNA to be examined. Powdered agarose was added to an appropriate volume of 1 X TAE buffer 
in a 500 ml Erlenmeyer flask. This was then heated in a microwave, with frequent mixing, until 
the agarose had fully dissolved. The gel was allowed to cool and poured into a sealed casting 
unit. A gel comb was inserted and the gel to cool to 40 – 50 oC. At this point, ethidium bromide 
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(Section 2.1.7.3) was added to the solution (2.5 µl ethidium bromide per 100 ml molten agarose). 
The gel was then allowed to set for 30 min. Once set, the gel comb was removed gently and the 
gel casting unit containing the agarose gel was placed into the gel tank, with the wells nearest the 
negative electrode. 1 X TAE buffer (Section 2.1.7.2) was then poured into the gel tank to fully 
submerge the gel. 
2.2.3.8.2 Loading and Running Samples on an Agarose Gel 
DNA samples were prepared for loading by adding 1 volume of 6 X loading dye (Section 
2.1.7.4) to 5 volumes DNA sample. DNA fragment size was estimated by running molecular 
weight markers alongside the unknown samples. The different molecular weight markers used in 
this study are outlined in Section 2.1.7.6. Gels were electrophoresed at 90 – 120 volts for 60 – 90 
min. Gels were visualised under UV light and images captured using a Syngene G:Box. 
2.2.3.8.3 DNA Gel Extraction 
DNA gel extraction was carried out using the QIA quick gel extraction kit (Qiagen, UK). All 
reagents and columns were supplied with the kit and the procedure was carried out according to 
the manufacturer’s instructions. DNA was eluted in 50 µl of sterile molecular grade H2O.  
2.2.4  Generation of A. fumigatus Mutant strains 
2.2.4.1  Generation of Constructs for A. fumigatus gene deletions 
A bipartite gene disruption strategy was employed for the generation of A. fumigatus mutant 
strains in this study (Nielsen et al., 2006). This strategy involved the generation of two constructs 
which each contain a partial fragment of a pyrithiamine resistance gene (ptrA) from A. oryzae. 
(Kubodera et al., 2000) ligated to a 5’ or 3’ flanking region of the gene of interest. These two 
constructs overlap and upon homologous recombination reconstitute the deletion cassette in vivo. 
The ptrA gene was excised from a plasmid vector pSK275 (a kind gift from Prof. Sven 
Krappmann, Erlangen, Germany) using restriction enzymes. 5’ and 3’ flanking regions of the 
gene of interest were amplified from A. fumigatus genomic DNA via PCR (Section 2.2.3.2) using 
primers with restriction sites incorporated. Flanking regions of 1 – 1.5 kb were amplified and 
digested with the same restriction enzymes as ptrA to make the ends compatible for ligation 
(Section 2.2.3.5). The ligation products provided the template for a subsequent round of PCR 
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where nested primers amplified the flanking region and a partial fragment of ptrA. Schematic 
representation of the bipartite gene deletion strategy is illustrated in Figure 2.2. PCR products 
were extracted using a Qiagen gel extraction kit. Successful transformation of A. fumigatus 
protoplasts generated potential A. fumigatus transformants which had the ability to grow on 
pyrithiamine selection plates. This only occurred with the successful integration of a fully 
reconstituted ptrA. These transformants were then screened by Southern blot analysis (Section 
2.2.5) where a single homologous integration of ptrA in place of the gene of interest was desired. 
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Figure 2.2. A schematic representation of the bipartite strategy for gene deletion in A. fumigatus, 
using ptrA as a selection marker. 
63 
 
2.2.4.2  Generation of Constructs for complementation of egtA in ΔegtA26933 
To restore A. fumigatus egtA back into the genome of A. fumigatus ΔegtA26933, a construct 
containing the full egtA sequence with the respective 5’and 3’ flanking regions was generated. 
The primers used for the complemented construct are listed in Table 2.5. The egtA coding 
sequence was PCR amplified from wild-type genomic DNA using the primers egtA5 and egtA6. 
The PCR products were cloned into the pCR®2.1-TOPO vector (Section 2.2.3.6) to create 
pegtA. This vector was then linearised using a restriction enzyme that had a unique site in the 
sequence, AatII. For the selection marker, the hygromycin resistance plasmid, pAN7.1 was used, 
which contains the hygromycin resistance gene hph. The linearised pegtA was then transformed 
into protoplasts of A. fumigatus ΔegtA alongside pAN7.1 and grown on media containing 
hygromycin. Successful transformants were identified by the ability to grow on hygromycin due 
to the presence of the hph gene. Potential transformants were screened by Southern blot analysis 
(Section 2.2.5). 
12.2.4.3 A. fumigatus Protoplast Preparation 
Three 500 ml Erlenmeyer flasks containing 100 ml AMM (Section 2.1.1.1.4) were inoculated 
with 500 µl conidia each. These cultures were incubated overnight at 37 
o
C, shaking at 200 rpm. 
The mycelia were harvested by filtering through autoclaved miracloth and washed with 
autoclaved dH2O. The mycelia were blotted gently on autoclaved paper towel in order to remove 
excess liquid. 1.5 g of mycelia was weighed out in duplicate and each was added to lysis buffer 
(15 ml) (Section 2.1.8.4). Both tubes were shaken vigorously in order to remove large mycelial 
clumps. The tubes were then incubated horizontally at 30 
o
C, shaking at 100 rpm for 30 min. 
Following this incubation, the mycelia were disrupted with vigorous pipetting using a P1000 
micropipette set to 800 µl in order to break up all mycelial clumps. The tubes were then returned 
to incubation at 30 
o
C, shaking at 100 rpm for a further 2.5 h. The tubes were then placed in ice 
for 5 min, followed by centrifugation at 900 rpm for 18 min with the brake turned off. The 
supernatant was filtered through autoclaved miracloth into a new 50 ml tube and the volume 
brought up to 40 ml with 0.7 M KCl (Section 2.1.8.1). The tubes were centrifuged at 3300 rpm 
for 12 min with the brake turned off. The supernatant was discarded and the pellet resuspended 
in 0.7 M KCl (10 ml) (Section 2.1.8.1). The previous centrifugation step was then repeated. The 
supernatant was discarded and the tubes were inverted on autoclaved paper towels in order to 
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remove excess liquid. The pellet was resuspended in Buffer L6 (70 µl) (Section 2.1.8.6) by 
gentle pipetting. The tubes were centrifuged at 600 rpm for 1 min with the brake turned off and 
the solutions pooled together. The protoplasts were viewed on a haemocytometer using a 
microscope to ensure yield and viability were adequate. The protoplasts were stored on ice prior 
to use in the transformation protocol. 
2.2.4.4  A. fumigatus Protoplast Transformation  
Between 2 µg and 7 µg of 5’ and 3’ constructs were mixed together in a 50 ml tube for each 
transformation, with the final volume brought up to 50 µl with buffer L6 (Section 2.1.8.6). 150 
µl of A. fumigatus protoplasts were added to the constructs. A negative control was prepared by 
adding 15 µl of A. fumigatus protoplasts to buffer L6 (185 µl) (Section 2.1.8.6). Buffer L7 (50 
µl) (Section 2.1.8.7) was added to both DNA containing and negative control mixtures and 
mixed with gentle swirling. These were placed on ice for 20 min. Following this, buffer L7 (1 
ml) (Section 2.1.8.7) was added to each mixture and left at room temperature for 5 min. Buffer 
L6 (5 ml) (Section 2.1.8.6) was added to each tube and stored on ice until plating. 
2.2.4.5  Plating of A. fumigatus Transformation Protoplasts 
1.8% (w/v) regeneration agar (25 ml) (Section 2.1.1.5.1) containing pyrithiamine (0.1 µg/ml) or 
hygromycin (100 µg/ml) (Section 2.1.6) was poured into 90 mm petri dishes. Plates were stored 
at room temperature until required. For each transformation, six plates containing the selection 
agent and two plates without were prepared. For the negative control, 1.25 ml of A. fumigatus 
protoplasts from the negative control transformation were added to a sterile tube and the volume 
made up to 6 ml with 0.7% (w/v) regeneration agar (Section 2.1.1.5.2). This was then poured 
onto a plate containing a selection agent. For the protoplast viability control, two tubes were 
prepared: containing 12.5 µl and 1.25 µl transformed A. fumigatus protoplasts respectively. The 
volume of both tubes was brought up to 6 ml with 0.7% (w/v) regeneration agar (Section 
2.1.1.5.2). These tubes were then poured onto the two plates containing no selection agent. The 
remaining transformed A. fumigatus were brought up to a volume of 30 ml with 0.7% (w/v) 
regeneration agar (Section 2.1.1.5.2). 6 ml of this solution was then poured onto 5 plates 
containing selection agent. All plates were stored overnight at room temperature. 
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2.2.4.6  Overlaying of A. fumigatus Transformation Plates 
0.7% (w/v) regeneration agar (36 ml) (Section 2.1.1.5.2) containing pyrithiaimine (0.1 µg/ml) or 
hygromycin (100 µg/ml) was prepared in a sterile tube. 6 ml of this was poured onto each of the 
5 transformation plates as well as the negative control. All plates were the incubated at 37 
o
C for 
approximately 5-7 days or until colonies were observed on top of the overlay layer. The 
appearance of colonies on the proplast viability control plates confirms that viable protoplasts 
had been generated 
2.2.4.7  Isolation of A. fumigatus Transformants following Transformation 
Potential transformants exhibited the ability to grow on transformation plates containing the 
selective agent. Spores from each transformant were picked aseptically from the transformation 
plates and point inoculated onto fresh AMM agar (Section 2.1.1.1.5) plates containing the 
selection agent. The plates were then incubated at 37 
o
C in a static incubator until colonies were 
observed. The individual colonies were excised from the plates using the base of a P1000 tip. 
The plugs were transferred to sterile 1.5 ml tubes containing PBS (750 µl). The tubes were 
vortexed vigorously to release the conidia into solution and the solutions stored at 4 
o
C until 
needed. 500 µl of conidial suspension from each potential A. fumigatus transformant was 
pipetted into separate 50 ml Erlenmeyer flasks containing 20 ml Sabouraud Dextrose broth 
(Section 2.1.1.3). The cultures were incubated overnight at 37 
o
C with shaking at 200 rpm. The 
cultures were then harvested and DNA extraction (Section 2.2.3.1) was performed for Southern 
blot analysis (Section 2.2.5).  
2.2.4.8  Single Spore Isolation of A. fumigatus Transformant Colonies 
Following a first round of Southern blot analysis, transformants showing a correct signal were 
selected for single spore isolation. This was done to ensure that a transformant contained a 
homogenous single nucleus and that it was not a heterokaryon. Potential transformants were 
diluted by serial dilutions ranging from 10
-2
 to 10
-6
 in sterile PBS (Section 2.1.4). 50 µl of the 
each dilution was spread onto separate AMM plates containing a selective agent and incubated at 
37 
o
C in a static incubator until colonies were observed. Conidia from individual colonies were 
isolated in sterile PBS (Section 2.1.4) and inoculated into Sabouraud Dextrose media (20 ml) 
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(Section 2.1.1.3) and incubated as per Section 2.2.4.7. Mycelia were then harvested and 
subjected to a second round of Southern blot analysis (Section 2.2.5). 
2.2.5  Southern Blot Analysis 
2.2.5.1  Synthesis of DIG-labelled Probes 
The probes used in Southern analysis were generated by PCR (Section 2.2.3.2) with the 
incorporation of DIG-labelled dNTPs. PCR products were resolved on a 1 % agarose gel and the 
bands excised (Section 2.2.3.8.3). DNA was denatured by heating at 95 
o
C for 5 min on a heating 
block. 400 ng of the DNA was added to 15 ml membrane pre-hybridisation buffer (Section 
2.1.9.6.2) which had been heated to 65 
o
C for 30 min. The probe was stored at – 20 oC and 
heated at 65 
o
C for 30 min before use in Southern analysis. 
2.2.5.2  DNA Transfer 
Genomic DNA was isolated from potential transformants (Section 2.2.3.1) and digested using a 
suitable restriction endonuclease (Section 2.2.3.4). The enzyme chosen would cut on either the 5’ 
or 3’ side of the gene of interest, once inside the wild-type loci and once inside the replacement 
gene for the mutant loci. This would generate different sized bands on the blot for the wild-type 
and mutants strains, allowing for identification of successfully generated mutants. The digested 
DNA was resolved on a 0.7 % (w/v) agarose gel (Section 2.2.3.8). After the DNA was resolved 
sufficiently, it was placed on a UV cross linking machine (Stratagene, La Jolla, CA) and pulsed 
at 800 KJ. Following this, the Southern tower was set up (Figure 2.3). The tower was constructed 
on a Bio-Rad electrophoresis tank with the two reservoirs on either side filled with Southern 
transfer buffer (Section 2.2.9.1). Two large sheets of filter paper were draped between the two 
reservoirs until they were soaked in the transfer buffer. The DNA gel was placed face down on 
top of these. Nylon membrane (H+ Bond Nylon Membrane, GE Electric) was placed on top of 
the gel, followed by 3 pieces of filter paper. 3 stacks of pocket-sized tissue paper were then 
placed on top of the filet paper. A glass plate was placed on top of the stack and a duran 
containing 400 ml H2O was placed on top of this. The Southern blot tower was left overnight at 
room temperature.  
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2.2.5.3  Pre-hybridisation of the Nylon Membrane 
Following overnight incubation the nylon membrane was washed for 20 min in 2 X SSC buffer 
(Section 2.1.9.3) followed by crosslinking in the UV crosslinking machine. The membrane was 
then placed in a Hybaid tube and pre-hybridisation buffer (20 ml) (Section 2.1.9.6.1) was placed 
inside. The tube was incubated at 42 
o
C in a hybaid oven whilst rotating for 5 – 6 h to block the 
membrane. 
 
 
Figure 2.3. Schematic representation of the Southern transfer tower. 
2.2.5.4  Addition of DIG-labelled probe to Southern Blot 
Following pre-hybridisation of the Southern blot the pre-hybridisation buffer was removed. The 
DIG-labelled probe (Section 2.2.5.1) was pre-heated to 65 
o
C for 30 min and then added to the 
tube. The tube was then incubated overnight at 42 
o
C whilst rotating to allow the probe to 
hybridise to regions of homology on the membrane. Following the overnight incubation, the 
probe was removed and stored at – 20 oC.  
 
 
68 
 
2.2.5.5  DIG Detection 
After probing, the membrane was removed from the Hybaid tube and was washed with 0.1 % 
(w/v) SDS / 1 X SCC buffer (Section 2.1.9.5) for 15 min. This wash was repeated once and then 
the membrane returned to the Hybaid tube. 0.1 % (w/v) SDS / 1 X SCC buffer (20 ml) (Section 
2.1.9.5), which had been pre-heated to 65 
o
C, was added to the tube and it was rotated in the 
Hybaid oven at 65 
o
C for 15 min. This wash was repeated once and then the solution discarded. 
DIG wash buffer (10 ml) (Section 2.1.9.6.7) was added to the tube and the tube rotated at room 
temperature for 5 min. The buffer was then discarded and the membrane was blocked with DIG 
buffer 2 (15 ml) (Section 2.1.9.6.5) for 30 min whilst rotating at room temperature. Following 
the blocking step, Anti-Digoxigenin-AP conjugate (Section 2.1.9.6.8) (20 ml) was added and the 
tube rotated at room temperature for 30 min. The antibody solution was then discarded and DIG 
wash buffer (15 ml) (Section 2.1.9.6.7) was added to the tube and rotated at room temperature 
for 15 min. This wash step was repeated once. Following the wash steps, DIG buffer 3 (10 ml) 
(Section 2.1.9.6.6) was added and the tube rotated at room temperature for 5 min. The buffer was 
then poured off and CSPD substrate (5 ml) (Section 2.1.9.6.9) was added. This was rotated at 
room temperature for 5 min. The CSPD substrate was collected in a tube covered in tin foil and 
stored at 4 
o
C. The membrane was removed from the Hybaid tube, wrapped in a single layer of 
cling film and incubated at 37 
o
C for 15 min. 
2.2.5.6 Developing the Southern blot membrane 
The cling film wrapped membrane was taped into a photo developer cassette and an X-ray film 
was placed over the membrane. The X-ray film was allowed to expose for 2 – 3 h initially, 
followed by an overnight exposure. Following exposure, the X-ray film was removed and placed 
in developer solution (Section 2.1.9.6.11) until a signal was visible on the X-ray film. The X-ray 
film was then briefly washed with H2O and then placed into fixer solution (Section 2.1.9.6.12). 
Alternatively, instead of using the X-ray film, a digital image of the blot was obtained by 
exposing the membrane in a Syngene Image Station for 1 h. 
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2.2.6  RNA Analysis 
2.2.6.1  RNA Isolation 
A. fumigatus liquid cultures, which were incubated at 37 
o
C for the required time, were filtered 
through autoclaved miracloth, washed with autoclaved H2O and the mycelia collected. Mycelia 
were snap frozen in liquid N2 and ground to a fine powder in liquid N2. The RNA was isolated 
using the RNeasy Kit supplied by Qiagen, according to the manufacturer’s instructions. β-
mercaptoethanol (10 μl) was added to Buffer RLC (1 ml) before RNA extraction. For each 
sample, 100 mg of ground mycelia were placed in sterile 2 ml tubes. Buffer RLC (QIAshredder 
spin columns. The columns were centrifuged at 13,000 x g for 2 min. The flow through was 
transferred to new 1.5 ml tubes, avoiding the cell debris pellet. 0.5 volumes of molecular grade 
ethanol (100 %) was added to the lysates and mixed immediately. Samples were then transferred 
to RNeasy spin columns, which were placed in 2 ml collection tubes. Columns were centrifuged 
at 10,000 x g for 15 s. The flow through was discarded. Buffer RW1 (700 μl) was added to the 
columns and then centrifuged at 10,000 x g for 15 s. The flow through was discarded. Buffer 
RPE (500 μl) was added to the columns and centrifuged at 10,000 x g for 15 s. The flow through 
was discarded. Buffer RPE (500 μl) was added to the columns and centrifuged at 10,000 x g for 
2 min. The spin columns were removed and placed in new collection tubes and centrifuged for 2 
min at 13,000 x g, to remove residual buffer. The spin columns were placed in sterile 1.5 ml 
tubes. RNase-free water (50 μl) was added to the columns and the RNA was eluted by 
centrifuging at 10,000 x g for 1 min. The RNA samples were stored at –70 °C until required. 
2.2.6.2  DNase Treatment of RNA samples 
A DNase 1 kit from Sigma was used to DNase treat RNA samples. RNA samples (Section 
2.2.6.1) (500 ng) were adjusted to a final volume of 8 μl in molecular grade H2O. 10 X Reaction 
Buffer (1 μl) and DNase (1 μl) were added to the RNA samples and the mixture was left to 
incubate at room temperature for 15 min. Stop Solution (1 μl) was added to the reaction and they 
were then incubated at 70 
o
C for 10 min. The samples were chilled on ice and stored at – 70 oC if 
not for immediate use. 
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2.2.6.3  cDNA Synthesis 
cDNA synthesis was carried out using qScript cDNA Supermix (Quanta BioSciences) using the 
reagents supplied in the kit and following the manufacturer’s instructions. 
2.2.6.4  Semi-quantitative RT-PCR 
PCR was carried out on the cDNA samples (Section 2.2.6.3) as described in Section 2.2.3.2 
using appropriate target gene primers (Table 2.5). The A. fumigatus calmodulin (calm) gene 
(AFUA_4g10050) was used as a housekeeping gene (Burns et al., 2005). The primers calmF and 
calmR (Table 2.5) span an intronic region in calm, resulting in an amplicon size of 617 bp from 
gDNA and an amplicon size of 314 bp from cDNA. This allows the detection of any 
contaminating gDNA in the cDNA samples. The RT-PCR amplicons were resolved on a 0.7 % 
(w/v) Agarose Gel (Section 2.2.3.8) and visualised using a Syngene G:Box. 
2.2.6.5  Quantitative RT-PCR (qRT-PCR) 
RNA samples to be analysed by qRT-PCR were extracted as described in Section 2.2.6.1, DNase 
treated (Section 2.2.6.2) and cDNA synthesised (Section 2.2.6.3). qRT-PCR was carried out 
using the LightCycler® 480 Real-Time PCR System (Roche) and LightCycler® 480 SYBR 
Green I Master (Roche). PCR reactions were carried out in 96-well plates in a reaction volume of 
10 μl containing 1 μl of template cDNA. Relative quantification analysis of differences in gene 
expression between different growth conditions and/or A. fumigatus strains was carried out using 
the Relative Quantification module, allowing for differences in gene expression levels between 
samples to be calculated. Standard curves for the gene calm (internal control) and genes of 
interest were created to measure PCR efficiency. Standard curves were prepared for calm and 
each of the genes of interest by creating 5 orders of 4 fold serial dilutions of control cDNA in 
molecular grade H2O using 5 experimental replicates for each dilution series and for each PCR 
reaction with their respective specific primer pairs. Standard curves were calculated using the 
Absolute Quantification Module which yielded a specific efficiency figure based on the reaction. 
An efficiency of 2 ± 0.2 meant the PCR was successful and was saved for reference during 
experiments using these same cycling requirements for subsequent qRT-PCR. For this cDNA 
was diluted 1:2 in order for it to fit within the standard curve, and was done in quintuplicate for 
each sample and for each gene of interest being amplified. All samples and standards were 
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cycled 45 times as per manufacturer’s instructions. Relative expression was calculated using the 
2-(Delta Delta C(T)) method (Livak & Schmittgen, 2001) on the LightCycler® software. Results 
were given as a bar chart and table depicting the mean values for all genes and the relative ratio 
of a particular gene of interest:calm expression. Negative controls containing 1 μl of molecular 
grade water were performed in triplicate on each 96-well plate, and Tm Calling Analysis was 
performed after each PCR reaction to check that only one PCR product was present in each well 
following the PCR run. 
2.2.7  A. fumigatus Plate Assays 
Conidial stocks from A. fumigatus wild-type and mutant strains (Table 2.2) were diluted to a 
concentration of 1 x 10
6
 conidia/ml in PBS and 5 μl of each dilution was used to spot test plates. 
Plates were incubated at 37 ºC and growth was measured after 72 h by measuring the radial span 
of fungal colonies. Plate assays were performed independently three times, and radial growths 
(mm) of colonies were tested for significant differences by means of a one-way ANOVA. Strains 
were tested for growth on agar with a variety of supplements and these are summarized in Table 
2.1. Plate assays to analyse A. fumigatus response to light took place in an incubator with an 
LED light. Control plates were grown in the dark by covering them in tinfoil.  
2.2.8  Bradford Protein Assay 
Bio-Rad protein assay dye was diluted 1/5 in PBS (Section 2.1.12.5) prior to use. The sample to 
be assayed was also diluted appropriately (1/5 – 1/20). 20 μl of sample was added to 980 μl of 
the diluted Bio-Rad protein assay dye and mixed thoroughly. The final sample (1 ml) was 
transferred to a 1 ml plastic cuvette and incubated for 5 min at room temperature. The A595 was 
read relative to a blank and the protein concentration was determined based on values obtained 
from a standard curve. All samples were prepared and analysed in duplicate. 
2.2.9  A. fumigatus Protein Extraction 
A. fumigatus liquid cultures were harvested using miracloth and dried using tissue paper to 
remove excess liquid. Harvested mycelia were then placed into a 50 ml tube, snap frozen in 
liquid N2 and lyophilised overnight. 100 mg of lyophilised mycelia was weighed into a 1.5 ml 
tube and tungsten bead added. The sample was bead beaten for 5 min at 30 Hz. Whole protein 
72 
 
lysate extraction buffer (500 µl) (Section 2.1.12.1) containing 30 mM DTT was added to the 
sample and the bead beating repeated (samples to be analysed using o-Phthalaldehyde (Section 
2.2.12.3), were lysed in A. fumigatus phosphate lysis buffer (Section 2.1.12.2) instead of the Tris 
based lysis buffer). The sample was then left on ice for 1 h. Following this incubation, the 
sample was centrifuged at 12,000 x g at 4 
o
C for 15 min. The supernatant was then transferred to 
a clean 1.5 ml tube. Protein lysates were stored at -20 
o
C.  
2.2.10  Organic extraction of A. fumigatus Supernatants 
20 ml of A. fumigatus culture supernatants were added to 20 ml chloroform in 50 ml falcon tubes 
in the fumehood. Samples were shaken vigorously by hand, with intermittent gas release 
followed by centrifugation for 5 min at 2000 x g. The lower organic layers were removed to new 
50 ml falcon tubes and stored at -20
o
C.  
2.2.11  Rotary Evaporation of Organic Extraction Samples 
Organic extracts (Section 2.2.10) were placed in an evaporation bulb and the bulb was 
evaporated under vacuum whilst sitting in a water bath set to 60 
o
C (Stuart RE300DB digital 
water bath). The chloroform evaporated leaving the dried organic extract in the bulb. The 
extracts were resuspended in HPLC grade methanol (250 µl) until all the dried material was fully 
resuspended. The resuspended extract was centrifuged at 13,000 x g for 5 min and the 
supernatant transferred to a new 1.5 ml tube and stored at -20 
o
C.  
2.2.12  Metabolite Analysis 
2.2.12.1 5’-Iodoacetamidofluorescein (5’-IAF) Labelling 
30 µl of lysate from A. fumigatus (Section 2.2.9), N. tabacum (Section 2.2.14.2),EGT standard or 
GSH standard were placed in 1.5 ml tubes. PBS (105 µl) (Section 2.1.4) and methanol (15 µl) 
were added to the samples and the tubes vortexed. 50 µl of each sample solution was added to a 
new 1.5 ml tube. 3 mg/ml 5’-IAF (10 µl) (Section 2.1.11.2) was added to the solutions and the 
tubes vortexed briefly. The samples were then incubated at room temperature in the dark for 40 
min. The tubes were then centrifuged at 13,000 x g for 5 min. The supernatants were then 
removed to a new 1.5 ml tube and the pellets discarded. Samples were stored on ice in the dark 
until needed. 
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2.2.12.2 TCA Precipitation of 5’-IAF Labelled Samples 
5’-IAF labelled samples to be analysed by LC-MS/MS were TCA precipitated prior to analysis. 
100 % (w/v) TCA (5 µl) (Section 2.1.13.1) was added to 45 µl of 5’-IAF labelled lysates or EGT 
standard (Section 2.2.12.1). The samples were incubated at 4 
o
C in the dark for 2 h. Following 
the incubation, the samples were centrifuged at 12,000 x g at 4 
o
C for 15 min. The supernatants 
were then removed to a new 1.5 ml tube and the pellets discarded. Samples were stored on ice in 
the dark until needed. 
2.2.12.3 o-Phthalaldehyde (OPA) Labelling of A. fumigatus protein lysates 
50 µl of room temperature OPA was added to 10 µl of A. fumigatus protein lysate extracted in 
phosphate lysis buffer (Section 2.2.9) or 10 µl 2 mM histidine standard in 50 mM phosphate, pH 
7.6. Samples were allowed to sit for 90 s at room temperature and then centrifuged at 13,000 x g 
for 1 min. 50 µl of the solution was then placed in a HPLC vial and analysed via RP-HPLC 
(Section 2.2.12.6) immediately.  
2.2.12.4 Filtration of N. tabacum  lyates using an Amicon centrifuge filter 
200 µl of N. tabacum lysates (Section 2.2.14.2) was placed in an Amicon 3 kDa centrifuge filter. 
The filter was centrifuged at 4,000 x g for 30 min and the filtrate was then transferred to a clean 
1.5 ml tube using a micropipette 
2.2.12.5 Determination of Ergothioneine reactivity with H2O2 
Reactivity between EGT and H2O2 was analysed by incubating 3 mM EGT with either 3 mM 
H2O2 or an equivalent volume of dH2O for 3 h at room temperature. Triplicate specimens were 
then analyzed by back-titration to detect remaining EGT by labeling the solutions with 5’-IAF 
(Section 2.2.12.1) followed by detection via RP-HPLC analysis (Section 2.2.12.6). Peak areas of 
residual EGT amounts were compared using unpaired t-test. 
2.2.12.6 Metabolite Analysis Using RP-HPLC 
Organic extracts from supernatants (Section 2.2.11), 5’-IAF labelled samples (Section 2.2.12.1) 
and OPA labelled samples (Section 2.2.12.3) were analysed by RP-HPLC (Agilent 1200 system 
or Shimadzu prominence HPLC system) using a C18 RP-HPLC column (Agilent Zorbax Eclipse 
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XDB-C18 Semi-preparative; 5 mm particle size; 4.6 x 250 mm) at a flow rate of 1 ml/min. A 
mobile phase of H2O (Section 2.1.10.1) and acetonitrile (Section 2.1.10.2) with TFA, was used 
under various gradient conditions. Injection volume was 20 µl. Unlabelled metabolites were 
detected at 254 nm using the photodiode array detector, while 5’-IAF labelled samples were 
detected using the fluorescence detector, using an excitation wavelength of 494 nm, and an 
emission wavelength of 518 nm. OPA labelled samples were detected using the fluorescence 
detector, using an excitation wavelength of 340 nm, and an emission wavelength of 455 nm. 
2.2.12.7 Metabolite Analysis using LC-MS/MS 
Organic extracts from supernatants (Section 2.2.11) or TCA precipitated 5’-IAF labelled 
mycelial lysates (Section 2.2.12.2) were analysed by LC-MS/MS. All samples were filtered 
through 0.2 µm cellulose spin-filters (Costar) before transfer to polypropylene vials. Samples 
were loaded onto a Zorbax 300 SB C-18 Nano-HPLC chip (150 mm x 75 µm) at a flow rate of 4 
µl/min. Metabolites were eluted using the appropriate gradient with a post run of 5 min. MSn 
was carried out on the 3 most abundant precursor ions at each timepoint, with n ranging from 2 
to 5, depending on the analysis. Singly charged ions were not excluded from analysis, with the 
precursor range adjusted to include ions with m/z between 15 and 2200. 
2.2.13  Measurement of Intracellular GSH and GSSG 
This method measures levels of intracellular glutathione in A. fumigatus. Levels of total 
glutathione and levels of glutathione disulfide (GSSG) are measured directly. By subtracting the 
levels of GSSG from total glutathione, levels of reduced glutathione (GSH) can be determined. 
The assay involves the reduction of 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB) by GSH. 
Reduction of DTNB releases 5-thio-2-nitrobenzoic acid (TNB) as well as forming glutathione-
TNB adducts (GS-TNB). Glutathione reductase (with NADPH as an electron donor) cleaves this 
adduct, releasing further free TNB, which can be detected at 412 nm. The released GSH is then 
free to react with DTNB again, repeating the cycle (Figure 2.4). As glutathione reductase 
converts GSSG to GSH, this method measures total glutathione. In order to measure GSSG 
levels, samples are treated with 2-vinylpyridine. 2-vinylpyridine covalently reacts with GSH, but 
not GSSH. Thus, when DTNB and glutathione reductase is added only the GSSG present in the 
sample reacts to release TNB for measurement at 412 nm. The rate of TNB formation is 
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proportional to the amount of GSH present in the sample. This method was developed from Thon 
et al. (2010) and Rahman et al. (2006) and has previously been used to measure glutathione 
levels in A. fumigatus (O’Keeffe et al., 2010). Care was taken throughout the protocol to avoid 
exposing samples to light. All tubes were covered in tinfoil and a lid was kept on the ice box. 
 
Figure 2.4. Overview of the glutathione assay. Reduction of DTNB by GSH produces TNB and 
GS-TNB. GS-TNB is then enzymatically reduced to GSH via glutathione reductase and 
NADPH, releasing free TNB. The GSH is then free to react with DTNB again, restarting the 
cycle. This recycling process releases free TNB, which can be measured at 412 nm and thus 
forms the basis of the glutathione assay. 
2.2.13.1 Sample Preparation 
A. fumigatus mycelia were harvested through miracloth and dried on tissue paper to remove 
excess liquid. Mycelia were then snap-frozen in liquid N2 and crushed into a powder using a 
mortar and pestle. 200 mg of crushed mycelia were added to a 2 ml tube containing 5 % (w/v) 
SSA (250 µl) (Section 2.1.15.4). This was repeated for each sample into a tube containing whole 
protein lysate extraction buffer (Section 2.1.12.1). A tungsten bead was added to each sample 
and they were bead beaten at 30 Hz for 3 min, followed by centrifugation at 12,000 x g for 10 
min at 4 
o
C. The supernatant from samples bead beaten in whole protein lysate extraction buffer 
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were used to perform a Bradford assay (Section 2.2.8). The supernatants from samples bead 
beaten in 5% (w/v) SSA were removed to tubes covered in tinfoil and neutralised using 50 % 
(v/v) triethanolamine (Section 2.1.15.5). The samples were diluted (1/10 – 1/30) in assay buffer 
(Section 2.1.15.3) and centrifuged at 12,000 x g for 10 min at 4 
o
C. The supernatants were 
removed to clean 1.5 ml tubes. Samples were stored at -70 
o
C if not assayed immediately.  
2.2.13.2 GSH Standard Preparation 
GSH (1 mg/ml) (Section 2.1.15.10) was diluted 1/100 in assay buffer (Section 2.1.15.3) to give a 
working solution of 10 µg/ml. A 26.4 nmol/ml stock was prepared by adding 800 µl of the 
working solution to 200 µl assay buffer (Section 2.1.15.3). A series of 1:1 dilutions were 
performed to obtain the following set of standards: 13.2, 6.6, 3.3, 1.65, 0.825 and 0.4125 
nmol/ml. 
2.2.13.3 GSSG Standard Prepartion 
GSSG (2 mg/ml) (Section 2.1.15.11) was diluted 1/100 in assay buffer (Section 2.1.15.3) to give 
a working solution of 20 µg/ml. A 26.4 nmol/ml stock was prepared by adding 800 µl of the 
working solution to 200 µl assay buffer (Section 2.1.15.3). A series of 1:1 dilutions were 
performed to obtain the following set of standards: 13.2, 6.6, 3.3, 1.65, 0.825 and 0.4125 
nmol/ml. 
2.2.13.4 Pre-treatment of GSSG samples 
GSSG standards and samples to be assayed for GSSG were pre-treated with 2-vinylpyridine. 2-
vinylpyridine (2 µl) (Section 2.1.15.6) was added to 100 µl of GSSG standards (Section 
2.2.13.3), samples to be assayed for GSSG (Section 2.2.13.1) and a blank sample (assay buffer 
(Section 2.1.15.3). This was carried out in the fume hood. The samples were incubated at room 
temperature for 1 h, before 50 % (v/v) triethanolamine (6 µl) (Section 2.1.15.5) was added to 
each sample to neutralise the 2-vinylpyridine. The samples were incubated for 10 min at room 
temperature before being assayed. 
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2.2.13.5 Glutathione Assay 
All samples to be assayed for GSH or GSSG were assayed in the same manner. 20 µl each 
standard/sample/blank was added to a clear 96-well microtiter plate. To these, 10 mM DTNB 
and glutathione reductase (44.2 µl) (Section 2.1.15.8) was added and left for 30 s. 5 mM 
NADPH (Section 2.1.15.9.2) (42 µl), the electron donor for glutathione reductase, was then 
added to each well and the plate shaken gently to mix. The absorbance at 412 nm was measured 
after 90 s. 
2.2.14  Q-Exactive Mass Spectrometry 
2.2.14.1 Preparation of A. fumigatus samples for Q-Exactive Mass spectrometry 
Harvested mycelia were snap frozen in liquid N2 and crushed using a mortar and pestle in liquid 
N2. 200 mg of mycelia powder was weighed into a 2 ml tube. Whole protein lysate extraction 
buffer (Section 2.1.12.1) (500 µl) was added to the tube. The suspension was sonicated using a 
Sonoplus HD 2200 sonicator and an MS72 sonication probe (Bandelin Electronic, Germany) at 
10% power, cycle 6 for 10 s. This was repeated twice, with samples cooled on ice in between 
each sonication. The suspension was then sonicated using sonication probe MS73 (Bandelin 
Electronic, Germany) at 10% power, cycle 6 for 10 s. Lysates were then incubated on ice for 1 h, 
followed by centrifugation at 12,000 x g for 10 min at 4 
o
C. The supernatants were transferred to 
fresh 1.5 ml tubes and the centrifugation step was repeated to obtain clarified supernatants. A 
Bradford assay (Section 2.2.8) was carried out to determine the protein concentration in each 
sample. 100 % TCA (Section 2.1.13.1) was added to samples (1 mg total protein) to a final 
concentration of 15 % (v/v). The samples were vortexed briefly and incubated at 4 
o
C for 2 h. 
Samples were centrifuged at 12,000 x g for 10 min at 4 
o
C and the supernatant was discarded. 
Ice-cold acetone (500 µl) was added to each protein pellet, pipetted briefly and then incubated at 
-20 
o
C for 2 h. Samples were centrifuged at 12,000 x g for 10 min at 4 
o
C and the supernatant 
was discarded. The acetone wash was repeated twice (an overnight incubation, followed by 
another 2 h incubation). After the acetone was removed from the final washes, the pellets were 
allowed to dry for no more than 5 min. Each pellet was then resuspended in protein resuspension 
buffer (80 µl) (Section 2.1.13.3). A Bradford assay was carried out to determine the protein 
concentration of each sample. 
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2.2.14.2 Protein Extraction from Nicotiana tabacum leaves 
Leaves from N. tabacum plant were removed from the stem, snap frozen in liquid N2 and crushed 
using a mortar and pestle in liquid N2. 400 mg of N. tabacum leaf powder was weighed into a 2 
ml tube. Whole protein lysate extraction buffer (Section 2.1.12.1) (500 µl) was added to the tube. 
The suspension was sonicated using a Sonoplus HD 2200 sonicator and an MS72 sonication 
probe (Bandelin Electronic, Germany) at 10% power, cycle 6 for 10 s. This was repeated twice, 
with samples cooled on ice in between each sonication. The suspension was then sonicated using 
sonication probe MS73 (Bandelin Electronic, Germany) at 10% power, cycle 6 for 10 s. Lysates 
were then incubated on ice for 1 h, followed by centrifugation at 12,000 x g for 10 min at 4 
o
C. 
The supernatants were transferred to fresh 1.5 ml tubes and the centrifugation step was repeated 
to obtain clarified supernatants. The pH of the lysates was checked using a pH strip and adjusted 
to pH 7.5 using 2 M Trizma Base if necessary. A Bradford assay (Section 2.2.8) was carried out 
to determine the protein concentration in each sample.  
2.2.14.3 Preparation of Nicotiana tabacum lysates for Trypsin digestion 
100 % TCA (Section 2.1.13.1) was added to N. tabacum lysates (Section 2.2.14.2) (1 mg total 
protein) to a final concentration of 15 % (v/v). The samples were vortexed briefly and incubated 
at 4 
o
C for 2 h. Samples were centrifuged at 12,000 x g for 10 min at 4 
o
C and the supernatant 
was discarded. Ice-cold acetone (500 µl) was added to each protein pellet, pipetted briefly and 
then incubated at -20 
o
C for 2 h. Samples were centrifuged at 12,000 x g for 10 min at 4 
o
C and 
the supernatant was discarded. The acetone wash was repeated twice (an overnight incubation, 
followed by another 2 h incubation). After the acetone was removed from the final washes, the 
pellets were allowed to dry for no more than 5 min. Each pellet was then resuspended in protein 
resuspension buffer (80 µl) (Section 2.1.13.3). A Bradford assay was carried out to determine the 
protein concentration of each sample. 
2.2.14.4 Protein Digestion for Q-Exactive Mass Spectometry 
Samples (15 µl; 50 µg) in protein resuspension buffer (Section 2.1.13.1 or Section 2.1.13.3) were 
brought to room temperature for 10 min to ensure urea was in solution. 50 mM ammonium 
bicarbonate (78.5 µl) (Section 2.1.13.2) was added to each sample. DTT (1 µl) (Section 2.1.13.3) 
was added to each sample, followed by incubation at 56 
o
C for 20 min. Samples were allowed to 
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cool to room temperature before addition of IAA (2.7 µl) (Section 2.1.13.4). Samples were then 
incubated at room temperature in the dark for 15 min. ProteaseMax (1 µl) (Section 2.1.13.8) and 
trypsin (1.8 µl) (Section 2.1.13.6) was then added to each sample, followed by overnight 
incubation at 37 
o
C. The following day, samples were spun briefly to collect any condensate and 
acidified by adding TFA (1 µl). The samples were the vortexed and incubated at room 
temperature for 5 min. Samples were then centrifuged at 13,000 x g for 10 min at room 
temperature. Supernatants were then transferred to clean 1.5 ml tubes. Samples were then dried 
down using a speedy vac (DNA Speedy Vac Concentrator, Thermo Scientific) and the pellets 
stored at -20 
o
C. 
2.2.14.5 ZipTip ® Pipette Tip Protocol 
The sample pellets were resuspended in resuspension buffer (20 µl) (Section 2.1.14.1) and 
sonicated for 2 min in a sonication bath to aid pellet resuspension. The samples were then 
centrifuged briefly. The ZipTip was then wet by aspirating and dispensing wetting solution (10 
µl) (Section 2.1.14.3) into the tip. This was repeated 5 times. The ZipTip was then equilibrated 
by aspirating and dispensing 10 µl equilibration solution (Section 2.1.14.2) into the tip. This was 
repeated 5 times. To bind the sample to the ZipTip, 10 µl of the resuspended sample was 
aspirated and dispensed ten times. The Ziptip was the washed by aspirating and dispensing 10 µl 
of the washing solution (Section 2.1.14.2) from the tip into a waste tube. This was repeated 5 
times. The sample was then eluted from the Ziptip by aspirating and dispensing 10 µl elution 
solution (Section 2.1.14.4) into a new 1.5 ml tube 5 times. The eluted sample was then dried 
down using a speedy vac and resuspended in 15 µl Q-Exactive Loading Buffer (Section 
2.1.13.9). The samples were stored at -4 
o
C until analysis. 
 2.2.14.6 Q-Exactive Mass Spectrometry Method 
Peptide mixtures for label free quantitative (LFQ) proteomic analysis were run on a Thermo 
Fisher Q-Exactive mass spectrometer coupled to a Dionex RSLCnano. LC gradients ran from 4-
35 % B over 2 h, and data was collected using a Top15 method for MS/MS scans. Comparative 
proteome abundance and data analysis was performed using MaxQuant software (Version 
1.3.0.5) (Cox and Mann, 2008), with Andromeda used for database searching and Perseus used 
to organise the data (Version 1.4.1.3). Carbamidomethylation of cysteines was set as a fixed 
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modification, while oxidation of methionines and acetylation of N-termini were set as variable 
modifications. The maximum peptide/protein false discovery rates (FDR) were set to 1% based 
on comparison to a reverse database. The LFQ algorithm was used to generate normalised 
spectral intensities and calculate relative protein abundance. Proteins that matched to a 
contaminants database or the reverse database were removed and proteins were only retained in 
final analysis if detected in at least three replicates from at least one sample. Quantitative 
analysis was performed using a t-test to compare pairs of samples, and proteins with significant 
change in abundance (p value < 0.05; fold change ≥ 2) were included in the quantitative results. 
Qualitative analysis was also performed, to detect proteins that were found in at least 3 replicates 
of a particular condition, but undetectable in the other sample condition. MASCOT MS/MS Ion 
search, with interrogation of the NCBI (National Centre for Biotechnology Information, 
http://www.ncbi.nlm.nih.gov) database, was used for protein identification. 
2.2.15  H2DCFDA Superoxide Detection in A. fumigatus 
A. fumigatus conidia (1 × 10
6
 conidia/ml per well, in 6 well plates) were added to Sabouraud 
liquid media (4 ml/well) (Section 2.1.1.3) and incubated for 24 h at 37°C, static. Each well 
contained a sterile glass microscope slide. After removal of the top layer of mycelia, H2O2 (3 
mM final concentration) or an equivalent volume (120 µl) of molecular grade H2O were added to 
wells. Plates were re-incubated 37°C, static, for 30 min, culture supernatants removed and 
mycelial mats washed once with 4 ml PBS (Section 2.1.4) for 5 min. After PBS removal, 
Sabouraud medium (3 ml) containing 2′,7′-dichlorodihydrofluorescein diacetate (2.5 µg/ml) 
(Section 2.1.16) was added to each well followed by incubation 37°C for 40 min, static. After 
washing twice with PBS (2×20 min each) (Section 2.1.4), mycelia were visualised using a 
fluorescent microscope (GFP filter: Ex/Em: 492–495/517–527 nm). Fluorescence from duplicate 
samples was quantified by measuring Integrated Density Value (IDV) of selected areas from 
each image (n = 5/treatment). 
2.2.16  Conidial Quantification 
A. fumigatus colonies were grown on AMM (Section 2.1.1.1.5) for 72 h at 37 
o
C. Plugs were 
taken from the centre of each colony and placed into PBS (1 ml) (Section 2.1.4) in 1.5 ml tubes. 
After vigorous vortexing, 20 µl of each solution was placed on a haemocytometer and quantified. 
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Mean conidial concentrations were computed from 3 independent colonies. Conidial 
concentrations were compared via unpaired t-test. 
2.2.17  Statistical Analysis 
All data was analysed using built-in GraphPad prism version 5.01 functions, as specified. The 
level of significance was set at p < 0.05 (*), p < 0.001 (**), and p < 0.0001 (***), unless 
otherwise stated. Post-hoc comparisons between groups were performed using the Bonferroni 
multiple comparisons test, unless otherwise stated.  
2.2.18   Multiple Sequence Alignment  
Amino acid sequences were obtained from the Ensembl genome browser 
(http://www.ensembl.org/) and were aligned using the Kalign program 
(http://www.ebi.ac.uk/Tools/msa/kalign/). 
2.2.19  Software Graphing 
All graphs were compiled using Graphpad Prism version 5.01, unless otherwise stated. 
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3.1  Introduction 
Ergothioneine (EGT) is low molecular mass thiol produced by non-yeast fungi and select 
bacteria. A tri-N-methylated and sulphurised histidine derivative, EGT has been demonstrated to 
have antioxidant properties, however it is yet to be characterised in A. fumigatus (Cheah and 
Halliwell, 2012; Jones et al., 2014). The first identification of EGT in A. fumigatus was made by 
Gallagher et al. (2012), where it was observed that deletion of gliK resulted in augmented levels 
of EGT. A. fumigatus ΔgliK exhibited a range of other phenotypes, including abrogated gliotoxin 
production, sensitivity to exogenous gliotoxin, sensitivity to H2O2 and perturbed levels of SAM 
and SAH upon gliotoxin exposure (Gallagher et al., 2012; Owens et al., 2015). As a putative 
antioxidant, elevated EGT may be linked to H2O2 stress observed in ΔgliK. Furthermore, as the 
EGT biosynthetic pathway involves SAM-dependant methylation and as the thiol group is likely 
sourced from cysteine, EGT biosynthesis is linked metabolically with the SAM/SAH cycle and 
gliotoxin biosynthesis; both of which are disrupted in ΔgliK. EGT may therefore play an 
important role in adapting to gliK deletion in A. fumigatus. However, in the absence of 
characterised EGT function in A. fumigatus, this can only be speculated. A gene deletion strategy 
was therefore implemented to investigate EGT function in A. fumigatus. 
EGT biosynthesis in fungi has been demonstrated to require two enzymes. The first of these, 
which has been characterised in N. crassa (Egt-1) and S. pombe (Egt1), catalyses tri-N-
methylation of histidine to form hercynine, followed by iron(II)-dependant oxidative 
sulphurisation to form hercynylcysteine sulphoxide (Figure 3.1) (Bello et al., 2012; Pluskal et al., 
2014). Egt-1 is a fusion protein of bacterial EgtD and EgtB, which carry out the methylation and 
sulphurisation steps respectively (Seebeck, 2010). The second enzyme in fungal EGT 
biosynthesis is carried out by a pyridoxal phosphate (PLP)-dependant cysteine desulphurase. 
This enzyme catalyses the cleavage of the cysteine residue in hercynylcysteine sulphoxide at the 
sulphur atom to yield EGT (Figure 3.1). This enzyme has been characterised in S. pombe (Egt2) 
and is homologous to bacterial EgtE. It has been noted in both fungi and bacteria that the 
cysteine desulphurase step can be carried out non-specifically and that the cysteine desulphurase 
encoded within the EGT biosynthetic gene cluster is not essential for EGT biosynthesis 
(Seebeck, 2010; Pluskal et al., 2014).  
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Figure 3.1. EGT biosynthesis in fungi and bacteria. The fungal pathway, outlined in red, 
involves two enzymes which catalyse a 3 step biosynthetic pathway. The bacterial pathway, 
outlined in blue, involves four enzymes which catalyse four biosynthetic reactions. Fungal EGT 
biosynthesis utilises cysteine instead of γ-glutamylcysteine and does not produce the 
intermediate γ-glutamylhercynylcysteine sulphoxide (Seebeck, 2010; Bello et al., 2012; Pluskal 
et al., 2014). 
The genes encoding EGT biosynthetic enzymes in A. fumigatus have not yet been identified. 
Identification of the EGT biosynthetic genes in A. fumigatus would allow for targeted deletion in 
order to investigate EGT biosynthesis and function in A. fumigatus. Furthermore, creation of an 
EGT null mutant in a ΔgliK background would facilitate further investigation into the role of 
EGT in ΔgliK as discussed previously. 
Two genes which may be of interest in the context of investigating EGT function in A. fumigatus 
are AFUA_2G09110 (palA) and AFUA_8G01930 (vipC). palA encodes for a phenylalanine 
ammonia lyase (PAL) which catalyses the breakdown of phenylalanine into ammonia and trans-
84 
 
cinnamic acid (Camm and Towers, 1973). PAL is of much interest in plants due it its role in 
producing phenyl propanoid compounds, which function in a variety of cellular processes, most 
prominently in defence against pathogens (Zhang and Liu , 2015). However, PAL has not been 
characterised in fungi beyond catabolism of phenylalanine for carbon and nitrogen utilisation 
(Hyun et al., 2011). PAL is thus an intriguing enzyme in A. fumigatus in the context of 
investigating EGT, as PAL has been demonstrated to produce phenyl propanoid molecules in 
plants that have antioxidant properties (Korkina, 2007). PAL may therefore represent a novel 
facet of oxidative stress defence in fungi. Furthermore, Muramatsu et al. (2013) reported an 
ergothionase from Burkholderia sp. HME13 with 17 % similarity to PAL. PAL may therefore 
function in EGT catabolism, which has not been observed in fungi previously.  
VipC is a SAM-dependant methyltransferase which has been demonstrated to regulate the switch 
between sexual and asexual reproduction in A. nidulans. VipC responds to environmental signals 
such as a light and interacts with the nuclear velvet complex to regulate the transcription of genes 
promoting sexual or asexual development (Sarikaya-Bayram et al., 2014). VipC function has not 
been elucidated in A. fumigatus and it is difficult to predict how it might function compared to its 
well characterised role in A. nidulans due to the differences in sexual development between the 
two Aspergilli. While sexual development is readily activated in A. nidulans when grown in the 
absence of light, A. fumigatus requires very specific conditions to activate sexual development 
(O’Gorman et al., 2009). VipC may still regulate asexual development in A. fumigatus however, 
as it is the dominate life cycle observed. EGT has been demonstrated to influence conidiation in 
N. crassa, with Δegt-1 exhibiting reduced conidiation and conidial survival (Bello et al., 2012, 
2014) Furthermore, EGT is speculated to influence SAM/SAH levels. As a trimethylated 
metabolite, EGT biosynthesis interacts significantly with the SAM/SAH cycle as the 
biosynthesis of 1 mol of EGT requires 3 mol of SAM. Abrogation of EGT biosynthesis may 
therefore disrupt SAM/SAH ratios. As a SAM-dependant methyltransferase, VipC is likely 
sensitive to alterations in SAM/SAH levels. Thus, analysis of VipC in A. fumigatus may 
contribute to characterisation of EGT function. 
In order to investigate these genes and their products, a strategy of gene deletion was 
implemented. Gene deletion is a valuable tool that has been used to study the functions of genes 
in filamentous fungi such as A. fumigatus (Wiemann and Keller, 2014). Through analysis of any 
85 
 
phenotypes that are observed in the absence of the gene, the function of the gene can be inferred. 
This reverse genetic analysis has been used several times in the past to elucidate gene function, 
for example with the regulator of secondary metabolism, laeA (Bok and Keller, 2004). Gene 
deletion strategies commonly involve replacing or disrupting the gene of interest with a selection 
marker. Auxotrophic markers can be used in background strains which have been engineered to 
have an autotrophy. An example of this is the pyrG gene (Weidner et al., 1998), which can be 
used as a selection marker in uracil/uradine auxotrophs. Alternatively, anti-fungal drug resistance 
genes such as ptrA and hph can be used as selection markers. The ptrA gene provides resistance 
to pyrithiamine, while hph endows resistance to hygromycin (Cullen et al., 1987; Kubodera et 
al., 2002). 
A bipartite gene deletion strategy was employed in this study. The bipartite gene deletion method 
allows for targeted deletion or disruption of genes. This method involves two constructs, which 
consist of either the 5’ or 3’ flanking region of the gene of interest fused to a fragment of a 
selection marker. The two fragments of the selection marker on either construct overlap, which 
serves as a site for homologous recombination. These constructs are transformed into A. 
fumigatus protoplasts using polyethylene glycol (PEG) and CaCl2. Upon transformation, 
homologous recombination of the constructs with the flanking regions of the gene of interest 
causes a third recombination event within the overlapping segment of the selection marker. This 
results in an intact selection marker gene, in place of the gene of interest (Figure 3.2).  
As two targeted recombination events are required in order for integration of an intact selection 
marker into the target genome, the rate of false positives is reduced. Thus, this method is more 
efficient than single construct deletion strategies (Nielsen et al., 2006). Following gene deletion 
is important to complement the mutant by reinserting the gene. This ensures that any phenotypes 
observed can be attributed to the loss of the gene, and not the expression of the selection marker. 
 
 
 
 
86 
 
 
Figure 3.2. Schematic representation of the bipartite method of gene deletion used in this study. 
ptrA is used as an example of a selection marker.  
The objectives of the work presented in this chapter were to: 
(i) Identify EGT biosynthetic genes in A. fumigatus via bioinformatic analysis. 
(ii) Generate gene deletion mutants and complemented strains in A. fumigatus 
ATCC26933 for the EGT biosynthetic genes identified in (i). Furthermore, generate 
deletion mutants for vipC and palA in A. fumigatus ATCC26933. Additionally it was 
hypothesised the generation of an EGT null mutant in a gliK background could yield 
useful information.   
(iii) Confirm all gene deletions and completed strains by semi-quantitative RT-PCR. 
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3.2   Results 
3.2.1  Bioinformatic identification of EGT biosynthetic genes in A. fumigatus 
3.2.1.1  Identification of A. fumigatus egtA  
BLAST searches (http://blast.ncbi.nlm.nih.gov/Blast.cgi) revealed AFUA_2G15650 to be a 
possible homologous enzyme to M. smegmatis EgtB and EgtD in A. fumigatus. 
AFUA_2G15650, annotated as DUF323, also had homology to NCU04343 (Egt-1) in N. crassa, 
and SPBC1604.01 (Egt1) in S. pombe. AFUA_2G15650 was therefore renamed EgtA.  In A. 
fumigatus, EgtA comprises 844 amino acids, has domains of a histidine-specific SAM-dependent 
methyltransferase at the N-terminal end, a sulphatase-modifying factor enzyme 1 at the C-
terminal end and an intervening 5-histidylcysteine sulphoxide synthase domain (Figure 3.3). 
EgtA shows 82 % similarity with S. pombe Egt1, 80 % similarity with N. crassa Egt-1, 38 % 
similarity with M. smegmatis EgtB and 28 % similarity with M. smegmatis EgtD (Figure 3.4). 
The egtA genomic sequence is 2890 bp long and contains six introns 
(http://www.aspergillusgenome.org/cgi-
bin/locus.pl?locus=AFUA_2g15650&organism=A_fumigatus_Af293).  
 
 
Figure 3.3. EgtA domain architecture, 844 amino acids in length. Domains include a 
methyltransferase domain at the N-terminal end, a sulphatase-modifying factor enzyme 1 at the 
C-terminal and an internal 5’-histidylcysteine sulphoxide synthase domain.  
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Figure 3.4. Alignment of A. fumigatus EgtA (AFUA_2G15650), N.crassa Egt-1 (NCU04343), S. 
pombe Egt1 (SPBC1604.01) and M. smegmatis EgtD (MSMEG_6247) and EgtB 
(MSMEG_6249). 
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3.2.1.2 Identification of egtB and nfs1 as putative EGT biosynthetic genes in A. 
fumigatus 
BLAST searches (http://blast.ncbi.nlm.nih.gov/Blast.cgi) revealed AFUA_2G13295 as a possible 
homologous enzyme to M. smegmatis EgtE (MSMEG_6246) and S. pombe Egt2 
(SPBC660.12c). AFUA_2G13295, annotated as a putative aminotransferase, was therefore 
renamed EgtB. A. fumigatus EgtB is 453 amino acids in length and contains a cysteine 
desulphurase domain as well as a PLP-binding pocket. (Figure 3.5). EgtB shows 30 % similarity 
with S. pombe Egt2 and 27 % similarity with M. smegmatis EgtE (Figure 3.6). The egtB genomic 
sequence is 1510 bp long and contains two introns (http://www.aspergillusgenome.org/cgi-
bin/locus.pl?dbid=ASPL0000362536). 
 
Figure 3.5. EgtB domain architecture, 453 amino acids in length. Domains include a cysteine 
desulphurase domain, which itself contains a PLP-binding pocket. 
As is it has been demonstrated in both M. smegmatis and S. pombe that the cysteine desulphurase 
step in EGT biosynthesis can be carried out non-specifically, a second enzyme, Nfs1 
(AFUA_3G14240), was identified as a possible alternative candidate for completing the final 
step of EGT biosynthesis. Nfs1 has 26 % similarity to A. fumigatus EgtB, 28 % similarity with 
M. smegmatis EgtE and 23 % similarity with S. pombe Egt2 (Figure 3.6), and like EgtB, contains 
cysteine desulphurase and PLP-binding domains (http://www.aspergillusgenome.org/cgi-
bin/locus.pl?locus=AFUA_3G14240&organism=A_fumigatus_Af293). 
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Figure 3.6. Alignment of A. fumigatus EgtB (AFUA_2G13295), S. pombe Egt2 (SPBC660.12c). 
A. fumigatus Nfs1 (AFUA_3G14240), and M. smegmatis EgtE (MSMEG_6246). 
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3.2.2  Generation of A. fumigatus egtA deletion and complemented strains 
3.2.2.1  Generation of deletion constructs for transformation of egtA 
In order to investigate the function of egtA (AFUA_2G15650), a gene deletion strategy was 
employed (Figure 3.7). Protoplast transformations were performed using the background strain 
ATCC26933. This background was chosen due to the high amounts of gliotoxin it produces 
(Schrettl et al., 2010). ATCC26933 was transformed with two DNA constructs, each of which 
contained an incomplete fragment of the pyrithiamine resistance gene (ptrA) released from the 
plasmid pSK275 via restriction digest. These fragments were fused to 1090 bp and 1066 bp of 5’ 
and 3’ egtA flanking sequences respectively. The fragments shared an overlapping region of the 
ptrA gene spanning 561 bp, allowing for recombination of the complete cassette upon 
transformation. Homologous recombination of the flanking region in each fragment allowed for 
targeted disruption of the egtA gene with the intact ptrA gene. Due to the size of egtA, a small 
fragment of the 3’ section of the gene remained following the deletion transformation (Figure 
3.7).  
To aid generation of the deletion constructs, an egtA deletion mutant in the AfS77 strain (A kind 
gift from Professor Hubertus Haas, Innsbruck, Austria) was used as a template for PCR. The 
AfS77 strain is a ΔakuA::loxP derivative of ATCC46645 (Hartmann et al., 2010), which 
produces low levels of gliotoxin. For this reason it was unsuitable for this study, however using it 
as a template for PCR allowed for the generation of deletion constructs with a single round of 
PCR (Figure 3.7) when two rounds are normally necessary (Section 2.2.4.1).  
The 5’ deletion construct was amplified by PCR, using primers egtA1 and oAoptrA1, for a 
product of 2022 bp (Figure 3.8). The 3’ deletion construct was amplified similarly, using primers 
egtA4 and oAoptrA 2, for a product of 2476 bp (Figure 3.8). The products were gel purified 
(Section 2.2.3.8.3) to ensure no non-specific products were present.  
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Figure 3.7. A schematic representation of the bipartite strategy for the deletion of egtA in A. 
fumigatus ATCC26933, using ptrA as a selection marker.  
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Figure 3.8. Final egtA gene deletion constructs. Lane L: NEB 1 kb DNA Ladder (Section 
2.1.7.6). Lane 1: PCR 1 (2022 bp), the 5’ flanking region of egtA fused to a partial fragment of 
the ptrA selection marker. Lane 2: PCR 2 (2427 bp), the 3’ flanking region of of egtA fused to a 
partial fragment of the ptrA selection marker. 
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3.2.2.2 Generation of 5’ DIG-labelled probe by PCR for ΔegtA transformant 
identification  
A single 5’ upstream probe was prepared by PCR amplification for use in Southern blot analysis. 
The probe was generated using DIG-labelled nucleotides, which allowed for detection during 
Southern blot analysis (Section 2.2.5.1). A 5’ probe was made using primers egtA2 and egtA5 
which amplified a 1090 bp region just upstream of egtA (Figure 3.9). 
 
 
 
Figure 3.9. Generation of DIG-labelled nucleotide probe which facilitated ΔegtA detection with 
Southern blot analysis. Lane L: NEB 1 kb DNA Ladder (Section 2.1.7.6).  Lane 1: egtA 5’ DIG 
labelled nucleotide probe. Lane 2: positive control using standard dNTPs.  
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3.2.2.3   Deletion of egtA in A. fumigatus ATCC26933 
The egtA deletion constructs from Section 3.2.2.1 were transformed into A. fumigatus 
ATCC26933 protoplasts, which were prepared as described in section 2.2.4.3. Approximately 3 
μg total of 5’ and 3’ construct was used per transformation event. The transformation procedure 
was carried out as described in Section 2.2.4.4. Transformants were selected on agar plates 
containing pyrithiamine (100 ng/ml). Colonies with the ability to grow on these plates were 
predicted to have an intact ptrA gene incorporated into their genome, and thus considered 
potential ΔegtA transformants. 
Following the transformation event, 23 colonies were observed on pyrithiamine selection plates. 
Genomic DNA from 10 of these colonies was digested using SphI restriction endonuclease. 
These were screened by Southern analysis (section 2.2.5) using a 5’ probe (Section 3.2.2.2). The 
Southern strategy used to confirm egtA deletion is outlined in Figure 3.10. The mutant band 
(2045 bp) was present in transformant 2 (Figure 3.11). This colony was selected for single spore 
isolation (Section 2.2.4.8). Eight single spore isolates of transformant 2 were digested with SphI 
and a second round of Southern blot analysis using the 5’ probe was performed. All eight isolates 
displayed the correct band for egtA deletion, confirming a single integration of the ptrA gene in 
place of egtA (Figure 3.12). 
 
Figure 3.10. A schematic of the Southern blot strategy employed to detect the deletion of egtA. 
DNA was digested using SphI restriction endonuclease. The digested DNA was screened using a 
5’ probe. A correct gene deletion event would result in a band of 2045 bp in length. Wild-type 
SphI digested DNA would result in a band of 6769 bp in length.  
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Figure 3.11. Southern Analysis of potential egtA deletion mutants in A. fumigatus strain 
ATCC26933 using a 5’ probe. Successful deletion of egtA was indicated by the presence of a 
single 2045 bp band. Lane L: Roche Molecular Weight Ladder VII, DIG labelled (Section 
2.1.7.6). Lanes 1-10: Potential ΔegtA transformants. Lane PC: ΔegtAAfS77 (2045 bp). Lane WT: 
ATCC26933 (6769 bp). Transformant 2 displays the correct band for the ΔegtA genotype.  
 
 
 
Figure 3.12. Southern Analysis of single spore isolates of a potential egtA deletion mutant using 
a 5’ probe. Successful deletion of egtA was indicated by the presence of a single 2045 bp band. 
Lane L: Roche Molecular Weight Ladder VII, DIG labelled (Section 2.1.7.6). Lanes 1-8: Single 
spore isolates. Lane PC: ΔegtAAfS77 (2045 bp). Lane WT: ATCC26933 (6769 bp). All single 
spore isolates display the correct band for the ΔegtA genotype.  
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3.2.2.4  Generation of the egtA complementation construct 
Once egtA had been successfully deleted it was necessary to reintroduce the gene into the 
genome of ΔegtA26933. This ensured that any phenotypes observed could be solely attributed to 
the deletion of egtA. The egtA complementation strategy is outlined in Figure 3.13. To 
complement ΔegtA, a PCR fragment containing the egtA locus, including promoter and 
terminator, was amplified using primers egtA5 and egtA6 (Figure 3.14). This was then inserted 
into the pCR® 2.1-TOPO vector, to create pegtA. Insertion of egtA was confirmed by colony 
PCR (Figure 3.15) and restriction digest (Figure 3.116). The pegtA vector was linearised using 
AatII and co-transformed into the ΔegtA mutant alongside pAN7.1, which contains the hph 
selection marker for hygromycin resistance. 
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Figure 3.13. A schematic representation of the complementation strategy for the re-insertion of 
egtA in A. fumigatus ΔegtA26933, using hph as a selection marker.  
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Figure 3.14. Amplification of egtA, including 5’ and 3’ flanking regions, for TOPO cloning. 
Lane L: NEB 1 kb DNA Ladder (Section 2.1.7.6).  Lane 1: Amplified egtA gene and flanking 
regions (4079 bp).  
 
Figure 3.15. Colony PCR of transformed E. coli TOP10 cells to test for insertion of egtA and 
flanking regions into the pCR®2.1-TOPO vector. Lane L: NEB 1 kb DNA Ladder (Section 
2.1.7.6). Lanes 1 – 7: Transformed colonies Lane PC: gDNA positive control. Lane NC: 
Negative control.  
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Figure 3.16. Restriction digest with BssHII to check the orientation of egtA and flanking region 
insert in the pegtA plasmid. A 5’ – 3’ insertion was indicated by two bands, 6324 bp and 1658 bp 
in length. Lane L: NEB 1 kb DNA Ladder (Section 2.1.7.6). Lane NC: empty pCR®2.1-TOPO 
vector digested with BssHII (3931 bp). Lane 1: pegtA digested with BssHII (6324 bp and 1658 
bp).  
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3.2.2.5 Generation of 3’ DIG-labelled probe by PCR for egtAC transformant 
identification  
The 5’ probe used to detect ΔegtA (Section 3.2.2.2) was unsuitable for detecting egtAC so it was 
necessary to generate a 3’ probe. The probe was generated using DIG-labelled nucleotides as 
before and was made using primers egtA4 and egtA6 which amplified a 1066 bp region just 
downstream of egtA (Figure 3.17) 
 
.  
Figure 3.17. Generation of DIG-labelled nucleotide probe which facilitated ΔegtA and egtAC 
detection with Southern blot analysis. Lane L: NEB 1 kb DNA Ladder (Section 2.1.7.6).  Lane 1: 
egtA 3’ DIG labelled nucleotide probe. Lane 2: positive control using standard dNTPs.  
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3.2.2.6  Southern blot analysis of transformants from A. fumigatus egtA 
complementation 
Figure 3.18 illustrates the Southern strategy employed to confirm egtA complementation. 86 
colonies were observed on the hygromycin plates. These were screened via Southern blot in 
groups of 20. Genomic DNA from these potential transformants was digested with BamHI and 
probed with the 3’ probe (Section 3.2.2.5). Southern analysis (Section 2.2.5) identified one 
tranformant which showed the correct banding pattern (2087 bp & 6467 bp) for 
complementation of egtA (Figure 3.19).  
 
 
 
Figure 3.18. A schematic of the Southern blot strategy employed to detect re-insertion of egtA 
into ΔegtA26933. DNA was digested using BamHI. The digested DNA was screened using a 3’ 
probe. A correct gene insertion event would result in bands of 2087 bp and 6467 bp. ΔegtA26933 
BamHI digested DNA would result in a band of 2087 bp. Wild-type BamHI digested DNA 
would result in a band of 3651 bp.  
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Figure 3.19. Southern Analysis of potential egtA
C
 transformants in A. fumigatus ΔegtA26933 using 
a 3’ probe. Successful insertion of egtA was indicated by the presence of two bands, 2087 bp and 
6467 bp. Lane L: Roche Molecular Weight Ladder VII, DIG labeled (Section 2.1.7.6). Lane WT: 
ATCC26933 (6467 bp). Lane Δ: ΔegtA26933 (2087 bp). Lanes 1-10: Potential egtA
C
 
transformants. Transformant 6 displays the correct banding pattern for the egtA
C
 genotype.  
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3.2.2.7  Semi-quantitative RT-PCR Analysis of egtA expression in ΔegtA26933 and 
egtA
C26933 
The deletion of A. fumigatus egtA from ATCC26933 and its subsequent complementation was 
confirmed by Southern analysis. Semi-quantitative RT-PCR (section 2.2.6.4) was employed to 
confirm that the deletion of egtA resulted in the cessation of egtA expression and that the 
restoration of egtA expression was evident in egtA
C26933
. Both wild-type and mutant strains were 
cultured in Sabouraud Dextrose liquid broth and incubated at 37 °C for 24 h. Total RNA was 
extracted and subjected to cDNA synthesis (Section 2.2.6.4). RT-PCR was carried out using the 
primers QPCR egtA F and QPCR egtA R (Table 2.5). Expression of egtA was evident in A. 
fumigatus wild-type and egtA
C26933
 and absent from ΔegtA26933. This confirmed that egtA 
expression was abrogated by egtA deletion and restored in the complemented strain (Figure 
3.20). 
 
 
Figure 3.20. Confirmation of the absence of egtA expression in A. fumigatus ΔegtA26933 and its 
restoration in egtA
C26933
 by semi-quantitative RT-PCR (n = 2 biological replicates per condition). 
calm is used as cDNA control (Burns et al., 2005). gDNA was used as a positive control. NC: 
negative control; no cDNA or DNA present in amplification reactions. 
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3.2.3  Generation of an egtB deletion strain in A. fumigatus ATCC26933  
3.2.3.1  Generation of deletion constructs for transformation of egtB 
A gene deletion strategy was employed to investigate the function of egtB (AFUA_2G13295) 
(Figure 3.21). Protoplast transformations were performed using the background strain 
ATCC26933. As before, this is due to the high levels of gliotoxin produced. It would also allow 
for a comparison with ΔegtA26933. As with the deletion of egtA (Section 3.2.2.1), ATCC26933 
was transformed with two DNA constructs which comprised of either the 5’ or 3’ flanking 
sequence of egtB fused to an incomplete fragment of the ptrA gene. The 5’ construct consisted of 
1459 bp of upstream flanking region fused to 1527 bp of ptrA fragment. The 3’ construct 
consisted of 1337 bp of downstream flanking region fused to 1083 bp of ptrA fragment. The two 
constructs shared 561 bp of overlap within the ptrA gene, which served as a site for homologous 
recombination.  
The two fragments were generated using two round of PCR. The 5’ and 3’ flanking regions of 
egtB were amplified from ATCC26933 genomic DNA. The 5’ flanking region was amplified 
using the primers egtB1 and egtB2 (1560 bp), while the 3’ flanking region was amplified using 
the primers egtB4 and egtB5 (1509 bp) (Figure 3.22). The flanking regions were excised using 
gel purification (section 2.2.3.8.3) and digested using SpeI (5’ region) and HindIII (3’ region). 
The ptrA selection marker was released from plasmid pSK275 by digestion with SpeI and 
HindIII (Figure 3.23), and ligated with the two digested flanking regions. The final deletion 
constructs were amplified from the ligation product using primers egtB3 and PTRoptrA2 for the 
5’ construct (2989 bp) and primers egtB6 and PTRoptrA1 for the 3’ construct (2420 bp) (Figure 
3.24). The products were gel purified (Section 2.2.3.8.3) to ensure no non-specific products were 
present.  
 
 
 
 
106 
 
 
Figure 3.21. A schematic representation of the bipartite strategy for the deletion of egtB in A. 
fumigatus ATCC26933, using ptrA as a selection marker.  
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Figure 3.22. PCR products of the flanking regions of egtB. Lane L: NEB 1 kb DNA Ladder 
(Section 2.1.7.6).  Lane 1: PCR 1 (1560 bp), the 5’ flanking region of egtB. Lane 2: PCR 2 (1509 
bp), the 3’ flanking region of egtB. 
 
Figure 3.23. Restriction digest of the pSK275 plasmid with SpeI and HindIII to release ptrA. 
Lane L: NEB 1 kb DNA Ladder (Section 2.1.7.6).  Lane 1: pSK275 digested with SpeI and 
HindIII , releasing ptrA (2045 bp).  
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Figure 3.24. Final egtB gene deletion constructs. (A) Lane L: NEB 1 kb DNA Ladder (Section 
2.1.7.6). Lane 1: PCR 3 (2986 bp), the 5’ flanking region of egtB fused to a partial fragment of 
the ptrA selection marker. (B) Lane L: NEB 1 kb DNA Ladder (Section 2.1.7.6). Lane 1: PCR 4 
(2420 bp), the 3’ flanking region of egtB fused to a partial fragment of the ptrA selection marker.  
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3.2.3.2 Generation of 3’ DIG-labelled probe by PCR for ΔegtB transformant 
identification  
A single 3’ downstream probe was prepared by PCR amplification for use in Southern blot 
analysis. The probe was generated using DIG-labelled nucleotides, which allowed for detection 
during Southern blot analysis (Section 2.2.5). A 3’ probe was made using primers egtB4 and 
egtA6 which amplified a 1358 bp region just downstream of egtB (Figure 3.25). 
 
 
 
Figure 3.25. Generation of DIG-labelled nucleotide probe which facilitated ΔegtB detection with 
Southern blot analysis. Lane L: NEB 1 kb DNA Ladder (Section 2.1.7.6).  Lane 1: egtB 3’ DIG 
labelled nucleotide probe. Lane 2: positive control using standard dNTPs.  
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3.2.3.3   Deletion of egtB in A. fumigatus ATCC26933 
The egtB deletion constructs from Section 3.2.3.1 were transformed into A. fumigatus 
ATCC26933 protoplasts, which were prepared as described in section 2.2.4.3. Approximately 3 
μg total of 5’ and 3’ construct was used per transformation event. The transformation procedure 
was carried out as described in Section 2.2.4.4. Transformants were selected on agar plates 
containing pyrithiamine (100 ng/ml). Colonies with the ability to grow on these plates were 
predicted to have an intact ptrA gene incorporated into their genome, and thus considered 
potential ΔegtB transformants. 
Following the transformation event, 11 colonies were observed on pyrithiamine selection plates. 
Genomic DNA from these colonies was digested using pspOMI. These were screened by 
Southern analysis (section 2.2.5) using a 3’ probe (Section 3.2.3.3). The Southern strategy used 
to confirm egtB deletion is outlined in Figure 3.26. The mutant band (2288 bp) was present in 
transformants 3 and 11 (Figure 3.27), meaning these two transformants were potential ΔegtB 
mutants. 
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Figure 3.26. A schematic of the Southern blot strategy employed to detect the deletion of egtB. 
DNA was digested using pspOMI. The digested DNA was screened using a 3’ probe. A correct 
gene deletion event would result in a band of 2288 bp. Wild-type pspOMI digested DNA would 
result in a band of 5826 bp.  
 
Figure 3.27. Southern Analysis of potential egtB deletion mutants in A. fumigatus strain 
ATCC26933 using a 3’ probe. Successful deletion of egtB was indicated by the presence of a 
single 2288 bp band. Lane L: Roche Molecular Weight Ladder VII, DIG labelled (Section 
2.1.7.6). Lane WT: ATCC26933 (5826 bp). Lanes 1-11: Possible ΔegtB transformants. 
Transformants 3 and 11 display the correct band for the ΔegtB genotype.  
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3.2.3.4 Semi-quantitative RT-PCR Analysis of egtB expression in ΔegtB 
transformants
 
The deletion of A. fumigatus egtB from ATCC26933 was detected by Southern analysis in two 
transformants, 3 & 11. Semi-quantitative RT-PCR (section 2.2.6.5) was employed to confirm 
that the deletion of egtB resulted in the cessation of egtB expression in the two transformants. 
Both wild-type and mutant strains were cultured in Sabouraud Dextrose liquid broth and 
incubated at 37 °C for 24 h. Total RNA was extracted and subjected to cDNA synthesis (Section 
2.2.6.3). RT-PCR was carried out using the primers QPCR egtB F and QPCR egtB R (Table 2.5). 
Expression of egtB was evident in A. fumigatus wild-type and egtB transformant 11 and absent 
from ΔegtB transformant 3 (Figure 3.28). This confirmed that egtB expression was abrogated by 
egtB deletion in transformant 3. Transformant 11 was discarded as it continued to express egtB. 
 
 
 
Figure 3.28. Confirmation of the absence of egtB expression in A. fumigatus ΔegtB transformant 
3, but not transformant 11, by semi-quantitative RT-PCR (n = 2 biological replicates per 
condition). calm is used as cDNA control (Burns et al., 2005). gDNA was used as a positive 
control. NC: negative control; no cDNA or DNA present in amplification reactions. 
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3.2.4  Generation of a vipC deletion strain in A. fumigatus ATCC26933 
3.2.4.1  Generation of deletion constructs for transformation of vipC 
A gene deletion strategy was employed to investigate the function of vipC (AFUA_8G01930) 
(Figure 3.29). Protoplast transformations were performed using the background strain 
ATCC26933, as this allow for a comparison with ΔegtA26933 and ΔegtB26933. Following the same 
strategy as the previous transformations, ATCC26933 was transformed with two DNA constructs 
which comprised of either the 5’ or 3’ flanking sequence of vipC fused to an incomplete 
fragment of the ptrA gene. The 5’ construct consisted of 1301 bp of upstream flanking region 
fused to 1527 bp of ptrA fragment. The 3’ construct consisted of 1031 bp of downstream 
flanking region fused to 1083 bp of ptrA fragment. The two constructs shared 561 bp of overlap 
within the ptrA gene, which would serve as a site for homologous recombination. 
The two fragments were generated using two round of PCR. The 5’ and 3’ flanking regions of 
vipC were amplified from ATCC26933 genomic DNA. The 5’ flanking region was amplified 
using the primers vipC1 and vipC2 (1617 bp), while the 3’ flanking region was amplified using 
the primers vipC4 and vipC5 (1536 bp) (Figure 3.30). The flanking regions were excised using 
gel purification (section 2.2.3.8.3) and digested using SpeI (5’ region) and HindIII (3’ region). 
The ptrA selection marker was released from plasmid pSK275 by digestion with SpeI and 
HindIII (Figure 3.30), and ligated with the two digested flanking regions. The final deletion 
constructs were amplified from the ligation product using primers vipC3 and oAoptrA2 for the 5’ 
construct (2828 bp) and primers vipC6 and oAoptrA1 for the 3’ construct (2114 bp) (Figure 
3.31). The products were gel purified (Section 2.2.3.8.3) to ensure no non-specific products were 
present.  
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Figure 3.29. A schematic representation of the bipartite strategy for the deletion of vipC in A. 
fumigatus ATCC26933, using ptrA as a selection marker.  
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Figure 3.30. Restriction digest of the pSK275 plasmid with SpeI and HindIII to release the ptrA 
gene and PCR products of the flanking regions of vipC. Lane L: NEB 1 kb DNA Ladder (Section 
2.1.7.6).  Lanes 1 & 2: pSK275 digested with SpeI and HindIII , releasing ptrA (2045 bp). Lanes 
3 & 4: PCR 1 (1617 bp), the 5’ flanking region of vipC. Lanes 5 & 6: PCR 2 (1536 bp), the 3’ 
flanking region of vipC.  
 
Figure 3.31. Final vipC gene deletion constructs. Lane L: NEB 1 kb DNA Ladder (Section 
2.1.7.6). Lanes 1 - 3: PCR 3 (2828 bp), the 5’ flanking region of vipC fused to a partial fragment 
of the ptrA selection marker. Lanes 4 - 6: PCR 4 (2114 bp), the 3’ flanking region of vipC fused 
to a partial fragment of the ptrA selection marker.  
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3.2.4.2 Generation of 5’ DIG-labelled probe by PCR for ΔvipC transformant 
identification  
A single 3’ downstream probe was prepared by PCR amplification for use in Southern blot 
analysis. The probe was generated using DIG-labelled nucleotides, which allowed for detection 
during Southern blot analysis (Section 2.2.5). A 3’ probe was made using primers vipC1 and 
vipC3 which amplified a 1402 bp region just downstream of egtB (Figure 3.32). 
 
Figure 3.32. Generation of DIG-labelled nucleotide probe which facilitated ΔvipC detection with 
Southern blot analysis. Lane L: NEB 1 kb DNA Ladder (Section 2.1.7.6).  Lane 1: vipC 5’ DIG 
labelled nucleotide probe. Lane 2: positive control using standard dNTPs.  
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3.2.4.3   Deletion of vipC in A. fumigatus ATCC26933 
The vipC deletion constructs from Section 3.2.4.1 were transformed into A. fumigatus 
ATCC26933 protoplasts, which were prepared as described in section 2.2.4.3. Approximately 3 
μg total of 5’ and 3’ construct was used per transformation event. The transformation procedure 
was carried out as described in Section 2.2.4.4. Transformants were selected on agar plates 
containing pyrithiamine (100 ng/ml). Colonies with the ability to grow on these plates were 
predicted to have an intact ptrA gene incorporated into their genome, and thus considered 
potential ΔvipC transformants. 
Following the transformation event, 29 colonies were observed on pyrithiamine selection plates. 
Genomic DNA from 10 of these colonies was digested using EcoRI. These were screened by 
Southern analysis (section 2.2.5) using a 5’ probe (Section 3.2.4.2). The Southern strategy used 
to confirm vipC deletion is outlined in Figure 3.33. The mutant band (5880 bp) was present in 
transformant 9 (Figure 3.34), meaning this transformant is a potential ΔvipC mutant. 
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Figure 3.33. A schematic of the Southern blot strategy employed to detect the deletion of vipC. 
DNA was digested using EcoRI. The digested DNA was screened using a 5’ probe. A correct 
gene deletion event would result in a band of 1458 bp. Wild-type EcoRI digested DNA would 
result in a band of 5880 bp.  
 
Figure 3.34. Southern Analysis of potential vipC deletion mutants in A. fumigatus strain 
ATCC26933 using a 5’ probe. Successful deletion of vipC was indicated by the presence of a 
single 1458 bp band. Lane L: Roche Molecular Weight Ladder VII, DIG labelled (Section 
2.1.7.6). Lane WT: ATCC26933 (5880 bp). Lanes 1-10: Potential ΔvipC transformants. 
Transformant 9 displays the correct band for the vipC genotype.  
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3.2.4.4  Semi-quantitative RT-PCR Analysis of vipC expression in ΔvipC26933 
The deletion of A. fumigatus vipC from ATCC26933 was detected by Southern analysis in a 
single transformant. Semi-quantitative RT-PCR (section 2.2.6.4) was employed to confirm that 
the deletion of the vipC gene abrogated expression of vipC.  Both wild-type and mutant strains 
were cultured in Sabouraud Dextrose liquid broth and incubated at 37 °C for 24 h. Total RNA 
was extracted and subjected to cDNA synthesis (Section 2.2.6.3). RT-PCR was carried out using 
the primers QPCR vipC F and QPCR vipC R (Table 2.5). Expression of vipC was present in A. 
fumigatus wild-type and absent from ΔvipC (Figure 3.35). This confirmed deletion of vipC in 
ΔvipC26933. 
 
 
 
Figure 3.35. Confirmation of the absence of vipC expression in A. fumigatus ΔvipC by semi-
quantitative RT-PCR (n = 2 biological replicates per condition). calm is used as cDNA control 
(Burns et al., 2005). gDNA was used as a positive control. NC: negative control; no cDNA or 
DNA present in amplification reactions. 
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3.2.5  Generation of a palA deletion strain in A. fumigatus ATCC26933 
3.2.5.1  Generation of deletion constructs for transformation of palA 
A gene deletion strategy was employed to investigate the function of palA (AFUA_2G09110) 
(Figure 3.36). Protoplast transformations were performed using the background strain 
ATCC26933, as this allow for a comparison with ΔegtA26933 and ΔegtB26933. As before, 
ATCC26933 was transformed with two DNA constructs which comprised of either the 5’ or 3’ 
flanking sequence of palA fused to an incomplete fragment of the ptrA gene. The 5’ construct 
consisted of 1292 bp of upstream flanking region fused to 1527 bp of ptrA fragment. The 3’ 
construct consisted of 1098 bp of downstream flanking region fused to 1119 bp of ptrA fragment. 
The two constructs shared 561 bp of overlap within the ptrA gene, served as a site for 
homologous recombination. 
The two fragments were generated using two round of PCR. The 5’ and 3’ flanking regions of 
palA were amplified from ATCC26933 genomic DNA. The 5’ flanking region was amplified 
using the primers palA1 and palA2 (1489 bp), while the 3’ flanking region was amplified using 
the primers palA4 and palA5 (1430 bp) (Figure 3.37). The flanking regions were excised using 
gel purification (section 2.2.3.8.3) and digested using SpeI (5’ region) and KpnI (3’ region). The 
ptrA selection marker was released from plasmid pSK275 by digestion with SpeI and KpnI 
(Figure 3.38), and ligated with the two digested flanking regions. The final deletion constructs 
were amplified from the ligation product using primers palA3 and oAoptrA2 for the 5’ construct 
(2819 bp) and primers palA6 and oAoptrA1 for the 3’ construct (2217 bp) (Figure 3.39). The 
products were gel purified (Section 2.2.3.8.3) to ensure no non-specific products were present.  
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Figure 3.36. A schematic representation of the bipartite strategy for the deletion of palA in A. 
fumigatus ATCC26933, using ptrA as a selection marker.  
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Figure 3.37. PCR products of the flanking regions of palA. Lane L: NEB 1 kb DNA Ladder 
(Section 2.1.7.6).  Lane 1: PCR 1 (1489 bp), the 5’ flanking region of palA. Lane 2: PCR 2 (1430 
bp),the 3’ flanking region of palA. 
.  
Figure 3.38. Restriction digest of the pSK275 plasmid with SpeI and KpnI to release the ptrA 
gene. Lane L: NEB 1 kb DNA Ladder (Section 2.1.7.6).  Lanes 1 & 2: pSK275 digested with 
SpeI and HindIII , releasing ptrA (2085 bp).  
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Figure 3.39. Final palA gene deletion constructs. (A) Lane L: NEB 1 kb DNA Ladder (Section 
2.1.7.6). Lanes 1 & 2: PCR 3 (2819 bp), the 5’ flanking region of palA fused to a partial 
fragment of the ptrA selection marker. (B) Lane L: NEB 1 kb DNA Ladder (Section 2.1.7.6). 
Lanes 1 & 2: PCR 4 (2217 bp), the 3’ flanking region of palA fused to a partial fragment of the 
ptrA selection marker.  
 
 
 
 
 
 
 
 
124 
 
3.2.5.2 Generation of 3’ DIG-labelled probe by PCR for ΔpalA transformant 
identification  
A single 3’ downstream probe was prepared by PCR amplification for use in Southern blot 
analysis. The probe was generated using DIG-labelled nucleotides, which allowed for detection 
during Southern blot analysis (Section 2.2.5). A 3’ probe was made using primers palA4 and 
palA6 which amplified a 1402 bp region just downstream of palA (Figure 3.40). 
 
Figure 3.40. Generation of DIG-labelled nucleotide probe which facilitated ΔpalA detection with 
Southern blot analysis. Lane L: NEB 1 kb DNA Ladder (Section 2.1.7.6).  Lane 1: palA 3’ DIG 
labelled nucleotide probe. Lane 2: positive control using standard dNTPs.  
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3.2.5.3  Deletion of palA in A. fumigatus ATCC26933 
The palA deletion constructs from Section 3.2.5.1 were transformed into A. fumigatus 
ATCC26933 protoplasts, which were prepared as described in section 2.2.4.3. Approximately 3 
μg total of 5’ and 3’ construct was used per transformation event. The transformation procedure 
was carried out as described in Section 2.2.4.4. Transformants were selected on agar plates 
containing pyrithiamine (100 ng/ml). Colonies with the ability to grow on these plates were 
predicted to have an intact ptrA gene incorporated into their genome, and thus considered 
potential ΔpalA transformants. 
Following the transformation event, 24 colonies were observed on pyrithiamine selection plates. 
Genomic DNA from 12 of these colonies was digested using BamHI. These were screened by 
Southern analysis (section 2.2.5) using a 3’ probe (Section 3.2.5.2). The Southern strategy used 
to confirm palA deletion is outlined in Figure 3.41. The mutant band (5124 bp) was present in 
transformant 1 (Figure 3.42), meaning this transformant is a potential ΔpalA mutant. However 
there was a faint wild-type band visible in transformant 1 so it was decided to create single spore 
isolates of the colony to ensure it was a clean deletion. DNA from five single spore isolates of 
transformant 1 were digested with BamHI and a second round of Southern blot analysis using the 
3’ probe was performed. Isolates 1, 3, 4 & 5 displayed the correct band for palA deletion, while 
transformant 2 contained the wild-type band and two etopic integrations (Figure 3.43). Isolate 5 
was therefore chosen to create the stock of ΔpalA. 
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Figure 3.41. A schematic of the Southern blot strategy employed to detect the deletion of palA. 
DNA was digested using BamHI. The digested DNA was screened using a 3’ probe. A correct 
gene deletion event would result in a band of 5124 bp. Wild-type BamHI digested DNA would 
result in a band of 3791 bp.  
 
 
 
Figure 3.42. Southern Analysis of potential palA deletion mutants in A. fumigatus strain 
ATCC26933 using a 3’ probe. Successful deletion of palA was indicated by the presence of a 
single 5124 bp band. Lane L: Roche Molecular Weight Ladder VII, DIG labelled (Section 
2.1.7.6). Lane WT: ATCC26933 (5124 bp). Lanes 1-12: Potential ΔpalA transformants. 
Transformant 1 displays the correct band for the ΔpalA genotype.  
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Figure 3.43. Southern Analysis of single spore isolates of a potential palA deletion mutant using 
a 3’ probe. Successful deletion of palA was indicated by the presence of a single 5124 bp band. 
Lane L: Roche Molecular Weight Ladder VII, DIG labelled (Section 2.1.7.6), Lanes 1-5: Single 
spore isolates. Lane WT: ATCC26933 (3791 bp). Isolates 1, 3, 4 & 5 display the correct band for 
the ΔpalA genotype.  
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3.2.5.4  Semi-quantitative RT-PCR Analysis of palA expression in ΔpalA26933 
The deletion of A. fumigatus palA from ATCC26933 was detected by Southern analysis in a 
single transformant. Semi-quantitative RT-PCR (section 2.2.6.4) was employed to confirm that 
the deletion of the palA gene prevented expression of palA. Both wild-type and mutant strains 
were cultured in Sabouraud Dextrose liquid broth and incubated at 37 °C for 24 h. Total RNA 
was extracted and subjected to cDNA synthesis (Section 2.2.6.3). RT-PCR was carried out using 
the primers QPCR palA F and QPCR palA R (Table 2.5). Expression of palA was present in A. 
fumigatus wild-type and absent from ΔpalA (Figure 3.44). This confirmed deletion of palA in 
ΔpalA26933. 
 
 
Figure 3.44. Confirmation of the absence of palA expression in A. fumigatus ΔpalA by RT-PCR 
(n = 2 biological replicates per condition). calm is used as cDNA control (Burns et al., 2005). 
gDNA was used as a positive control. NC: negative control; no cDNA or DNA present in 
amplification reactions. 
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3.2.6  Attempted deletion of nfs1 in ATCC26933 
A gene deletion strategy was employed to investigate the function of nfs1 (AFUA_3G14240). 
Protoplast transformations were performed using the background strain ATCC26933, as this 
would allow for a comparison with ΔegtB26933. As before, ATCC26933 was transformed with 
two DNA constructs which comprised of either the 5’ or 3’ flanking sequence of nfs1 fused to an 
incomplete fragment of the ptrA gene.  
nfs1 flanking regions were amplified using nfs1.1 and nfs1.2 (5’ flanking) and nfs1.4 & nfs1.5 
(3’ flanking). These were digested with NotI and HindIII respectively and ligated to ptrA, which 
had been released from pSK275 using the same enzymes. The final constructs were generated by 
PCR; primers nfs1.3 and oAoptrA 2 used for the 5’ construct and nfs1.6 and oAoptrA 1 used for 
the 3’ construct. 
The constructs were transformed into ATCC26933 as described (section 2.2.4.4). The 
transformation was attempted six times, varying the amount of total construct used from 2 – 5 
µg, however no nfs1 deletion mutant was generated. nfs1 is essential in Saccharomyces 
cerevisiae (Li et al., 1999) and may be essential to A. fumigatus as well. This could explain why 
no deletion mutant was generated despite multiple attempts. 
3.2.7  Attempted generation of a ΔegtA::ΔgliK double mutant 
In order to investigate the apparent relationship between GliK activity and EGT biosynthesis 
(Gallagher et al., 2012) it was decided to generate a ΔegtA::ΔgliK double mutant. This was 
approached in two different ways: deleting egtA in a ΔgliK background, and deleting gliK in a 
ΔegtA background. In both cases the background strain already contained ptrA so it was 
necessary to use hph, the hygromycin resistance gene as a selection marker. In either strategy, 
the deletion constructs consisted of flanking regions of the target gene fused to overlapping 
fragments of the hph gene. 
For deleting egtA in ΔgliK, the 5’ flanking region was amplified using the primers egtA_HYG_1 
and egtA1. The 3’ flanking region was amplified using primers egtA_HYG_2 and egtA4. These 
were digested using SalI and BamHI respectively. The constructs were then ligated to hph, which 
had been released from pAN7.1 using the same enzymes. The final constructs were generated by 
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PCR; primers egtA3 and HYoptrA1 used for the 5’ construct and egtA6 and YGoptrA2 used for 
the 3’ construct. 
For deleting gliK in ΔegtA, the 5’ flanking region was amplified using the primers gliK_HYG_1 
and gliK_HYG_2. The 3’ flanking region was amplified using primers gliK_HYG_4 and 
gliK_HYG_5. These were digested using SphI and BamHI. The constructs were then ligated to 
hph, which had been released from pAN7.1 using the same enzymes. The final constructs were 
generated by PCR; primers gliK_HYG_3 and HYoptrA1 used for the 5’ construct and 
gliK_HYG_6 and YGoptrA2 used for the 3’ construct. 
Transformation using either set of constructs was attempted 12 times in total. Several 
supplements (Table 3.1) to aid protoplast regeneration were added to the regeneration media. 
Furthermore, the ΔegtAAfS77 mutant, with increased homologous recombination (Hartmann et al., 
2010), was used as the background strain for gliK deletion. A summary of all transformation 
attempts can be seen in Table 3.1. 
Despite these exhaustive efforts, no ΔegtA::ΔgliK double mutant was generated. This indicates 
that simultaneous absence of egtA and gliK may be fatal in A. fumigatus.  
Table 3.1. Summary of all attempts at generating a ΔegtAΔgliK mutant, including any 
supplements added to the media. 
Transformation 
Attempts 
Target Gene Background Strain Supplement 
3 egtA ΔgliK26933 None 
2 gliK ΔegtA26933 None 
1 gliK ΔegtA26933 0.2 mM EGT 
1 gliK ΔegtA26933 1 mM EGT 
1 gliK ΔegtA26933 5 mM GSH 
1 gliK ΔegtA26933 + 50 % sucrose 
1 gliK ΔegtA26933 - 50 % sucrose 
2 gliK ΔegtAAfS77 None 
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3.3  Discussion 
This chapter describes the work done to identify and delete the putative EGT biosynthetic genes 
in A. fumigatus ATCC26933: egtA and egtB. The generation of vipC and palA deletion mutants 
in ATCC26933 was also undertaken. Additionally the re-insertion of the egtA gene into 
ΔegtA26933 was presented. Absence of gene expression was confirmed via RT-PCR of all four 
gene deletion mutants, while restoration of egtA expression in egtA
C26933
 was also demonstrated. 
Furthermore, the attempted deletion of nfs1 in ATCC26933 and generation of a ΔegtA::ΔgliK 
double mutant are also described. 
EGT biosynthetic genes were identified via bioinformatic analysis. A. fumigatus egtA was 
identified through BLAST searches of N. crassa egt-1, S. pombe egt1 and M. smegmatis egtD 
and egtB. egtA encodes for a proteins with 844 amino acids and contains a methyltransferase 
domain, a sulphatase-modifying factor domain and a 5’-histidylcysteine sulphoxide synthase 
domain.  A. fumigatus egtB was identified through BLAST searches of S. pombe egt2 and M. 
smegmatis egtE. egtB encodes for a protein 453 amino acids in length and contains cysteine 
desulphurase and PLP-binding domains. Additionally, Nfs1 was identified as an alternative 
candidate for performing the cysteine desuphurase step in EGT biosynthesis. 
A bipartite method (Nielsen et al., 2006) was employed to delete the genes described. All genes 
were targeted using two constructs. These constructs consisted of ~1 – 1.5 kb of flanking region 
fused to a fraction of the ptrA gene. The constructs were then transformed into protoplasts of 
ATCC26933. Selection of potential transformants took place on pyrithiamine plates, with an 
intact ptrA cassette necessary for growth. 
Deletion constructs for ΔegtA26933 were generated directly from ΔegtAAfS77. It was decided to 
delete egtA in ATCC26933 due to the high amounts of gliotoxin it produces compared to AfS77. 
Gallagher et al. (2012) demonstrated that EGT levels increase significantly when gliK is deleted. 
ΔgliK is gliotoxin deficient and the subsequent rise in EGT provoked a question about the 
relationship between the two metabolites. Thus deletion of egtA in a high gliotoxin producing 
strain was deemed the optimal strategy for investigating this phenomenon. Additionally, this 
provided the opportunity to compare egtA deletion in strains producing different levels of 
gliotoxin. 
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The ΔegtA transformation produced 23 colonies. A screen of 10 colonies by Southern blot 
revealed one transformant which displayed the mutant band only (2045 bp). However, as the blot 
lacked clarity, it was decided to subject the colony to single spore isolation and a second round 
of Southern analysis to ensure a clean deletion had taken place. Southern analysis of 8 single 
spore isolates revealed all eight isolates displayed a single mutant band, and thus the 
transformation as considered a success.  
The construct for complementation of ΔegtA was generated by cloning of the egtA gene and 
flanking regions into a pCR®2.1-TOPO vector, to create pegtA. Linearisation of this vector in 
the 5’ flanking region allowed for the homologous recombination of the 5’ flanking region and 
insertion of the egtA gene upstream of the original locus. The hph gene for hygromycin 
resistance was used as a selection marker for this transformation, with the pAN7.1 vector co-
transformed alongside the complementation constructs. Optimally, the hph gene would have 
been included in the complementation vector so it could be transformed as a single construct. 
However, insertion of the hph gene into the pegtA vector would have rendered linearization 
within one of the egtA flanking regions impossible due to the limited number of unique 
restriction sites. Thus, it was necessary to transform pegtA and pAN7.1 independently. This 
resulted in a large amount of false positives (86 colonies observed on the hygromycin plates 
following the transformation) because pAN.7.1 could be integrated into a target protoplast 
independent of the complementation construct. One transformant was observed that displayed 
the correct banding pattern for egtA
C
 when analysed by Southern blot. 
Semi-quantitative RT-PCR was employed to analyse gene expression following the deletion and 
complementation of egtA. Gene expression was absent in ΔegtA26933 and re-instated in egtAC26933. 
This confirmed that the deletion of egtA in ATCC26933 and its complementation in ΔegtA26933. 
Deletion constructs for egtB, vipC and palA were generated by the amplification of the respective 
gene’s flanking regions from ATCC26933 genomic DNA. These flanking regions were digested 
via restriction endonucleases and ligated to ptrA which had been released from pSK275. A final 
round of PCR generated the final constructs, which consisted of a flanking region fused to a 
fragment of the ptrA gene. The transformation for the deletion of egtB produced 11 colonies, 
which were screened via Southern blotting and revealed 2 transformants with the correct ΔegtB 
band (2288 bp). The transformation for the deletion of vipC produced 29 colonies. Screening 10 
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of these revealed a single transformant which displayed the correct band for ΔvipC (1458 bp). 
The transformation for the deletion of palA produced 24 colonies. Screening 12 of these revealed 
a single transformant which displayed the correct band for ΔpalA (5124 bp). However, there was 
a slight wild-type band (3791 bp) visible on the blot so it was decided to carry out single spore 
isolation of the transformant to ensure a clean deletion of palA was present. 5 single spore 
isolates were analysed, with 4 of them showing the correct banding pattern for palA deletion. 
Isolate 2 however displayed the wild-type band in addition to two etopic integrations. This 
genotype likely contributed to the faint wild-type band in the original colony and single spore 
isolation was necessary to obtain a clean ΔpalA mutant. Due to time constraints, 
complementation of these genes was not carried out. 
Semi-quantitative RT-PCR was employed to analyse gene expression of potential ΔegtB, ΔvipC 
and ΔpalA mutants. Two potential ΔegtB mutants had been identified, so semi-quantitative RT-
PCR analysis was carried out on both. This revealed that while no egtB expression was present in 
transformant 3, transformant 11 continued to express egtB. Therefore transformant 3 was 
considered a successful egtB deletion and transformant 11 was discarded. Semi-quantitative RT-
PCR demonstrated the absence of expression of vipC and palA in ΔvipC26933 and ΔpalA26933, 
respectively. 
In addition to the four genes successfully deleted, two deletion mutants were attempted which 
were unsuccessful: the deletion of nfs1 in ATCC26933 and the generation of a ΔegtAΔgliK 
double mutant. nfs1 was targeted as it was identified as a potential enzyme for the cysteine 
desulfurase step in EGT biosynthesis. This transformation was attempted six times, with no 
transformants displaying the correct band for nfs1 deletion from any of the attempts. While nfs1 
has been successfully deleted in S. pombe (Pluskal et al., 2014), it is an essential gene in S. 
cerevisiae (Li et al., 1999). It is therefore possible that nfs1 is also essential in A. fumigatus and 
any deletion of nfs1 would be lethal. 
Double deletion of egtA and gliK was proposed and attempted due to the increased levels of EGT 
observed in the gliotoxin null mutant ΔgliK (Gallagher et al., 2012). A double mutant would 
have aided in elucidating the mechanism behind this increase in EGT and help with analysing 
any relationship between gliotoxin and EGT. Availability of this mutant was sought in two 
different ways, deletion of egtA in ΔgliK and deletion of gliK in ΔegtA. In addition to this, 
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several supplements and alterations to the regeneration media were made in an attempt to recover 
transformed protoplasts (Table 3.1). EGT (0.2 mM and 1mM) and GSH (5 mM) were added to 
the media in case the loss of EGT was leading to a lethal rise in ROS or depletion of 
antioxidants. Sucrose levels were altered ± 50% in case osmotic stress. Furthermore, the deletion 
of gliK was attempted in the ΔegtAAfS77 background. AfS77 contains a deletion of the akuA gene, 
which encodes for the Ku70 component of the non-homologous end joining pathway. Absence of 
Ku70 results in an increased frequency of homologous recombination, which aids gene deletion 
(Krappmann et al., 2006, Hartmann et al., 2010). 
Overall and disappointingly, generation of a ΔegtA::ΔgliK double mutant was attempted 12 
times with no success. The observed rise of EGT in ΔgliK (Gallagher et al., 2012)  suggests that 
the antioxidant plays an important role in the absence of gliK; indeed ΔgliK shows sensitivity to 
H2O2 compared to wild-type, suggesting a disruption of redox homeostasis (Gallagher et al., 
2012; Sheridan et al., 2015). This data suggests that EGT may well be essential in ΔgliK. 
All new strains generated were used to explore the mechanism and functionality of EGT 
biosynthesis in A. fumigatus; as outlined in subsequent chapters. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
Chapter 4 
Characterisation of Ergothioneine  
Biosynthesis and Functionality in A. fumigatus 
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4.1  Introduction 
The availability of an A. fumigatus egtA deletion strain as detailed in Chapter 3 presented the 
opportunity to perform phenotypic analysis in order to elucidate gene function, which will aid in 
determining if egtA contributes to EGT biosynthesis in A. fumigatus. This would also allow for 
the first functional characterisation of EGT in A. fumigatus, an opportunistic human pathogen. 
Functional characterisation of EGT in fungi is lacking, with the work of Bello et al. (2012, 2014) 
providing the only significant data. Bello et al. demonstrated that EGT protects N. crassa conidia 
against tert-butyl hydroperoxide and contributes to conidial health and conidiogenesis. No role 
for EGT in S. pombe was demonstrated, despite the generation of an egt1 deletion mutant 
(Pluskal et al., 2014).  The augmented EGT levels in A. fumigatus ΔgliK observed by Gallagher 
et al. (2012) offered insight into potential EGT function in A. fumigatus. ΔgliK exhibited a 
variety of phenotypes in addition to increased EGT levels, including abrogated gliotoxin, 
production, sensitivity to exogenous gliotoxin, sensitivity to H2O2 and perturbed levels of SAM 
and SAH (Gallagher et al., 2012; Owens et al., 2015). The putative role for EGT as an 
antioxidant may be related to H2O2 sensitivity in ΔgliK and as a sulphurised and trimethylated 
metabolite, EGT biosynthesis may be linked with both gliotoxin biosynthesis and SAM/SAH 
metabolism, both of which are disrupted in ΔgliK. Further characterisation of EGT is therefore 
needed to elucidate the metabolic and redox alterations taking place in ΔgliK. 
The work by Gallagher et al. (2012) also presented a novel strategy for detecting EGT via 
alkylation with 5’-iodoacetamidofluorescein (5’-IAF) in combination with either RP-HPLC or 
LC-MS/MS. 5’-IAF reacts with thiol groups to form a stable thioester bond at physiological pH. 
Alkylation with 5’-IAF decreases the polarity of EGT, resulting in increased retention time in 
RP-HPLC and LC-MS/MS. This leads to improved separation during chromatography, aiding 
identification. Additionally, 5’-IAF can be detected via fluorescence detector (Ex/Em: 494/518 
nm), increasing the confidence of identification via RP-HPLC. 5’-IAF can also be used in the 
detection of GSH in the same manner (Gallagher et al., 2012). This method has been 
subsequently and independently utilised for the identification of EGT in human serum (Sotgia et 
al., 2013, 2014). 
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Oxidative stress occurs as a result of elevated levels of reactive oxygen species (ROS). ROS are 
produced via various metabolic pathways, particularly aerobic respiration (Takemoto et al., 
2007; Starkov, 2008) and comprise of superoxide (
•
O2¯), the hydroxyl radical (
•
OH) and 
hydrogen peroxide (H2O2) (Turrens et al., 2003). Excess ROS can lead to modification of 
cellular components, which can interfere with both metabolism and regulatory pathways. 
Therefore, management of ROS is an essential part of cellular homeostasis (Lushchak, 2011). 
Excess ROS is managed by various enzymes, such as superoxide dismutase, peroxidases and 
catalases. Additionally, low molecular mass molecules such as glutathione (GSH) also contribute 
to oxidative stress defence (Halliwell and Gutteridge, 2007). The ratio of reduced (GSH) to 
oxidised (GSSG) glutathione is carefully maintained and changes to the GSH/GSSG ratio is 
indicative of a change in the redox state of the cell. GSH/GSSG ratio can be measured through 
the reduction of DTNB, utilising glutathione reductase, as described in Section 2.2.13 (Thon et 
al., 2010; Rahman et al., 2006). EGT has been characterised as an antioxidant in N. crassa and 
several bacterial species (Bello et al., 2012, 2014; Sao Emani et al., 2013; Saini et al., 2015) and 
thus may contribute to oxidative stress defence in A. fumigatus. 
Oxidative stress sensitivity is commonly investigated through the use of reagents that induce 
elevated levels of ROS. H2O2, menadione and diamide were employed for this purpose in this 
study. H2O2 acts to induce ROS in organisms by increasing the intracellular peroxide and 
superoxide levels, and leads to the formation of 
•
OH radicals (Lessing et al., 2007). As a result, 
oxidation products such as sulfinic-acid, sulfenic-acid, sulfonic-acid and methionine sulfoxide 
are formed (Thon et al., 2010). Menadione is an organic molecule which can induce the 
formation of superoxides, H2O2 and 
•
OH radicals. It has also been observed that menadione can 
chemically modify cell components via arylation and enhance membrane fluidity (Pusztahelyi et 
al., 2010). Diamide induces oxidative stress in a different manner to H2O2 and menadione. 
Instead of inducing the formation of radicals, diamide oxidizes the GSH thiol to form disulphide 
groups. Without a free thiol group, GSH cannot scavenge free radicals and as such cannot 
contribute to oxidative stress defence (López-Mirabal and Winther, 2008). By depleting GSH 
levels in such a way, diamide induces oxidative stress. 
In conjunction with the above reagents, ROS levels in A. fumigatus were investigated by 
fluorescent microscopy using 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA; Figure 4.1), 
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a reduced form of fluorescein. H2DCFDA is a cell permeable indicator of ROS. Fluorescence of 
this probe is activated upon oxidative cleavage of the acetate group, converting H2DCFDA into 
2',7'-dichlorofluorescein. 2’,7’-dichlorofluorescein is then detectable via fluorescence (Ex/Em: 
492–495/517–527 nm), which can be measured to give an indication of ROS levels in mycelia. 
This method has been previously employed in A. fumigatus to investigate gliotoxin and H2O2 
interaction (Owens et al., 2014). 
 
Figure 4.1. Structure of 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA) 
EGT function in organisms that cannot biosynthesise it naturally, such as plants and mammals, is 
a topic of much interest (Spicer et al., 1951; Aruoma et al., 1999; Deiana et al., 2004; Ey et al., 
2007; Markova et al., 2009; Song et al. 2010). It has been demonstrated that plants can obtain 
EGT from symbiotic microorganisms (Park et al., 2010); however its role in plants is as yet 
unclear. In order to develop a better understanding of EGT function in plants, a Nicotiana 
tabacum strain was transformed with A. fumigatus egtA and nfs1 (performed by Professor Phil 
Dix, Dr. Peter Medgyesy and Dr. Éva Horvath, Maynooth University). The egtA and nfs1 genes 
were cloned individually into pZ1S-197 plasmids for transformation into N. tabacum. The pZS-
197 plasmid facilitates integration of a gene of interest into the N. tabacum chloroplast genome 
and confers resistance to spectinomycin (Svab and Maliga, 1993). The N. tabacum 
transformation for egtA and nfs1 was carried out as per Figure 4.2. Gene insertion was confirmed 
via PCR. 
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Figure 4.2. Schematic outline of the N. tabacum transformation process. 
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The aim of the work presented in this chapter was to: 
(i) Determine if egtA is essential for EGT biosynthesis in A. fumigatus. 
(ii) Investigate the phenotypic effect of EGT loss in A. fumigatus following exposure to 
ROS inducing agents, cell wall perturbing agents and gliotoxin. 
(iii) Investigate EGT interplay with H2O2 in A. fumigatus. 
(iv) Analyse the effect of EGT loss on total glutathione and GSH/GSSG ratio 
(v) Determine if EGT influences gliotoxin biosynthesis and gliotoxin self-protection. 
(vi) Determine if EGT loss affects conidiation in A. fumigatus. 
(vii) Determine if EgtA and Nfs1 are present in N. tabacum L. cv. Petit Havana:egtA:nfs1 
and investigate if this strain can biosynthesise EGT. 
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4.2  Results 
4.2.1  Analysis of EGT production in ATCC26933, ΔegtA26933 and egtAC26933 
4.2.1.1  Detection of EGT via RP-HPLC 
5’-IAF alkylation allowed for the detection of EGT via RP-HPLC. The retention time of EGT 
was determined by comparing chromatograms from 5’-IAF labelled EGT standard and 5’-IAF 
only control to identify the derivatized EGT peak. EGT was determined to elute at 12.4 min 
(Figure 4.3).  
 
Figure 4.3. Detection of EGT by RP-HPLC. EGT is demonstrated to elute at 12.4 min.  
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4.2.1.2 Analysis of EGT production in ATCC26933, ΔegtA26933 and egtAC26933 via  
RP-HPLC 
Mycelia from 72 h cultures of ATCC26933, ΔegtA26933 and egtAC26933 in Czapek-Dox broth were 
harvested and mycelial lysates obtained as per Section 2.2.9. Mycelial lysates were alkylated 
using 5’-IAF as described in Section 2.2.12.1 and analysed via RP-HPLC (Section 2.2.12.6) 
using the fluorescence detector and an Ex/Em of 494/518 nm. EGT was detected in ATCC26933 
and egtA
C26933, but was absent in ΔegtA26933 (Figure 4.4). This demonstrates that egtA is essential 
for EGT production in A. fumigatus, confirming it functions as an EGT biosynthetic gene. EGT 
levels were demonstrated to be elevated approximately fivefold in egtA
C26933
 compared to 
ATCC26933 (P = 0.0007). 
 
 
 
 
 
 
 
 
142 
 
 
Figure 4.4. Detection and measurement of 5’-IAF alkylated EGT via RP-HPLC in ATCC26933, 
ΔegtA26933 and egtAC26933. (A) Detection of 5’-IAF alkylated EGT in ATCC26933 and egtAC26933 
at a retention time of 12.4 min. No EGT was detected in ΔegtA26933 (B) Comparison of EGT 
levels in ATCC26933, ΔegtA26933 and egtAC26933. EGT is absent in ΔegtA26933. EGT levels were 
significantly (P = 0.0007) elevated in egtA
C26933
 compared to ATCC26933. 
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4.2.1.3  Detection of EGT via LC-MS/MS 
5’-IAF alkylation also facilitated EGT detection via LC-MS/MS. Alkylated EGT was identified 
using its known fragmentation pattern (Figure 4.5) (Gallagher et al., 2012). 5’-IAF alkylated 
EGT has been identified as having a single charged m/z of 617 (M + H)
+
 and a m/z of 309 (M + 
H)
2+
 when double protonated. The daughter ions m/z 573 and m/z 514 have also been detected 
using tandem mass spectrometry as well as their double protonated versions m/z 287 and m/z 257 
respectively (Figure 4.5)(Gallagher et al., 2012). EGT eluted at 5.3 min (Figure 4.5). 
4.2.1.4  Analysis of EGT production in ΔegtA26933 via LC-MS/MS 
Mycelia from 72 h cultures of ATCC26933, ΔegtA26933 and egtAC26933 in Czapek-Dox broth were 
harvested and mycelial lyastes obtained as per Section 2.2.9. Mycelial lysates were alkylated 
using 5’-IAF (Section 2.2.12.1), TCA precipitated (Section 2.2.12.2) and analysed via LC-
MS/MS (Section 2.2.12.7). In addition, an EGT standard was alkylated and TCA precipitated as 
before was analysed in the same manner. Extracted ion chromatograms (m/z: 617) for 
ATCC26933, ΔegtA26933 and egtAC26933 revealed the presence of EGT in the wild-type and 
complemented strains, while no EGT was detected for ΔegtA26933 (Figure 4.6). This 
unambiguously confirmed the absence of EGT in ΔegtA26933 and its restoration in egtAC26933. 
EGT levels are elevated approximately threefold in egtA
C26933
 compared to ATCC26933. 
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Figure 4.5. 5’-IAF alkylated EGT detection via LC-MS/MS. (A) Extracted ion chromatogram (m/z: 617) for alkylated EGT standard. 
EGT elutes at 5.3 min. (B) Signature ion breakdown for 5’-IAF alkylated EGT. (C) 5’-IAF-EGT molecular ion: (M + H)+ = m/z 617 
and (M + H)
2+
 = m/z 309 (double protonated). (D) 5’IAF-EGT daughter ion, with a neutral loss of 44 from the loss of COO- from the 
molecular ion: (M + H)
+
 = m/z 573  and (M + H)
2+
 = m/z 287 (double protonated). (E) 5’IAF-EGT, with a neutral loss of 103 from 
with the loss of COO- and N(CH3)3+ from the molecular ion: (M + H)+ = m/z 514 and (M + H)2+ = m/z 257 (double protonated) 
(Gallagher et al., 2012).  
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Figure 4.6. Detection of 5’-IAF labelled EGT via LC-MS/MS (A) Extracted Ion 
Chromatographs (m/z: 617) from ATCC26933, ΔegtA26933 and egtA
C26933
, in addition to an EGT 
standard. A peak at 5.3 min was confirmed to be EGT. This peak was absent from ΔegtA26933, 
confirming the absence of EGT from the mutant. (B) Comparison of EGT (m/z: 617) peak 
intensity. EGT is absent in ΔegtA26933. Levels of EGT are significantly (P = 0.0004) increased in 
egtA
C26933
 compared to ATCC26933.  (C) Signature Ion breakdown corresponding to 5’-IAF 
labelled EGT.  
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4.2.2  Phenotypic analysis of ΔegtA26933 in response to ROS inducing agents 
4.2.2.1 Phenotypic analysis of ATCC26933, ΔegtA26933 and egtAC26933 in response to 
H2O2 
Sensitivity to H2O2 was tested at a range of 0 – 4 mM as per Section 2.2.7. Comparison of the 
radial growth of ATCC26933, ΔegtA26933 and egtAC26933 colonies revealed no significant 
difference between the two strains at 1mM and 2 mM H2O2. However, radial growth of 
ΔegtA26933 at 3mM H2O2 was significantly reduced compared to ATCC26933and egtA
C26933
 (P = 
0.0081) (Figure 4.7). No growth was observed for any of the strains at 4mM H2O2. Loss of egtA 
therefore results in sensitivity to high levels of H2O2. This demonstrates that EGT functions as an 
antioxidant and protects against high levels of ROS in A. fumigatus. 
4.2.2.2 Phenotypic analysis of ATCC26933, ΔegtA26933 and egtAC26933 in response to 
menadione 
Sensitivity to menadione was tested at a range of 0 – 60 µM as per Section 2.2.7. Significant 
reduction in the radial growth of ΔegtA26933 colonies compared to ATCC26933 and egtAC26933 
colonies was observed at 40 µM (P = 0.0043) and 60 µM (P = 0.0013) menadione (Figure 4.8). 
However no significant difference in radial growth at 20 µM menadione was observed for any of 
the three strains. Deletion of egtA therefore results in sensitivity to high concentrations of 
menadione. EGT therefore protects against high levels of menadione induced ROS further 
emphasising the role of EGT as an antioxidant in A. fumigatus. 
4.2.2.3 Phenotypic analysis of ATCC26933, ΔegtA26933 and egtAC26933 in response to 
diamide 
Diamide sensitivity was tested at a range of 0 – 1.75 mM as per Section 2.2.7. No significant 
differences in the radial growth of ATCC26933, ΔegtA26933 and egtAC26933 colonies were 
observed at any concentration of diamide tested (Figure 4.9). egtA deletion, and the consequent 
absence of EGT, therefore has no effect on defence against diamide induced oxidative stress in 
A. fumigatus. Therefore, it can be concluded that EGT is not involved in conferring protection 
against diamide induced oxidative stress. 
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Figure 4.7. H2O2 sensitivity assay performed on AMM agar. (A) Comparison of radial growth of 
ATCC26933, ΔegtA26933 and egtAC26933 on AMM agar plates containing 0 to 4 mM H2O2. 
ΔegtA26933 shows a significant (P = 0.0081) reduction in growth compared to ATCC26933 and 
egtA
C26933
 at 3 mM H2O2. No growth was detected for any of the three strains at 4 mM H2O2. (B) 
Images of ATCC26933, ΔegtA26933 and egtAC26933 colonies on AMM plates containing 0 and 3 
mM H2O2. A visible decrease in the size of the ΔegtA
26933
 colony can be observed compared to 
the ATCC26933 and egtA
C26933
 colonies at 3 mM H2O2. 
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Figure 4.8. Menadione sensitivity assay performed on AMM agar. (A) Comparison of radial 
growth ATCC26933, ΔegtA26933 and egtAC26933 on AMM agar plates containing 0 to 60 µM 
menadione. ΔegtA26933 shows a significant reduction in growth compared to ATCC26933 and 
egtA
C26933
 at 40 µM (P = 0.0043) and 60 µM (P = 0.0013) menadione. (B) Images of 
ATCC26933, ΔegtA26933 and egtAC26933 colonies on AMM plates containing 0 and 60 µM 
menadione. A visible decrease in the size of the ΔegtA26933 colony can be observed compared to 
the ATCC26933 and egtA
C26933
 colonies at 60 µM menadione. 
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Figure 4.9. Diamide sensitivity assay performed on AMM agar. (A) Comparison of radial 
growth of ATCC26933, ΔegtA26933 and egtAC26933 on AMM agar plates containing 0 to 1.75 mM 
diamide. ΔegtA26933 shows no significant difference in radial growth compared to ATCC26933 
and egtA
C26933
 at any concentration of diamide tested. (B) Images of ATCC26933, ΔegtA26933 and 
egtA
C26933
 colonies on AMM plates containing 0 and 1.75 mM diamide. A slight decrease in the 
size of the ΔegtA26933 colony can be observed compared to the ATCC26933 colonies at 1.75 mM 
diamide, however it is too small to be significant. 
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4.2.3   Measurement of ROS levels in ΔegtA26933 following H2O2 exposure 
ROS levels in ATCC26933 and ΔegtA26933 with and without 3 mM H2O2 were analysed via 
fluorescence microscopy as described in Section 2.2.15. Under basal conditions, ROS levels in 
ΔegtA26933 were significantly (P = 0.0089) lower than ATCC26933 (Figure 4.10). This suggests 
that ΔegtA26933 is compensating for the absence of EGT under basal conditions. Addition of 3 
mM H2O2 resulted in significantly (P = 0.038) elevated ROS in ΔegtA
26933
 compared to 
ATCC26933 (Figure 4.10). This demonstrates that absence of EGT leads to reduced antioxidant 
potential, resulting in elevated ROS when challenged with H2O2. This supports previous data 
demonstrating that EGT is important for detoxifying high levels of H2O2 in A. fumigatus. 
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Figure 4.10. Analysis of ROS levels via fluorescent microscopy using H2DCFDA in 
ATCC26933 and ΔegtA26933 with and without H2O2. (A) Microscopy images, showing both the 
bright field and GFP filter for each image.  (B) Comparison of integrated density values obtained 
for each strain and condition. Under basal conditions, ATCC26933 shows higher levels of ROS 
compared to ΔegtA26933 (P = 0.0089). ΔegtA26933 demonstrates higher levels of ROS compared to 
ATCC26933 when exposed to 3 mM H2O2 (P = 0.038).  
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4.2.4  qRT- PCR Analysis of egtA expression following H2O2 Exposure 
As results from plate assays (Section 4.2.2) and fluorescent microscopy (Section 4.2.3) indicated 
EGT is involved in oxidative stress defence, analysis of egtA expression in response to H2O2 was 
undertaken. Quadruplicate cultures of ATCC26933 were grown in Sabouraud Dextrose broth for 
23 h at 37 
o
C, 200 rpm shaking. Following 23 h incubation, H2O2 was added in duplicate to a 
final concentration of 3 mM. As a control, an equivalent volume of sterile H2O was added in 
duplicate. The cultures were then incubated as before for 1 h. Following this incubation, the 
mycelia were harvested from each culture. RNA isolation (Section 2.2.6.1), DNase treatment 
(Section 2.2.6.2) and cDNA synthesis (Section 2.2.6.3) then followed. qRT-PCR was then 
undertaken as described in Section 2.2.6.5. qRT-PCR analysis revealed relative egtA expression 
increased significantly (P = 0.0002) when exposed to 3 mM H2O2 for 1 h (Figure 4.11). This 
threefold increase in egtA expression in response to ROS further elaborates that EGT has a 
protective role against oxidative stress in A. fumigatus.  
 
 
Figure 4.11. Quantitative RT-PCR data showing the relative expression of egtA in ATCC26933 
following exposure to 3 mM H2O2. egtA expression was significantly (P = 0.0002) increased in 
ATCC26933 when exposed to H2O2 compared to control levels.  
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4.2.5  RP-HPLC analysis of EGT levels following H2O2 exposure 
As it was demonstrated that egtA expression increased in response to H2O2 (Section 4.2.4), it was 
necessary to analyse EGT levels following a similar treatment to see if a corresponding rise in 
EGT levels was observed. Quadruplicate cultures of ATCC26933 were grown in Czapek-Dox 
broth for 71 h at 37 
o
C, 200 rpm shaking. Following this incubation, H2O2 was added in duplicate 
to a final concentration of 3 mM. As a control, an equivalent volume of sterile H2O was added in 
duplicate. The cultures were then incubated as before for 1 h. Following this incubation, the 
mycelia were harvested from each culture. Mycelial lyastes were then obtained as per Section 
2.2.9. Mycelial lysates were labelled using 5’-IAF as described in Section 2.2.12.1 and analysed 
via RP-HPLC (Section 2.2.12.6) using fluorescence detection with an Ex/Em of 494/518 nm. 
Unexpectedly, RP-HPLC analysis revealed a non-significant reduction in EGT levels in 
ATCC26933 following 3 mM H2O2 exposure (Figure 4.12). This presents a contradictory 
situation, whereby the biosynthetic gene, egtA, shows an increase in expression following H2O2 
exposure, but the cognate metabolite shows a small decrease.  
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Figure 4.12. Analysis of EGT levels in ATCC26933 following incubation with 3 mM H2O2. (A) 
RP-HPLC chromatograms showing the detection of alkylated EGT in ATCC26933 with and 
without the addition of 3 mM H2O2. (B) Comparison of alkylated EGT peak areas from RP-
HPLC analysis. Addition of H2O2 resulted in a non-significant reduction in EGT levels compared 
to the control.  
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4.2.6  Analysis of EGT reactivity with H2O2 
The apparent contradictory data between egtA expression and EGT levels prompted an 
investigation into the interplay between EGT and H2O2. EGT was incubated with H2O2 for 3 h, 
followed by back-titration, alkylation and RP-HPLC analysis (Section 2.2.12.5) in order to 
determine if EGT levels are altered by H2O2 exposure. RP-HPLC analyses revealed that the 
residual EGT levels were significantly decreased (P = 0.029) in the samples exposed to H2O2 
compared to the control samples (Figure 4.13). This data suggests that EGT is dissipated in the 
process of detoxifying H2O2, which is consistent with data from Servillo et al. (2015).  
 
 
 
Figure 4.13. Analysis of EGT reavtivity with H2O2. (A) RP-HPLC chromatograms showing the 
detection of alkylated EGT with and without the addition of 3 mM H2O2. (B) Comparison of 
alkylated EGT peak area following RP-HPLC analysis. Addition of H2O2 resulted in a significant 
(P = 0.029) decrease in EGT levels compared to the control.  
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4.2.7  Glutathione analysis in ATCC26933, ΔegtA26933 and egtAC26933 
4.2.7.1  Total glutathione measurement via LC-MS/MS 
Mycelia from triplicate 72 h cultures of ATCC26933, ΔegtA26933 and egtAC26933 in Czapek-Dox 
broth were harvested and cell lysate supernatants obtained as per Section 2.2.9. The presence of 
DTT in the lysis buffer reduces GSSG to GSH, allowing for total glutathione measurement.  
Mycelial lysates were alkylated using 5’-IAF (Section 2.2.12.1), TCA precipitated (Section 
2.2.12.2) and analysed via LC-MS/MS (Section 2.2.12.7). In addition, a GSH standard, alkylated 
with 5’-IAF and TCA precipitated as before, was analysed in the same manner. Alkylated GSH 
was demonstrated to elute at 5.9 min, with an m/z of 695 (Gallagher et al., 2012). Extracted ion 
chromatograms (m/z: 695) for the samples show GSH present in all 3 strains. However 
ΔegtA26933 shows significantly (P = 0.0016) elevated levels of GSH compared to ATCC26933 
and egtA
C26933 
(Figure 4.14). This suggests that loss of EGT in A. fumigatus results in an increase 
in total intracellular GSH, which is likely to compensate for the drop in antioxidant potential. 
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Figure 4.14. Total glutathione detection via LC-MS/MS in ATCC26933, ΔegtA26933 and 
egtA
C26933
. (A) Extracted Ion Chromatographs (m/z: 695) following LC-MS/MS analysis of TCA 
precipitated alkylated mycelial extracts. A peak at 5.9 min was confirmed to be GSH. (B) 
Signature ion breakdown corresponding to alkylated GSH. (C) Comparison of peak height data 
from LC-MS analysis. GSH levels are significantly (P = 0.0016) increased in ΔegtA26933 
compared to the wild-type and complemented strains. 
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4.2.7.2  Measurement of GSH/GSSG ratio in ATCC26933, ΔegtA26933 and egtAC26933 
4.2.7.2.1 GSH and GSSG standard curve determination 
In order to measure the intracellular levels of total GSH and GSSG, standard curves for GSH and 
GSSG were constructed as described in Sections 2.2.13.2 and 2.2.13.3 respectively. The 
standards were prepared at a concentration range of 26.4 – 0.4125 nmol/ml and assayed as 
described in Section 2.2.13.5. A linear relationship occurs between the concentration of 
glutathione and the absorbance. The standard curves (Figure 4.15) were used in subsequent 
assays to calculate the amount of intracellular GSH and GSSG in mycelial extracts (O’Keeffe et 
al., 2013). 
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Figure 4.15. Standard curves for the measurement of GSH and GSSG. (A) Standard curve for 
the measurement of GSH (B) Standard curve for the measurement of GSSG.  
160 
 
4.2.7.2.2 Analysis of GSH/GSSG ratios in ATCC26933, ΔegtA26933 and egtAC26933 
Duplicate cultures of ATCC26933, ΔegtA26933 and egtAC26933 were grown in Czapek-Dox broth 
for 72 h. Mycelia were harvested, lysed and the GSH/GSSG assay carried out as per Section 
2.2.13, using the standard curves generated in Section 4.2.7.2.1 for quantitation of GSH and 
GSSG. The GSH/GSSG ratio increased from 2.7 in ATCC26933 to 3.16 in ΔegtA26933 and 
decreased to 1.52 in egtA
C26933 
(Table 4.1). It appears that loss of EGT leads to an increase in 
GSH/GSSG ratio, which indicates ΔegtA26933 is under less oxidative stress than wild-type. This 
may be due to the increase in total GSH seen before (Section 4.2.7.1). With the exception of 
GSSG levels in ΔegtA26933 and egtAC26933 (P = 0.0301), none of the differences in GSH and 
GSSG levels were deemed significant (Figure 4.16).  
Table 4.1. GSH/GSSG ratios in ATCC26933, ΔegtA26933 and egtAC26933. 
Strain GSH/GSSG Ratio 
ATCC26933 2.7 
ΔegtA26933 3.16 
egtA
C26933
 1.52 
 
Figure 4.16. Measurement of GSH and GSSG levels in ATCC26933, ΔegtA26933 and egtAC26933. 
All differences were non-significant, with the exception of GSSG levels in ΔegtA26933 and 
egtA
C26933
 (P = 0.0301).  
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4.2.8  Comparison of glutathione in ΔegtA26933 and ΔegtAAfS77 
4.2.8.1  Total glutathione measurement via LC-MS/MS 
Mycelia from triplicate 72 h cultures of ATCC26933, ΔegtA26933, AfS77 and ΔegtAAfS77 in 
Czapek-Dox broth were harvested and cell lysate supernatants obtained as per Section 2.2.9. The 
presence of DTT in the lysis buffer reduced GSSG to GSH, allowing for total glutathione 
measurement. Mycelial lysates were alkylated (Section 2.2.12.1), TCA precipitated (Section 
2.2.12.2) and analysed via LC-MS/MS (section 2.2.12.7). In addition, a GSH standard labelled 
with 5’-IAF and TCA precipitated as before was analysed in the same manner. 5’-IAF alkylated 
GSH was demonstrated to elute at 6.2 min, with an m/z of 695. Extracted ion chromatograms 
(m/z: 695) for the samples show GSH present in all 4 strains (Figure 4.17). While deletion of 
egtA in ATCC26933 resulted in an increase in total GSH (as demonstrated previously in Section 
4.2.7.1), the same deletion in AfS77 had no effect on GSH levels. It appears the levels of total 
GSH in ATCC26933 are significantly (P = 0.0083) lower than those in AfS77. This difference in 
total GSH in the background strains may explain the difference in GSH response to egtA 
deletion.  
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Figure 4.17. Comparison of GSH levels in ATCC26933, AfS77 and their respective ΔegtA  
mutants. (A) Extracted Ion Chromatographs (m/z: 695) following LC-MS/MS analysis of TCA 
precipitated alkylated extracts from ATCC26933, ΔegtA26933, AfS77 and ΔegtAAfS77 , in addition 
to a GSH standard. (B) Comparison of peak height data from LC-MS analysis.  Levels of GSH in 
ATCC26933 were significantly lower than those of ΔegtA26933 (P = 0.0144), AfS77 (P = 0.0083) 
and ΔegtAAfS77 (P = 0.0049).  
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4.2.8.2  Ananlysis of GSH/GSSG ratios in AfS77, ΔegtAAfS77 and ΔegtACAfS77 
Duplicate cultures of AfS77, ΔegtAAfS77 and egtACAfS77 were grown in Czapek-Dox broth for 72 
h. Mycelia were harvested, lysed and the GSH/GSSG assay carried out as per Section 2.2.13, 
using the standard curves generated in Section 4.2.7.2.1 for quantitation of GSH and GSSG. The 
GSH/GSSG ratio increases from 1.4 in AfS77 to 3.74 in ΔegtAAfS77 and decreased to 0.64 in 
egtA
CAfS77 
(Table 4.2). This follows the same trend seen in the ATCC26933 background, 
whereby egtA deletion causes the GSH/GSSG ratio to rise, and then fall again in the 
complemented strain. With the exception of GSH levels in ΔegtAAfS77 and egtACAfS77 (P = 
0.0011), none of the differences in GSH and GSSG levels were deemed significant (Figure 4.18).  
Table 4.2. GSH/GSSG ratios in AfS77, ΔegtAAfS77 and egtACAfS77. 
Strain GSH/GSSG Ratio 
AfS77 1.4 
ΔegtA
AfS77
 3.74 
egtA
CAfS77
 0.64 
 
Figure 4.18. Measurement of GSH and GSSG levels in AfS77, ΔegtAAfS77 and egtACAfS77.  All 
differences were non-significant, with the exception of GSH levels in ΔegtAAfS77 and egtACAfS77 
(P = 0.0011).  
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4.2.9  Analysis of gliotoxin production in ATCC26933 and ΔegtA26933 
4.2.9.1  Analysis of gliotoxin production in ATCC26933 and ΔegtA26933 via RP-HPLC 
Supernatants from triplicate 72 h cultures of ATCC26933 and ΔegtA26933 in Czapek-Dox broth 
were collected and organic extraction carried out as per Section 2.2.10. The organic extracts 
were then analysed via RP-HPLC (Section 2.2.12.6). In addition, a gliotoxin control was 
analysed in the same manner. Gliotoxin was detected at 14.9 min and was observed to be present 
in both ATCC26933 and ΔegtA26933 (Figure 4.19). However a comparison between ATCC26933 
and ΔegtA26933 of gliotoxin peak areas revealed ΔegtA26933 produced significantly less gliotoxin 
(P = 0.0003). Therefore it appears that the inability to biosynthesise EGT impacts negatively 
upon gliotoxin production.  
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Figure 4.19. Gliotoxin detection via RP-HPLC in ATCC26933 and ΔegtA26933. (A) RP-HPLC 
analysis of organic extracts from the supernatants of 72 h cultures (n = 3) of ATCC26933 and 
ΔegtA26933. Gliotoxin is present in both chromatograms at 14.9 min. (B) Comparison of gliotoxin 
peak area from RP-HPLC analysis for ATCC26933 and ΔegtA26933 performed in triplicate. 
Gliotoxin levels were found to be significantly (P = 0.0003) lowered in ΔegtA26933 compared to 
ATCC26933. 
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4.2.9.2 Analysis of gliotoxin production in ATCC26933 and ΔegtA26933 via              
LC-MS/MS 
Supernatants from triplicate 72 h cultures of ATCC26933 and ΔegtA26933 in Czapek-Dox broth 
were collected and organic extraction carried out as per Section 2.2.10. The organic extracts 
were then analysed via LC-MS/MS (Section 2.2.12.7). In addition a gliotoxin standard was 
analysed in the same manner. Gliotoxin was determined to elute at 6.3 min, with a m/z of 327. 
Extracted ion chromatograms (m/z: 327) for ATCC26933 and ΔegtA26933 confirmed the presence 
of gliotoxin in both strains (Figure 4.20). Comparison of gliotoxin peak intensity revealed that 
gliotoxin levels in ΔegtA26933 are significantly (P = 0.0002) decreased compared to ATCC26933. 
This is in agreement with data from RP-HPLC. 
4.2.9.3 Analysis of bis-methylgliotoxin production in ATCC26933 and ΔegtA26933 via 
LC-MS/MS 
Supernatants from triplicate 72 h cultures of ATCC26933 and ΔegtA26933 in Czapek-Dox broth 
were collected and organic extraction carried out as per Section 2.2.10. The organic extracts 
were then analysed via LC-MS/MS (Section 2.2.12.7). Bis-methylgliotoxin (BmGT) was 
determined to elute at 6.7 min, with a m/z of 357 (Domingo et al., 2012; Dolan et al., 2014). 
Extracted ion chromatograms (m/z: 357) for ATCC26933 and ΔegtA26933 confirmed the presence 
of BmGT in both strains (Figure 4.21). Comparison of BmGT peak intensity revealed that 
BmGT production in ΔegtA26933 is significantly (P = 0.0371) decreased compared to 
ATCC26933.  
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Figure 4.20. Gliotoxin detection via LC-MS/MS in ATCC26933 and ΔegtA26933. (A) Extracted 
Ion Chromatographs (m/z: 327) following LC-MS/MS analysis of organic extracts of 
supernatants from ATCC26933 and ΔegtA26933, in addition to a gliotoxin standard. A peak at 6.3 
min was confirmed to be gliotoxin. (B) Comparison of gliotoxin peak intensity. Gliotoxin levels 
are significantly (P = 0.0002) reduced in ΔegtA26933 compared to ATCC26933.  (C) Signature ion 
breakdown corresponding to gliotoxin.  
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Figure 4.21. BmGT detection via LC-MS/MS in ATCC26933 and ΔegtA26933. (A) Extracted Ion 
Chromatographs (m/z: 357) following LC-MS/MS analysis of organic extracts of supernatants 
from ATCC26933 and ΔegtA26933 A peak at 6.7 min was confirmed to be BmGT.  (B) 
Comparison of BmGT (m/z:357) peak intensity. Levels of BmGT are significantly (P = 0.0371) 
reduced in ΔegtA26933 compared to ATCC26933. (C) Signature ion breakdown corresponding to 
BmGT (Domingo et al., 2012; Dolan et al., 2014).  
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4.2.10  Analysis of gliotoxin self-protection in ATCC26933 and ΔegtA26933 
4.2.10.1 Phenotypic analysis of ATCC26933 and ΔegtA26933 in response to gliotoxin 
Continuing the investigation into the relationship between gliotoxin and EGT, gliotoxin 
sensitivity assays (Section 2.2.7) were performed in order to ascertain if EGT conferred any 
protection against gliotoxin. Sensitivity to gliotoxin was tested at a range of 0 – 20 µg/ml. 
Following 72 h growth, no significant difference in radial growth between ATCC26933 and 
ΔegtA26933 was observed at any concentration of gliotoxin (Figure 4.22). As ΔegtA26933 did not 
show any sensitivity towards gliotoxin, it was concluded that EGT has no role in gliotoxin self-
protection in A. fumigatus. 
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Figure 4.22. Gliotoxin sensitivity assay performed on AMM agar for 72 h to test for sensitivity 
to gliotoxin. (A) Comparison of the radial growth of ATCC26933 and ΔegtA26933 on AMM 
plates containing gliotoxin ranging from 0 to 20 µg/ml. No significant change in radial growth is 
observed for either strain at any concentration of gliotoxin (B) Images of ATCC26933 and 
ΔegtA26933 colonies on AMM plates containing 0 to 20 µg/ml gliotoxin. No visible differences in 
growth between the two strains can be observed at any concentration of gliotoxin tested.  
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4.2.10.2 Label-Free Quantitative Proteomic analysis demonstrates GliT induction in 
ΔegtA26933 following gliotoxin exposure 
Label-free quantitative (LFQ) proteomic analysis was employed to investigate GliT induction 
following gliotoxin exposure in ΔegtA26933. Quadruplicate ΔegtA26933 cultures in AMM were 
incubated for 69 h at 37 
o
C, 200 rpm shaking. Gliotoxin was added in duplicate to a final 
concentration of 5 µg/ml. An equivalent volume of methanol was added in duplicate. The 
cultures were then incubated as before for a further 3 h. Following this incubation, the mycelia 
were harvested from each culture and processed for Q-Exactive Mass Spectrometry analysis as 
per Section 2.2.14.1. Samples were then digested using sequencing grade trypsin (Section 
2.2.14.4), purified, normalised and desalted using ZipTips ® (Section 2.2.14.5) and analysed on 
a Q-Exactive mass spectrometer (Section 2.2.14.6). 19 peptides for GliT were detected, with 
sequence coverage of 77.2 % (Figure 4.23). GliT underwent a log2 1.14 fold increase in 
abundance in ΔegtA26933 exposed to gliotoxin compared to ΔegtA26933 exposed to methanol (P = 
0.043). GliT is therefore induced by gliotoxin exposure in ΔegtA26933. 
 
Figure 4.23. The amino acid sequence for GliT, with detected peptides highlighted in red (19 
peptides, 77.2 % coverage).  
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4.2.11  Analysis of conidiation in ATCC26933 and ΔegtA26933 
Colonies from ΔegtA26933 grown on AMM for 72 h exhibited visibly paler conidia compared to 
those of ATCC26933 (Figure 4.24A). Levels of conidiation in ATCC26933 and ΔegtA26933 were 
then measured via haemocytometry (Section 2.2.16). Conidiation levels in ΔegtA26933 were 
significantly lower (P = 0.0426) than those of ATCC26933 (Figure 4.24B). EGT absence 
appears to cause a reduction in conidiation levels in A. fumigatus, suggesting EGT may be 
involved in conidiation 
 
Figure 4.24. Conidiation in ATCC26933 and ΔegtA26933. (A) Comparison of conidial colour and 
appearance in colonies reveal colonies from egtA
26933
 appear to produce paler conidia than the 
colonies of ATCC26933. (B) Comparison of conidiation levels from ATCC26933 and egtA
26933
. 
Levels of conidiation are significantly (P = 0.0426) lower in egtA
26933
 compared to ATCC26933.  
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4.2.12 Phenotypic analysis of ATCC26933, ΔegtA26933 and egtAC26933 in response to 
cell wall perturbing agents 
4.2.12.1 Phenotypic analysis of ATCC26933, ΔegtA26933 and egtAC26933 in response to 
congo red 
Sensitivity to congo red was tested at a range of 0 – 50 µg/ml as per Section 2.2.7. ΔegtA26933 
demonstrated a significant decrease in radial growth compared to ATCC26933 and egtA
C26933
 at 
30 µg/ml (P = 0.0132), 40 µg/ml (P = 0.0014) and 50 µg/ml (P = 0.0046) congo red. Yet, no 
significant difference radial growth was observed at 0 – 20 µg/ml congo red (Figure 4.25). 
Absence of EGT therefore results in sensitivity to congo red. This indicates that egtA deletion 
may cause alterations to the composition of the fungal cell wall. 
4.2.12.2 Phenotypic analysis of ATCC26933, ΔegtA26933 and egtAC26933 in response to 
calcofluor white 
Sensitivity to calcofluor white (CFW) was tested at a range of 0 – 100 µg/ml as per Section 
2.2.7. ΔegtA26933 demonstrated a significant decrease in radial growth compared to ATCC26933 
and egtA
C26933
 at 60 µg/ml (P = 0.0155), 80 µg/ml (P = 0.0249) and 100 µg/ml (P = 0.0001) 
CFW. No significant difference in radial growth was observed at 0 – 40 µg/ml CFW (Figure 
4.26). Absence of EGT therefore results in sensitivity to CFW. This further indicates that egtA 
deletion may cause significant changes to the cell wall in A. fumigatus. 
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Figure 4.25. Congo red sensitivity assay performed on AMM for 72 h. (A) Comparison of radial 
growth of ATCC26933, ΔegtA26933 and egtAC26933 on AMM agar plates containing 0 - 50 µg/ml 
congo red. ΔegtA26933 shows a significant decrease in radial growth compared to ATCC26933 
and egtA
C26933
 when grown at 30 µg/ml (P = 0.0132), 40 µg/ml (P = 0.0014) and 50 µg/ml (P = 
0.0046) congo red. (B) Images of ATCC26933, ΔegtA26933 and egtAC26933 colonies on 0 and 50 
µg/ml congo red. A visible decrease in the size of the ΔegtA26933 colony can be observed 
compared to the ATCC26933 and egtA
C26933
 colonies at 50 µg/ml congo red. 
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Figure 4.26. CFW sensitivity assay performed on AMM for 72 h. (A) Comparison of radial 
growth of ATCC26933, ΔegtA26933 and egtAC26933 on AMM agar plates containing 0 - 100 µg/ml 
CFW. ΔegtA26933 shows a significant decrease in radial growth compared to ATCC26933 and 
egtA
C26933
 when grown at 60 µg/ml (P = 0.0155), 80 µg/ml (P = 0.0249) and 100 µg/ml (P = 
0.0001) CFW. (B) Images of ATCC26933, ΔegtA26933 and egtAC26933 colonies on 0 and 100 
µg/ml CFW. A visible decrease in the size of the ΔegtA26933 colony can be observed compared to 
the ATCC26933 and egtA
C26933
 colonies at 100 µg/ml CFW. 
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 4.2.13  Analysis of N. tabacum L. cv. Petit Havana:egtA:nfs1 
EGT is taken up by plants from symbiotic microorganisms (Park et al., 2010), however little data 
is available on the function of EGT in plants. In order to address this, an N. tabacum strain 
transformed with A. fumigatus egtA and nfs1 was generated by Prof. Phil Dix, Dr. Peter 
Medgyesy and Dr. Éva Horvath (Maynooth University). By generating a N. tabacum strain 
capable of biosynthesising EGT, EGT function in plants could be characterised. It was thus 
necessary to verify the presence of EgtA and Nfs1 proteins in N. tabacum leaf lysates via Q-
Exactive mass spectrometry. Furthermore, LC-MS/MS analysis was undertaken to investigate if 
EGT biosynthesis had occurred in the transformed N. tabacum strain. 
 4.2.13.1 Proteomic Analysis of N. tabacum L. cv. Petit Havana:egtA:nfs1 
Cell lysates from leaves of wild-type L. cv. Petit Havana and L. cv. Petit Havana:egtA:nfs1 were 
obtained as per Section 2.2.14.2. Lysates were then concentrated, washed, reduced and alkylated 
as per Section 2.2.14.3. Samples were then trypsin digested (Section 2.2.14.4), purified, 
normalised and desalted using ZipTips ® (2.2.14.5) and analysed by Q-Exactive mass 
spectrometry (Section 2.2.14.6). Q-Exactive analysis failed to identify EgtA or Nfs1 peptides in 
either sample. This suggests that the EgtA and Nfs1 proteins are absent or are below the levels of 
detection in L. cv. Petit Havana:egtA:nfs1.  
4.2.13.2 EGT analysis in N. tabacum L. cv. Petit Havana:egtA:nfs1 
Lysate supernatants from leaves of wild-type L. cv. Petit Havana and L. cv. Petit 
Havana:egtA:nfs1 were obtained as per Section 2.2.14.2. Lysate supernatants were then filtered 
through an Amicon 3 kDa centrifuge filter (Section 2.2.12.4) and the filtrate collected. Lysate 
filtrates were then alkylated (Section 2.2.12.1), TCA precipitated (Section 2.2.12.2) and analysed 
via LC-MS/MS (Section 2.2.12.7).  In addition, an EGT standard alkylated with 5’-IAF and TCA 
precipitated as before was analysed in the same manner. 5’-IAF alkylated EGT eluted at 7.5 min, 
with an m/z of 617. Extracted ion chromatograms (m/z: 617) for wild-type L. cv. Petit Havana 
and L. cv. Petit Havana:egtA:nfs1 demonstrate that EGT is absent in the wild-type strain and 
present in the transformed strain (Figure 4.27). Transformation of N. tabacum with egtA and nfs1 
therefore confers the ability to biosynthesise EGT. 
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Figure 4.27. Detection of alkylated EGT in L. cv. Petit Havana:egtA:nfs1. (A) Extracted Ion 
Chromatographs (m/z: 617) for wild-type L. cv. Petit Havana and L. cv. Petit Havana:egtA:nfs1, 
in addition to an EGT standard. A peak at 7.5 min in the transformed strain was confirmed to be 
EGT. This peak was absent from the wild-type strain. (B) Signature Ion breakdown 
corresponding to 5’-IAF alkylated EGT (Gallagher et al., 2012) in L. cv. Petit Havana:egtA:nfs1. 
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4.3   Discussion 
This chapter presents the work done to investigate the function of A. fumigatus egtA, as well as 
the role of EGT in A. fumigatus ATCC26933. egtA was demonstrated to be essential for EGT 
biosynthesis, facilitating investigation into the role of the metabolite in A. fumigatus. EGT 
absence resulted in sensitivity to high concentrations of H2O2 and menadione, confirming a role 
for EGT as an antioxidant in A. fumigatus. GSH levels in the ATCC26933 background increased 
following EGT deletion, but the same effect was not observed in the AfS77 background. 
However GSH/GSSG ratios were similarly altered in both backgrounds. EGT loss also had an 
impact on apparently unrelated systems, with gliotoxin levels significantly reduced, levels of 
conidiation attenuated and sensitivity to cell wall perturbing agents observed in ΔegtA26933. 
RP-HPLC and LC-MS/MS analysis was employed to investigate the effect of egtA deletion and 
complementation on EGT production in A. fumigatus ATCC26933. No EGT was in egtA
26933
, 
while reinsertion of the gene restored EGT production in egtA
C26933
. Thus egtA was shown to be 
essential for EGT production in A. fumigatus. Interestingly, EGT production in egtA
C26933
 was 
elevated compared to ATCC26933. This may be due to differences in gene regulation due to 
egtA reinsertion outside of its natural locus in egtA
C26933
. This data demonstrates unambiguously 
that egtA is essential for EGT biosynthesis and represents the first targeted deletion of an EGT 
biosynthetic gene in fungi as previous work from Bello et al. (2012) and Pluskal et al. (2014) 
utilised mutants obtained from deletion libraries. Furthermore, A. fumigatus ΔegtA represents the 
first EGT null mutant in the Aspergillus spp. and the first EGT deletion mutant in a fungal 
pathogen of humans. 
ΔegtA26933, alongside ATCC26933 and egtAC26933, was subjected to oxidative stress via H2O2, 
menadione and diamide assay for sensitivity to elevated ROS. The role of EGT as antioxidant in 
fungi is unclear. egt-1 deletion in N. crassa caused no sensitivity to Cu
2+
 or menadione, however 
N. crassa conidia showed sensitivity to 2 mM tert-butyl hydroperoxide (Bello et al., 2012). In S. 
pombe, an egt1 deletion mutant showed no deleterious effects when exposed to hydrogen 
peroxide (0 – 2 mM) and tert -butyl hydroperoxide (0 – 0.5 mM) (Pluskal et al., 2014). Plate 
assays for H2O2 with ATCC26933, ΔegtA
26933
 and egtA
C26933 revealed ΔegtA26933 was sensitive to 
H2O2 compared to the wild-type and complemented strains at a concentration of 3 mM only. At 1 
mM and 2 mM H2O2, no difference between the three strains was observed, however at 3 mM, 
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radial growth of ΔegtA26933 was reduced dramatically. None of the three strains were capable of 
growth at 4 mM, suggesting 3 mM H2O2 is approaching the limit of H2O2 that wild-type A. 
fumigatus can tolerate. Thus it appears that EGT absence is deleterious only at very high levels 
of H2O2. In testing menadione sensitivity, it was found that ΔegtA
26933
 was significantly sensitive 
compared to ATCC26933 and egtA
C26933
 at concentrations of 40 µM and 60 µM. At 20 µM, no 
difference between the 3 strains was observed. This suggests EGT has an important role in 
protection from superoxide radicals in A. fumigatus, however it may not be the primary 
mechanism of defence. No significant differences were observed in any of the strains following 
diamide exposure. This indicates that EGT does not confer protection against diamide-mediated 
GSH depletion, which may be due to the elevated levels of GSH observed. 
The role of EGT in oxidative stress defence was further illustrated by fluorescence analysis using 
H2DCFDA. H2DCFDA is used as an indicator of ROS levels via fluorescence, allowing for the 
measurement of ROS levels in A. fumigatus mycelia. Upon exposure to 3 mM H2O2, ROS levels 
in ΔegtA26933 were found to be significantly elevated compared to ATCC26933. This 
demonstrates that EGT functions to dissipate ROS in A. fumigatus and its absence in ΔegtA26933 
leads to elevated ROS and impaired growth as observed in the H2O2 plate assay. Interestingly, 
under basal conditions, ΔegtA26933 displayed lower levels of ROS than ATCC26933. This 
suggests compensatory mechanisms may be in place consequent to EGT loss. The results of the 
oxidative stress testing, combined with fluorescent microscopy using H2DCFDA, show that EGT 
functions as an antioxidant in A. fumigatus. However, high levels of induced stress, particularly 
with H2O2, were necessary to show the effects of EGT loss. This indicates that EGT is important 
for detoxifying high levels of ROS in A. fumigatus. This could be due to the physical properties 
of EGT, which confer increased stability compared to other low molecular mass thiols such as 
GSH (Cheah and Halliwell, 2012). It may be that EGT is not essential for detoxifying low levels 
of ROS as it can be effectively dissipated by other facets of the oxidative stress defence system.  
At high levels of ROS, when these other components of the oxidative stress defence system have 
been exhausted, EGT is then available to dissipate the remaining ROS.  Thus EGT may be an 
“antioxidant of last resort”.  
The elucidation of EGT function as an antioxidant in A. fumigatus may help explain in part the 
rise in intracellular EGT observed by Gallagher et al. (2012) in ΔgliK. A. fumigatus ΔgliK 
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displayed sensitivity to H2O2, suggesting gliK deletion leaves A. fumigatus vulnerable to elevated 
levels of ROS. The increase in EGT observed may be a counter-measure to try and combat this 
sensitivity. If this is the case, it could explain the inability to generate a ΔegtA::ΔgliK double 
mutant. EGT may be essential for maintaining redox homeostasis following the deletion of gliK, 
which would explain the observed rise of intracellular EGT in ΔgliK. If this is the case, 
concurrent absence of EgtA and GliK would not be viable. This would further underline the 
importance of EGT as an antioxidant in A. fumigatus. 
egtA response to H2O2 was demonstrated via qRT-PCR. A. fumigatus ATCC26933 exposed to 3 
mM H2O2 showed elevated egtA expression in comparison to control conditions. Relevantly, 
Northern blot analysis has demonstrated that egtA expression is increased following exposure to 
1 mM H2O2, signifying that low levels of ROS are capable of inducing egtA expression 
(Sheridan et al., 2016).  This would suggest that EGT levels are increased in response to elevated 
ROS, which might be expected given that EGT has been demonstrated to function as an 
antioxidant in A. fumigatus. However this was not the case, as RP-HPLC analysis demonstrated 
that EGT levels showed a non-significant drop following H2O2 exposure. While this result was 
unexpected, analysis of EGT-H2O2 interaction provided an explanation. Co-incubation of EGT 
and H2O2 resulted in decreased EGT levels when measured by RP-HPLC, which suggests that 
EGT reactivity with ROS dissipates the antioxidant. This is consistent with data from Servillo et 
al. (2015) who demonstrated EGT degradation into hercynine and sulphurous acid upon 
oxidation (Figure 4.28). Thus it appears that egtA expression rises in response to H2O2 in order to 
maintain EGT levels, as they are dissipated by elevated ROS. Note that different media was used 
for the qRT-PCR and EGT analyses. Sabouraud Dextrose broth was used for the qRT-PCR 
analysis in order to facilitate hyphal growth. Czapeck-Dox broth was used for EGT analysis to 
facilitate optimal EGT production. 
Analysis of total GSH levels and GSH/GSSG ratio in ATCC26933, ΔegtA26933 and egtAC26933 
was carried out to investigate if egtA deletion affected GSH biosynthesis or cellular redox status. 
GSH and EGT are linked metabolically as cysteine provides the thiol group in both metabolites. 
Furthermore, EGT and GSH are redox active molecules that form part of the oxidative stress 
defence system. Thus EGT absence may result in alterations to GSH metabolism and redox state.  
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Figure 4.28. The oxidative degradation pathway of EGT. Upon oxidation, EGT forms EGT 
disulphide, which undergoes further oxidation to form EGT disulphide S-monoxide. EGT 
disulphide S-monoxide is then hydrolysed  to form the unstable intermediate EGT sulphinic acid. 
EGT sulphinic acid is degraded rapidly to yield hercynine and sulphurous acid (Servillo et al., 
2015). 
Measurement of total GSH by LC-MS/MS revealed total GSH levels were significantly elevated 
in ΔegtA26933 and returned to wild-type levels in egtAC26933. EGT loss therefore appears to lead to 
an increase in total GSH. This is likely to compensate for the loss antioxidant potential resulting 
from EGT absence. Measuring the GSH/GSSG ratios of ATCC26933, ΔegtA26933 and egtAC26933 
revealed a rise in the GSH/GSSG ratio in ΔegtA26933. This suggests that ΔegtA26933 is under less 
oxidative stress than the wild-type or complemented strain. This may be due to the increase in 
total GSH observed and would explain the lower levels of ROS observed in ΔegtA26933 through 
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fluorescent microscopy under basal conditions. Alternatively, EGT absence may leads to 
increased oxidative stress, prompting the increase in total GSH observed, resulting in an increase 
in GSH/GSSG ratio. 
Comparison of total glutathione levels in ΔegtA26933 and ΔegtAAfS77 and their respective 
background strains revealed an intriguing difference between the strains. While egtA deletion in 
ATCC26933 led to a significant elevation in total glutathione, the same effect was not observed 
in ΔegtAAfS77, where no significant change in total GSH was observed. Interestingly, the basal 
levels of total GSH in the two wild-type strains were significantly different. Total glutathione 
levels in ATCC26933 were observed to be significantly lower than those of AfS77. This may 
explain the need to increase total glutathione following egtA deletion in ATCC26933, but not in 
AfS77. Analysis of GSH/GSSG ratios in the AfS77 background strains revealed a similar pattern 
in ratio change to ATCC26933. Like ATCC26933, egtA deletion led to an increase in 
GSH/GSSG ratio, while complementation lowered GSH/GSSG ratio. This suggests that loss of 
EGT has a similar effect on GSH redox state across the two background strains, even though 
total GSH levels differ.  
EGT was observed to be elevated in A. fumigatus ΔgliK (Gallagher et al., 2012), the first 
identification of EGT in A. fumigatus. GliK catalyses a bis-glutamyl elimination step in gliotoxin 
biosynthesis, following double thiolation with GSH. GliK is essential for gliotoxin biosynthesis 
and gliK deletion results in abrogation of gliotoxin production (Gallagher et al., 2012; Scharf et 
al., 2013). Furthermore, ΔgliK exhibited sensitivity to exogenous gliotoxin. The reason for this 
sensitivity remains to be fully elucidated, however it has been demonstrated that GliT induction 
following exogenous gliotoxin exposure is decreased in ΔgliK compared to wild-type (Gallagher 
et al., 2012; Owens et al., 2015). GliT is important for gliotoxin self-protection and induction of 
GliT following exogenous gliotoxin exposure forms part of the self-protection mechanism 
(Schrettl et al., 2010; Scharf et al., 2010).  In order to investigate if increased levels of EGT in 
ΔgliK were linked to concurrent abrogated gliotoxin biosynthesis and sensitivity to exogenous 
gliotoxin, gliotxin biosynthesis and self-protection were analysed in ΔegtA26933. Gliotoxin 
analysis was carried out via RP-HPLC and LC-MS/MS on organic extracts from ATCC26933 
and ΔegtA26933. ΔegtA26933 was still capable of producing gliotoxin, however levels of gliotoxin 
were significantly lower than wild-type. Furthermore, LC-MS/MS analysis revealed BmGT was 
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also reduced in ΔegtA26933 compared to ATCC26933. This suggests that EGT loss is deleterious 
to gliotoxin production. Another explanation is that gliotoxin production could be curtailed in 
order to increase total GSH. GSH is essential for gliotoxin biosynthesis (Davis et al., 2011; 
Scharf et al., 2011), and in order to increase total GSH as observed in ΔegtA26933, GSH may be 
diverted from gliotoxin biosynthesis. No sensitivity to gliotoxin was observed in ΔegtA26933 
compared to ATCC26933. Furthermore, GliT was demonstrated to be induced by exogenous 
gliotoxin in ΔegtA26933. This indicates that the gliotoxin self-protection mechanism remains intact 
in the absence of EGT. Therefore EGT appears to have no role in self-protection against 
gliotoxin. 
Absence of EGT in A. fumigatus was demonstrated to result in alterations to conidia. ΔegtA26933 
colonies exhibited paler conidia in comparison to ATCC26933. Furthermore, levels of 
conidiation in ΔegtA26933 were reduced compared to ATCC26933. EGT therefore appears to 
function in promoting conidiation and conidial health in A. fumigatus. This may occur through 
the management of ROS levels. ROS is well known to function as a signaling agent and it has 
been demonstrated influence cellular differentiation, virulence and hyphal growth in fungi 
(Breitenbach et al, 2015). Relevantly, ROS has been linked with conidiation in Epichloë festucae 
(Kayano et al, 2013). Thus, perturbations in ROS levels due to EGT absence may result in 
altered conidiation as observed. EGT has also been demonstrated to function in conidial 
protection and conidiogenesis in N. crassa (Bello et al., 2012, 2014). 
EGT absence in A. fumigatus was demonstrated to result in sensitivity to cell wall perturbing 
agents. ΔegtA26933 was significantly sensitive to congo red compared to ATCC26933 and 
egtA
C26933
 at concentrations of 30, 40 and 50 µg/ml.  ΔegtA26933 was also significantly sensitive 
to CFW compared to ATCC26933 and egtA
C26933
 at concentrations of 60, 80 and 100 µg/ml.  
Both congo red and CFW disrupt cell wall biosynthesis by inhibiting chitin and β(1,3)-glucan 
biosynthesis (Roncero and Duran, 1985). This indicates that egtA deletion causes alterations to 
cell wall biosynthesis in A. fumigatus, resulting in the observed sensitivity to congo red and 
CFW. As with conidiation, this may be due to changes in ROS signalling, as ROS has been 
demonstrated to regulate cell wall biosynthesis in plants (Kärkönen and Kuchitsu, 2015).  
Analysis of a N. tabacum L. cv. Petit Havana strain transformed with A. fumigatus egtA and nfs1 
was undertaken in order to investigate EGT biosynthesis in an organism than cannot synthesise 
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EGT naturally. Proteomic analysis failed to detect the presence of either EgtA or Nfs1 proteins. 
Despite this, EGT was still detected in L. cv. Petit Havana:egtA:nfs1 lysate filtrates at low levels 
and demonstrated to be absent in wild-type N. tabacum. Thus, EGT was demonstrated to be 
biosynthesised in N. tabancum L. cv. Petit Havana:egtA:nfs1. This was unexpected given that 
EgtA and Nfs1 were not detected via proteomic analysis, and this suggests that the abundance of 
EgtA and Nfs1 in L. cv. Petit Havana:egtA:nfs1 is below the threshold of detection. This 
demonstrates that detectable levels of EGT can still be catalysed by enzymes at very low 
abundance. Moreover, this data emphasises the role of egtA in EGT biosynthesis and supports 
the hypothesis that nfs1 also may contribute to EGT biosynthesis. Furthermore, confirmation of 
EGT expression in N. tabacum L. cv. Petit Havana:egtA:nfs1 represents an important step in the 
generation of a system for studying EGT function in organisms that ordinarily acquire EGT from 
the environment.  
To summarise, egtA was confirmed as an essential gene for EGT biosynthesis. EGT provides a 
protective role against high levels of H2O2- and menadione-induced oxidative stress. egtA levels 
increase in response to 3 mM H2O2 in order to maintain EGT levels as it is dissipated in 
detoxifying H2O2. Total GSH levels are significantly increased following egtA deletion in 
ATCC26933, but not AfS77. This may be due to the differences in the basal levels of total GSH 
between the two background strains. Loss of EGT leads to reduced gliotoxin production, but 
gliotoxin self-protection functions at the same level as wild-type. EGT absence also leads to 
changes in conidiation and cell wall biosynthesis. Expression of egtA and nfs1 in N. tabacum led 
to the detection of EGT in plant lysate filtrates, even though presence of the two proteins was too 
low to detect. 
This data presents the first characterisation of EGT biosynthesis and function in A. fumigatus. In 
addition to contributing to oxidative stress defence, EGT influences gliotoxin biosynthesis, GSH 
biosynthesis, conidiation and cell wall integrity. In order to further assess the global systems 
impact of EGT absence, ATCC26933 and ΔegtA26933 were investigated via label-free quantitative 
(LFQ) proteomic analysis, as presented in Chapter 5 .
  
 
 
 
 
 
 
 
 
Chapter 5 
Comparative LFQ Proteomic Analysis 
of A. fumigatus ATCC26933 and ΔegtA
26933 
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5.1   Introduction 
Chapter 4 demonstrated the importance of A. fumigatus ΔegtA26933 as a system for investigating 
EGT functionality in A. fumigatus. In the absence of egtA, EGT production was abrogated and 
led to the observation of phenotypes such as oxidative stress sensitivity, increased GSH 
production, decreased gliotoxin biosynthesis, reduced levels of conidiation and alterations to cell 
wall biosynthesis. In this chapter, ΔegtA26933 is further analysed via comparative label-free 
quantitative (LFQ) proteomics. A comparison of the ATCC26933 proteome to that of the 
ΔegtA26933 proteome would elucidate the effect of EGT loss the A. fumigatus proteome. As well 
as analysing the two strains under basal conditions, both strains were analysed under ROS 
inducing conditions. 3 mM H2O2 was used to induce ROS as it has been demonstrated to result in 
reduced radial growth in ΔegtA26933 compared to ATCC26933. Furthermore, egtA expression was 
induced by exposure to 3 mM H2O2 in ATCC26933. For these reasons, comparative LFQ 
proteomics was undertaken on ATCC26933 and ΔegtA26933 cultures exposed to 3 mM H2O2 to 
gain a greater insight into how A. fumigatus responds to high levels of ROS in the absence of 
EGT. 
Comparative proteomics aims to investigate changes at a proteome level in different strains (e.g. 
wild-type and mutant) or strains grown in different conditions (e.g. ± oxidative stress, hypoxia, 
antibiotic presence, etc (Lessing et al., 2007; Gautam et al., 2008; Vodisch et al., 2011). By 
identifying proteins with differential abundance or that are present/absent in one sample 
compared to the other, the effect of a mutation or growth condition on an organism can be 
inferred. The “classic” proteomic strategy involved the separation of proteins by 2D-
polyacrylamide gel electrophoresis (2D-PAGE) followed by identification of spots by mass 
spectrometry (Carberry and Doyle, 2007). However advances in high resolution mass 
spectrometry have led to the use of LFQ proteomics (Zhu et al., 2009). This involves analysis of 
trypsin-digested whole cell protein lysates using a high resolution mass spectrometer, such as 
Thermo-Fisher’s Q-Exactive Hybrid-Quadrupole Orbitrap (Scheltema et al., 2014), which was 
used in this study. One advantage of the LFQ proteomic strategy over the classic 2D-PAGE 
strategy is the increase in sensitivity; LFQ proteomic analysis has a three- to four-fold increase in 
protein dynamic range compared to 2D-PAGE strategies (Wang et al., 2008). Therefore, LFQ 
proteomics, using high resolution mass spectrometry, allows for the detection of low abundance 
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proteins that would not be detected via 2D-PAGE. Furthermore, detection of proteins that are 
very hydrophobic, contain transmembrane regions, have a larger molecular mass or have an 
extreme pI can be limited by 2D-PAGE (Bantscheff et al., 2007). For these reasons, LFQ 
proteomics allows for greater depth of analysis compared to 2D-PAGE combined with mass 
spectrometry. 
Comparative proteomics has been utilised in the study of A. fumigatus numerous times to 
investigate proteomic response to a range of conditions. Investigation of A. fumigatus under 
different growth conditions such as oxidative stress (Lessing et al., 2007), hypoxia (Vodisch et 
al., 2011), heat shock (Albrecht et al., 2010) and gliotoxin exposure (Schrettl et al., 2010) has 
revealed essential processes in response to their respective conditions. Owens et al. (2014) 
utilised comparative proteomics to investigate A. fumigatus response to co-incubation with H2O2 
and gliotoxin. Proteomic analysis has also been employed to investigate A. fumigatus response to 
antifungal drugs, including amphotericin B (Gautam et al., 2008), coumarin (Singh et al., 2012) 
and caspofungin (Cagas et al., 2011) with the aim of elucidating the molecular mechanisms of 
the drugs and identifying novel target pathways. Proteomic analysis can be used to investigate 
specific cellular components, such as the cell wall, secretome and conidia (Bruneau et al., 2001; 
Singh et al., 2010; Teutschbein et al., 2010).  Moloney et al. (2016) investigated the microsomal 
proteome of A. fumigatus in response to iron-deplete conditions. Additionally, comparative 
proteomics has been used to characterise deletion mutants in A. fumigatus.  Owens et al. (2015) 
demonstrated proteomic analysis of several gliotoxin cluster mutants, including ΔgliK, ΔgliG 
and ΔgliA.  Relevantly, Lessing et al. (2007) investigated the oxidative stress sensitive mutant, 
Δyap1, via 2D-PAGE combined with LC-MS/MS. This was used to identify targets of yap1, a 
transcription factor key to oxidative stress defence. O’Keeffe et al. (2013) studied the proteomic 
response of ΔelfA, another mutant sensitive to elevated ROS, to oxidative stress conditions.  
Comparative proteomics has therefore been established as a robust method of analysis for A. 
fumigatus. The work presented in this chapter represents the first large scale proteomic 
investigation into EGT function performed in any organism and as such represents an important 
study for A. fumigatus and for studies into EGT functionality as a whole. 
The aim of the work presented in this chapter was to carry out comparative LFQ proteomics on 
ATCC26933 and ΔegtA26933 under basal conditions and following addition of 3 mM H2O2. 
187 
 
5.2  Results 
5.2.1 LFQ Proteomic Analysis of ATCC26933 and ΔegtA26933 under basal 
conditions and following H2O2 exposure 
ATCC26933 and ΔegtA26933 (n = 4 biological replicates each) were cultured in Sabouraud-
Dextrose media for 23 h at 37
o
C, 200 rpm. This was followed by H2O2 addition (3 mM final) or 
equivalent volume of H2O for 1 h. These incubation times and conditions were chosen in order to 
mirror qRT-PCR analysis which demonstrated increased egtA expression following H2O2 
exposure (Section 4.2.4). Following 1 h incubation, mycelia were harvested from each culture 
and processed for Q-Exactive Mass Spectrometry analysis as per Section 2.2.14.1. Samples were 
then digested using sequencing grade trypsin (Section 2.2.14.4), purified, normalised and 
desalted using ZipTips ® (Section 2.2.14.5) and analysed on the Q-Exactive mass spectrometer 
(Section 2.2.14.6). Data was analysed via Max Quant in the following manner:  
(i) Comparison of ATCC26933 and ΔegtA26933 under basal conditions. 
(ii) Comparison of ATCC26933 and ΔegtA26933 under ROS conditions.  
(iii) Comparison of ΔegtA26933 under basal and ROS conditions. 
(iv) Comparison of ATCC26933 under basal and ROS conditions. 
Significantly enriched functional categories of proteins were identified using the web based 
application FungiFun 2 (Priebe et al., 2015; https://elbe.hki-jena.de/fungifun/fungifun.php) 
5.2.1.1 LFQ Proteomic Comparison of ATCC26933 and ΔegtA26933 under basal 
conditions 
A proteomic comparison of ATCC26933 and ΔegtA26933 under basal conditions was undertaken 
to investigate the effect of EGT loss in A. fumigatus in the absence of external oxidative 
stressors. Proteomic comparisons revealed that 26 proteins showed increased abundance or were 
unique in ΔegtA26933 compared to ATCC26933, while 121 proteins showed decreased abundance 
or were absent in ΔegtA26933 compared to ATCC26933. This is a total of 147 proteins that 
showed differential abundance due to the loss of EGT, which suggests that even without any 
induced stress, EGT loss causes significant proteomic remodelling in A. fumigatus. Figure 5.1 
summarises the most significantly enriched functional categories of the proteins showing 
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differential abundance. The full list of proteins showing differential abundance can be seen in 
Appendix 1.  
A number of proteins with differential abundance were reductases, oxidases, stress response 
proteins and enzymes with oxidising products (Table 5.1). This suggests at a shift in redox 
homeostasis, which is reflected by the changes in these redox sensitive proteins. Of particular 
interest is HapC (AFUA_1G03840), the redox sensitive subunit of the CCAAT-Binding 
Complex (CBC), which is absent in ΔegtA26933 compared to ATCC26933. Thon et al. (2010) 
demonstrated in Aspergillus nidulans that the CBC is essential for oxidative stress defence. 
HapC function in the CBC is to sense the redox status of the cell. This is achieved via oxidative 
modification of thiol groups within its histone fold motif. HapC was demonstrated to be essential 
for correct CBC function, with impaired oxidative stress response demonstrated upon HapC 
deletion. The absence of HapC in ΔegtA26933 would therefore indicate a defective oxidative stress 
response in this mutant.  
The gliotoxin oxidoreductase, GliT (AFUA_6G09740), was also observed to be absent in 
ΔegtA26933 compared to ATCC26933 (Table 5.1). The absence of this protein was of interest due 
to the observed drop in gliotoxin production following egtA deletion in ATCC26933 (Section 
4.2.9). GliT is involved in disulphide bridge closure in gliotoxin biosynthesis and gliotoxin 
production is abrogated in its absence (Schrettl et al., 2010). Thus, GliT is essential for gliotoxin 
biosynthesis and the decrease in abundance following egtA deletion may well be responsible for 
the observed reduction in gliotoxin levels. 
Proteins involved in the biosynthesis of other secondary metabolites also demonstrated 
differential abundance in ΔegtA26933. A SirN-like methyltransferase (AFUA_8G00550), 
predicted to be involved in pseurotin A biosynthesis (V disch et al., 2011) showed a log2 1.28 
fold increase in abundance. OrdA (AFUA_8G00510), a cytochrome P450 enzyme encoded 
within the fumagillin cluster (Lin et al., 2013), was demonstrated to be absent in ΔegtA26933 
(Table 5.1). 
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Figure 5.1. Significantly enriched functional categories of proteins showing differential 
abundance in ΔegtA26933 compared to ATCC26933 under basal conditions. The number under 
each category represents the number of proteins detected within that category. (A) Significantly 
enriched functional categories from proteins showing increased abundance, whereby all 26 
proteins in the data set were annotated. (B) Significantly enriched functional categories from 
proteins showing decreased abundance, whereby 119 out of 121 proteins in the data set were 
annotated. 
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Another protein of interest from this data set was cystathionine γ-synthase (CGS; 
AFUA_7G01590), which was observed to be absent in ΔegtA26933 compared to ATCC26933 
(Table 5.1). CGS catalyses the formation of cystathionine from homoserine and cysteine 
(Ravanel, 1997) and its absence in ΔegtA26933 suggests that cystathionine production is attenuated 
when EGT biosynthesis is abrogated. The absence of CGS may be related to the rise in total 
glutathione observed in ΔegtA26933 (Section 4.2.7.1). Cysteine is essential for glutathione 
biosynthesis (Lu, 2009), in addition to being a substrate of CGS in cystathionine biosynthesis. 
Therefore, it is feasible that CGS may be decreased in abundance in order to preserve cysteine 
for the production of glutathione (Figure 5.2).  
 
Figure 5.2. Comparison of ΔegtA26933 and ATCC26933 under basal conditions showing an 
absence of cystathionine γ-synthase (CGS), which converts cysteine to cystathionine.  This could 
be facilitating the switch towards increased glutathione production. 
Conidial health and conidiation was of interest as ΔegtA26933 displayed paler conidia compared to 
wild-type as well as lower levels of conidiation (Section 4.2.10), evidence of a role for EGT in 
conidial protection and conidiation in A. fumigatus. Bello et al. (2012, 2014) also reported 
conidial sensitivity to peroxide and lower levels of conidiogenesis in N. crassa. In this context, 
the absence of several conidial proteins was of interest (Table 5.1). These include 
mannosyltransferases PMT2 (AFUA_1G07690)(Fang et al., 2010) and PMT4 
(AFUA_8G04500)(Mouyna et al., 2010), conidial hydrophobin RodB (AFUA_1G17250)(Paris 
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et al, 2003a), developmental regulator FlbA (AFUA_2G11180)(Yu et al., 1996) and extracellular 
developmental signal biosynthesis protein FluG (AFUA_3G07140)(Mah and Yu, 2006). The 
unavailability of these proteins due to EGT absence is further evidence of the role of EGT in 
conidiation and conidial health in A. fumigatus. 
Potentially related to this is the increase (log2 1.23 fold) in the methyltransferase VipC 
(AFUA_8G01930) in ΔegtA26933 compared to ATCC26933 under basal conditions. In A. 
nidulans, VipC interacts with the velvet complex and has been shown to play a role in 
controlling the switch between sexual and asexual reproduction. Relevantly, a VipC 
overexpression mutant demonstrated reduced asexual reproduction (Sarikaya-Bayram et al., 
2014). VipC has yet to be characterised in A. fumigatus, however the evidence from A. nidulans 
suggests that the differential abundance of VipC observed could be linked to the abnormal 
conidiation demonstrated in ΔegtA26933. 
The protein showing the largest increase in abundance in ΔegtA26933 compared to ATCC26933 
under basal conditions was phenylalanine ammonia lyase (PAL; AFUA_2G09110)(Table 5.1). 
PAL showed a log2 2.71 fold increase in ΔegtA
26933
 compared to ATCC26933. PAL is involved 
in the breakdown of phenylalanine, converting it into ammonia and trans-cinnamic acid (Camm 
and Towers, 1973). PAL is associated with defence from pathogens in plants (Shadle et al., 
2003; Kim and Hwang, 2014; Tonnessen et al., 2015), and has also been implicated in oxidative 
stress defence (Desikan et al., 1998; Lee et al., 2003). Thus, this observed increase in abundance 
may be part of an alternative oxidative stress defence in the absence of EGT. 
Five proteins related to A fumigatus cell wall biosynthesis were noted to show differential 
abundance in ΔegtA26933 compared to ATCC26933 (Table 5.1). This was of interest because 
ΔegtA26933 exhibited decreased radial growth in comparison to ATCC26933 and egtAC26933 when 
exposed to the cell wall perturbing agents congo red and CFW. 1,3-beta-glucanosyltransferase 
(GEL5; AFUA_8G02130) showed a log2 1.18 fold increase, while chitin synthase activator Chs3 
(AFUA_3G05580), a putative cell wall protein (AFUA_3G081110), a putative MAP kinase 
kinase (Mkk2;AFUA_1G05800)(Valiante et al., 2009) and a putative cell wall glucanase 
(AFUA_3G09250) were absent. In addition, the mannosyltransferases PMT2 and PMT4, which 
are both absent in ΔegtA26933 compared to ATCC26933 and discussed previously in relation to 
conidial health, also function in cell wall biosynthesis in A. fumigatus (Mouyna et al., 2010; Fang 
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et al., 2010). The differential abundance of these proteins supports previous data that suggested 
EGT absence leads to cell wall alterations.  
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Table 5.1. Selected proteins with significant log2 fold change or absent in A. fumigatus ∆egtA
26933
 compared to ATCC26933 under 
basal conditions. Data sorted by fold change, in descending order. 
Protein Description Present/log2 
(Fold Change) 
p value Peptides Sequence 
coverage 
[%] 
Protein IDs 
phenylalanine ammonia-lyase 2.70643 0.000688551 26 52.8 AFUA_2G09110 
1,3-beta-glucanosyltransferase (GEL5) 1.17592 0.00673139 4 8.8 AFUA_8G02130 
2-dehydropantoate 2-reductase 1.48361 0.018129 5 16.7 AFUA_4G13960 
Methyltransferase SirN-like, putative 1.28453 0.0206547 19 76 AFUA_8G00550 
Methyltransferase LaeA-like, putative (VipC) 1.22923 0.0152246 6 13.8 AFUA_8G01930 
Sulfhydryl oxidase 1.22122 0.008832 7 37.3 AFUA_3G08850 
Oxidoreductase, 2OG-Fe(II) oxygenase family 1.10977 0.018011 16 58.7 AFUA_1G01000 
Oxidoreductase, short chain dehydrogenase/reductase 
family -1.0044 0.00741 13 86.4 AFUA_5G14000 
Cytochrome P450 monooxygenase, putative -1.01068 0.030958 15 34.7 AFUA_6G02210 
5-oxo-L-prolinase, putative -1.08559 0.000788 65 63.9 AFUA_6G14330 
Isoflavone reductase family protein (Oxidoreductase 
activty) -1.09131 0.021158 13 57 AFUA_1G12510 
Mitochondrial enoyl reductase, putative -1.23179 0.001484 17 61.8 AFUA_3G03330 
Oxidoreductase, zinc-binding dehydrogenase family, 
putative -2.01615 0.02697 12 61 AFUA_1G15610 
CCAAT-binding factor complex subunit HapC Absent n/a 3 23.8 AFUA_1G03840 
Cystathionine gamma-synthase Absent n/a 7 30.6 AFUA_7G01590 
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Protein Description Present/log2 
(Fold Change) 
p-value Peptides Sequence 
coverage 
[%] 
Protein IDs 
Cytochrome c oxidase assembly protein (Pet191), 
putative Absent n/a 2 26.5 AFUA_5G08965 
MAP kinase kinase (Mkk2), putative Absent n/a 2 5.8 AFUA_1G05800 
Protein O-mannosyl transferase (PMT2) Absent n/a 3 4.1 AFUA_1G07690 
Conidial hydrophobin RodB Absent n/a 5 67.9 AFUA_1G17250 
Chitin synthase activator (Chs3), putative Absent n/a 7 16.1 AFUA_3G05580 
Extracellular developmental signal biosynthesis 
protein FluG Absent n/a 8 15.8 AFUA_3G07140 
Cell wall protein, putative Absent n/a 2 2.9 AFUA_3G08110 
Cell wall glucanase, putative Absent n/a 3 8 AFUA_3G09250 
Gliotoxin oxidoreductase GliT Absent n/a 9 43.4 AFUA_6G09740 
Cytochrome P450 oxidoreductase OrdA-like, putative Absent n/a 5 11.9 AFUA_8G00510 
Mannosyltransferase PMT4 Absent n/a 3 5.4 AFUA_8G04500 
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5.2.1.2 LFQ Proteomic Comparison of ATCC26933 and ΔegtA26933 under ROS 
conditions 
A proteomic comparison of ATCC26933 and ΔegtA26933 following the addition of 3 mM H2O2 
was undertaken in investigate the effect of EGT loss on the ability of A. fumigatus to respond to 
high levels of H2O2-induced stress. Proteomic comparisons revealed 250 proteins showed 
increased abundance or were unique in ΔegtA26933 compared to ATCC26933 under ROS 
conditions, while 40 proteins showed decreased abundance or were absent in ΔegtA26933 
compared to ATCC26933 under ROS conditions. This represents a total of 290 proteins which 
showed differential abundance under oxidative stress conditions due to EGT deficiency in A. 
fumigatus. This is an increase on the 147 proteins showing differential abundance in ΔegtA26933 
compared to ATCC6933 under basal conditions and indicates that addition of 3 mM H2O2 
induces an even greater proteomic remodelling in ΔegtA26933 compared to ATCC269333. Figure 
5.3 summarises the most significantly enriched functional categories of the proteins showing 
differential abundance. The full list of proteins showing differential abundance can be seen in 
Appendix 2. 
As with ΔegtA26933 compared to ATCC26933 under basal conditions (Section 5.2.1.1), a number 
of proteins with differential abundance were reductases, oxidases, stress response proteins and 
enzymes with oxidising products (Table 5.2). With the addition of H2O2, even more of these 
proteins show differential abundance. This is indicative of a severe change in redox homeostasis, 
likely due to EGT absence and concurrent cellular inability to dissipate high levels of H2O2- 
induced ROS, as demonstrated at the phenotypic level in the data presented in Chapter 4.  
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Figure 5.3. Significantly enriched functional categories of proteins showing differential 
abundance in ΔegtA26933 compared to ATCC26933 under ROS conditions. The number under 
each category represents the number of proteins detected within that category. (A) Significantly 
enriched functional categories from proteins showing increased abundance, whereby 237 out of 
250 proteins in the data set were annotated. (B) Significantly enriched functional categories from 
proteins showing decreased abundance, whereby 37 out of 40 proteins in the data set were 
annotated. 
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Following the absence of CGS in ΔegtA26933 under basal conditions, the differential abundance of 
another cystathionine related enzyme upon addition of H2O2 was of much interest. Cystathionine 
β-lyase (CBL; AFUA_4G03950) showed a log2 3.1 fold increase in abundance in ΔegtA
26933
 
compared to ATCC26933 under ROS conditions (Table 5.2). CBL catalyses the conversion of 
cystathionine to homocysteine, ammonia and pyruvate. Homocysteine is part of the methionine 
cycle, which involves S-adenosylmethionine (SAM), the universal methyl donor (Ravanel, 
1997)(Figure 5.4). SAM is essential for EGT biosynthesis, as it is a key substrate for the tri-
methylation of histidine to form hercynine. Significantly, 3 mol of SAM are required to produce 
1 mol of EGT, meaning EGT biosynthesis utilises SAM intensively. The observed rise in CBL 
may be part of a shift towards attempted EGT biosynthesis due to increased levels of ROS, even 
though the necessary enzyme, EgtA, is absent. 
 
Figure 5.4. Comparison of ΔegtA26933 and ATCC26933 upon addition of 3 mM H2O2 shows an 
increased abundance of cystathionine β-lyase, which converts cystathionine to homocysteine. 
This could result in increased production of SAM, which is essential for EGT biosynthesis. 
Related to this, HisF (AFUA_2G06230), an imidzole glycerol phosphate synthase subunit, 
showed a log2 1.11 fold increase in ΔegtA
26933
 compared to ATCC26933 following the addition 
of H2O2 (Table 5.2). HisF is essential for histidine biosynthesis, as it catalyses the closure of the 
imidazole ring (Rieder et al., 1994). This suggests that ΔegtA26933 attempts to increase levels of 
histidine production. Histidine is a key precursor for EGT biosynthesis and an increase in 
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histidine levels would be necessary in order to increase EGT production. Relevantly, attenuated 
histidine levels have been associated with heavy metal toxicity in A. fumigatus, indicating that 
histidine availability is an important factor in cellular defence (Dietl et al., 2016). Furthermore, a 
log2 2.22-fold increase in a putative sulphite reductase (AFUA_2G15590) likely indicates an 
increased need for sulphur in ΔegtA26933, which could reflect attempted EGT production, or an 
increase in GSH biosynthesis (Table 5.2).  
Several proteins related to secondary metabolism were shown to have increased abundance in 
ΔegtA26933 compared to ATCC26933 under ROS conditions (Table 5.2). These were an aflatoxin 
B1-aldehyde reductase (AFUA_1G13370), a hybrid NRPS/PKS (PsoA; AFUA_8G00540), an 
aldehyde reductase (GliO; AFUA_5G02020), a putative NRPS-like enzyme (AFUA_5G10120) 
and a SirN-like methyltransferase (AFUA_8G00550). This aligns with the differential abundance 
of two proteins related to secondary metabolism under basal conditions, which suggests an 
increase in secondary metabolism in response to H2O2 in the absence of EGT. 
Two proteins with increased abundance in ΔegtA26933 compared to ATCC26933 under basal 
conditions were VipC and PAL (Table 5.1). Upon addition of 3 mM H2O2, both of these proteins 
showed an even larger increase in abundance in ΔegtA26933 compared to ATCC26933 under ROS 
conditions (Table 5.2). VipC showed a log2 1.23 fold increase under basal conditions, while it 
showed a log2 2.5 fold increase in abundance under ROS conditions. PAL showed a log2 2.71 
fold increase in ΔegtA26933 compared to ATCC26933 under basal conditions, while it showed a 
log2 3.73 fold increase under ROS conditions. This suggests that the cause of the increased 
abundance these proteins in ΔegtA26933 under basal conditions is exacerbated by an increase in 
ROS. 
Following the observation of five cell wall related proteins with differential abundance in 
ΔegtA26933 compared to ATCC26933 under basal conditions, two additional cell wall related 
proteins also showed differential abundance in ΔegtA26933 compared to ATCC26933 under 
elevated ROS conditions. A putative class V chitinase (AFUA_3G11280) showed a log2 2.05 
fold increase and a putative cell wall integrity signalling protein (AFUA_6G07520) showed a 
log2 1.63 fold increase. This is further evidence of changes in cell wall biosynthesis due to EGT 
loss, following the differential abundance of several cell wall proteins in ΔegtA26933 compared to 
ATCC26933 under basal conditions. 
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Table 5.2. Selected proteins with significant log2 fold change or unique/absent in A. fumigatus ∆egtA
26933
 compared to ATCC26933 
under ROS conditions. Data sorted by fold change, in descending order. 
Protein Description Present/log2  
(Fold Change) 
p-value Peptides Sequence 
coverage 
[%] 
Protein IDs 
Flavin containing amine oxidase, putative Unique n/a 3 9.3 AFUA_3G12150 
Cytochrome P450, putative Unique n/a 1 4 AFUA_5G01360 
Autophagy protein Atg20, putative Unique n/a 3 7.5 AFUA_2G14160 
Epoxide hydrolase, putative Unique n/a 4 19 AFUA_2G16900 
Protein kinase Yak1, putative Unique n/a 4 5.5 AFUA_4G03850 
Zinc-binding oxidoreductase CipB Unique n/a 6 28.8 AFUA_4G00700 
NADPH-dependent FMN reductase Lot6, putative 4.40163 0.00432 8 69.2 AFUA_7G06600 
Phenylalanine ammonia-lyase 3.72865 0.0202547 26 55.8 AFUA_2G09110 
Pyridoxal kinase, putative 3.61996 0.007665 7 34.6 AFUA_1G02900 
NmrA-like family protein 3.19014 0.010049 8 44.7 AFUA_6G00280 
Cystathionine beta-lyase MetG 3.09553 0.0355343 8 32.5 AFUA_4G03950 
Oxidoreductase, 2OG-Fe(II) oxygenase family 2.88667 0.002938 18 60 AFUA_1G01000 
Short chain dehydrogenase family protein 2.87187 0.011169 6 23 AFUA_1G16630 
CsgA-like short chain dehydrogenase/reductase, putative 2.86184 0.046537 6 62.8 AFUB_075540 
NifU-related protein 2.62307 0.048628 7 44.8 AFUA_1G04680 
Flavin-binding monooxygenase-like protein 2.56424 0.027902 8 21.2 AFUA_6G01900 
Ortholog(s) have cytochrome-c oxidase activity 2.50787 0.028945 5 21.3 AFUA_Mt00120 
Methyltransferase LaeA-like, putative (VipC) 2.49862 0.0001273 9 21.5 AFUA_8G01930 
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Protein Description Present/log2  
(Fold Change) 
p-value Peptides Sequence 
coverage 
[%] 
Protein IDs 
Short-chain dehydrogenase, putative 2.45341 0.019904 7 29.3 AFUA_8G00280 
Sulfite reductase, putative 2.22575 0.003046 35 31.2 AFUA_2G15590 
NADH-ubiquinone oxidoreductase subunit GRIM-19, 
putative 2.20179 0.038593 4 34.6 AFUA_3G08770 
Class V chitinase, putative 2.04796 0.025086 14 56.8 AFUA_3G11280 
Aflatoxin B1-aldehyde reductase GliO-like, putative 2.01845 0.049263 13 48.3 AFUA_1G13370 
DUF255 domain protein 1.88685 0.041084 12 20.8 AFUA_1G12370 
2-dehydropantoate 2-reductase 1.80192 0.041835 4 16.1 AFUA_3G00740 
Cell wall integrity signaling protein Lsp1/Pil1, putative 1.63067 0.0084455 10 41.5 AFUA_6G07520 
2-oxo acid dehydrogenases acyltransferase, putative 1.62889 0.037992 17 46.3 AFUA_4G12010 
Hybrid NRPS/PKS enzyme, putative (PsoA) 1.54538 0.0288011 45 16.2 AFUA_8G00540 
NADH-ubiquinone oxidoreductase 304 kDa subunit 1.50531 0.043681 16 52.1 AFUA_6G08810 
Methyltransferase SirN-like, putative 1.47973 0.0227853 21 78.2 AFUA_8G00550 
AhpC/TSA family protein 1.44847 0.014711 11 54.1 AFUA_6G12500 
NADH-dependent flavin oxidoreductase, putative 1.43235 0.030737 33 76.1 AFUA_7G06420 
Pyridoxal reductase (AKR8), putative 1.42837 0.01439 11 38.6 AFUA_1G10270 
Aldehyde reductase (GliO), putative 1.40263 0.0179692 28 84.1 AFUA_5G02020 
Glycerol dehydrogenase (GldB), putative 1.37995 0.019009 30 85.5 AFUA_4G11730 
NRPS-like enzyme, putative 1.33723 0.0410764 41 44.1 AFUA_5G10120 
Arsenate reductase (Arc2), putative 1.27464 0.027714 9 63.3 AFUA_6G13400 
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Protein Description Present/log2  
(Fold Change) 
p-value Peptides Sequence 
coverage 
[%] 
Protein IDs 
2-methylcitrate dehydratase, putative 1.23478 0.009205 38 65.2 AFUA_6G03730 
DNA damage-inducible protein 1 1.21829 0.034152 24 73.8 AFUA_7G06050 
Short chain dehydrogenase/reductase family protein 1.17302 0.024341 13 80.5 AFUA_1G00990 
Imidazole glycerol phosphate synthase subunit hisF 1.10807 0.024405 32 74.4 AFUA_2G06230 
Pyridoxamine phosphate oxidase, putative 1.13607 0.038128 17 52.4 AFUA_5G10650 
Aldehyde dehydrogenase, putative -1.07759 0.046538 24 53.7 AFUA_2G00720 
Cytochrome B -1.13698 0.017889 2 4.9 AFUA_Mt00001 
Trimethyllysine dioxygenase TmlH, putative -1.27237 0.027847 6 25.2 AFUA_1G06180 
Glycerol kinase, putative -1.99179 0.048473 7 20.7 AFUA_4G11540 
Ferrooxidoreductase Fet3, putative Absent n/a 2 5.6 AFUA_5G03790 
Oxidoreductase CipA-like, putative Absent n/a 3 13.4 AFUA_1G12460 
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5.2.1.3  LFQ Proteomic Comparison of ΔegtA26933 under ROS and basal conditions 
A proteomic comparison of ΔegtA26933 with and without 3 mM H2O2 was undertaken to assess 
the impact of high levels of oxidative stress on ΔegtA26933. A total of 132 proteins showed 
differential abundance in ΔegtA26933 when exposed to 3 mM H2O2 compared to ΔegtA
26933
 under 
basal conditions. Of these, 113 showed an increase in abundance, while 19 proteins showed a 
decrease in abundance. Figure 5.5 summarises the most significantly enriched functional 
categories of the proteins showing differential abundance. The full list of proteins showing 
differential abundance can be seen in Appendix 3. 
One protein of interest showing differential abundance is a putative superoxide dismutase copper 
chaperone, Lys7 (AFUA_2G09700), which shows a log2 -1.12 fold decrease in abundance. 
Copper is an essential co-factor for many superoxide dismutases (Miyayama et al., 2011) and 
superoxide dismutase copper chaperones are responsible for delivery of copper to superoxide 
dismutase. Decreased abundance of Lys7 in ΔegtA26933 following exposure to 3 mM H2O2 may 
indicate defective superoxide dismutase behaviour. Alternatively, it may point towards a shift in 
copper homeostasis. 
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Figure 5.5. Significantly enriched functional categories of proteins showing differential 
abundance in ΔegtA26933 under ROS conditions compared to ΔegtA26933 under basal conditions. 
The number under each category represents the number of proteins detected within that category. 
(A) Significantly enriched functional categories from proteins showing increased abundance, 
whereby 109 out of 113 proteins in the data set were annotated. (B) Significantly enriched 
functional categories from proteins showing decreased abundance, whereby 18 out of 19 proteins 
in the data set were annotated. 
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5.2.1.4  LFQ Proteomic Comparison of ATCC26933 under ROS and basal conditions 
A proteomic comparison of ATCC26933 with and without 3 mM H2O2 was undertaken to assess 
the impact of high levels of oxidative stress on ATCC26933. This would allow for a comparison 
with ΔegtA26933 with and without 3 mM H2O2 (Section 5.2.1.3). A total of 71 proteins showed 
differential abundance in ATCC26933 following exposure to 3 mM H2O2. Of these, 28 proteins 
showed increased abundance, while 43 proteins showed decreased abundance. Figure 5.6 
summarises the most significantly enriched functional categories of the proteins showing 
differential abundance. The full list of proteins showing differential abundance can be seen in 
Appendix 4. 
One protein of interest showing differential abundance is HapC (AFUA_1G03840), the redox 
sensitive subunit of the CBC. HapC is absent in ATCC26933 upon addition of 3 mM H2O2. This 
is of interest because HapC is absent in ΔegtA26933 compared to ATCC26933 under basal 
conditions (Section 5.2.1.1). The observation that HapC is absent upon addition of H2O2 in 
ATCC26933 suggests that this is a result of dealing with high levels of ROS. An increase in ROS 
due to loss of EGT may explain the absence of HapC in ΔegtA26933 compared to ATCC26933 
under basal conditions 
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Figure 5.6. Significantly enriched functional categories of proteins showing differential 
abundance in ATCC26933 under ROS conditions compared to ATCC26933 under basal 
conditions. The number under each category represents the number of proteins detected within 
that category. (A) Significantly enriched functional categories from proteins showing increased 
abundance, whereby 27 out of 28 proteins in the data set were annotated. (B) Significantly 
enriched functional categories from proteins showing decreased abundance, whereby 41 out of 
43 proteins in the data set were annotated. 
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5.3  Discussion 
LFQ proteomics provided powerful insight into the systems affected by abrogation of EGT 
biosynthesis in A. fumigatus. Comparing ΔegtA26933 to ATCC26933 under both basal and ROS 
conditions revealed significant proteomic remodelling due to egtA deletion. Under basal 
conditions, 147 proteins were observed to have differential abundance in ΔegtA26933 compared to 
ATCC26933. Upon addition of 3 mM H2O2, the number of proteins with differential abundance 
in ΔegtA26933 compared to ATCC26933 increased to 290. This suggests that induction of 
oxidative stress has a significant impact on A. fumigatus when EGT is absent, and is underlined 
by the number of proteins showing differential abundance in each strain when challenged with 
H2O2. Comparison of ATCC26933 under basal and ROS conditions reveals that 71 proteins 
show differential abundance. Comparing ΔegtA26933 under basal and ROS conditions reveals 132 
proteins with differential abundance, an increase of 85.9 % compared to ATCC26933. This 
further underlines the effect of EGT loss on A. fumigatus  
Many proteins with differential abundance in ΔegtA26933 compared to ATCC26933 under both 
basal and ROS conditions were reductases, oxidases, stress response proteins and enzymes with 
oxidising products (Tables 5.1 & 5.2). This strongly suggests a disruption of redox homeostasis 
and oxidative stress defence in the ΔegtA26933 mutant, compared to ATCC26933, particularly 
when exposed to 3 mM H2O2, and implicates a role for EGT in oxidative stress defence and 
regulating redox homeostasis. 
Of particular importance was HapC, the redox sensitive subunit of the CBC (Thon et al., 2010). 
The CBC is essential for sensing changes in the redox status of the cell and for mounting an 
effective response to oxidative stress (Thon et al., 2010). HapC was absent in ATCC26933 under 
ROS conditions compared to ATCC26933 under basal conditions (Appendix 4). The absence of 
HapC in the wild-type strain following addition of 3 mM H2O2 indicates that absence of HapC is 
a result of dealing with ROS. HapC was also absent in ΔegtA26933 compared to ATCC26933 
under basal conditions. As HapC absence is associated with elevated ROS, this would indicate 
that ΔegtA26933 is undergoing oxidative stress under basal conditions. This is further evidence of 
the role of EGT in maintaining redox homeostasis. 
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Differential abundance of two cystathionine related proteins in ΔegtA26933 under either basal or 
ROS conditions, respectively, indicates that the inability to biosynthesise EGT reveals the 
molecular wiring necessary to integrate EGT biosynthesis into A. fumigatus cellular systems. 
Cystathionine is a sulphur-containing metabolite involved in cysteine and methionine 
metabolism (Ravanel, 1997). Cystathionine γ-synthase (CGS; AFUA_7G01590), was absent in 
ΔegtA26933 compared to ATCC26933 under basal conditions (Table 5.1), while cystathionine β-
lyase (CBL; AFUA_4G03950) showed a log2 3.1 fold increase in abundance in ΔegtA
26933
 
compared to ATCC26933 under ROS conditions (Table 5.2). CGS catalyses the formation of 
cystathionine from homoserine and cysteine. CBL catalyses the conversion of cystathionine to 
homocysteine, ammonia and pyruvate (Ravanel, 1997). This indicates that under basal 
conditions, due to CGS absence, ΔegtA26933 undergoes a metabolic shift from producing 
cystathionine to conserving cysteine (Figure 5.7). Under ROS conditions, ΔegtA26933 undergoes a 
metabolic shift to convert cystathionine to homocysteine. The move towards cysteine 
conservation under basal conditions may be to facilitate increased glutathione biosynthesis, while 
the move towards homocysteine may be to provide the SAM necessary for EGT biosynthesis 
(Figure 5.4). This latter observation is supported by the log2 1.11 fold increase in HisF, essential 
for histidine biosynthesis, while a log2 2.22 fold increase in abundance of a putative sulphite 
reductase indicated an increased need for sulphur, which could be linked to abortive attempts to 
biosynthesise EGT. Cystathionine is at the centre of both metabolic pathways involved, which 
indicates a “cystathionine switch” is a novel molecular mechanism at the heart of sulphur 
metabolism in A. fumigatus. 
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Figure 5.7. The “cystathionine switch” in A. fumigatus. (A) Comparison of ΔegtA26933 and 
ATCC26933 under basal conditions showing an absence of cystathionine γ-synthase, which 
converts cysteine to cystathionine.  This may facilitate a switch towards increased glutathione 
production. (B) Comparison of ΔegtA26933 and ATCC26933 upon addition of 3 mM H2O2 shows 
an increased abundance of cystathionine β-lyase, which converts cystathionine to homocysteine. 
This is predicted to result in increased production of SAM, which is essential for EGT 
biosynthesis. 
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It was observed in the gliotoxin null mutant ΔgliK that EGT levels were increased. This led to a 
hypothesis that EGT and gliotoxin biosynthesis is linked (Gallagher et al., 2012).  It was 
demonstrated that levels of gliotoxin were reduced in ΔegtA26933 (Section 4.2.9), which was 
further evidence of cross-talk between EGT and gliotoxin biosynthesis (Sheridan et al., 2015). 
The gliotoxin oxidoreductase GliT was observed to be absent in ΔegtA26933 compared to 
ATCC26933 under basal conditions. GliT is essential for gliotoxin production, catalyzing the 
closure of the disulphide bridge, as was demonstrated in A. fumigatus ΔgliT, which is unable to 
produce gliotoxin (Schrettl et al., 2010). Absence of GliT in ΔegtA26933 is likely to be the cause 
of the observed drop in gliotoxin production. As GliT is an oxidoreductase, it may be affected by 
a shift in redox homeostasis, as it was observed that many other redox active enzymes showed 
differential abundance (Table 5.1). Indeed, gliotoxin itself has redox activity (Gardiner et al., 
2005) and the reduced levels observed may be in response to the altered redox state in 
ΔegtA26933. 
A key phenotype of ΔgliT was severe sensitivity to exogenous gliotoxin (Schrettl et al., 2010; 
Scharf et al., 2010). However gliotoxin sensitivity was not observed in ΔegtA26933 (Section 
4.2.10.1), despite the absence of GliT under basal conditions. This can be explained by the 
induction of GliT in ΔegtA26933 as demonstrated in Section 4.2.10.2. Thus it appears that GliT is 
absent under basal conditions, which could diminish gliotoxin production, but GliT is still 
induced by gliotoxin exposure for the purpose of self-protection (Schrettl et al., 2010; Scharf et 
al., 2010). Induction of GliT by exogenous gliotoxin has been previously observed in wild-type 
A. fumigatus and is considered part of the self-protection strategy (Schrettl et al., 2010; Scharf et 
al., 2010). Relevantly, GliT is regulated independently of the rest of the gli cluster, meaning 
gliotoxin self-protection and gliotoxin biosynthesis can function autonomously (Schrettl et al., 
2010). 
It appears that gliotoxin is not the only secondary metabolite affected by the loss of EGT. 
Several proteins involved in the biosynthesis of secondary metabolites were observed to exhibit 
differential abundance under both basal and ROS conditions. OrdA (AFUA_8G00510), a 
cytochrome P450 enzyme encoded within the fumagillin cluster (V disch et al., 2011), was 
demonstrated to be absent in ΔegtA26933 compared to ATCC26933 under basal conditions. Two 
proteins associated with pseurotin A biosynthesis were observed to show increased abundance in 
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ΔegtA26933 compared to ATCC26933. Abundance of PsoA (AFUA_8G00540), a hybrid 
NRPS/PKS, was increased by log2 1.28 fold in egtA
26933
 compared to ATCC26933 under ROS 
conditions and it has been demonstrated that deletion or overexpression of psoA leads to absence 
or increased abundance of pseurotin A, respectively (Maiya et al., 2007). A putative SirN-like 
methyltransferase (AFUA_8G00550) had increased abundance in ΔegtA26933 compared to 
ATCC26933 under both basal (log2 1.28 fold) and ROS (log2 1.48 fold) conditions. Alcazar-
Fuoli et al. (2014) demonstrated that deletion of the AFUA_8G00550 gene resulted in a near 
total absence of pseurotin A, indicating this enzyme plays an important role in pseurotin A 
biosynthesis. This data suggests a potential increase in pseurotin A biosynthesis in ΔegtA26933, 
particularly when it is challenged with H2O2. Pseurotin A has been known to be induced by 
hypoxic conditions (V disch et al., 2011), so it may form part of the stress response, particularly 
in the absence of EGT. 
Other proteins with differential abundance in ΔegtA26933 compared to ATCC26933, not 
associated with a specific metabolite but predicted to be involved in secondary metabolism, were 
an aflatoxin B1-aldehyde reductase (AFUA_1G13370), an aldehyde reductase (GliO; 
AFUA_5G02020) and a putative NRPS-like enzyme (AFUA_5G10120) (Khaldi et al., 2010). 
All three showed increased abundance in ΔegtA26933 compared to ATCC26933 under ROS 
conditions. This further emphasises the alterations which occur in secondary metabolism in A. 
fumigatus in the absence of EGT. This is indicative of a “cross-talk” between secondary 
metabolite systems, which is a well observed phenomenon (Sheridan et al., 2015). 
A role for EGT in conidial health and conidiation in A. fumigatus was apparent following the 
observation that A. fumigatus ΔegtA26933 colonies appeared paler and produced lower levels of 
conidia than ATCC26933. EGT also appeared to be involved in conidial protection and 
conidiogenesis in N. crassa (Bello et al., 2012, 2014). Therefore the absence of several conidial 
related proteins in ΔegtA26933 compared to ATCC26933 was of particular interest. These were: 
PMT2, PMT4, FluG, FlbA and RodB. The mannosyltransferases PMT2 (AFUA_1G07690) and 
PMT4 (AFUA_8G04500) have both been demonstrated to play an important role in conidiation. 
Deletion of PMT4 led to highly reduced conidiation (Mouyna et al., 2010), while reduced 
expression of pmt2 was associated with reduced conidiation and lagged germination times (Fang 
et al., 2010).  FluG (AFUA_3G07140) and FlbA (AFUA_2G1118) are signalling proteins 
211 
 
associated with conidial development in A. fumigatus (Mah and Yu, 2006; Park and Yu, 2016). 
Deletion mutants for both proteins were associated with reduced conidiation and delayed 
expression of BrlA (Figure 5.8), which is essential for conidiation in A. fumigatus. Conidial 
hydrophobin RodB (AFUA_1G17250) is one of two proteins (Along with RodA) that form part 
of the rodlet layer on the cell wall of A. fumigatus conidia (Paris et al., 2003a). The rodlet layer 
forms a hydrophobic layer around the conidial cell wall, which favours aerial buoyancy and thus 
aids dispersal of conidia through the air. While RodA may have a role in protecting conidia from 
macrophages, the role of RodB appears to be entirely structural (Paris et al., 2003a).  
 
Figure 5.8. Schematic representing the regulation of asexual development in A. fumigatus. FluG 
and FlbA (outlined in blue), absent in ΔegtA26933 compared to ATCC26933, are upstream 
regulators of the asexual development central regulatory pathway (outlined in red). Image 
redrawn from Mah and Yu. (2005), Sheppard et al. (2005) and Alkhayyat et al. (2015). 
My data demonstrates that EGT loss leads to an absence of a range of proteins associated with A. 
fumigatus conidia, with two mannosyltransferases, two signaling proteins and one structural 
protein affected. This indicates that EGT plays a significant role in conidiation in A. fumigatus, 
potentially through the management of ROS levels. ROS is known to function as signalling 
molecules in fungi and has been demonstrated to regulate cellular differentiation, virulence and 
hyphal growth (Breitenbach et al., 2015). Kayano et al. (2013) have reported that conidiation, in 
addition to polarised growth and hyphal fusion, is regulated by ROS in Epichloë festucae. Thus, 
the defects in conidiation observed in ΔegtA26933 may be due to altered cellular redox state. 
212 
 
Phenotypic characterisation of ΔegtA26933 in Chapter 4 demonstrated that ΔegtA26933 is 
significantly sensitive to cell wall perturbing agents compared to ATCC26933 (Section 4.2.12). 
This indicated that EGT absence resulted in alterations to A. fumigatus cell wall composition. 
This was supported by proteomic data which demonstrated several proteins related to cell wall 
biosynthesis were found to have differential abundance in ΔegtA26933 compared to ATCC26933 
under basal conditions. A 1,3-beta-glucanosyltransferase (GEL5; AFUA_8G02130) showed a 
log2 1.18 fold increase in abundance. This is a glycosylphosphatidylinositol (GPI)-anchored 
protein involved in the elongation of the β(1-3) glucans in the cell wall (Gastebois et al., 2010). 
The putative chitin synthase activator Chs3 (AFUA_3G05580) was shown to be absent in 
ΔegtA26933 compared to ATCC26933. Chitin synthase activators play a role in the activity and 
localization of chitin synthases. Loss of a chitin synthase activator causes decreased abundance 
of chitin in the cell wall (Reyes et al., 2007). A putative cell wall glucanase CRH3 
(AFUA_3G09250) was also demonstrated to be absent in ΔegtA26933 compared to ATCC26933. 
CRH3 is an ortholog of S. cerevisiae CRH1, a chitin transglycosylase, which functions to 
transfer chitin to β(1-6) and β(1-3) glucans in the cell wall (Cabib, 2009; Mouya et al., 2013). 
The mannosyltransferases PMT2 (AFUA_1G07690) and PMT4 (AFUA_8G04500) were 
described previously due to their role in conidiation and were both absent in ΔegtA26933 
compared to ATCC26933 under basal conditions. However both proteins have been 
demonstrated to participate in cell wall biosynthesis as well. Decreased expression of pmt2 
resulted in sensitivity to cell wall-perturbing agents and alterations to cell wall contents (Fang et 
al., 2010). Electron microscopy analysis of a PMT4 deletion mutant revealed an electron-dense 
layer at the surface of the cell wall that was not observed in the wild-type. This suggests that an 
increase in secreted proteins to the cell wall is observed following PMT4 deletion (Mouyna et 
al., 2010). AFUA_3G08110, described as a putative cell wall protein, was also absent in 
ΔegtA26933. Little information is available about the function or role of this protein in the cell wall 
of A. fumigatus, though downregulation of gene transcript has been associated with exposure to 
amphotericin B, calcium and human platelets (Soriani et al., 2008; Gautam et al., 2008; 
Perkhofer et al., 2015). This suggest that downregulation of the AFUA_3G08110 gene is 
associated with stress. The putative MAP kinase kinase Mkk2 (AFUA_1G05800) has been 
demonstrated to form part of the cell wall integrity (CWI) signalling pathway and deletion of 
mkk2 resulted in a significant drop in radial growth and sensitivity to cell wall-perturbing agents 
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(Valiante et al., 2009). Given its role in CWI signalling, the absence of Mkk2 is likely 
responsible for the differential abundance of the other cell wall proteins observed. 
Under ROS conditions, two cell wall biosynthesis proteins had differential abundance in 
ΔegtA26933 compared to ATCC26933. A putative class V chitinase (AFUA_3G11280) showed a 
log2 2.05 fold increase in abundance. Chitinases catalyse the hydrolytic breakdown of glycan 
bonds in chitin and play a role in reshaping the cell wall (Adams, 2004). A putative cell wall 
integrity signalling protein (Lsp1/Pil1; AFUA_6G07520) showed a log2 1.63 fold increase in 
abundance in ΔegtA26933 compared to ATCC26933 under ROS conditions.  
As demonstrated, loss of EGT leads to differential regulation of a variety of cell wall related 
proteins, particularly under basal conditions. The absence of the MAP kinase kinase Mkk2 is of 
particular significance as it is it part of the CWI signalling pathway and its absence could be 
expected to have a knock-on effect on other proteins due to its role in regulating transcription 
(Valiante et al., 2009). This proteomic data, in concurrence with the phenotypic data that 
demonstrated ΔegtA26933 is sensitive to cell wall perturbing agents, demonstrates that EGT 
absence results in alterations to cell wall biosynthesis in A. fumigatus. As with conidiation, this 
may linked with perturbations in ROS signalling. It has been observed in plants that ROS 
signalling regulates the cell wall (Kärkönen and Kuchitsu, 2015). However to my knowledge, 
this has not been observed in fungi before. 
The methyltransferase VipC was demonstrated to have increased abundance in ΔegtA26933 
compared to ATCC26933 under basal conditions (log2 1.23 fold) and shows a larger increase in 
abundance under ROS conditions (log2 2.5 fold). VipC was characterised in A. nidulans by 
Sarikaya-Bayram et al. (2014), where it was demonstrated that VipC, in conjunction with a 
second methyltransferase, VapB, interacts with the velvet complex (VelB-VeA-LaeA) to 
regulate activation of sexual development. Elgabbar and Han (2015) attempted to investigate 
VipC function in A. fumigatus through the generation of a deletion mutant. However no 
phenotype was observed and thus VipC function in A. fumigatus remains to be elucidated. VipC 
function, as described in A. nidulans, may not carry over to A. fumigatus due to the differences in 
sexual development between A. nidulans and A. fumigatus. While A. nidulans readily switches 
between sexual and asexual development depending on light exposure, with VipC playing a key 
role in differentiation, asexual development dominates in A. fumigatus. Indeed, identification of a 
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sexual cycle in A. fumigatus was only confirmed within the last decade, with specific conditions 
required for the formation of sexual fruiting bodies (6 months incubation at 30 
o
C on parafilm-
sealed Oatmeal agar in darkness)(O’Gorman et al., 2009). Thus it appears that sexual 
development only occurs in A. fumigatus under very specific circumstances, in contrast to A. 
nidulans where sexual development occurs readily (Sarikaya-Bayram et al., 2014). Due to the 
significant differences in environmental triggers necessary for sexual development between these 
two Aspergilli, it cannot be assumed that VipC function is identical in A. fumigatus. Given the 
dominance of the asexual cycle A. fumigatus, the paler conidia and reduced conidiation 
phenotypes observed in ΔegtA26933, the subsequent proteomic data describing the absence of five 
conidial related proteins ΔegtA26933 and concurrent proteomic data demonstrating increased 
abundance of VipC in ΔegtA26933, a role for VipC in regulating asexual development in A. 
fumigatus is a distinct possibility.  
VipC had increased abundance in ΔegtA26933 compared to ATCC26933 under basal conditions 
(log2 1.23 fold). This increase in abundance is larger under ROS conditions (log2 2.5 fold), where 
it shows more than twice an increase in ΔegtA26933 compared to ATCC26933 upon addition of 
H2O2. As a SAM-dependant methyltransferase, VipC may be regulated by availability of 
intracellular SAM. It has been demonstrated that addition of H2O2 increased the abundance of 
CBL, which was predicted to increase levels of intracellular SAM. Thus, the larger increase in 
abundance of VipC in ΔegtA26933 compared to ATCC26933 under ROS conditions may be due to 
increased availability of SAM.  
An increase in abundance of phenylalanine ammonia lyase (PAL; AFUA_2G09110) was 
observed in ΔegtA26933 compared to ATCC26933 under basal conditions (log2 2.71 fold), where 
it was the protein with the largest increase in abundance in the data set (Appendix 1). Under ROS 
conditions, PAL showed an even greater increase in abundance in ΔegtA26933 compared to 
ATCC26933 (log2 3.73 fold). This indicates that PAL is of particular significance in ΔegtA
26933
 
and addition of H2O2 increases the demand for PAL. PAL is involved in the breakdown of 
phenylalanine, converting it into ammonia and trans-cinnamic acid (Camm and Towers, 1973). 
This reaction is carried out in fungi in order to release carbon and nitrogen from phenylalanine, 
in a catabolic reaction (Fritz et al., 1976). In plants however, PAL is involved in defence through 
the generation of phenyl compounds. While this strategy has been well documented in response 
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to infection (Shadle et al., 2003; Kim and Hwang, 2014; Tonnessen et al., 2015), genes encoding 
for PAL have been noted to be induced through oxidative stress (Desikan et al., 1998; Lee et al., 
2003). Furthermore, Gao et al. (2008) demonstrated a rise in PAL in the leaves and roots of 
Jatropha curcas L. seedlings in response to copper induced stress.  While this has not been 
observed in fungi previously, this rise in PAL in response to EGT loss could be compensating for 
the loss of an oxidative stress defence mechanism in EGT by providing an alternative means of 
dissipating ROS. 
There are, however, alternative hypotheses for the increased abundance of PAL. PAL has been 
noted to have a high similarity to histidine ammonia lyase (HAL)(Schwede et al., 1999), an 
enzyme which catalyses the breakdown of histidine in a similar manner to PAL. In the absence 
of EGT biosynthesis, histidine levels may elevated as it is not being used for EGT production. In 
this instance, histidine may need to be catabolised, requiring the use of a HAL. If PAL was 
misannotated, or otherwise have HAL activity, increased abundance of the protein would be 
required to dissipate elevated histidine levels. 
Another potential reason for increased abundance of PAL involves ergothioneine degradation. 
Muramatsu et al. (2013) noted in Burkholderia sp. HME13 that an enzyme with ergothionase 
degradation activity showed 17 % similarity to PAL. This raises the possibility that the PAL 
observed is actually an ergothionase, indeed a fungal ergothionase would be a particularly novel 
discovery. Thus the increased abundance of PAL in ΔegtA26933 raises several intriguing 
questions, which warrant future investigation. 
The work presented in this chapter demonstrates that loss of EGT in A. fumigatus affects a range 
of systems including redox homeostasis, sulphur metabolism, secondary metabolism, conidiation 
& conidial health and the cell wall. This data has greatly aided in elucidation of phenotypes 
observed in ΔegtA26933 in Chapter 4, including the identification of key proteins which may play 
crucial roles in particular phenotypes, such as HapC in oxidative stress sensitivity, GliT in 
reduced gliotoxin production and VipC in reduced conidiation. The observation of a 
“cystathionine switch” was another significant find from this data, a novel switch in sulphur 
metabolism centred on cystathionine. The increased abundance of a PAL in ΔegtA26933 compared 
to ATCC26933 under basal conditions, and furthermore under ROS conditions, raised several 
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questions as its role in A. fumigatus. For this reason, PAL, alongside VipC which was also 
discussed in this chapter, were investigated further in Chapter 6. 
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6.1  Introduction  
The work presented in Chapters 4 and 5 characterised EGT functionality in A. fumigatus. 
Through analysis of the ΔegtA26933 mutant, EGT was demonstrated to function as an antioxidant 
that plays a key role in protection against high levels of ROS. Furthermore, EGT absence altered 
conidiation, cell wall integrity signalling and secondary metabolism. Three proteins were 
identified for further study with the aim of further understanding EGT biosynthesis and function 
in A. fumigatus, and the systems with which it interacts. These were phenylalanine ammonia 
lyase (PAL; AFUA_2G09110), EgtB (AFUA_2G13295) and VipC (AFUA_8G01930). Deletion 
mutants for the corresponding gene for each protein were created described as Chapter 3.  
PAL catalyzes the conversion of phenylalanine into ammonia and trans-cinnamic acid (Camm 
and Towers, 1973). It was observed to have increased abundance in ΔegtA26933 compared to 
ATCC26933 under both basal and ROS conditions. Under basal conditions, PAL had a log2 2.71 
fold increase in abundance in ΔegtA26933, the largest increase in abundance of any proteins in that 
data set. Under ROS conditions, PAL had a log2 3.73 fold increase in abundance. Thus, PAL was 
identified as a protein which may play a key role in A. fumigatus adaptation to egtA deletion. 
PAL activity has been detected in a diverse range of plants, select fungi and two prokaryotes: 
Streptomyces verticillatu and Streptomyces maritimus (Hyun et al., 2011; Xiang and Moore, 
2005).  PAL function has been extensively studied in plants, where it is of much interest due to 
involvement in the first and committed step of the phenyl propanoid pathway (Zhang and Liu, 
2015). By converting phenylalanine into trans-cinnamic acid, phenylalanine can be diverted 
from primary to secondary metabolism. Trans-cinnamic acid is then converted into a range of 
metabolites with important physiological functions. The best characterised function of these 
phenyl propanoid compounds is in defence against pathogens (Shadle et al., 2003; Kim and 
Hwang, 2014; Tonnessen et al., 2015). However, they also function in mechanical support 
(Davin and Lewis, 1992), stress defence (Dixon and Paiva, 1995), pigments (Holton and 
Cornish, 1995), and signalling (Xie et al., 1995). PAL is proposed to act as a regulator of the 
biosynthesis of these compounds, as gene expression is induced by environmental factors such as 
pathogenic attacks, tissue wounding, UV irradiation, exposure to heavy metals, low 
temperatures, and low levels of nitrogen, phosphate, or ions (Dixon and Paiva, 1995; Weisshaar 
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and Jenkins, 1998). PAL, through the production of these phenyl propanoid compounds, has also 
been demonstrated to play a role in plant development (Jones, 1984). 
In contrast to plants, PAL function in fungi has not been studied nearly as extensively. PAL 
activity has been demonstrated in several basidiomycetes such as Rhodotorula (Ogata et al., 
1967), Ustilago hordei (Kim et al., 1996), Schizophyllum commune (Moore and Towers, 1967), 
and Sporobolomyces roseus (Camm and Towers, 1969). Additionally, it has been reported in 
deuteromycetes such as Alternaria sp. (Pridham and Woodhead, 1974), Rhizoctonia solani 
(Kalghatgi et al., 1974) and Penicillium brevicompactum (Campbell et al., 1987). PAL function 
has been demonstrated in a single ascomycete, Nectria cinnabarina (Swimburne and Brown, 
1975). No role beyond catabolism of phenylalanine has been demonstrated in fungi, where it has 
been shown that PAL can catabolise phenylalanine for use as a carbon or nitrogen source in 
Rhodotorula glutinis (Marusich et al., 1981). Lentinus lepideus produces phenylpropanoid 
compounds from cinnamic acid derived from phenylalanine via PAL. These include p-coumaric 
acid, caffeic acid, isoferulic acid, phloretic acid, and p-methoxycinnamic acid (Power et al., 
1965). No physiological role for these compounds has been determined however. The production 
of benzoic acid derivatives from trans-cinnamic acid has also been demonstrated (Nambudiri et 
al., 1970; Campbell et al., 1987). 
Thus, no clear function for fungal PAL has been determined beyond phenylalanine catabolism. 
The observed increased abundance of PAL in ΔegtA26933 under both basal and ROS conditions is 
therefore intriguing. Several phenylpropanoid compounds are known to have antioxidant activity 
(Korkina, 2007) and PAL gene expression has been demonstrated to be induced in plants by 
exposure to oxidative stress (Desikan et al., 1998; Lee et al., 2003). Increased PAL abundance 
may therefore be an oxidative stress response in the absence of EGT.  Alternatively, this may be 
a misannotation of a closely related histidine ammonia lyase (HAL) (Schwede et al., 1999), 
which may have increased abundance to catabolise increased levels of histidine resulting from 
loss of EGT biosynthesis. Finally, Muramatsu et al. (2013) reported an ergothionase from 
Burkholderia sp. HME13 with 17 % similarity to PAL. Suggesting PAL may have ergothioneine 
degradation activity. 
EgtB is predicted to catalyse the final step of EGT biosynthesis, which is the conversion of 
hycynylcysteine sulphoxide into EGT via cleavage of the cysteine residue at the sulphur atom 
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(Figure 6.1). egtB was identified as an ortholog of S. pombe egt2 (Pluskal et al., 2014). Deletion 
of egt2 in S. pombe resulted in a 74.5 % reduction in EGT levels compared to wild-type. As 
residual levels of EGT remained, egt2 was determined to be non-essential for EGT production in 
S. pombe. Pluskal et al. speculated that the final reaction may be catalysed non-specifically by 
other PLP-binding enzymes. This is supported by data from Seebeck (2010), who demonstrated 
that EGT could be produced in vitro using an unrelated PLP-binding β-lyase from Erwinia 
tasmaniensis, which cannot biosynthesise EGT. By using the ΔegtB26933 mutant, it can be 
determined whether egtB contributes to EGT biosynthesis in A. fumigatus, and if it is essential 
for EGT biosynthesis if that is the case. 
 
Figure 6.1. Proposed EGT biosynthetic pathway for A. fumigatus. EgtA catalyses the first two 
steps, converting histidine into hercynine and hercynine into hercynalcysteine sulphoxide. EgtB 
catalyses the final step, converting hercynylcysteine sulphoxide into ergothioneine. 
VipC is a methyltransferase that has been demonstrated to regulate sexual and asexual 
development in response to the presence or absence of light in A. nidulans (Sarikaya-Bayram et 
al., 2014). In A. nidulans, VipC functions in conjunction with a second methyltransferase, VapB. 
In the absence of appropriate environmental signal (i.e. light), the VipC-VapB complex is 
tethered to the membrane bound VapA. While VipC-VapB is bound, the nuclear complex VelB-
VeA-LaeA activates transcription for sexual development. When exposed to light, VipC-VapB is 
released from VapA and localises to the nucleus. In the nucleus, VipC-VapB interacts with VeA, 
reducing the nuclear import and protein stability of the VelB-VeA-LaeA complex, and thus 
repressing sexual development. Simultaneously, VapB decreases histone 3 lysine 9 
trimethylation, which activates brlA and abaA transcription, resulting in asexual development 
(Figure 6.2). Deletion of VipC in A. nidulans resulted in decreased asexual development and 
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increased sexual development when grown in light, compared to wild-type. No changes were 
observed when grown in darkness, demonstrating that VipC functions to regulate development in 
response to light. 
 
Figure 6.2. Regulation of sexual and asexual development in response to light in A. nidulans. 
(A) VipC-VapB remains tethered to membrane bound VapA in the absence of light. VelC-VeA-
LaeA complex is localized to the nucleus and induces sexual development. (B) VipC-VapB is 
released from VapA and localizes to the nucleus when exposed to light. VipC-VapB reduces 
VelC-VeA-LaeA stability and nuclear import. Increased levels of nuclear VapB induce asexual 
development. Image adapted from Sarikaya-Bayram et al. (2014). 
Unexpectedly, VipC was found to have increased abundance in A. fumigatus ΔegtA26933 under 
basal conditions (log2 1.23 fold; Table 5.1), which further increased under ROS conditions (log2 
2.5 fold; Table 5.2). ΔegtA26933 had reduced levels of conidiation compared to ATCC26933 and 
the increased abundance of VipC was hypothesised to be involved in this phenotype due to its 
role in regulating asexual development in A. nidulans. However, it cannot be assumed that VipC 
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functions identically in A. fumigatus as sexual development is significantly different in A. 
fumigatus compared to A. nidulans. While A. nidulans readily forms sexual fruiting bodies when 
grown in the absence of light, A. fumigatus requires very specific conditions to activate sexual 
development (O’Gorman et al., 2009). Given the role of VipC in regulating development in 
response to environmental conditions in A. nidulans, and the differences in environmental 
conditions required to activate sexual development in these two species, VipC could be 
speculated to function differently in A. fumigatus. Elgabbar and Han (2015) attempted to 
investigate VipC function in A. fumigatus by generating a ΔvipC mutant. However they did not 
report any phenotypes and concluded that due to redundancy, no role for VipC in A. fumigatus 
could be established. However as a consequence of LFQ proteomic data demonstrating increased 
VipC abundance in ΔegtA26933, ΔvipC26933 was employed to investigate VipC function in A. 
fumgatus, and also to elucidate the link between VipC and egtA deletion. 
The aim of the work presented in this chapter was to:  
(i) Investigate the phenotypic effect of palA deletion in A. fumigatus following exposure 
to ROS inducing agents, gliotoxin and high concentrations of His and Phe. 
(ii) Investigate the effect of palA deletion on gliotoxin production and levels of 
intracellular EGT and His in A. fumigatus. 
(iii) Determine if egtB contributes to EGT biosynthesis in A. fumigatus. 
(iv) Investigate the effect of egtB deletion in A. fumigatus following exposure to ROS 
inducing agents and gliotoxin. 
(v) Investigate the effect of egtB deletion on gliotoxin and glutathione production in A. 
fumigatus. 
(vi) Determine if vipC deletion affects growth and/or development in A. fumigatus. 
(vii) Investigate the effect of light exposure on ΔvipC growth and development 
(viii) Investigate the effect of vipC deletion on EGT, gliotoxin and glutathione biosynthesis 
in A. fumigatus. 
(ix) Investigate the effect of vipC deletion in A. fumigatus following exposure to ROS 
inducing agents and gliotoxin. 
(x) Investigate the effect of vipC deletion on the A. fumigatus proteome using LFQ 
proteomic analysis. 
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6.2  Results 
6.2.1  Phenotypic characterisation of ΔpalA26933  
6.2.1.1  Analysis of EGT production in ATCC26933 and ΔpalA26933 via RP-HPLC 
Mycelia from 72 h cultures of ATCC26933 and ΔpalA26933 in Czapek-Dox broth were harvested 
and cell lysate supernatants obtained as per Section 2.2.9. Lysate supernatants were alkylated 
using 5’-IAF as described in Section 2.2.12.1 and analysed via RP-HPLC (Section 2.2.12.6) 
using fluorescence detection at Ex/Em of 494/518 nm. EGT was detected in both ATCC26933 
and ΔpalA26933 at a retention time of 12.4 min (Figure 6.3). Comparing EGT levels by measuring 
the peak area of 5’-IAF alkylated EGT revealed no significant difference in EGT levels in 
ATCC26933 and ΔpalA26933. Deletion of palA therefore had no effect on EGT production, 
suggesting PAL does not influence EGT biosynthesis in A. fumigatus. 
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Figure 6.3. Detection and measurement of 5’-IAF alkylated EGT via RP-HPLC. (A) Detection 
of 5’-IAF alkylated EGT in ATCC26933 and ΔpalA26933 at a retention time of 12.4 min. (B) 
Comparison of EGT levels in ATCC26933 and ΔpalA26933. No significant difference in the levels 
of EGT was observed in ATCC26933 and ΔpalA26933.  
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6.2.1.2 Phenotypic analysis of ATCC26933 and ΔpalA26933 in response to ROS 
inducing agents 
6.2.1.2.1 Phenotypic analysis of ATCC26933 and ΔpalA26933 in response to H2O2 
Sensitivity to H2O2 was tested at a range of 0 – 3 mM as per Section 2.2.7. Comparison of radial 
growth of ATCC26933 and ΔpalA26933 colonies revealed no significant difference between the 
two strains at any concentration of H2O2 tested (Figure 6.4). Deletion of palA therefore does not 
lead to sensitivity to H2O2 induced stress. 
6.2.1.2.2 Phenotypic analysis of ATCC26933 and ΔpalA26933 in response to menadione 
Sensitivity to menadione was tested at a range of 0 – 60 µM (Section 2.2.7). Comparison of 
radial growth of ATCC26933 and ΔpalA26933 colonies revealed no significant difference between 
the two strains at any concentration of menadione tested (Figure 6.5). Deletion of palA therefore 
does not lead to sensitivity to menadione induced stress.  
6.2.1.2.3 Phenotypic analysis of ATCC26933 and ΔpalA26933 in response to diamide 
Sensitivity to diamide was tested at a range of 0 – 1.75 mM (Section 2.2.7). No significant 
differences in the radial growth of ΔpalA26933 colonies compared to ATCC26933 colonies were 
observed at any concentration of diamide tested (Figure 6.6). Deletion of palA therefore does not 
lead to sensitivity to diamide induced stress.  
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Figure 6.4. H2O2 sensitivity assay performed on AMM agar for 72 h. (A) Comparison of radial 
growth of ATCC26933 and ΔpalA26933 on AMM agar plates containing 0 to 3 mM H2O2. 
ΔpalA26933 shows no significant difference in radial growth compared to ATCC26933 at any 
concentration of H2O2 tested. (B) Images of ATCC26933 and ΔpalA
26933
 colonies on AMM 
plates containing 0 to 3 mM H2O2. No visible decrease in the size of the ΔpalA
26933
 colonies can 
be observed compared to the ATCC26933 colonies at any concentration of H2O2 tested.  
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Figure 6.5. Menadione sensitivity assay performed on AMM agar for 72 h. (A) Comparison of 
radial growth of ATCC26933 and ΔpalA26933 on AMM agar plates containing 0 to 60 µM 
menadione. ΔpalA26933 shows no significant difference in radial growth compared to 
ATCC26933 at any concentration of menadione tested. (B) Images of ATCC26933 and 
ΔpalA26933 colonies on AMM plates containing 0 to 60 µM menadione. No visible decrease in 
the size of the ΔpalA26933 colonies can be observed compared to the ATCC26933 colonies at any 
concentration of menadione tested.  
227 
 
 
Figure 6.6. Diamide sensitivity assay performed on AMM agar for 72 h. (A) Comparison of 
radial growth of ATCC26933 and ΔpalA26933 on AMM agar plates containing 0 to 1.75 mM 
diamide. ΔpalA26933 shows no significant difference in radial growth compared to ATCC26933 at 
any concentration of diamide tested. (B) Images of ATCC26933 and ΔpalA
26933
 colonies on 
AMM plates containing 0 to 1.75 mM diamide. No visible decrease in the size of the ΔpalA26933 
colonies can be observed compared to the ATCC26933 colonies at any concentration of diamide 
tested.  
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6.2.1.3  Analysis of histidine levels in ATCC26933 and ΔpalA26933 via RP-HPLC 
Mycelia from 72 h cultures of ATCC26933 and ΔpalA26933 in Czapek-Dox broth were harvested 
and cell lysate supernatants obtained as per Section 2.2.9 using A. fumigatus phosphate lysis 
buffer (Section 2.1.12.2). Lysate supernatants and a His standard were labelled using OPA as 
described in Section 2.2.12.3 and analysed via RP-HPLC (Section 2.2.12.6) using fluorescence 
detection at an Ex/Em 340/455 nm. His was detected a retention time of 13.4 min and was 
present in both ATCC26933 and ΔpalA26933 (Figure 6.7). Comparison of His peak height 
intensities revealed there was no significant difference in His levels in ATCC26933 and 
ΔpalA26933. His levels are therefore unaffected by deletion of palA in A. fumigatus. A peak at 
12.5 min appears to be increased in ΔpalA compared to ATCC26933. This could be due to 
alterations in the levels of another amino acid. 
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Figure 6.7. Detection and measurement of OPA labelled His via RP-HPLC. (A) Detection of 
OPA labelled His in a His standard, ATCC26933 and ΔpalA26933. His is detected at 13.4 min and 
was detected in both ATCC26933 and ΔpalA26933. (B) Comparison of His peak heights 
ATCC26933 and ΔpalA26933. No significant difference in the levels of His was observed in 
ATCC26933 and ΔpalA26933.  
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6.2.1.4 Phenotypic analysis of ATCC26933 and ΔpalA26933 in response to 
phenylalanine and histidine 
Sensitivity assays for Phe and His were performed in order to determine if palA deletion resulted 
in sensitivity to high levels of either amino acid.  Sensitivity to Phe was tested at a concentration 
of 150 mM, while sensitivity to His was tested at a concentration of 200 mM (Section 2.2.7). 
Comparison of radial growth of ATCC26933 and ΔpalA26933 colonies revealed no significant 
difference between the two strains when grown on 150 mM Phe or 200 mM His (Figure 6.8). 
Loss of palA therefore does not result in sensitivity to Phe or His. 
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Figure 6.8. Sensitivity assay for Phe and His performed on AMM agar for 72 h. (A) Comparison 
of radial growth of ATCC26933 and ΔpalA26933 on AMM agar plates containing no additive, 150 
mM Phe or 200 mM His. No significant difference in the radial growth of the ΔpalA26933 colonies 
compared to ATCC26933 was observed under any of the conditions tested. (B) Images of 
ATCC26933 and ΔpalA26933 colonies on AMM plates containing no additive, 150 mM Phe or 
200 mM His. No visible difference in the size of the ΔpalA26933 colonies can be observed 
compared to the ATCC26933 colony in any of the conditions tested. 
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6.2.1.5  Analysis of gliotoxin production in ATCC26933 and ΔpalA26933 via RP-HPLC 
Supernatants from triplicate 72 h cultures of ATCC26933 and ΔpalA26933 in Czapek-Dox broth 
were collected and organic extraction carried out as per Section 2.2.10. The organic extracts 
were then analysed via RP-HPLC (Section 2.2.12.6). In addition, a gliotoxin standard was 
analysed in the same manner. Gliotoxin was detected at 14.9 min and was observed to be present 
in both ATCC26933 and ΔpalA26933 (Figure 6.9). A comparison of ATCC26933 and ΔpalA26933 
gliotoxin peak areas shows no significant difference in gliotoxin levels in ΔpalA26933 compared to 
ATCC26933. Deletion of palA therefore has no impact on gliotoxin biosynthesis. 
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Figure 6.9. Gliotoxin detection via RP-HPLC in ATCC26933 and ΔpalA26933. (A) RP-HPLC 
analysis of organic extracts from the supernatants of 72 h cultures of ATCC26933 and ΔpalA26933 
(n = 3). Gliotoxin is present in both chromatograms at 14.9 min. (B) Comparison of gliotoxin 
peak area from RP-HPLC analysis for ATCC26933 and ΔpalA26933 performed in triplicate. No 
significant difference in gliotoxin levels were observed in ΔpalA26933 compared to ATCC26933.  
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6.2.1.6  Phenotypic analysis of ATCC26933 and ΔpalA26933 in response to gliotoxin 
Sensitivity to gliotoxin was tested at a range of 0 – 20 µg/ml as per (Section 2.2.7). No 
significant differences in the radial growth of ΔpalA26933 colonies compared to ATCC26933 
colonies were observed at any concentration of gliotoxin tested (Figure 6.10). Loss of palA 
therefore has no effect on gliotoxin sensitivity, it can therefore be concluded that palA is not 
involved in gliotoxin self-protection in A. fumigatus. 
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Figure 6.10. Gliotoxin sensitivity assay performed on AMM agar for 72 h. (A) Comparison of 
radial growth of ATCC26933 and ΔpalA26933 on AMM agar plates containing 0 to 20 µg/ml 
gliotoxin. ΔpalA26933 shows no significant difference in radial growth compared to ATCC26933 
at any concentration of gliotoxin tested. (B) Images of ATCC26933 and ΔpalA
26933
 colonies on 
AMM plates containing 0 to 20 µg/ml gliotoxin. No visible decrease in the size of the ΔpalA26933 
colonies can be observed compared to ATCC26933 colonies at any concentration gliotoxin 
tested.  
 
236 
 
6.2.2  Phenotypic charactarisation of ΔegtB26933 
6.2.2.1  Analysis of EGT production in ATCC26933 and ΔegtB26933 
6.2.2.1.1 Analysis of EGT production in ATCC26933 and ΔegtB26933 via RP-HPLC 
Mycelia from 72 h cultures of ATCC26933 and ΔegtB26933 in Czapek-Dox broth were harvested 
and cell lysate supernatants obtained as per Section 2.2.9. Normalised lysate supernatants were 
labelled using 5’-IAF as described in Section 2.2.12.1 and analysed via RP-HPLC (Section 
2.2.12.6) using fluorescence detection at Ex/Em of 494/518 nm. EGT was detected in both 
ATCC26933 and ΔegtB26933 at a retention time of 12.4 min (Figure 6.11A). Comparing EGT 
levels by measuring the peak area of 5’-IAF alkylated EGT revealed ΔegtB26933 produced 
significantly (P = 0.0465) lower levels of EGT compared to ATCC26933 (Figure 6.11B). EGT 
levels in ΔegtB26933 were 72 % of ATCC26933 EGT levels. From this data, it can be concluded 
that egtB contributes to EGT biosynthesis, but is not essential for its production. 
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Figure 6.11. Detection and measurement of 5’-IAF alkylated EGT. (A) Detection of 5’-IAF 
alkylated EGT in ATCC26933 and ΔegtB26933 at a retention time of 12.4 min. (B) Comparison of 
EGT levels in ATCC26933 and ΔegtB26933. EGT levels are significantly lower in ΔegtB26933 
compared to ATCC26933 (P = 0.0465).  
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6.2.2.1.2 Analysis of EGT production in ATCC26933 and ΔegtB26933 via LC-MS/MS 
Mycelia from 72 h cultures of ATCC26933 and ΔegtB26933 and in Czapek-Dox broth were 
harvested and cell lysate supernatants obtained as per Section 2.2.9. Lysate supernatants were 
alkylated using 5’-IAF (Section 2.2.12.1), TCA precipitated (Section 2.2.12.2) and analysed via 
LC-MS/MS (Section 2.2.12.7). In addition, an alkylated and TCA precipitated EGT standard was 
analysed in the same manner. 5’-IAF alkylated EGT eluted at 5.3 min, with an m/z of 617 
(Gallagher et al., 2012). Extracted ion chromatograms (m/z: 617) for ATCC26933 and ΔegtB26933 
demonstrated the presence of EGT in ATCC26933 and ΔegtB26933 (Figure 6.12). Comparison of 
EGT peak intensity confirmed ΔegtB26933 produced significantly (P = 0.0432) reduced levels of 
EGT compared to ATCC26933. This data is in agreement with the data from RP-HPLC (Section 
6.2.2.1.1) and confirms egtB is not essential for, but does contribute to, EGT biosynthesis. 
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Figure 6.12. Detection of alkylated EGT via LC-MS/MS.
 
(A) Extracted Ion Chromatographs 
(m/z: 617) from ATCC26933, ΔegtB26933 and an EGT standard. A peak at 5.3 min was confirmed 
to be EGT. EGT was demonstrated to be present in both ATCC26933 and ΔegtB26933. (B) 
Signature ion breakdown corresponding to alkylated EGT (Gallagher et al., 2012). (C) 
Comparison of EGT (m/z: 617) peak intensity. Levels of EGT are significantly (P = 0.0432) 
reduced in ΔegtB26933 compared to ATCC26933.  
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6.2.2.2 Phenotypic analysis of ATCC26933 and ΔegtB26933 in response to ROS 
inducing agents 
6.2.2.2.1 Phenotypic analysis of ATCC26933 and ΔegtB26933 in response to H2O2 
Sensitivity to H2O2 was tested at a range of 0 – 3 mM as per Section 2.2.7. Comparison of radial 
growth of ATCC26933 and ΔegtB26933 colonies revealed no significant difference between the 
two strains at 1mM and 2 mM H2O2. At 3mM H2O2, radial growth of ΔegtB
26933
 was 
significantly (P = 0.0434) reduced compared to ATCC26933 (Figure 6.13). Loss of egtB 
therefore leads to sensitivity to high levels of H2O2. This demonstrates that a reduction of EGT 
levels may contribute to sensitivity to high levels of H2O2 induced ROS. 
6.2.2.2.2 Phenotypic analysis of ATCC26933 and ΔegtB26933 in response to menadione 
Sensitivity to menadione was tested at a range of 0 – 60 µM as per Section 2.2.7. Significant 
reduction in the radial growth of ΔegtB26933 colonies compared to ATCC26933 colonies was 
observed at 20 µM (P = 0.0132), 40 µM (P = 0.0013) and 60 µM (P = 0.0003) menadione 
(Figure 6.14). Loss of egtB therefore leads to sensitivity to menadione at all concentrations 
tested. Partial loss of EGT due to egtB deletion therefore appears to result in severe sensitivity to 
menadione.  
6.2.2.2.3 Phenotypic analysis of ATCC26933 and ΔegtB26933 in response to diamide 
Sensitivity to diamide was tested at a range of 0 – 1.75 mM as per Section 2.2.7. No significant 
differences in the radial growth of ΔegtB26933 colonies compared to ATCC26933 colonies were 
observed at any concentration of diamide tested (Figure 6.15). Loss of egtB, and the consequent 
reduction in EGT levels, therefore has no effect on defence against diamide induced oxidative 
stress in A. fumigatus. 
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Figure 6.13. H2O2 sensitivity assay performed on AMM agar. (A) Comparison of radial growth 
of ATCC26933 and ΔegtB26933 on AMM agar plates containing 0 to 3 mM H2O2. ΔegtB
26933
 
shows a significant (P = 0.0434) reduction in growth compared to ATCC26933 at 3 mM H2O2. 
(B) Images of ATCC26933 and ΔegtB26933 colonies on AMM plates containing 0 to 3 mM H2O2. 
A visible decrease in the size of the ΔegtB26933 colony can be observed compared to the 
ATCC26933 colony at 3 mM H2O2.  
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Figure 6.14. Menadione sensitivity assay performed on AMM agar. (A) Comparison of radial 
growth of ATCC26933 and ΔegtB26933 on AMM agar plates containing 0 to 60 µM menadione. 
ΔegtB26933 shows a significant reduction in growth compared to ATCC26933 at 20 µM (P = 
0.0132), 40 µM (P = 0.0013) and 60 µM (P = 0.0003) menadione. (B) Images of ATCC26933 
and ΔegtB26933 colonies on AMM plates containing 0 to 60 µM menadione. A visible decrease in 
the size of the ΔegtB26933 colonies can be observed compared to the ATCC26933 colonies at all 
concentrations of menadione tested. 
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Figure 6.15. Diamide sensitivity assay performed on AMM agar. (A) Comparison of radial 
growth of ATCC26933 and ΔegtB26933 on AMM agar plates containing 0 to 1.75 mM diamide. 
ΔegtB26933 shows no significant difference in radial growth compared to ATCC26933 at any 
concentration of diamide tested. (B) Images of ATCC26933 and ΔegtB26933 colonies on AMM 
plates containing 0 to 1.75 mM diamide. No visible differences in the size of the ΔegtB26933 
colonies can be observed compared to the ATCC26933 colonies at all concentrations of diamide 
tested.  
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6.2.2.3 Total Glutathione measurement in ATCC26933 and ΔegtB26933 via             
LC-MS/MS 
Mycelia from triplicate 72 h cultures of ATCC26933 and ΔegtB26933 in Czapek-Dox broth were 
harvested and cell lysate supernatants obtained as per Section 2.2.9. The presence of DTT in the 
lysis buffer reduces GSSG to GSH, allowing for total glutathione measurement.  Lysate 
supernatants were alkylated using 5’-IAF (Section 2.2.12.1), TCA precipitated (Section 2.2.12.2) 
and analysed via LC-MS/MS (Section 2.2.12.7). In addition, a GSH standard alkylated with 5’-
IAF and TCA precipitated as before was analysed in the same manner. Alkylated GSH was 
demonstrated to elute at 5.9 min, with an m/z of 695 (Gallagher et al., 2012). Extracted ion 
chromatograms (m/z: 695) for the samples show GSH present in both strains (Figure 6.16). 
Comparison of GSH levels reveal a slight decrease in ΔegtB26933 compared to ATCC26933, 
however this was not significant. Partial loss of EGT in ΔegtB26933 therefore does not result in 
differential levels of GSH. This is in contrast to ΔegtA26933, where complete loss of EGT resulted 
in increased levels of GSH (Section 4.2.8.1). 
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Figure 6.16. Total glutathione detection via LC-MS in ATCC26933 and ΔegtB26933 (A) 
Extracted Ion Chromatographs (m/z: 695) following LC-MS/MS analysis of TCA precipitated 
alkylated mycelial extracts from ATCC26933 and ΔegtB26933, in addition to a GSH standard. A 
peak at 5.9 min was confirmed to be GSH. (B) Signature ion breakdown corresponding to 
alkylated GSH (Gallagher et al., 2012). (C) Comparison of GSH levels in ATCC26933 and 
ΔegtB26933. No significant difference in GSH levels are observed in ΔegtB26933 compared to wild-
type. 
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6.2.2.4  Analysis of gliotoxin production in ATCC26933 and ΔegtB26933 via RP-HPLC 
Supernatants from triplicate 72 h cultures of ATCC26933 and ΔegtB26933 in Czapek-Dox broth 
were collected and organic extraction carried out as per Section 2.2.10. The organic extracts 
were then analysed via RP-HPLC (Section 2.2.12.6). In addition, a gliotoxin standard was 
analysed in the same manner. Gliotoxin was detected at 14.9 min and was observed to be present 
in both ATCC26933 and ΔegtB26933 (Figure 6.17). A comparison of ATCC26933 and ΔegtB26933 
gliotoxin peak areas shows no significant difference in the levels of gliotoxin produced. Deletion 
of egtB therefore has no impact on gliotoxin biosynthesis. 
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Figure 6.17. Gliotoxin detection via RP-HPLC in ATCC26933 and ΔegtB26933. (A) RP-HPLC 
analysis of organic extracts from the supernatants of 72 h cultures of ATCC26933 and ΔegtB26933 
(n = 3). Gliotoxin is present in both chromatograms at 14.9 min. (B) Comparison of gliotoxin 
peak area from RP-HPLC analysis for ATCC26933 and ΔegtB26933 performed in triplicate. No 
significant difference in gliotoxin levels were observed in ΔegtB26933 compared to ATCC26933.  
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6.2.2.5  Phenotypic analysis of ATCC26933 and ΔegtB26933 in response to gliotoxin 
Sensitivity to gliotoxin was tested at a range of 0 – 20 µg/ml as per Section 2.2.7. No significant 
differences in the radial growth of ΔegtB26933 colonies compared to ATCC26933 colonies were 
observed at any concentration of gliotoxin tested (Figure 6.18). Deletion of egtB, and the 
consequent reduction in EGT levels, therefore has no effect on self-protection from gliotoxin in 
A. fumigatus. 
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Figure 6.18. Gliotoxin sensitivity assay performed on AMM agar for 72 h. (A) Comparison of 
radial growth of ATCC26933 and ΔegtB26933 on AMM agar plates containing 0 to 20 µg/ml 
gliotoxin. No significant reduction in growth was observed in ΔegtB26933 compared to 
ATCC26933 at any concentration of gliotoxin tested. (B) Images of ATCC26933 and ΔegtB26933 
colonies on AMM plates containing 0 to 20 µg/ml gliotoxin. No visible decrease in the size of 
the ΔegtB26933 colonies can be observed compared to the ATCC26933 colonies at any 
concentration of gliotoxin tested.  
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6.2.3  Phenotypic characterisation of ΔvipC26933 
6.2.3.1  Analysis of growth and development in ΔvipC26933compared to ATCC26933 
6.2.3.1.1 Analysis of growth and development in ΔvipC26933compared to ATCC26933 
on solid Media 
Conidia from ATCC26933 and ΔvipC26933 were point inoculated onto AMM agar in triplicate as 
per Section 2.2.7 and incubated at 37 
o
C for 72 h. Comparison of the radial growth of resulting 
ATCC26933 and ΔvipC26933 colonies revealed ΔvipC26933 colonies show a significant (P = 
0.0036) increase in radial growth compared to ATCC26933 (Figure 6.19A). Additionally, an 
abundance of aerial hyphae are visible at the centre of the ΔvipC26933 colonies that are not present 
on ATCC26933 colonies (Figure 6.19C and 6.19D). Deletion of vipC in ATCC26933 results in 
differential growth, with increased radial growth and the presence of aerial hyphae. This is 
evidence that VipC is involved in growth and development in A. fumigatus.  
6.2.3.1.2 Analysis of growth in ΔvipC26933compared to ATCC26933 in Liquid Media 
Cultures (n = 5) of ATCC26933 and ΔvipC26933 in AMM were incubated for 72 h at 37 oC, 200 
rpm shaking. Cultures were then harvested through miracloth, snap frozen and lyophilised 
overnight. Comparison of the dry weight of mycelia reveals a significant increase (P = 0.0012) in 
the dry weight of ΔvipC26933 mycelia, compared to ATCC26933 mycelia (Figure 6.19B). This is 
further evidence that VipC plays a role in the growth of A. fumigatus. 
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Figure 6.19. Analysis of differential growth in ΔvipC26933 compared to ATCC26933 (A) 
Comparison of ATCC26933 and ΔvipC26933 radial growth. Radial growth is significantly 
increased in ΔvipC26933 (P = 0.0036) compared to ATCC26933. (B) Comparison of dry weight of 
mycelia from liquid culture from ATCC26933 and ΔvipC26933. Mycelial dry weight was 
significantly increased in ΔvipC26933 (P = 0.0012) compared to ATCC26933. (C) Images of 
ATCC26933 and ΔvipC26933   colonies demonstrating increased radial growth and presence of 
aerial hyphae in ΔvipC26933. (D) Images of ATCC26933 and ΔvipC26933   colonies demonstrating 
the presence of aerial hyphae on the ΔvipC26933 colony.  
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6.2.3.1.3 Analysis of growth and development in ΔvipC26933compared to ATCC26933 
on solid media in response to light 
Conidia from ATCC26933 and ΔvipC26933 were point inoculated onto AMM agar in triplicate as 
per (Section 2.2.7). Inoculated plates were incubated for 72 h in either darkness or light. 
Significantly decreased radial growth was demonstrated in both ATCC26933 and ΔvipC26933 in 
light compared to radial growth in darkness (P = 0.0161 for both strains) (Figure 6.20A). 
ΔvipC26933 had significantly increased radial growth compared to ATCC26933 when grown in 
both light and darkness (P = 0.0002 for both conditions) (Figure 6.20A). The increased radial 
growth phenotype in ΔvipC26933 therefore was not affected by the presence or absence of light. 
This was not the case with the aerial hyphae phenotype, however. Aerial hyphae were observed 
on ΔvipC26933 colonies grown in darkness. This was not observed on ΔvipC26933 grown in light or 
for ATCC26933 colonies grown in darkness or light (Figure 6.20B and 6.20C). The presence of 
aerial hyphae on ΔvipC26933 therefore only occurs when grown in the dark. This indicates that 
VipC has a role in suppressing aerial hyphae formation in A. fumigatus when grown in darkness, 
but not light. VipC function in A. fumigatus may be at least partially regulated by environmental 
signals. 
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Figure 6.20. Comparison of ATCC26933 and ΔvipC26933 colonies grown in darkness and in 
light. (A) Comparison of radial growth of ATCC26933 and ΔvipC26933 colonies grown in 
darkness and in light. Radial growth was increased in both strains grown in darkness compared 
to light (P = 0.0161 for both strains). ΔvipC26933 demonstrated increased growth compared to 
ATCC26933 in both darkness and in light (P = 0.0002 for both conditions). (B) Photographs of 
ATCC26933 and ΔvipC26933 colonies, demonstrating increased radial growth of ΔvipC26933 
colonies when grown in both darkness and light. Aerial hyphae are only visible on ΔvipC26933 
colonies grown in dark. (C) Side-view photographs of ATCC26933 and ΔvipC26933 colonies, 
demonstrating aerial hyphae growth on ΔvipC26933 colonies grown in darkness.  
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6.2.3.2  Analysis of EGT production in ATCC26933 and ΔvipC26933 via RP-HPLC 
Mycelia from 72 h cultures of ATCC26933 and ΔvipC26933 in Czapek-Dox broth were harvested 
and cell lysate supernatants obtained as per Section 2.2.9. Lysate supernatants were alkylated 
using 5’-IAF as described in Section 2.2.12.1 and analysed via RP-HPLC (Section 2.2.12.6) 
using fluorescence detection at Ex/Em of 494/518 nm. EGT was detected in both ATCC26933 
and ΔvipC26933 at a retention time of 12.4 min (Figure 6.21). Comparing EGT levels by 
measuring the peak area of 5’-IAF alkylated EGT revealed no significant difference in EGT 
levels in ATCC26933 and ΔvipC26933. Deletion of VipC therefore had no effect on EGT 
production, suggesting VipC does not influence EGT biosynthesis in A. fumigatus. 
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Figure 6.21. Detection and measurement of alkylated EGT via RP-HPLC. (A) Detection of 
alkylated EGT in ATCC26933 and ΔvipC26933 at a retention time of 12.4 min. (B) Comparison of 
EGT levels in ATCC26933 and ΔvipC26933. No significant difference in the levels of EGT was 
observed in ATCC26933 and ΔvipC26933.  
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6.2.3.3 Phenotypic analysis of ATCC26933 and ΔvipC26933 in response to ROS 
inducing agents 
6.2.3.3.1 Phenotypic analysis of ATCC26933 and ΔvipC26933 in response to H2O2 
Sensitivity to H2O2 was tested at a range of 0 – 3 mM as per Section 2.2.7. Comparison of radial 
growth of ATCC26933 and ΔvipC26933 colonies revealed no significant difference between the 
two strains at any concentration of H2O2 tested (Figure 6.22). Loss of vipC therefore does not 
lead to sensitivity to H2O2 induced stress.  
6.2.3.3.2 Phenotypic analysis of ATCC26933 and ΔvipC26933 in response to menadione 
Sensitivity to menadione was tested at a range of 0 – 60 µM as per Section 2.2.7. Comparison of 
radial growth of ATCC26933 and ΔvipC26933 colonies revealed no significant difference between 
the two strains at any concentration of menadione tested (Figure 6.23). Loss of vipC therefore 
does not lead to sensitivity to menadione induced stress.  
6.2.3.3.3 Phenotypic analysis of ATCC26933 and ΔvipC26933 in response to diamide 
Sensitivity to diamide was tested at a range of 0 – 1.75 mM as per Section 2.2.7. No significant 
differences in the radial growth of ΔvipC26933 colonies compared to ATCC26933 colonies were 
observed at any concentration of diamide tested (Figure 6.24). Loss of vipC therefore does not 
lead to sensitivity to diamide induced stress.  
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Figure 6.22. H2O2 sensitivity assay performed on AMM agar for 72 h. (A) Comparison of radial 
growth of ATCC26933 and ΔvipC26933 on AMM agar plates containing 0 to 3 mM H2O2. 
ΔvipC26933 shows no significant difference in radial growth compared to ATCC26933 at any 
concentration of H2O2 tested. (B) Images of ATCC26933 and ΔvipC
26933
 colonies on AMM 
plates containing 0 to 3 mM H2O2. No visible decrease in the size of the ΔvipC
26933
 colonies was 
observed compared to the ATCC26933 colonies at any concentration of H2O2 tested.  
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Figure 6.23. Menadione sensitivity assay performed on AMM agar for 72 h. (A) Comparison of 
radial growth of ATCC26933 and ΔvipC26933 on AMM agar plates containing 0 to 60 µM 
menadione. ΔvipC26933 shows no significant difference in radial growth compared to 
ATCC26933 at any concentration of menadione tested. (B) Images of ATCC26933 and 
ΔvipC26933 colonies on AMM plates containing 0 to 60 µM menadione. No visible decrease in 
the size of the ΔvipC26933 colonies was observed compared to the ATCC26933 colonies at any 
concentration of menadione tested. 
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Figure 6.24. Diamide sensitivity assay performed on AMM agar for 72 h. (A) Comparison of 
radial growth of ATCC26933 and ΔvipC26933 on AMM agar plates containing 0 to 1.75 mM 
menadione. ΔvipC26933 shows no significant difference in radial growth compared to 
ATCC26933 at any concentration of diamide tested. (B) Images of ATCC26933 and ΔvipC26933 
colonies on AMM plates containing 0 to 1.75 mM diamide. No visible decrease in the size of the 
ΔvipC26933 colonies was observed compared to the ATCC26933 colonies at any concentration of 
diamide tested. 
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6.2.3.4 Total glutathione measurement in ATCC26933 and ΔvipC26933 via              
LC-MS/MS 
Mycelia from triplicate 72 h cultures of ATCC26933 and ΔvipC26933 in AMM were harvested 
and cell lysate supernatants obtained as per Section 2.2.9. The presence of DTT in the lysis 
buffer reduces GSSG to GSH, allowing for total glutathione measurement.  Lysate supernatants 
were alkylated using 5’-IAF (Section 2.2.12.1), TCA precipitated (Section 2.2.12.2) and 
analysed via Thermo Q-Exactive LC-MS/MS (Section 2.2.12.7). In addition, a GSH standard 
labelled with 5’-IAF and TCA precipitated as before was analysed in the same manner. 5’-IAF 
alkylated GSH was demonstrated to elute at 46 min, with an m/z of 695 (Gallagher et al, 2012). 
Extracted ion chromatograms (m/z: 695) for the samples show GSH present in both ATCC26933 
and ΔvipC26933. ΔvipC26933 shows significantly (P = 0.0352) reduced levels of GSH compared to 
ATCC26933 (Figure 6.25). Therefore, vipC deletion resulted in a significant decrease (90 %) in 
total intracellular glutathione, indicating a novel interaction between VipC functionality and 
GSH biosynthesis.  
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Figure 6.25. Total glutathione detection via LC-MS in ATCC26933 and ΔvipC26933 (A) 
Extracted ion chromatographs (m/z: 695) following LC-MS/MS analysis of TCA precipitated 
alkylated mycelial extracts from ATCC26933 and ΔvipC26933, in addition to a GSH standard. A 
peak at 46 min was confirmed to be GSH. Note that Y-axis differ by 10-fold for ATCC26933 
and ΔvipC26933 chromatograms. (B) Signature ion breakdown corresponding to alkylated GSH 
(Gallagher et al., 2012). (C) Comparison of GSH levels in ATCC26933 and ΔvipC26933. GSH 
levels in ΔvipC26933 were significantly (P = 0.0352) reduced compared to ATCC26933.  
 
 
 
262 
 
6.2.3.5  Analysis of Conidiation in ATCC26933 and ΔvipC26933 
Triplicate colonies of ATCC26933 and ΔvipC26933 were grown on AMM for 72 h and levels of 
conidiation were measured via haemocytometry (Section 2.2.16). A non-significant reduction in 
conidiation in ΔvipC26933 compared to ATCC26933 was observed (Figure 6.26). Deletion of vipC 
therefore does not affect levels of conidiation in A. fumigatus. 
 
  
 
 
 
 
 
 
 
 
Figure 6.26. Comparison of conidiation levels from ATCC26933 and ΔvipC26933. Levels of 
conidiation are lower in ΔvipC compared to ATCC26933, however the difference is not 
significant.  
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6.2.3.6  Analysis of gliotoxin production in ATCC26933 and ΔvipC26933 via RP-HPLC 
Supernatants from triplicate 72 h cultures of ATCC26933 and ΔvipC26933 in Czapek-Dox broth 
were collected and organic extraction carried out as per Section 2.2.10. The organic extracts 
were then analysed via RP-HPLC (Section 2.2.12.6). In addition, a gliotoxin standard was 
analysed in the same manner. Gliotoxin was detected at 14.9 min and was observed to be present 
in both ATCC26933 and ΔvipC26933 (Figure 6.27). A comparison of ATCC26933 and ΔvipC26933 
gliotoxin peak areas shows a non-significant increase in gliotoxin levels in ΔvipC26933 compared 
to ATCC26933. Deletion of vipC therefore has no impact on gliotoxin biosynthesis. 
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Figure 6.27. Gliotoxin detection via RP-HPLC in ATCC26933 and ΔvipC26933. (A) RP-HPLC 
analysis of organic extracts from the supernatants of 72 h cultures of ATCC26933 and ΔvipC26933 
(n = 3). Gliotoxin is present in both chromatograms at 14.9 min. (B) Comparison of gliotoxin 
peak area from RP-HPLC analysis for ATCC26933 and ΔvipC26933 performed in triplicate. A 
non-significant increase in gliotoxin levels is observed in ΔvipC26933 compared to ATCC26933.  
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6.2.3.7  Phenotypic analysis of ATCC26933 and ΔvipC26933 in response to gliotoxin 
Sensitivity to gliotoxin was tested at a range of 0 – 20 µg/ml as per Section 2.2.7. No significant 
differences in the radial growth of ΔvipC26933 colonies compared to ATCC26933 colonies were 
observed at any concentration of gliotoxin tested (Figure 6.28). Deletion of vipC therefore has no 
effect on gliotoxin sensitivity, it can therefore be concluded that VipC is not involved in 
gliotoxin self-protection in A. fumigatus. 
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Figure 6.28. Gliotoxin sensitivity assay performed on AMM agar for 72 h. (A) Comparison of 
radial growth of ATCC26933 and ΔvipC26933 on AMM agar plates containing 0 to 20 µg/ml 
gliotoxin. ΔvipC26933 shows no significant difference in radial growth compared to ATCC26933 
at any concentration of gliotoxin tested. (B) Images of ATCC26933 and ΔvipC
26933
 colonies on 
AMM plates containing 0 to 20 µg/ml gliotoxin. No visible decrease in the size of the ΔvipC26933 
colonies can be observed compared to the ATCC26933 colonies at any concentration gliotoxin 
tested.  
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6.2.3.8 LFQ Proteomic Analysis of ATCC26933 and ΔvipC26933 under basal 
conditions 
ATCC26933 and ΔvipC26933 (n = 3 biological replicates each) were cultured in AMM media for 
72 h at 37 
o
C, 200 rpm shaking. This media and incubation conditions was chosen in order to 
mirror that of Section 6.2.3.1.2, which demonstrated increased dry weight of mycelia in 
ΔvipC26933 compared to ATCC26933. Following this incubation, the mycelia were harvested 
from each culture and processed for Q-Exactive Mass Spectrometry analysis as per Section 
2.2.14.1. Samples were then digested using sequencing grade trypsin (Section 2.2.14.4), purified, 
normalised and desalted using ZipTips ® (Section 2.2.14.5) and analysed on a Q-Exactive mass 
spectrometer (Section 2.2.14.6). Data was analysed via Max Quant, comparing ΔvipC26933 to 
ATCC26933. Significantly enriched functional categories of proteins were identified using the 
web based application FungiFun 2 (Priebe et al., 2015; https://elbe.hki-
jena.de/fungifun/fungifun.php) 
Surprisingly. a total of 474 proteins had altered abundance in ΔvipC26933 compared to 
ATCC26933. Of these, 132 proteins had increased abundance, while 342 proteins had decreased 
abundance. Loss of vipC therefore induced significant proteomic remodelling in A. fumigatus. A 
full list of proteins with differential abundance can be seen in Appendix 5. Figure 6.29 
summarises the most significantly enriched functional categories of the proteins showing 
differential abundance.  
ΔvipC26933 displayed differential growth compared to ATCC26933, with increased radial growth 
and the presence of aerial hyphae indicative of altered growth regulation. Several proteins with 
increased abundance in ΔvipC26933 compared to ATCC26933 were identified with key roles in 
the regulation of fungal growth. These were Rho GTPase Rho1 (AFUA_6G06900; log2 1.19 
fold), Rho GTPase Rho3 (AFUA_3G06690; Unique) and transcriptional activator SomA 
(AFUA_7G02260; Unique) (Table 6.1). The Rho GTPases have been demonstrated to regulate 
the actin cytoskeleton arrangement in A. fumigatus (Dichtl et al., 2010), while SomA deletion 
resulted in slow growth and impaired asexual development (Lin et al., 2015). Increased 
abundance of these proteins as a result of vipC deletion provides a mechanism for the growth 
phenotypes observed in ΔvipC26933. The increased growth is also reflected in significantly 
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enriched protein categories, with membrane proteins (n = 17), hyphal tip proteins (n = 2) and 
proteins involved in chromosome organisation (n = 2) indicative of cell growth (Figure 6.29A). 
Conidial hydrophobin RodB (AFUA_1G17250) exhibited a log2 -5.22 fold decrease in 
abundance in ΔvipC26933. Although vipC deletion did not affect conidiation levels, decreased 
abundance of this protein suggests that vipC may still influence the conidial proteome. However, 
hydrophobins have also been demonstrated to play an important role in aerial hyphae formation. 
In Schizophyllum commune, the Sc3p class I hydrophobin is secreted at the surface of the cell 
wall of aerial hyphal elements. This forms a rodlet layer at the interface between the cell wall 
and air (Wösten et al., 1994). Decrease abundance of RodB may therefore be linked to altered 
aerial hyphae growth observed in ΔvipC26933. 
Oxidoreducase activity (n = 67) and oxidation-reduction process (n = 69) were significantly 
enriched categories of proteins showing decreased abundance in ΔvipC compared to 
ATCC26933 (Figure 6.29B). This is indicative of a shift in the redox state of ΔvipC26933 
compared to ATCC26933. Related to this, catalase B (AFUA_3G02270; log2 -1.8 fold) and 
superoxide dismutase (AFUA_5G09240; log2 -2.82 fold) had decreased abundance in ΔvipC
26933 
(Table 6.1). These are important enzymes in oxidative stress defence (Imlay, 2002). 
Furthermore, two components of the CCAAT-binding factor complex (CBC) show increased 
abundance in ΔvipC26933 compared to ATCC26933. HapC (AFUA_1G03840) is unique in ΔvipC 
compared to ATCC26933, while HapE (AFUA_6G05300) shows an increase in abundance of 
log2 1.1 fold. As discussed previously, the CBC is essential for mounting an effective oxidative 
stress response (Thon et al., 2010). This is further indication of changes to the oxidative stress 
defense in ΔvipC26933. 
EgtB (AFUA_2G13295), predicted to catalyse the final step in EGT biosynthesis (Pluskal et al., 
2014), showed a log2 -1.35 fold decrease in abundance in ΔvipC compared to wild-type. This 
would appear to indicate a change in EGT biosynthesis, however measurement of EGT levels in 
ΔvipC26933 (Section 6.2.3.2) revealed no difference in EGT levels compared to ATCC26933. 
This is likely due to redundancy in catalysing the final step of EGT biosynthesis.  
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Table 6.1. Selected proteins with significant log2 fold change or unique/absent in A. fumigatus ∆vipC
26933
 compared to ATCC26933 
under basal conditions. Data sorted by fold change, in descending order. 
Protein Description Present/log2 
(Fold Change) 
p-value Peptides Sequence 
coverage 
[%] 
Protein IDs 
CCAAT-binding factor complex subunit HapC  Unique n/a 3 23.8 AFUA_1G03840 
Rho GTPase Rho3 Unique n/a 3 21.8 AFUA_3G06690 
Transcriptional activator SomA  Unique n/a 2 4.5 AFUA_7G02260 
Aflatoxin B1-aldehyde reductase GliO-like, putative  1.2167 0.001131 8 36.9 AFUA_1G13370 
Rho GTPase Rho1 1.19404 0.031796 10 64 AFUA_6G06900 
CCAAT-binding factor complex subunit HapE  1.09962 0.020565 5 25.1 AFUA_6G05300 
Methyltransferase SirN-like, putative -1.17769 0.014002 29 89.7 AFUA_8G00550 
Aminotransferase family protein, putative (EgtB) -1.34821 0.000589 21 74.6 AFUA_2G13295 
Catalase B (Antigenic catalase) (Slow catalase) -1.80239 0.007799 18 38.6 AFUA_3G02270 
Superoxide dismutase [Cu-Zn]  -2.82331 0.010068 13 82.9 AFUA_5G09240 
Conidial hydrophobin RodB  -5.21637 0.001205 4 61.4 AFUA_1G17250 
12-alpha,13-alpha-dihydroxyfumitremorgin C 
prenyltransferase Fumitremorgin biosynthesis protein H 
Absent n/a 9 36.3 AFUA_8G00250 
Verruculogen synthase (Fumitremorgin biosynthesis 
protein F) 
Absent n/a 6 26.5 AFUA_8G00230 
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Figure 6.29. Significantly enriched functional categories of proteins showing differential 
abundance in ΔvipC26933 compared to ATCC26933 under basal conditions. The number under 
each category represents the number of proteins detected within that category. (A) Significantly 
enriched functional categories from proteins showing increased abundance, whereby 127 out of 
132 proteins in the data set were annotated. (B) Significantly enriched functional categories from 
proteins showing decreased abundance, whereby 332 out of 342 proteins in the data set were 
annotated. 
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Dramatically, an array of proteins involved in glutathione and methionine metabolism underwent 
decreased abundance in ΔvipC26933 compared to ATCC26933 (Table 6.2). Enzymes which 
function primarily in the metabolism of glutathione showed decreased abundance in ΔvipC26933 
compared to ATCC26933, these include γ-glutamylcysteine synthetase regulatory subunit 
(AFUA_3G14280; log2 -1.16 fold), glutathione-specific γ-glutamylcyclotransferase 
(AFUA_3G08560; log2 -1.5 fold), glutathione oxidoreductase (AFUA_1G15960; log2 -1.91 fold) 
and glutathione synthetase (AFUA_5G06610; log2 -1.98 fold). Furthermore, enzymes which 
biosynthesise the precursors of glutathione, cysteine and glutamate (Lu, 2009), also had 
decreased abundance. These include cysteine synthase (AFUA_5G02180; log2 -1.55 fold), 
glutamate carboxypeptidase (AFUA_3G10650; log2 -1.94 fold), cystathionine γ-lyase 
(AFUA_8G04340; log2 -2.03 fold) and two glutaminases (AFUA_3G10310; log2 -2.75 fold and 
AFUA_6G09910; absent) (Figure 6.30). This data unambiguously demonstrates how glutathione 
biosynthesis is downregulated in ΔvipC26933, resulting in lower levels of glutathione, as observed 
(Figure 6.25). 
 In addition to this, 2 proteins associated with the glyoxalase system show decreased abundance 
in ΔvipC compared to ATCC26933. The glyoxalase system involves detoxifying hemithioacetal 
groups which form due to reactions between glutathione and aldehyde groups (Thornalley, 
1990). The proteins were lactoylglutathione lyases: AFUA_6G07940 (log2 -1.98 fold) and 
AFUA_2G13550 (Absent). Lactoylglutathione lyase (also known as glyoxalase I) catalyses the 
isomerisation of hemithioacetal adducts. A second enzyme (glyoxalase II) then catalyses the 
hydrolysis of the hemithioacetal adduct into glutathione and lactate. Decreased abundance of the 
lactoglutathione lyases may be due to decreased occurrence of hemithioacetal groups resulting 
from diminished levels of glutathione. 
The proteins involved in methionine metabolism were methionine synthase (AFUA_4G07360; 
log2 -1.25 fold) and adenosylhomocysteinase (AFUA_1G10130; log2 -1.8 fold). Methionine 
synthase catalyses the biosynthesis of methionine from homocysteine, while 
adenosylhomocysteinase cleaves S-adenosylhomocysteine (SAH) into homocysteine and 
adenosine (Figure 6.30). The decreased abundance of adenosylhomocysteinase is of particular 
interest as SAH is a potent inhibitor of methylation (Mandaviya et al., 2014). Increased levels of 
SAH caused by decreased abundance of adenosylhomocysteinase would lead to a decrease in 
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methylation.  As a methyltransferase, VipC activity is directly linked to SAM and SAH levels. 
These alterations in the abundances of methionine cycle proteins indicates VipC could play a 
role in regulating methylation levels. 
A number of proteins which function in the biosynthesis of secondary metabolism had 
differential abundance in ΔvipC26933 compared to ATCC26933 (Table 6.1). These include 
fumitremorgin biosynthesis protein F (AFUA_8G00230) and protein H (AFUA_8G00250) 
which were both absent in ΔvipC26933 compared to ATCC26933. A SirN-like methyltransferase, 
involved in pseurotin A biosynthesis (Alcazar-Fuoli et al., 2014) had a log2 -1.18 fold decrease in 
abundance. A putative Aflatoxin B1-aldehyde reductase (AFUA_1G13370) showed a log2 1.22 
fold increase in abundance in ΔvipC compared to ATCC26933. This indicates changes in 
secondary metabolism in A. fumigatus caused by vipC deletion.  
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Table 6.2. Proteins associated with glutathione and methionine metabolism with significant log2 fold decrease or absent in A. 
fumigatus ∆vipC26933 compared to ATCC26933 under basal conditions. Data sorted by fold change, in descending order. 
Protein Description Present/log2 
(Fold Change) 
p-value Peptides Sequence 
coverage 
[%] 
Protein IDs 
Gamma-cysteine synthetase regulatory subunit, putative -1.16194 0.029487 8 46.3 AFUA_3G14280 
Cobalamin-independent methionine synthase MetH/D  -1.25468 0.003155 67 73.8 AFUA_4G07360 
Glutathione-specific gamma-glutamylcyclotransferase  -1.50449 0.000284 8 40.3 AFUA_3G08560 
Cysteine synthase (O-acetylserine (Thiol)-lyase) (Csase)  -1.54878 0.002011 10 42 AFUA_5G02180 
Adenosylhomocysteinase  -1.79604 0.001039 36 74.2 AFUA_1G10130 
Glutamine synthetase, putative  -1.90463 0.016527 16 45.1 AFUA_6G03530 
Glutathione oxidoreductase Glr1, putative  -1.91151 0.009301 25 67.4 AFUA_1G15960 
Glutamate carboxypeptidase Tre2, putative -1.93664 0.033893 15 27.5 AFUA_3G10650 
Glutathione synthetase (GSH-S)  -1.97585 0.005413 21 63.8 AFUA_5G06610 
Lactoylglutathione lyase (Glyoxalase I)  -1.98281 0.009525 26 85.5 AFUA_6G07940 
Cystathionine gamma-lyase  -2.03402 0.007625 12 56.8 AFUA_8G04340 
Glutaminase, putative -2.74585 0.029525 18 33.6 AFUA_3G10910 
Lactoylglutathione lyase (Glo1), putative  Absent n/a 5 37.3 AFUA_2G13550 
Glutaminase, putative Absent n/a 17 28.7 AFUA_6G09910 
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Figure 6.30. Proteins associated with glutathione and methionine metabolism which show decreased abundance in ΔvipC26933 
compared to ATCC26933. Proteins with decreased abundance are shown in green. Abbreviations: GCS, Gamma-Glutamylcysteine 
Synthetase Regulatory Subunit; MS Methionine Synthase; GGCT, Glutathione-Specific Gamma-Glutamylcyclotransferase; CS, 
Cysteine Synthase; SAHase, Adenosylhomocysteinase; Glu-S, Glutamine Synthetase; GR, Glutathione Oxidoreductase; GSH-S, 
glutathione Synthase; CGL, Cystathionine γ-Lyase; Glnase, Glutaminase. 
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6.3  Discussion 
This chapter presents the work done to characterise A. fumigatus ΔpalA26933, ΔegtB26933 and 
ΔvipC26933. No phenotype was observed in ΔpalA26933. Analysis of EGT, His and gliotoxin levels 
in ΔpalA26933 revealed no significant difference compared to ATCC26933. Similarly, analysis of 
sensitivity to H2O2, menadione, diamide, His, Phe and gliotoxin showed no significant 
differences between ΔpalA26933 and ATCC26933. ΔegtB26933 had attenuated levels of EGT, 
confirming that EgtB forms part of the EGT biosynthetic pathway. EGT production was not 
completely abrogated in ΔegtB26933, as was observed in ΔegtA26933, meaning EgtB is not essential 
for EGT biosynthesis. Attenuated EGT levels in ΔegtB26933 resulted in sensitivity to H2O2 and 
menadione, further underlining the importance of EGT as an antioxidant in A. fumigatus. 
ΔvipC26933 had differential growth compared to ATCC26933, with increased growth in both solid 
and liquid media and the presence of aerial hyphae when grown on solid media. ΔvipC26933 also 
had reduced levels of GSH and decreased abundance of superoxide dismutase and catalase B in 
comparison to ATCC26933. LFQ proteomic analysis revealed ΔvipC26933 had decreased 
abundance of proteins associated with metabolic process, with prominent proteins involved in 
GSH, cysteine, glutamate and methionine metabolism identified. 
Phenylalanine ammonia lyase (PAL) has been demonstrated to function in stress response in 
plants through the production of phenyl propanoid compounds (Dixon and Paiva, 1995). 
Additionally, it has also been implicated in oxidative stress defence (Desikan et al., 1998; Lee et 
al., 2003; Gao et al., 2008). PAL (AFUA_2G09110) had increased abundance in ΔegtA26933 
compared to ATCC26933 under basal (log2 2.71 fold) and ROS (log2 3.73 fold) conditions.  
Thus, it was hypothesised that increased abundance of PAL may be part of an oxidative stress 
response in the absence of EGT. This would explain why PAL had a larger increase in 
abundance under ROS conditions compared to basal conditions. Assays for oxidative stress 
sensitivity using H2O2, menadione and diamide revealed no significant difference between 
ΔpalA26933 and ATCC26933. Deletion of palA therefore had no deleterious effect on oxidative 
stress defence in A. fumigatus. PAL therefore appears to play no role in protecting A. fumigatus 
from elevated ROS levels.  However it may be that PAL function in oxidative stress defence is 
only necessary when the oxidative stress defence system has been compromised (e.g. EGT 
absence).  
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PAL is known to have high similarity to histidine ammonia lyase (HAL)(Schwede et al., 1999), 
which breaks down histidine in manner similar to phenylalanine catabolism by PAL. It was 
speculated that if PAL was misannotated and had HAL activity, the observed increase in 
abundance in ΔegtA26933 may be due to increased histidine levels caused by absence of EGT 
biosynthesis, in which histidine is essential. In order to test this hypothesis, His levels in 
ΔpalA26933 and ATCC26933 were measured via RP-HPLC and sensitivity to 200 mM His was 
analysed.  RP-HPLC analysis revealed no significant difference in His levels in ATCC26933 and 
Δpal26933. Furthermore no sensitivity to exogenous His was observed in ΔpalA26933 compared 
ATCC26933. Deletion of palA in A. fumigatus therefore caused no changes in His levels nor 
impacted on detoxifying high concentrations of His. Thus no role for PAL in metabolising His 
could be identified.  
Another hypothesis for the increased abundance of PAL in ΔegtA26933 under both basal and ROS 
conditions was that it could be acting as an ergothionase. Muramatsu et al. (2013) reported an 
enzyme with ergothioneine degradation activity showed 17 % similarity to PAL in Burkholderia 
sp. HME13. If this was the case, EGT levels would be predicted to rise in ΔpalA26933 as EGT 
would not be broken down. However measurement of EGT levels in ΔpalA26933 and ATCC26933 
revealed no significant differences, meaning no role for PAL in ergothioneine degradation could 
be identified. 
Phe sensitivity analysis also revealed no significant differences between the radial growth of 
ATCC26933 and ΔpalA26933 when grown on 150 mM Phe. palA deletion therefore does not result 
in a deleterious accumulation of Phe following exposure to 150 mM Phe. This is likely due to 
other enzymes, such as phenylalanine hydroxylase (Flatmark and Stevens, 1999), affecting 
phenylalanine catabolism in the absence of PAL. 
ΔpalA26933 gliotoxin production was analysed via RP-HPLC, which revealed no significant 
difference in gliotoxin levels in comparison to ATCC26933. Furthermore, ΔpalA26933 displayed 
no sensitivity to gliotoxin in comparison to ATCC26933. palA deletion therefore has no impact 
on gliotoxin biosynthesis or self-protection from gliotoxin.  
Thus no role for PAL in A. fumigatus could be established. It may be that there is redundancy, 
resulting in no observable phenotype following palA
26933
 deletion. Additionally, it may be that 
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PAL function only became necessary following egtA deletion, hence the observed rise in 
abundance. Further investigation is required to elucidate the function of this protein in A. 
fumigatus. 
RP-HPLC and LC-MS/MS analysis of EGT levels in ATCC26933 and ΔegtB26933 demonstrated 
that ΔegtB26933 was capable of producing EGT, but at significantly reduced levels compared to 
ATCC26933. This demonstrates that EgtB participates in EGT biosynthesis. However, unlike 
ΔegtA26933, EGT production was not abrogated entirely. Thus egtB is not essential for EGT 
biosynthesis in A. fumigatus. This indicates that there is redundancy in the final step of EGT 
biosynthesis in A. fumigatus. Seebeck (2010) demonstrated that conversion of hercynylcysteine 
sulfoxide to EGT does not require a specific enzyme. A PLP-binding β-lyase (ETA_14770) from 
Erwinia tasmaniensis, which does not biosynthesise EGT, was capable of producing EGT in 
vitro from hercynylcysteine sulfoxide. Indeed, Seebeck also reported that prolonged incubation 
(10 h) of hercynylcysteine sulfoxide with PLP was found to produce significant amounts of 
EGT. Thus conversion of hercynylcysteine sulfoxide to EGT may happen spontaneously in the 
presence of PLP. As it has been demonstrated that this final step of EGT biosynthesis does not 
require a specific enzyme, it likely that in the absence of egtB, EGT biosynthesis is completed 
non-specifically in ΔegtB26933 by unrelated PLP-binding enzyme. 
Deletion of Schizosaccharomyces pombe egt2, an egtB ortholog, resulted in reduced EGT levels 
compared to wild-type (Pluskal et al., 2014). However S. pombe Δegt2 had a much greater 
reduction in EGT levels compared to A. fumigatus ΔegtB26933. egt2 deletion in  S pombe reduced 
EGT levels to 25.5 % of wild-type EGT levels, while A. fumigatus ΔegtB26933 EGT levels were 
72 % of ATCC26933 EGT levels. Thus egtB deletion in A. fumigatus results in smaller relative 
reduction in EGT levels compared to egt2 deletion in S. pombe. This suggests a key difference in 
EGT biosynthesis between the two organisms, with greater redundancy measures in A. fumigatus 
for egtB activity compared to egt2 in S. pombe. This could be due to relative importance of EGT 
in each organism. It has been demonstrated in Chapters 4 & 5 of this thesis that EGT loss in 
ΔegtA26933 affects redox homeostasis, oxidative stress defence, conidiation, cell wall integrity, 
glutathione metabolism and gliotoxin metabolism. In contrast to this, no phenotypes were 
observed in the EGT null S. pombe Δegt1. Thus EGT appears to play a much more prominent 
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role in A. fumigtaus compared to S. pombe. This may explain the need for increased redundancy 
for A. fumigatus egtB compared to S. pombe egt2. 
Sensitivity assays for H2O2, menadione and diamide revealed ΔegtB
26933
 is sensitive to H2O2 and 
menadione compared to ATCC26933, while no significant sensitivity to diamide was observed. 
ΔegtB26933 was sensitive to H2O2 compared to ATCC26933 at a concentration of 3 mM. 
However, no significant difference in radial growth between ΔegtB26933 and ATCC26933 was 
detected at 1 mM and 2 mM H2O2. ΔegtB
26933 
was sensitive to menadione compared to 
ATCC26933 at all concentrations of menadione tested (20 – 60 µM). egtB deletion in A. 
fumigatus therefore results in sensitivity to high levels of H2O2 induced ROS and to menadione 
induced superoxide radicals in particular. Diamide induced ROS however had no significant 
effect on ΔegtB26933 radial growth in comparison to ATCC26933.  
The results for ROS sensitivity in ΔegtB26933 are similar to those obtained for ΔegtA26933 (Section 
4.2.2). Both ΔegtA26933 and ΔegtB26933 were not sensitive to 1 mM and 2 mM H2O2 compared to 
ATCC26933, but displayed sensitivity to 3 mM H2O2 compared to ATCC26933. ΔegtA
26933
 and 
ΔegtB26933 were both significantly sensitive to menadione compared to ATCC26933 at 
concentrations of 40 µM and 60 µM. However, while ΔegtA26933 was not sensitive to 20 µM 
menadione in comparison to ATCC26933, ΔegtB26933 did display sensitivity at 20 µM 
menadione. Neither ΔegtA26933 nor ΔegtB26933 were sensitive to diamide compared to 
ATCC26933. Thus, ΔegtB displayed a similar phenotype to ΔegtA26933 in response to 3 mM 
H2O2 and was more sensitive to menadione in comparison to ATCC26933 than ΔegtA
26933
.  
That ΔegtB26933 matches and exceeds ΔegtA26933 sensitivity to H2O2 and menadione respectively 
was somewhat of a surprise given that ΔegtB26933 retains 71.1 % EGT production compared to 
ATCC26933, while EGT is abrogated in ΔegtA26933 entirely. This may be explained by 
differences in GSH levels in ΔegtA26933 and ΔegtB26933. GSH levels were significantly increased 
in ΔegtA26933 compared to ATCC26933, which is hypothesised to compensate for EGT absence. 
However, there were no significant differences in GSH levels in ΔegtB26933 compared to 
ATCC26933. This suggests that egtB deletion is not compensated for in the same manner as egtA 
deletion. This would explain why a partial loss of EGT in ΔegtB26933 resulted in similar 
sensitivity to ROS as complete loss of EGT in ΔegtA26933. That a partial loss of EGT can cause 
sensitivity further underlines the importance of EGT as an antioxidant in A. fumigatus. 
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Like GSH, gliotoxin levels were not significantly altered in ΔegtB26933 compared to 
ATCC26933. GSH and gliotoxin levels were increased and decreased respectively in ΔegtA26933 
in comparison to ATCC26933. This is a significant metabolic adjustment in response to 
abrogation of EGT biosynthesis. This does not occur in ΔegtB26933, which suggests that a partial 
reduction of EGT does not perturb A. fumigatus metabolism and/or cell redox state in the same 
manner as abrogated EGT biosynthesis. 
LFQ proteomic analysis of ΔvipC26933 and ATCC26933 revealed that 474 proteins had 
differential abundance in ΔvipC26933 compared to ATCC26933. 132 proteins had increased 
abundance, while 342 proteins had decreased abundance. This is a significant proteomic 
remodelling. Of note, “metabolic process” was a significantly enriched protein category amongst 
proteins with decreased abundance (Figure 6.29B). 101 proteins in the dataset were in this 
category, indicating a significantly altered metabolism due to vipC loss.   
Deletion of vipC in A. fumigatus resulted in altered growth phenotypes, with ΔvipC26933 
exhibiting increased radial growth on solid media and increased mycelial dry weight in liquid 
media compared to ATCC26933. Furthermore, ΔvipC26933 colonies had distinct aerial hyphae 
that were not present on ATCC26933. vipC deletion therefore resulted in differential growth and 
development in A. fumigatus. 
LFQ proteomics provided further insight into these phenotypes. SomA (AFUA_7G02260), a 
transcription factor that regulates growth and development in A. fumigatus, was unique in 
ΔvipC26933 compared to ATCC26933. Lin et al. (2015) demonstrated that deletion of somA in A. 
fumigatus resulted in attenuated radial growth and asexual development. SomA was 
demonstrated to regulate a number of developmental genes such as brlA, medA, stuA and flbA. 
Furthermore, Rho GTPases Rho1 (AFUA_6G06900; log2 1.2 fold) and Rho3 (AFUA_3G06690; 
unique) showed increased abundance in ΔvipC26933 compared to ATCC26933. Rho GTPases are 
small signaling proteins which play a central role in regulation of the actin cytoskeleton 
(Etienne-Manneville and Hall, 2002). Rho1 is essential in A. fumigatus and conditional 
downregulation of rho1 resulted in decreased radial growth, hyphal leakage and reduced 
conidiation (Dichtl et al., 2012).  Rho1 is also a key regulator of CWI signalling and 
predominantly localizes to the hyphal tip (Dichtl et al., 2010).  Rho3 also localises 
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predominantly to the hyphal tip and is predicted to regulate hyphal polarity and CWI signalling 
in conjunction with Rho1 (Dichtl et al., 2010).  
It can therefore be postulated that in wild-type A. fumigatus, VipC represses SomA, Rho1 and 
Rho3 as a method of regulating growth and development. In ΔvipC26933, SomA, Rho1 and Rho3 
are then increased in abundance, resulting in increased radial growth and the presence of aerial 
hyphae.  
That proteins associated with metabolic process have decreased abundance in ΔvipC26933 
compared to ATCC26933, while radial growth is increased, suggests that metabolic processes 
are sacrificed in order to focus on increased growth. This may be a “starvation response”, 
whereby radial growth rate is increased to search for and reach nutrients. vipC may control a 
metabolic switch between increased growth and metabolic processes and when deleted in 
ΔvipC26933, this response cannot be turned off. 
Aerial hyphae are linked with asexual development, as condiophores develop from the tips of 
aerial hyphae (Mah and Yu, 2006). Thus altered aerial hyphae growth could be linked to changes 
to asexual development following vipC deletion. Indeed, vipC deletion in A. nidulans resulted in 
a 70 – 75 % drop in asexual sporulation compared to wild-type when grown in light (Sarikaya-
Bayram et al., 2014). However, no significant difference in the levels of conidiation was 
observed in ΔvipC26933 compared to ATCC26933. Thus conidiation levels are regulated 
independently of vipC in A. fumigatus. This represents a significant deviation in the role of vipC 
in A. fumigatus compared to A. nidulans. Interestingly, conidial hydrophobin RodB 
(AFUA_1G17250) had a log2 -5.22 fold decrease in abundance in ΔvipC
26933
 compared to 
ATCC26933. RodB, in conjunction with RodA, comprise the hydrophobic rodlet layer on the 
surface of conidia (Paris et al., 2003a). The rodlet layer contributes to conidial buoyancy in the 
air, essential for conidial dispersion. vipC therefore may play a role in development of conidia, if 
not levels of conidiation. Additionally, hydrophobins have been demonstrated to be present in 
aerial hyphae and form rodlets that are part of an extracellular matrix that holds aerial hyphae 
together (Beauvais et al., 2007). Decrease in RodB abundance may therefore be linked to the 
alterations in aerial hyphae observed. 
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Curiously, these phenotypes observed in ΔvipC26933 are very similar to phenotypes observed in a 
ΔbrlA mutant. brlA is a central regulator of asexual development in A. fumigatus and its deletion 
resulted in increased hyphal mass and elongated aerial hyphae (Mah and Yu, 2006). However, 
unlike ΔvipC26933, ΔbrlA had a complete absence of asexual development. Relevantly, brlA is 
regulated by SomA (Figure 6.31), which had increased abundance in ΔvipC26933 compared to 
ATCC26933. Conditional downregulation of somA resulted in abolition of brlA expression (Lin 
et al., 2015). However, LFQ proteomic analysis did not show BrlA to have differential 
abundance. Whether BrlA is linked to the phenotypes observed in ΔvipC26933 can only be 
speculated from the data available, however the similarity in the phenotypes suggests that 
perturbations in asexual development regulation may be taking place, which could be linked in 
differential expression of SomA. 
 
Figure 6.31. Schematic representing the regulation of asexual development in A. fumigatus. 
SomA is an upstream regulator of BrlA, the first protein in the asexual development central 
regulatory pathway (BrlA, AbaA and WetA). VipC may contribute to regulation of conidia 
through repression of SomA.  Image modified from Mah and Yu (2005), Sheppard et al. (2005) 
and Alkhayyat et al. (2015). 
VipC was demonstrated to regulate sexual and asexual development in response to light in A. 
nidulans (Sarikaya-Bayram et al., 2014). Therefore ATCC26933 and ΔvipC26933 were incubated 
in the presence or absence of light in order to investigate if VipC activity changes in response to 
light in A. fumigatus. Both ATCC26933 and ΔvipC26933 had significantly decreased radial growth 
when grown in light compared to darkness. ΔvipC26933 had increased radial growth compared to 
ATCC26933 in both darkness and light, indicating that VipC regulates growth independently of 
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exposure to light. However the aerial hyphae present on ΔvipC26933 in the dark did not develop 
on ΔvipC26933 when grown in light. Aerial hyphae were not present on ATCC26933 when grown 
in darkness or light. Thus the presence of elongated aerial hyphae only occurs on ΔvipC26933 
when grown in darkness. This suggests that VipC suppresses development of aerial hyphae in 
darkness, but is regulated separately when grown in the light. VipC therefore does appear to 
regulate development in response to light, suggesting its role in A. fumigatus is not completely 
removed from the one it plays in A. nidulans. 
LFQ proteomics indicated a shift in the redox state of ΔvipC26933 in comparison to ATCC26933. 
Proteins involved with oxidoreducase activity (n = 67) and/or involved with oxidation-reduction 
process (n = 69) were significantly enriched protein categories amongst proteins with decreased 
abundance. Two components of the CCAAT-binding factor complex (CBC) showed increased 
abundance in ΔvipC26933 compared to ATCC26933. HapC (AFUA_1G03840) is unique in 
ΔvipC26933 compared to ATCC26933, while HapE (AFUA_6G05300) had a log2 1.1 fold increase 
in abundance. As discussed previously, the CBC is essential for co-coordinating the oxidative 
stress defence in eukaryotes (Thon et al., 2010). In Chapter 5, HapC was demonstrated to be 
absent in ATCC26933 under ROS conditions, suggesting that HapC absence is associated with 
increased ROS. HapC absence in ATCC26933 compared to ΔvipC26933 therefore indicates that 
ΔvipC26933 is experiencing less oxidative stress compared to ATCC26933. 
Indeed, two key oxidative stress defence proteins, catalase B (AFUA_3G02270; log2 -1.8 fold) 
and superoxide dismutase (AFUA_5G09240; log2 -2.82 fold), were decreased in abundance in 
ΔvipC26933. Catalases convert hydrogen peroxide in water and oxygen (Chelikani et al., 2004), 
while superoxide dismutase converts superoxide radicals into either water or hydrogen peroxide 
(McCord and Fridovich, 1969). In addition to this, total intracellular glutathione was reduced in 
ΔvipC26933 compared to ATCC26933. LFQ proteomics reveal decreased abundance of the 
glutathione biosynthetic enzymes γ-glutamylcysteine synthetase regulatory subunit 
(AFUA_3G14280; log2 -1.16 fold) and glutathione synthetase (AFUA_5G06610; log2 -1.98 
fold). Biosynthetic proteins of cysteine and glutamate, essential precursors of glutathione (Lu, 
2009), also had decreased abundance (Figure 6.32). Interestingly, EgtB (AFUA_2G13295), 
which catalyses the final step of EGT biosynthesis, also had decreased abundance. However, no 
significant difference in EGT levels in ATCC26933 and ΔvipC26933 was detected. 
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Despite the decreased abundance of oxidative stress defence proteins catalase B and superoxide 
dismutase, in addition to reduced levels of GSH, ΔvipC26933 displayed no sensitivity when 
challenged with ROS inducing agents. ΔvipC26933 was not sensitive to any concentration of H2O2, 
menadione or diamide tested compared to ATCC26933. This suggests that ΔvipC26933 can still 
mount an effective oxidative stress defence and that the observed reduction of oxidative stress 
defence mechanisms only occurs under basal conditions. It may be the case that levels of 
intracellular ROS are reduced in vipC
26933
 compared to ATCC26933. This can be explained by 
the observation that metabolic process is a significantly enriched category of proteins with 
decreased abundance (Figure 6.29B). ROS is a normal product of aerobic metabolism (Davies, 
1995); therefore reduced metabolic process could lead to reduced levels of ROS under basal 
conditions. If basal ROS is reduced, abundance of catalase B and superoxide dismutase, in 
addition to GSH levels, can be decreased without adversely affecting the cell. 
 
Figure 6.32. Proteins involved in the metabolism of glutathione, cysteine and glutamate have 
decreased abundance in ΔvipC26933. Abbreviations: GCS, Gamma-Glutamylcysteine Synthetase 
Regulatory Subunit; GGCT, Glutathione-Specific Gamma-Glutamylcyclotransferase; CS, 
Cysteine Synthase; Glu-S, Glutamine Synthetase; GR, Glutathione Oxidoreductase; GSH-S, 
glutathione Synthase; CGL, Cystathionine γ-Lyase; Glnase, Glutaminase. 
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The decreased abundance of methionine cycle enzymes, methionine synthase (AFUA_4G07360; 
log2 -1.25 fold) and adenosylhomocysteinase (AFUA_1G10130; log2 -1.8 fold) had potential 
implications for SAM and SAH levels. As VipC is a SAM-dependant methyltransferase, this was 
of particular interest. Methionine synthase catalyzes the formation of methionine from 
homocysteine. As methionine is the precursor of SAM, the universal methyl donor (Lieber and 
Packer, 2002), this would be expected to reduce SAM levels (Figure 6.33). vipC deletion may 
result in decreased utilisation of SAM, due to the absence of VipC SAM-dependant 
methyltransferase activity. This would result in increased levels of intracellular SAM and 
decreased levels of SAH. In this case, adenosylhomocysteinase abundance may be reduced due 
to the decreased levels of its substrate, SAH. Methionine synthase may undergo decreased 
abundance to attenuate SAM biosynthesis as SAM levels are already elevated. 
 
Figure 6.33. The components of the methionine cycle. Methionine synthase (MS) and 
adenosylhomocysteinease (SAHase) have decreased abundance in ΔvipC26933 compared to 
ATCC26933.  
LFQ proteomics indicated that ΔvipC26933 had altered secondary metabolism compared to 
ATCC26933. Fumitremorgin biosynthesis protein F (FtmF; AFUA_8G00230) and protein H 
(FtmH; AFUA_8G00250) which were both absent in ΔvipC26933 compared to ATCC26933. 
FtmH catalyses the final step in fumitremorgin B biosynthesis (Grundmann et al., 2008), while 
FtmF converts fumitremorgin B into verruculogen (Kato et al., 2011), a tremorgenic mycotoxin. 
Decreased abundance of these proteins indicates a shift in fumitremorgin biosynthesis away from 
verruculogen due to vipC
26933
 absence. A SirN-like methyltransferase (AFUA_8G00550) 
demonstrated to be important in pseurotin A biosynthesis, had a log2 -1.18 fold decrease in 
abundance (Alcazar-Fuoli et al., 2014). This indicates a likely reduction in pseurotin A levels in 
ΔvipC26933 in comparison to ATCC26933. A putative Aflatoxin B1-aldehyde reductase 
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(AFUA_1G13370), predicted to be involved in secondary metabolite biosynthesis (Khaldi et al., 
2010), showed a log2 1.22 fold increase in abundance in ΔvipC
26933
 compared to ATCC26933. 
Gliotoxin biosynthesis was unaffected by vipC deletion however. RP-HPLC analysis showed no 
significant difference in gliotoxin levels in ΔvipC26933 and ATCC26933. 
The data presented in this chapter demonstrates vipC functions in regulating growth, 
development and metabolism in A. fumigatus. This is a completely novel role for vipC, as 
previously the only function for vipC described was for controlling sexual and asexual 
development in A. nidulans. Elgabbar and Han (2015) attempted to characterise vipC in A. 
fumigatus through the creation of a ΔvipC mutant, but did not report any phenotypes and 
concluded that its role is redundant under normal culture conditions. That they did not observe 
the same growth phenotypes seen in ΔvipC26933 from this study may be due to differences in 
strain type or media. Furthermore, they lacked the insight from A. fumigatus ΔegtA data that we 
had and did not perform LFQ proteomic analysis.
 
The work presented in this chapter represents the first study of palA and egtB function in A. 
fumigatus and provides the first characterisation of vipC function in A. fumigatus. While no 
function for palA was elucidated, egtB was demonstrated to contribute to EGT biosynthesis. 
ΔegtB further emphasised the importance of EGT as an antioxidant, by demonstrating that a 
partial loss of EGT leads to ROS sensitivity. A novel role for vipC as a regulator of growth, 
development and metabolism was demonstrated, which had not been described in previous 
studies. This provides further insight into the metabolic changes observed in ΔegtA26933, where 
VipC had increased abundance compared to ATCC26933. 
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7.1  Introduction 
Many advances have been made in the study of ergothioneine in recent years. Seebeck (2010) 
presented the first elucidation of EGT biosynthesis in his seminal work using recombinant 
proteins cloned from Mycobacterium smegmatis. Following this, Bello et al. (2012) identified an 
enzyme required for EGT biosynthesis, egt1, in Neurospora crassa. This represented the first 
identification of an EGT biosynthetic gene in fungi. The second fungal EGT biosynthetic 
enzyme, egt2, was later identified by Pluskal et al. (2014) in Schizosaccharomyces pombe. The 
crystal structures of bacterial EgtB, EgtC and EgtD have been recently determined, furthering the 
understanding of EGT biosynthesis (Vit et al., 2014, 2015; Goncharenko et al., 2015). Studies 
into EGT functionality in fungi and bacteria have indicated a physiological role for EGT as an 
antioxidant (Bello et al., 2012, 2014; Sao Emani et al., 2013; Saini et al., 2015). EGT has also 
been associated with protection from heat (Alamgir et al., 2015), starvation response (Richard-
Greenblatt et al., 2015) and antibiotic resistance (Saini et al., 2015). EGT was demonstrated to 
protect against UV radiation in Methylobacterium (Alamgir et al, 2015), but not in N. crassa 
(Bello et al., 2014). No physiological role for EGT was determined in S. pombe from their study 
using the EGT null Δegt1 mutant (Pluskal et al., 2014). The role of EGT, if any, therefore 
appears to vary between species and the antioxidant function as elucidated in N. crassa by Bello 
et al. (2012, 2014) has been the only physiological role described for EGT in a fungus.  
Prior to this work, EGT biosynthesis and function had not been characterised in Aspergillus 
fumigatus, or any other human fungal pathogen. The first identification of EGT in A. fumigatus 
was made by Gallagher et al. (2012), who noted increased levels of EGT in the gliotoxin null 
mutant ΔgliK. ΔgliK exhibited many additional phenotypes, including abrogated gliotoxin 
production and sensitivity to H2O2 and exogenous gliotoxin. Whether increased levels of EGT 
were related to these phenotypes was a matter of speculation. 
This discussion will describe the identification and deletion of two EGT biosynthetic genes: egtA 
and egtB. Data from egtA and egtB gene deletion mutants facilitated the analysis of EGT 
functionality in A. fumigatus through phenotypic and LFQ proteomic analysis. Of particular 
interest is the role of EGT in oxidative stress defence, the metabolic and redox systems 
interactions between EGT, GSH and gliotoxin, and EGT function in regulating conidiation and 
cell wall integrity. PAL and VipC were identified for further study through LFQ proteomic 
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analysis of ΔegtA26933, which was facilitated by the generation of ΔpalA and ΔvipC mutants. 
While PAL function in A. fumigatus remains unclear, VipC was characterised, for the first time, 
to influence growth, development and metabolism. Finally, the function of VipC in A. fumigatus 
adaption to EGT absence will be discussed. 
7.2  Identification EGT biosynthetic genes in A. fumigatus 
egtA (AFUA_2G15650) was identified to encode a potential EGT biosynthetic enzyme in A. 
fumigatus via bioinformatic analysis of M. smegmatis egtB and egtD, N. crassa egt1 and S. 
pombe egt1. Chapter 3 detailed the generation of an egtA deletion mutant in A. fumigatus 
ATCC26933 using a bipartite gene deletion strategy. The egtA gene was then reinserted to 
generate the complemented strain, egtA
C26933
. RT-PCR was utilized to confirm absence of gene 
expression in ΔegtA26933 and reinstatement of gene expression in egtAC26933. In Chapter 4, RP-
HPLC and LC-MS/MS demonstrated complete absence of EGT production in ΔegtA26933 and 
restoration of EGT production in egtA
C26933
. This unambiguously proved EgtA to be an essential 
EGT biosynthetic enzyme, predicted to catalyse the first two steps of EGT biosynthesis (Figure 
7.1). 
Following the successful identification of egtA as an EGT biosynthetic gene, the question of a 
second EGT biosynthetic gene in A. fumigatus arose. egtB (AFUA_2G13295) was identified as a 
potential target, as it is a homolog of S. pombe egt2 (Pluskal et al., 2014). In Chapter 3, it was 
described how egtB was deleted and absence of egtB expression demonstrated via RT-PCR. EGT 
production in ATCC26933 and ΔegtB26933 was analysed as described in Chapter 6 and it was 
demonstrated that ΔegtB26933 produced significantly less EGT compared to ATCC26933. It was 
concluded that EgtB does contribute to EGT production but is not essential for its biosynthesis. 
This data is in agreement with work from Seebeck (2010) and Pluskal et al. (2012), who 
demonstrated that the conversion of hercynylcysteine sulphoxide to EGT can be completed non-
specifically, or even spontaneously, in the presence of the co-factor pyridoxal phosphate (PLP). 
EgtB was thus predicted to catalyse the final step of EGT biosynthesis (Figure 7.1), however this 
remains to be demonstrated biochemically. 
During investigation of the redundancy of EgtB, Nfs1 (AFUA_3G14240) was also identified as a 
possible candidate for catalyzing the final step of EGT biosynthesis. Like EgtB, Nfs1 is a PLP-
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dependant cysteine desulphurase that has been shown to provide inorganic sulphur for iron-
sulphur cluster proteins in Saccharomyces cerevisiae. However, multiple attempts at deleting 
Nfs1 in A. fumigatus proved unsuccessful, thus Nfs1 may be essential in A. fumigatus, as is the 
case in S. cerevisiae (Li et al., 1999). This would render generation of a deletion mutant 
impossible. Future studies into potential Nfs1 function in EGT biosynthesis could be undertaken 
through the generation of an A. fumigatus mutant with Nfs1 under the control of a conditional 
inducible promoter, such as the tet-on system (Helmschrott et al., 2013). 
 
Figure 7.1. EGT biosynthetic pathway for A. fumigatus as elucidated from ΔegtA26933 and 
ΔegtB26933. EgtA catalyses the first two steps, converting histidine into hercynine and hercynine 
into hercynylcysteine sulphoxide. EgtB may catalyse the final step, converting hercynylcysteine 
sulphoxide into ergothioneine. Conversion of hercynylcysteine to ergothioneine may take place 
by alternative mechanisms to EgtB. 
Another protein which could be contributing to EgtB redundancy is cystathionine β-lyase (CBL; 
AFUA_4G03950). Seebeck (2010) demonstrated that a PLP-binding β-lyase (ETA_14770) from 
Erwinia tasmaniensis could catalyse the final step of EGT biosynthesis in vitro. ETA_14770 is 
annotated as a cystathionine β-lyase by KEGG, suggesting that A. fumigatus CBL, which is also 
a PLP-binding enzyme (Ravanel, 1997), could also catalyse the conversion of hercynylcysteine 
sulphoxide to EGT. Relevantly, CBL had increased abundance in ΔegtA26933 compared to 
ATCC26933 under ROS conditions. This is considered to be part of a metabolic shift towards 
SAM production in order to facilitate abortive EGT biosynthesis. Thus, CBL contribution to 
EGT biosynthesis may actually be twofold, and it may also catalyze the formation EGT from 
hercynylcysteine sulphoxide as hypothesised. 
289 
 
This work represents the first identification of an EGT biosynthetic pathway in A. fumigatus and 
in turn the first identification of an EGT biosynthetic pathway in a human fungal pathogen. This 
is only the second time the possible final step in EGT biosynthesis has been identified in a 
eukaryote, which is of particular importance because S. pombe does not display any phenotype 
following the loss of EGT biosynthesis. EGT biosynthesis was also demonstrated in a Nicotiana 
tabacum strain transformed with genes cloned from A. fumigatus. LC-MS/MS analysis 
demonstrated that an N. tabacum strain transformed with A. fumigatus egtA and Nfs1 was able to 
produce EGT. That egtA is capable of catalysing EGT production in a plant is an important 
demonstration of its role in EGT biosynthesis. Whether Nfs1 contributed to EGT biosynthesis in 
N. tabacum is yet to be determined and will require analysis of N. tabacum strain transformed 
with egtA only. 
7.3 The role of EGT in A. fumigatus oxidative stress defence and redox 
homeostasis 
The availability of A. fumigatus strains with abrogated and reduced EGT production in the form 
of ΔegtA26933 and ΔegtB26933, respectively, allowed for functional analysis of EGT in A. 
fumigatus as outlined in Chapters 4 and 6. Sensitivity assays using ROS inducing agents with 
ATCC26933, ΔegtA26933 and egtAC26933 demonstrated that absence of EGT led to sensitivity to 3 
mM H2O2, but not at 1 mM or 2 mM. Similarly, absence of EGT led to sensitivity to 40 µM and 
60 µM menadione, but not 20 µM. Sensitivity assays with ATCC26933 and ΔegtB26933 
demonstrated similar results. Partial loss of EGT in ΔegtB26933 led to sensitivity to 3 mM H2O2 
and 20 – 60 µM menadione. The role of EGT for dissipating ROS was further underlined by 
fluorescent microscopy, which demonstrated that ΔegtA26933 possessed higher levels of ROS than 
ATCC26933 when exposed to 3 mM H2O2. Thus EGT was demonstrated to function as an 
antioxidant in A. fumigatus and to form an important component of the oxidative stress defence 
system in A. fumigatus. This was further emphasised by the demonstration that egtA was induced 
by 3mM H2O2. However, it was observed that instead of resulting in increased intracellular EGT 
levels, it instead replenished EGT as it was dissipated in the process of detoxifying H2O2, 
consistent with data from Servillo et al. (2015). 
In Chapter 5, LFQ proteomics demonstrated differential abundance of a multitude of reductases, 
oxidases, stress response proteins and enzymes with oxidising products in ΔegtA26933 compared 
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to ATCC26933 under both basal and ROS conditions. This is indicative of a shift in redox state 
due to EGT absence, particularly following exposure to 3 mM H2O2. Of particular importance 
was HapC, the redox sensitive subunit of the CCAAT-Binding Complex (CBC). The CBC 
senses changes in the redox state of the cell through modification of thiol groups within the 
histone fold motif of HapC. It then regulates Yap1 expression to coordinate oxidative stress 
response (Thon et al., 2010). HapC was demonstrated to be absent in ATCC26933 under ROS 
conditions compared to ATCC26933 under basal conditions, indicating HapC absence is a result 
of elevated ROS. HapC was also absent in ΔegtA26933 compared to ATCC26966 under basal 
conditions, which suggests that ΔegtA26933 is undergoing oxidative stress, even in the absence of 
a ROS inducing agent. This demonstrates that EGT absence leads to a significant shift in the 
redox state of the cell. 
EGT therefore appears to play an important role in detoxifying high levels of ROS, making it an 
“antioxidant of last resort”. This may be due to the properties of EGT that increase its stability. 
EGT exists in a thione state (Figure 1.8) at physiological pH and has a redox potential of - 0.06 
V, in contrast to other typical thiols, such as GSH, which typically range between -0.2 and -
0.32 V (Cheah and Halliwell, 2012). These factors combine to give EGT increased stability 
compared to other simple thiols. It can be speculated that these factors may allow EGT to avoid 
dissipation at low levels of ROS, when ROS can be effectively detoxified by other facets of the 
oxidative stress defence system such as superoxide dismutases, catalases and GSH. At high 
levels of ROS, when these other components of the oxidative stress defence system have been 
exhausted or overwhelmed, EGT is then available to dissipate the remaining ROS. To my 
knowledge, this represents a new concept in control of fungal redox homeostasis.  
The characterisation of EGT as an antioxidant in A. fumigatus offered insight into the observed 
rise in EGT levels in ΔgliK (Gallagher et al., 2012). In addition to increased levels of EGT, 
ΔgliK was demonstrated to have significant sensitivity to H2O2 compared to wild-type. The 
cause of this sensitivity has yet to be elucidated, however it is speculated that it may be due to  
interruption of the gliotoxin biosynthetic pathway following the incorporation of GSH, as GliK 
catalyses the enzymatic step directly following GliG (Figure 7.2) (Davis et al., 2011). Thus, gliK 
deletion may result in a “GSH sink”, as GSH is committed to the defective gliotoxin biosynthetic 
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pathway, resulting in compromised intracellular GSH content. EGT levels may therefore be 
increased in order to compensate for this possibility.  
 
Figure 7.2. An abridged schematic of the gliotoxin biosynthetic pathway, demonstrating GliG, 
GliK and GliT activity. Phenylalanine and serine are processed by GliP and GliC to form 
intermediate (1). (1) is then doubly thiolated using 2 GSH molecules by GliG, to form a 
sulphurised intermediate (2). (2) then undergoes bisglutamyl elimination, catalysed by GliK, to 
yield (3). (3) then undergoes several more enzymatic reactions to yield (4). The final product, 
gliotoxin, is then formed from (4) by the closure of the disulphide bridge via GliT (Schrettl et al., 
2010; Gallagher et al, 2012; Scharf et al., 2013). 
Increased levels of EGT to compensate for attenuated GSH levels in ΔgliK would indicate a key 
role for maintaining redox homeostasis following gliK deletion. This was underlined by the 
attempts at generating a ΔegtA::ΔgliK mutant as described in Chapter 3. Despite attempting the 
generation of the mutant multiple times, in a variety of conditions, no successful ΔegtA::ΔgliK 
mutant was generated. This indicated that the simultaneous absence of EgtA and GliK is not 
viable in A. fumigatus. Given the observed rise in EGT levels in ΔgliK, it is predicted that EGT is 
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essential to maintain redox homeostasis when gliK is deleted and thus a ΔegtA::ΔgliK mutant 
would not be viable. This amounts to experimental verification.  
7.4  Metabolic and redox interactions between EGT, GSH and gliotoxin 
In Chapter 4, it was also detailed how LC-MS/MS analysis of ATCC26933, ΔegtA26933 and 
egtA
C26933
 revealed a significant increase in total glutathione in ΔegtA26933 compared to 
ATCC26933 and egtA
C26933
. It was speculated that this may be a compensatory measure to deal 
with the absence of EGT. LFQ proteomics detailed in Chapter 5 described the absence of 
cystathionine γ-synthase (CGS; AFUA_7G01590) in ΔegtA26933 compared to ATCC26933 under 
basal conditions. CGS catalyses the conversion of cysteine into cystathionine, thus its absence 
would be expected to increase cysteine levels. This was speculated to be a measure to increase 
cysteine availability for GSH biosynthesis.  
Concurrently, RP-HPLC and LC-MS/MS analysis revealed a significant reduction in gliotoxin 
levels in ΔegtA26933 compared to ATCC26933. Related to this, LFQ proteomic analysis revealed 
that the gliotoxin oxidoreductase, GliT (AFUA_6G09740) (Schrettl et al., 2010; Scharf et al., 
2010), was absent in ΔegtA26933 compared to ATCC26933 under basal conditions. GliT catalyses 
disulphide bridge closure in A. fumigatus and has been demonstrated to be essential for gliotoxin 
biosynthesis (Figure 7.2) (Schrettl et al., 2010; Scharf et al., 2010). Thus, decreased gliotoxin 
levels in ΔegtA26933 may be caused by absence of GliT. GliT has also been demonstrated to play a 
key role in self-protection from gliotoxin (Schrettl et al., 2010) and its absence in ΔegtA26933 
might be expected to result in sensitivity to gliotoxin. However, sensitivity assays for gliotoxin 
revealed no significant sensitivity in ΔegtA26933 compared to ATCC26933. This was explained by 
the observation that GliT expression was induced by gliotoxin exposure, a response that been 
demonstrated previously in wild-type and considered part of the self-protection strategy in A. 
fumigatus. Relevantly, gliT is regulated independently of the rest of the gli cluster, which allows 
gliotoxin biosynthesis and self-protection to function autonomously (Schrettl et al., 2010).  
Gliotoxin and GSH metabolism is intrinsically linked because GSH is essential for gliotoxin 
biosynthesis. Davis et al. (2011) showed that GSH is incorporated into the gliotoxin biosynthetic 
pathway via the glutathione transferase GliG. Glutathione is the thiol source for gliotoxin, which 
is essential for its function, and deletion of gliG results in the complete abrogation of gliotoxin 
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biosynthesis (Figure 7.2). Thus the observed increase in GSH levels and concurrent decrease in 
gliotoxin levels in ΔegtA26933 could be related. Gliotoxin biosynthesis may be curtailed in order 
to diminish GSH incorporation into the gliotoxin biosynthetic pathway, thereby allowing for an 
increase in intracellular GSH. EGT therefore appears to be an important factor in gliotoxin 
production, as it compensates for reduced levels of intracellular GSH which is required for 
gliotoxin biosynthesis. In the absence of the antioxidant potential of EGT, GSH must be diverted 
from gliotoxin biosynthesis, resulting in reduced levels of gliotoxin. It may therefore be the case 
that EGT is required to maintain the optimal cellular redox state for high levels of gliotoxin 
production. 
This was further emphasised by results for total GSH measurement in AfS77 and ΔegtAAfS77. In 
contrast to ATCC26933, deletion of egtA in the AfS77 background resulted in no significant 
changes in GSH levels. However, it was particularly interesting that GSH levels in AfS77 were 
significantly increased compared to ATCC26933. AfS77 is derived from ATCC46645 
(Hartmann et al., 2010), which has been demonstrated to produce low levels of gliotoxin 
compared to ATCC26933 (Schrettl et al., 2010). Thus, in ATCC26933, decreased levels of GSH 
compared to AfS77 may be a result of increased gliotoxin biosynthesis, relative to AfS77. In 
ATCC26933, EGT is required for high levels of gliotoxin production, due to the necessary 
utilisation of GSH. When egtA is deleted and no EGT is present, a metabolic adjustment occurs 
whereby gliotoxin biosynthesis is decreased in order to increase GSH levels (Figure 7.3). 
Notably, the levels of GSH in ΔegtA26933 were similar to those of AfS77 and ΔegtAAfS77 (i.e. there 
was no significant differences in the levels of GSH in ΔegtA26933, AfS77 and ΔegtAAfS77). This 
same increase in GSH levels was not observed in ΔegtAAfS77 compared to AfS77, because low 
levels of gliotoxin production in AfS77 results in higher basal levels of GSH compared to 
ATCC26933. This meant that a metabolic adjustment was not required in the absence of EGT as 
GSH levels were already sufficient.  
The interplay between gliotoxin, GSH and EGT biosynthesis was also evident in ΔgliK. Deletion 
of gliK resulted in abrogated gliotoxin biosynthesis and increased levels of EGT (Gallagher et 
al., 2012). As discussed previously, this was speculated to be caused by the interruption of the 
gliotoxin biosynthetic pathway directly following the incorporation of GSH, resulting in a “GSH 
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sink”. Thus, we see gliotoxin and EGT biosynthesis as interlinked, with a possible involvement 
of GSH. 
It has therefore been demonstrated that A. fumigatus must carefully balance production of 
gliotoxin, GSH and EGT. As a result, disruption of one biosynthetic pathway may result in 
alterations in the other two. All three metabolites are redox-active molecules and, as such, the 
levels of each may be adjusted to maintain the redox homeostasis of the cell. As demonstrated in 
ΔegtA26933, abrogation of EGT resulted in a shift in the redox state of the cell, which required the 
alteration of gliotoxin and GSH biosynthesis to compensate (Figure 7.3). The biosynthetic 
pathways of gliotoxin, GSH are EGT are also linked metabolically, as cysteine provides the thiol 
group for all three; directly in the case of EGT and GSH and via GSH in the case of gliotoxin 
(Figure 7.3). Additionally, the biosynthesis of both gliotoxin and EGT contains 
methyltransferase steps, requiring SAM as a co-factor. Thus, availability of cysteine (and 
therefore sulphur) will impact biosynthesis of all three, while levels of SAM will affect EGT and 
gliotoxin biosynthesis. Production of these metabolites must therefore be balanced against the 
availability of cysteine and SAM. SAM levels are of particular interest in EGT biosynthesis as 3 
moles of SAM are required for every 1 mol of EGT produced. 
 
Figure 7.3. Interactions between EGT, GSH and gliotoxin in A. fumigatus. (A) In ATCC26933, 
high levels of gliotoxin biosynthesis result in reduced levels of intracellular GSH due to the 
double glutathiolation step in gliotoxin biosynthesis. This is facilitated by EGT which 
compensates for decreased levels of GSH. (B) In ΔegtA26933, absence of EGT results in a 
reduction in antioxidant potential, necessitating increased levels of GSH to compensate. GSH is 
thus diverted from gliotoxin biosynthesis, resulting in decreased levels of gliotoxin. 
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The importance of cysteine and SAM availability for these metabolic adjustments was 
emphasised by the observation of a “cystathionine switch”, as demonstrated in ΔegtA26933. Under 
basal conditions, cystathionine γ-synthase (CGS; AFUA_7G01590) was absent in ΔegtA26933 
compared to ATCC26933, while cystathionine β-lyase (CBL; AFUA_4G03950) had a log2 3.1 
fold increase in abundance in ΔegtA26933 compared to ATCC26933 under ROS conditions 
(Figure 7.4). In this manner, ΔegtA26933 can switch from directing cysteine towards GSH 
biosynthesis under basal conditions, to producing SAM to effect trimethylation of histidine for 
EGT biosynthesis under ROS conditions.  Cystathionine therefore appears to be at the nexus of 
the metabolic response to EGT absence and this suggests a prominent role for cystathionine in 
directing the metabolic thiol flux of the cell.  
7.5  The role of EGT in conidiation and cell wall integrity in A. fumigatus 
Chapter 4 detailed alterations to conidiation and the cell wall of ΔegtA26933 compared to 
ATCC26933. ΔegtA26933 was observed to produce paler conidia compared to ATCC26933 and 
measurement of conidiation revealed a significant decrease in conidiation levels in ΔegtA26933 
compared to ATCC26933. In addition to this, the cell wall integrity of ΔegtA26933 appeared to be 
altered compared to ATCC26933. This was demonstrated by sensitivity assays for congo red and 
calcofluor white, which showed ΔegtA26933 was sensitive to both dyes compared to ATCC26933. 
Both congo red and calcofluor white disrupt cell wall biosynthesis by inhibiting chitin and 
β(1,3)-glucan biosynthesis (Roncero and Duran, 1985). The sensitivity observed therefore 
indicated that chitin and β(1,3)-glucan content may be altered in the ΔegtA26933 cell wall 
compared to ATCC26933.  
Chapter 5 discussed LFQ proteomic analyses which provided further insight into the conidiation 
and cell wall phenotypes observed in ΔegtA26933. A number of proteins associated with 
conidiation were absent in ΔegtA26933 compared to ATCC26933 under basal conditions: 
mannosyltransferase PMT2 (AFUA_1G07690), mannosyltransferase PMT4 (AFUA_8G04500), 
conidial hydrophobin RodB (AFUA_1G17250), developmental regulator FlbA 
(AFUA_2G11180) and extracellular developmental signal biosynthesis protein FluG 
(AFUA_3G07140). FlbA  and FluG were of particular interest as they have been demonstrated to 
play an important role in upstream regulation of sexual development (Mah and Yu, 2006).  
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Figure 7.4. The “cystathionine switch” in A. fumigatus. (A) Comparison of ΔegtA26933 and 
ATCC26933 under basal conditions showing an absence of cystathionine γ-synthase, which 
normally converts cysteine to cystathionine.  This may facilitate a switch towards increased 
glutathione production. (B) Comparison of ΔegtA26933 and ATCC26933 upon addition of 3 mM 
H2O2 shows an increased abundance of cystathionine β-lyase, which converts cystathionine to 
homocysteine. This is predicted to result in increased production of SAM, which is essential for 
EGT biosynthesis. 
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The mannosyltransferases PMT2 and PMT4, absent in ΔegtA269332 compared to ATCC26933 
under basal conditions, have also been demonstrated to play a role in cell wall biosynthesis (Fang 
et al., 2010; Mouyna et al., 2010). Furthermore, chitin synthase activator Chs3 
(AFUA_3G05580), a putative cell wall protein (AFUA_3G081110), a putative MAP kinase 
kinase (Mkk2; AFUA_1G05800) and a putative cell wall glucanase (AFUA_3G09250) were 
absent in ΔegtA26933 compared to ATCC26933 under basal conditions. GEL5, a 1,3-beta-
glucanosyltransferase (AFUA_8G02130), showed a log2 1.18 fold increase in ΔegtA
26933
 
compared to ATCC26933 under basal conditions. Under ROS conditions, two proteins related to 
the A. fumigatus cell wall had differential abundance in ΔegtA26933 compared to ATCC26933: a 
putative class V chitinase (AFUA_3G11280; log2 2.05 fold) and a putative cell wall integrity 
signalling protein (AFUA_6G07520; log2 1.63 fold). The MAP kinase kinase Mkk2 is a key 
protein in the context of cell wall alterations in ΔegtA26933 as it functions as a signalling molecule 
in the cell wall integrity (CWI) pathway and thus regulates cell wall biosynthesis (Valiente et al., 
2009). Chs3 (AFUA_3G05580), the cell wall glucanase (AFUA_3G09250), GEL5 
(AFUA_8G02130) and the class V chitinase (AFUA_3G11280)  all function in the biosynthesis 
or arrangement of chitin and/or β(1,3)-glucans in the cell wall of A. fumigatus. This is relevant to 
the sensitivity to congo red and calcofluor white observed in ΔegtA26933 compared to 
ATCC26933, as both of these dyes inhibit chitin and β(1,3)-glucan biosynthesis (Roncero and 
Duran, 1985). Differential abundance of these proteins indicate altered chitin and β(1,3)-glucan 
levels, as predicted from the congo red and calcofluor white sensitivity assays. 
Thus, both conidiation and cell wall biosynthesis are altered in ΔegtA26933 compared to 
ATCC26933, indicating that absence of EGT leads to disruption of both processes. ROS has 
been demonstrated to function in signal transduction in fungi, with roles in cellular 
differentiation, virulence and hyphal growth previously demonstrated (Breitenbach et al., 2015). 
Relevantly, management of ROS has been linked with conidiation in Epichloë festucae (Kayano 
et al., 2013). To my knowledge, ROS signalling has not been associated with the cell wall of 
fungi before, however, ROS signalling has been well documented to play an important role in the 
cell wall of plants, regulating growth and development processes (Kärkönen and Kuchitsu, 
2015). It could therefore be speculated that EGT regulates conidiation and cell wall biosynthesis 
indirectly through the management of ROS levels. Thus, the redox shift resulting from EGT 
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absence in ΔegtA26933 would disrupt conidiation and cell wall biosynthesis as observed. Future 
work will further capture the molecular basis of these alterations in ΔegtA26933. 
Of interest, ΔgliK demonstrated a similar perturbation in cell wall related enzymes upon 
exposure to gliotoxin (Dr. Rebecca Owens and Professor Sean Doyle, personal communication). 
ΔgliK is sensitive to exogenous gliotoxin, though the reason for this sensitivity has not been 
elucidated (Gallagher et al., 2012). The reason behind this gliotoxin-induced disruption of the 
cell wall is unclear, but it could be linked to changes in the cellular redox state as indicated by 
the increased levels of EGT and H2O2 sensitivity observed in ΔgliK. Increased EGT levels may, 
therefore, be part of an attempt to maintain cell wall integrity. 
7.6  Investigations into PAL and VipC function in A. fumigatus 
LFQ proteomic analysis of ΔegtA26933 and ATCC26933 under basal and ROS conditions 
identified two proteins that had increased abundance in ΔegtA26933 compared ATCC26933 under 
basal conditions, and a larger increase in abundance under ROS conditions. These were 
phenylalanine ammonia lyase (PAL; AFUA_2G09110) and VipC (AFUA_8G01930) which 
were identified as proteins with a potentially important role in A. fumigatus adaption to EGT 
absence. Thus, deletion mutants for palA and vipC were generated as described in Chapter 3 to 
facilitate characterisation of PAL and VipC. 
PAL showed a log2 2.71 fold increase in ΔegtA
26933
 compared to ATCC26933 under basal 
conditions and a log2 3.73 fold increase in ΔegtA
26933
 compared to ATCC26933 under ROS 
conditions. A number of hypotheses were proposed for PAL function in A. fumigatus, including 
the generation of phenyl propanoid compounds as part of an oxidative stress defence strategy, 
catabolism of excess His due to abolition of EGT biosynthesis and a role as an ergothionase. 
However no phenotype was detected in ΔpalA26933 when compared to ATCC26933, despite a 
variety of analyses to test the above hypotheses. It may be that PAL function is not as prominent 
when all other systems are intact and the importance of PAL only comes to the fore when other 
systems are disrupted, such as in ΔegtA26933. As such, a double ΔegtA::ΔpalA mutant could 
greatly aid future study into PAL in A. fumigatus. 
VipC underwent a log2 1.23 fold abundance increase in ΔegtA
26933
 compared to ATCC26933 
under basal conditions and a log2 2.5 fold increase in abundance in ΔegtA
26933
 compared to 
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ATCC26933 under ROS conditions. VipC has been demonstrated to regulate sexual and asexual 
development is response to light in A. nidulans (Sarikaya-Bayram et al., 2014), however it was 
speculated that VipC function may differ in A. fumigatus due to significant differences in sexual 
development between the two Aspergilli (O’Gorman et al., 2009). Phenotypic characterisation of 
ΔvipC26933, as detailed in Chapter 6, revealed VipC absence caused unexpected alterations in 
growth in A. fumigatus. ΔvipC26933 displayed increased growth on solid media and in liquid 
culture. Additionally, ΔvipC26933 colonies had distinct aerial hyphae that were not visible on 
ATCC26933 colonies. LFQ proteomic analysis provided further insight into these phenotypes, 
revealing increased abundance of SomA and Rho GTPases Rho1 and Rho 3 in ΔvipC26933 
compared to ATCC26933.  SomA, Rho1 and Rho3 have been demonstrated to play key roles in 
the regulation of growth and development in A. fumigatus and the observed increase in 
abundance, in part at least, explains the observed growth phenotypes in ΔvipC26933 (Ditchl et al., 
2010, 2012; Lin et al., 2015). VipC therefore was demonstrated to influence growth and 
development in A. fumigatus. Interestingly, the aerial hyphae present on ΔvipC26933 colonies were 
not present on ΔvipC26933 colonies grown in light. This suggests a role for VipC in controlling 
development in response to environmental stimuli such as light. 
LFQ proteomics revealed altered abundance to key oxidative stress proteins in ΔvipC26933. HapC 
(AFUA_1G03840; unique) and HapE (AFUA_6G05300; log2 1.1 fold) had increased abundance 
in ΔvipC26933 compared to ATCC26933, while catalase B (AFUA_3G02270; log2 -1.8 fold) and 
superoxide dismutase (AFUA_5G09240; log2 -2.82 fold) had decreased abundance in ΔvipC
26933
 
compared to ATCC26933. Furthermore, LC-MS/MS analysis revealed that total GSH levels 
were significantly reduced in ΔvipC26933 compared to ATCC26933. HapC and HapE are 
components of the CBC, essential for mounting an effective oxidative stress response (Thon et 
al., 2010). As discussed previously, HapC absence was associated with increased levels of ROS. 
This suggests that ΔvipC26933 has decreased levels of ROS compared to ATCC26933. This is 
supported by the observation that despite decreased abundance of catalase B and superoxide 
dismutase, in addition to decreased levels of GSH, no sensitivity to ROS inducing agents was 
observed in ΔvipC26933 compared to ATCC26933. This suggests that vipC26933 has lower levels of 
basal ROS compared to ATCC26933 and this was speculated to be linked to the decreased 
abundance of proteins involved in metabolic processes. 
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This decrease in proteins associated with metabolic processes was especially evident for GSH 
metabolism. As discussed previously, GSH levels were reduced in ΔvipC26933 compared to 
ATCC26933. LFQ proteomic analysis revealed a decrease in abundance of a myriad of proteins 
associated with GSH biosynthesis (Figure 7.5) including proteins directly involved in 
metabolising GSH, and those which biosynthesise cysteine and glutamate, the precursors of 
GSH. This demonstrates a concerted move towards reduced GSH biosynthesis in ΔvipC26933. 
Related to this, 2 proteins associated with methionine metabolism had decreased abundance in 
ΔvipC26933 compared to ATCC26933. Methionine synthase (AFUA_4G07360) had a log2 -1.25 
fold decrease in abundance and adenosylhomocysteinase (AFUA_1G10130) had a log2 -1.8 fold 
decrease in abundance (Figure 7.5). These proteins are part of the methionine cycle and as such 
would be speculated to perturb cellular SAM/SAH levels. This in turn may be linked to the 
depressed metabolic processed observed as a proteomic level. Further study is definitely required 
to elucidate the exact effect these proteins have on SAM/SAH levels in ΔvipC26933.  
VipC was thus demonstrated to influence growth, development and metabolism in A. fumigatus. 
This was a completely novel role for a protein that had previously only been characterised as 
regulating sexual and asexual development in A. nidulans (Sarikaya-Bayram et al., 2014). While 
Elgabbar and Han (2015) attempted to investigate VipC function in A. fumigatus through the 
creation of a ΔvipC mutant, they did not observe any phenotypes. This data therefore represents 
the first characterisation of VipC in A. fumigatus. 
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Figure 7.5. Proteins associated with glutathione and methionine metabolism which show decreased abundance in A. fumigatus 
ΔvipC26933 compared to ATCC26933. Proteins with decreased abundance are shown in green. Abbreviations: GCS, Gamma-
Glutamylcysteine Synthetase Regulatory Subunit; MS Methionine Synthase; GGCT, Glutathione-Specific Gamma-
Glutamylcyclotransferase; CS, Cysteine Synthase; SAHase, Adenosylhomocysteinase; Glu-S, Glutamine Synthetase; GR, Glutathione 
Oxidoreductase; GSH-S, glutathione Synthase; CGL, Cystathionine γ-Lyase; Glnase, Glutaminase. 
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7.7  The role of VipC in A. fumigatus ΔegtA26933 
Interestingly, the results of the phenotypic characterisation of ΔvipC26933 provided insight into 
the observed increase in VipC abundance in ΔegtA26933 compared to ATCC26933 under both 
basal and ROS conditions.  Of particular interest was the analysis of total GSH via LC-MS/MS 
and supporting LFQ proteomic data which demonstrated that ΔvipC26933 had decreased levels of 
total GSH compared to ATCC26933. Thus, absence of VipC resulted in reduced levels of GSH. 
In ΔegtA26933, levels of total GSH were demonstrated to be increased compared to ATCC26933. 
Thus, decreased levels of total GSH are associated with absence of VipC in ΔvipC26933 and 
increased levels of total GSH are associated with increased abundance of VipC in ΔegtA26933. 
Levels of total GSH were therefore demonstrated to correlate with abundance of VipC in A. 
fumigatus, indicating that VipC possibly plays a role in regulating GSH biosynthesis.   
Related to this, both ΔvipC26933 and ΔegtA26933 appear to have experienced a shift in redox state 
following the respective gene deletions. ΔegtA26933 demonstrated altered abundance of a variety 
of reductases, oxidases, stress response proteins and enzymes with oxidising products, while 
ΔvipC26933 showed a decrease in abundance of proteins with oxido-reductase activity. A key 
protein in the redox shift of both mutants was HapC, as discussed previously. HapC was absent 
in ΔegtA26933 compared to ATCC26933, while it was unique in ΔvipC26933 compared to 
ATCC26933. 
VipC abundance therefore appears to correlate with absence of HapC, with increased abundance 
of HapC observed in in ΔvipC26933 and decreased abundance of HapC observed in ΔegtA26933, 
which has increased abundance of VipC. As HapC functions to detect changes in the redox state 
of the cell (Thon et al., 2010), this correlation suggests that VipC abundance is associated with 
increased levels of ROS, perhaps related to regulation of metabolic processes as discussed 
previously. It was noted that HapC was present in ATCC26933 in the ΔegtA26933 LFQ proteomic 
analysis and absent in ATCC26933 in the ΔvipC26933LFQ proteomic analysis. This was attributed 
to differences in the culture media, as the ΔegtA26933 study was performed using rich media 
(Sabaouraud Dextrose Broth) while the ΔvipC26933 study was performed in minimal media 
(AMM). 
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Another metabolic pathway altered by deletion of vipC was that of the methionine cycle (Owens 
et al., 2015). Methionine sythase and adenosylhomocysteinase both underwent decreased 
abundance in ΔvipC26933 compared to ATCC26933, which was speculated to disrupt SAM/SAH 
levels in ΔvipC26933 (Figure 7.5). Related to this, ΔegtA26933 under ROS conditions had increased 
abundance of CBL, which would increase levels of homocysteine (Ravanel, 1997) and was 
speculated to be part of a shift towards SAM production in order to attempt EGT biosynthesis 
(Figure 7.4). Thus we see decreased activity in the methionine cycle associated with absence of 
VipC and increased activity in the methionine cycle associated with increased abundance of 
VipC in ΔegtA26933. This represents another metabolic pathway potentially influenced by VipC in 
ΔegtA26933.  
The “cystathionine switch” was previously discussed in relation to prioritising the biosynthesis 
of either GSH or SAM in ΔegtA26933 (Figure 7.4). VipC has been demonstrated to influence both 
of these biosynthetic pathways (Figure 7.5), and thus may regulate the “cystathionine switch” 
observed in ΔegtA26933. In support of this, cystathionine γ-lyase (CGL; AFUA_8G04340) had a 
log2 -2.03 fold decrease in ΔvipC
26933
 compared to ATCC26933. CGL catalyses the conversion 
of cystathionine into cysteine, α-ketobutyrate, and ammonia (Ravanel, 1997). This is the 
opposite reaction to CGS, which is absent in ΔegtA26933 compared to ATCC26933 under basal 
conditions. Thus, VipC appears to controls the direction of cystathionine metabolism via 
regulation of enzymes catalysing its biosynthesis and catabolism. 
ΔegtA26933 demonstrated disruption to conidiation and cell wall biosynthesis, supported by LFQ 
proteomic data.  While ΔvipC26933 did not display any alteration in conidiation, the increased 
growth phenotype observed would require a concurrent increase in cell wall biosynthesis. LFQ 
proteomic data for ΔvipC26933 suggests increased abundance of VipC in ΔegtA26933 may have 
influenced the alterations in conidiation and cell wall biosynthesis observed. Specifically, SomA, 
Rho1 and Rho3, which had increased abundance in ΔvipC26933, have been demonstrated to 
regulate conidiation and/or cell wall biosynthesis. SomA is an important regulator of asexual 
development in A. fumigatus, regulating key developmental proteins such as brlA, medA, stuA 
and flbA (Lin et al., 2015). Rho1 participates in CWI signalling and conditional downregulation 
of rho1 resulted in reduced conidiation (Dichtl et al., 2010, 2012). Rho3 is also predicted to be 
involved in CWI signalling (Dichtl et al., 2010). Additionally, conidial hydrophobin RodB, 
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absent in ΔegtA26933, had a log2 -5.22 fold decrease in abundance.  Thus, VipC may influence 
conidiation and cell wall biosynthesis, even though no phenotype for conidiation reported in 
ΔvipC26933. It could be that absence of VipC does not result in a phenotype, but increased 
expression, as observed in ΔegtA26933 does.  If this was the case, increase abundance of VipC in 
ΔegtA26933 may be linked to the conidiation and cell wall phenotypes observed. Proposed 
mechanisms for the role of VipC in regulation of cell wall biosynthesis and conidiation are 
outlined in Figures 7.6 and 7.7 respectively. 
 
Figure 7.6. Proposed role for VipC in regulation of cell wall biosynthesis in A. fumigatus. Image 
modified from Ditchl et al. (2010). (A) In wild-type A. fumigatus, VipC negatively regulates Rho 
GTPases Rho1 and Rho3, which in turn regulate organisation of the actin cytoskeleton and CWI 
signalling. (B) In ΔvipC26933, absence of VipC leads to increased abundance of Rho1 and Rho3, 
as observed in LFQ proteomic analysis. Increased abundance of Rho1 and Rho3 results in 
positive regulation of the actin cystoskeleton and CWI signalling, which facilitates increased 
growth levels as observed. (C) In ΔegtA26933, VipC has increased abundance. This may lead to 
increased negative regulation of Rho1 and Rho3, resulting in disruption to the actin cytoskeleton 
and CWI signalling (Mkk2, a component of the CWI pathway, is absent in ΔegtA26933 compared 
to ATCC26933). This could explain the observed sensitivity to congo red and calcofluor white in 
ΔegtA26933. 
305 
 
 
Figure 7.7. Proposed role for VipC in regulation of conidiation in A. fumigatus. Image modified 
from Mah and Yu (2005), Sheppard et al. (2005) and Alkhayyat et al. (2015). (A) In wild-type, 
VipC contributes to regulation of conidiation via repression of the upstream regulator SomA. (B) 
In ΔvipC26933, absence of VipC results in increased abundance of SomA. However no discernible 
effect on conidiation was observed in ΔvipC26933. (C) Increased abundance of VipC in ΔegtA26933 
may result in increased repression of SomA. This would have impact downstream proteins, as 
observed by the absence of FluG and FlbA in ΔegtA26933 compared to ATCC26933. This results 
in reduced levels of conidiation, as observed. 
306 
 
Of interest, EgtB had a log2 -1.35 fold decrease in abundance in ΔvipC compared to 
ATCC26933. This would suggest at alterations to EGT biosynthesis in ΔvipC26933, however no 
significant difference in the levels of EGT was detected in ΔvipC26933 compared to ATCC26933. 
As discussed previously, while EgtB contributes to EGT biosynthesis, it is not essential for EGT 
production. It could be that through regulating EgtB levels, VipC only “fine-tunes” EGT levels 
in A. fumigatus and loss of VipC, therefore, does not lead to a significant change. Relevantly, it 
was speculated that increased abundance of CBL in ΔegtA26933 may be part of a shift towards 
increased SAM production in order to attempt EGT biosynthesis. Increased abundance of VipC 
may control that metabolic shift via control of the “cystathionine switch” as discussed previously 
and also through regulation of EgtB. 
This data indicates that increased abundance in VipC in ΔegtA26933, under both basal and ROS 
conditions, is responsible for many of the differences noted in ΔegtA26933 compared to 
ATCC26933 on both a phenotypic and proteomic level. VipC may therefore regulate the A. 
fumigatus response in adapting to EGT absence by regulating metabolic changes to order to 
maintain redox homeostasis in ΔegtA26933. This suggests that VipC function in A. fumigatus 
revolves around regulating metabolism in response to the changing environment of the cell. This 
is a completely novel role for VipC that has never been described before and was not reported in 
the study of A. fumigatus VipC by Elgabbar and Han (2015). 
7.8  Conclusion 
In summary, this thesis presents the first identification of an EGT biosynthetic pathway and the 
first characterisation of EGT function in A. fumigatus. EGT functions as an antioxidant in A. 
fumigatus and is important for detoxifying high levels of ROS. Deletion of egtA led to significant 
proteomic remodelling and caused a metabolic shift that resulted in increased levels of GSH and 
decreased levels of gliotoxin. EGT was thus demonstrated to play an important role in balancing 
GSH and gliotoxin biosynthesis. EGT absence also affected other systems, with conidiation and 
cell wall biosynthesis demonstrated to be altered in ΔegtA26933 compared to ATCC26933. It was 
hypothesised that through the management of ROS levels, EGT acts to regulate these processes. 
This thesis also presents the first functional characterisation of the methyltransferase VipC. VipC 
was demonstrated to influence growth, development and metabolism in A. fumigatus and appears 
to play a key role in regulating the metabolic response to EGT absence. 
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9.1  Appendix 1 
Table 9.1: Proteins with significant log2 fold change or unique/absent in A. fumigatus ∆egtA
26933
 compared to ATCC26933 under 
basal conditions. Data sorted by fold change, in descending order. 
Protein Description 
Present/log2 
(Fold Change) p value Peptides 
Sequence 
coverage [%] Protein IDs 
Uncharacterized protein Unique n/a 2 2.9 AFUA_1G16010 
HAD superfamily hydrolase, putative Unique n/a 5 15.5 AFUA_2G02580 
Bax Inhibitor family protein Unique n/a 2 8.5 AFUA_5G09310 
CaaX farnesyltransferase beta subunit Ram1 Unique n/a 4 12.9 AFUA_4G10330 
phenylalanine ammonia-lyase 2.70643 0.000689 26 52.8 AFUA_2G09110 
tRNA dihydrouridine synthase 1.53089 0.014702 10 22.6 AFUA_1G14770 
Endo alpha-1,4 polygalactosaminidase, putative 1.48557 0.030844 4 23 AFUA_3G07890 
2-dehydropantoate 2-reductase 1.48361 0.018129 5 16.7 AFUA_4G13960 
WD repeat-containing protein jip5 1.42535 0.049898 7 26.9 AFUA_6G07080 
Uncharacterized protein 1.33556 0.00468 11 42.2 AFUA_3G09110 
Polyadenylation factor subunit CstF64, putative 1.30692 0.02093 5 21.3 AFUA_2G09100 
Methyltransferase SirN-like, putative 1.28453 0.020655 19 76 AFUA_8G00550 
Methyltransferase LaeA-like, putative (VipC) 1.22923 0.015225 6 13.8 AFUA_8G01930 
Sulfhydryl oxidase 1.22122 0.008832 7 37.3 AFUA_3G08850 
GDSL Lipase/Acylhydrolase family protein 1.21561 0.026784 5 32.3 AFUA_2G08920 
Uncharacterized protein 1.20463 0.005663 2 9.1 AFUA_1G11480 
1,3-beta-glucanosyltransferase 1.17592 0.006731 4 8.8 AFUA_8G02130 
Lysine decarboxylase-like protein 1.11025 0.000385 7 29.2 AFUA_6G04800 
Oxidoreductase, 2OG-Fe(II) oxygenase family 1.10977 0.018011 16 58.7 AFUA_1G01000 
60S ribosomal protein L44 1.10977 0.006855 4 12 AFUA_2G08130 
YjgH family protein 1.10359 0.024331 7 56.3 AFUA_3G02253 
Zinc-binding alcohol dehydrogenase, putative 1.05598 0.000562 20 75.6 AFUA_8G02430 
Uncharacterized protein 1.05039 0.004103 3 50.6 AFUA_3G14660 
Profilin 1.04314 0.003378 8 71.3 AFUA_4G03050 
40S ribosomal protein S25, putative 1.03637 0.016534 5 32.3 AFUA_1G16523 
Glutathione S-transferase, putative 1.02663 0.015653 12 53.2 AFUA_2G00590 
Small nuclear ribonucleoprotein SmB, putative -1.00329 0.004928 6 25.2 AFUA_4G07740 
Oxidoreductase, short chain dehydrogenase/reductase family -1.0044 0.00741 13 86.4 AFUA_5G14000 
Cytochrome P450 monooxygenase, putative -1.01068 0.030958 15 34.7 AFUA_6G02210 
Uncharacterized protein -1.03003 0.009562 11 30.5 AFUA_3G02430 
Putative uncharacterized protein -1.05502 0.011856 4 31.3 AFUA_1G07430 
Alpha-1,4 glucan phosphorylase -1.05664 0.037906 14 23.2 AFUA_1G12920 
5-oxo-L-prolinase, putative -1.08559 0.000788 65 63.9 AFUA_6G14330 
Isoflavone reductase family protein (Oxidoreductase activty)  -1.09131 0.021158 13 57 AFUA_1G12510 
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Mitochondrial protein, putative -1.13605 0.000355 8 55.9 AFUA_6G08630 
Tripeptidyl-peptidase sed2 -1.15094 0.003075 14 34.6 AFUA_4G03490 
ATP dependent RNA helicase (Dob1), putative -1.20061 0.016778 14 19.1 AFUA_4G07160 
50S ribosomal protein L30, putative -1.20395 0.000141 5 52.1 AFUA_4G10480 
Mitochondrial enoyl reductase, putative -1.23179 0.001484 17 61.8 AFUA_3G03330 
Pyruvate decarboxylase, putative -1.23973 0.003236 12 37.2 AFUA_6G00750 
Protein arginine N-methyltransferase -1.26534 0.005959 14 24.1 AFUA_5G11610 
Glutathione S-transferase, putative -1.32809 0.006247 13 59.8 AFUA_4G14380 
Isochorismatase family hydrolase, putative -1.35348 0.000708 8 44.5 AFUB_024850 
Cyanamide hydratase, putative -1.5086 0.000348 10 59.8 AFUA_7G06270 
RWD domain protein (Gir2), putative -1.5132 0.027459 5 24.2 AFUA_4G12100 
Ribonuclease T2-like -1.52431 0.018544 2 5.1 AFUA_3G11220 
Threonine aldolase, putative -1.60586 0.010153 7 28.9 AFUA_7G06540 
Ribosome biogenesis protein (Rrs1), putative -1.62255 0.011722 4 30 AFUA_7G04430 
DNA-directed RNA polymerases i, ii, and iii 145 kDa polypeptide -1.73969 0.017096 2 26.9 AFUA_5G11120 
HypA-like protein, putative -1.902 0.022665 7 14.4 AFUA_5G03330 
Oxidoreductase, zinc-binding dehydrogenase family -2.01615 0.02697 12 61 AFUA_1G15610 
Elongation of fatty acids protein -2.05175 0.013248 4 14 AFUA_5G02760 
Coatomer subunit epsilon, putative -2.15529 0.012902 6 58 AFUA_1G13260 
Importin beta-5 subunit, putative -2.26175 0.006274 16 24.6 AFUA_2G15870 
High expression lethality protein Hel10, putative -3.18792 0.001458 4 39.1 AFUA_1G06580 
GTP:AMP phosphotransferase, mitochondrial Absent n/a 4 25.1 AFUA_1G03420 
CCAAT-binding factor complex subunit HapC Absent n/a 3 23.8 AFUA_1G03840 
Tartrate dehydrogenase, putative Absent n/a 6 22.3 AFUA_1G04150 
Protein vts1 Absent n/a 5 11.1 AFUA_1G04990 
MAP kinase kinase (Mkk2), putative Absent n/a 2 5.8 AFUA_1G05800 
Golgi phosphoprotein 3 (GPP34) domain containing protein Absent n/a 7 35.1 AFUA_1G06630 
Protein O-mannosyl transferase (PMT2) Absent n/a 3 4.1 AFUA_1G07690 
Ankyrin repeat protein Absent n/a 4 30.1 AFUA_1G09700 
Uncharacterized protein Absent n/a 12 14.3 AFUA_1G10400 
Mitochondrial dynamin GTPase (Msp1), putative Absent n/a 8 11.3 AFUA_1G11970 
Protein translocation complex componenet (Npl1), putative Absent n/a 8 15.8 AFUA_1G14940 
Uncharacterized protein Absent n/a 6 16.4 AFUA_1G15830 
Aminotransferase, class III Absent n/a 8 30.7 AFUA_1G16810 
Conidial hydrophobin RodB Absent n/a 5 67.9 AFUA_1G17250 
1-aminocyclopropane-1-carboxylate deaminase, putative Absent n/a 8 33.4 AFUA_2G01030 
Prefoldin subunit 3, putative Absent n/a 5 35.2 AFUA_2G02230 
Mitochondrial import inner membrane translocase subunit tim14 Absent n/a 2 17.1 AFUA_2G02700 
Histone deacetylase RpdA/Rpd3 Absent n/a 5 9.3 AFUA_2G03390 
Uridine kinase Absent n/a 7 18.5 AFUA_2G05430 
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NADH-ubiquinone oxidoreductase 64 kDa subunit, putative Absent n/a 6 11.4 AFUA_2G05450 
Pre-mRNA-splicing factor cef1 Absent n/a 9 15.2 AFUA_2G05540 
Rho GTPase ModA, putative Absent n/a 3 15.1 AFUA_2G05740 
Glutamate 5-kinase, putative Absent n/a 6 23 AFUA_2G07570 
Folic acid synthesis protein Absent n/a 6 16.5 AFUA_2G09840 
NOT2 family protein Absent n/a 6 13 AFUA_2G11130 
Developmental regulator FlbA Absent n/a 9 17.8 AFUA_2G11180 
Pre-rRNA processing protein Tsr1, putative Absent n/a 9 17.9 AFUA_2G12880 
Chromosome segregation protein SudA, putative Absent n/a 10 10.5 AFUA_2G14080 
Nuclear cohesin complex subunit (Psc3), putative Absent n/a 7 7.4 AFUA_2G16080 
DNA-directed RNA polymerase III RPC4, putative Absent n/a 3 6.2 AFUA_2G16170 
Amino acid transporter, putative Absent n/a 4 8.2 AFUA_2G17790 
FAD-dependent oxygenase, putative Absent n/a 4 10.3 AFUA_3G00840 
Chitin synthase activator (Chs3), putative Absent n/a 7 16.1 AFUA_3G05580 
Exosome complex exonuclease Rrp4, putative Absent n/a 4 16.4 AFUA_3G05860 
Pre-mRNA splicing factor, putative Absent n/a 6 14.7 AFUA_3G06440 
NIPSNAP family protein Absent n/a 8 29.6 AFUA_3G06660 
COP9 signalosome subunit 2 (CsnB), putative Absent n/a 6 15.7 AFUA_3G06700 
Extracellular developmental signal biosynthesis protein FluG Absent n/a 8 15.8 AFUA_3G07140 
Transcription elongation factor S-II Absent n/a 5 22 AFUA_3G07670 
PX domain protein Absent n/a 7 7.6 AFUA_3G08020 
Cell wall protein, putative Absent n/a 2 2.9 AFUA_3G08110 
Uncharacterized protein Absent n/a 4 49.1 AFUA_3G08370 
Glycine-rich RNA-binding protein, putative Absent n/a 3 45.8 AFUA_3G08580 
Cell wall glucanase, putative Absent n/a 3 8 AFUA_3G09250 
ADP-ribosylation factor 6, putative Absent n/a 6 53.8 AFUA_3G12080 
Enoyl-CoA hydratase/isomerase family protein Absent n/a 4 15.1 AFUA_3G14520 
Uncharacterized protein Absent n/a 4 16.8 AFUA_3G15010 
Uncharacterized protein Absent n/a 2 6.8 AFUA_4G03890 
Uncharacterized protein Absent n/a 4 12.6 AFUA_4G03990 
Uncharacterized protein Absent n/a 2 15.1 AFUA_4G06220 
Ribosome biogenesis protein ytm1 Absent n/a 10 35.2 AFUA_4G07630 
CaaX farnesyltransferase alpha subunit Ram2 Absent n/a 4 15.9 AFUA_4G07800 
Probable 4-hydroxyphenylpyruvate dioxygenase 2 Absent n/a 6 24.1 AFUA_4G10620 
DlpA domain protein Absent n/a 5 27 AFUA_4G10940 
Proteasome activator subunit 4, putative Absent n/a 18 12.5 AFUA_4G11290 
C6 finger domain protein, putative Absent n/a 7 15.5 AFUA_4G11850 
Nitrilase, putitive Absent n/a 6 35 AFUA_4G12240 
COP9 signalosome subunit 7 (CsnG), putative Absent n/a 5 28 AFUA_4G12630 
Citrate lyase beta subunit, putative Absent n/a 6 24.2 AFUA_4G13030 
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ATP-dependent RNA helicase has1 Absent n/a 8 14.8 AFUA_4G13330 
Carboxypeptidase S1, putative Absent n/a 4 10.2 AFUA_5G01200 
DUF455 domain protein Absent n/a 5 6.1 AFUA_5G01840 
Glycogen synthase Gsy1, putative Absent n/a 6 9 AFUA_5G02480 
Protein phosphatase regulatory subunit (Ssc1), putative Absent n/a 6 10.7 AFUA_5G02560 
GTP cyclohydrolase I, putative Absent n/a 6 16.8 AFUA_5G03140 
Translation initiation factor eIF4E3, putative Absent n/a 3 13.3 AFUA_5G03180 
RNA polymerase II transcription elongation factor (Ctr9), putative Absent n/a 9 10.5 AFUA_5G05870 
Uncharacterized protein Absent n/a 3 20.2 AFUA_5G08100 
Cytochrome c oxidase assembly protein (Pet191), putative Absent n/a 2 26.5 AFUA_5G08965 
Sec1 family superfamily Absent n/a 8 16.5 AFUA_5G10810 
Uncharacterized protein Absent n/a 4 43.9 AFUA_5G12325 
U6 small nuclear ribonucleoprotein (Lsm3), putative Absent n/a 3 74.7 AFUA_5G12570 
Uncharacterized protein Absent n/a 5 17.2 AFUA_5G14865 
Uncharacterized protein Absent n/a 2 15.3 AFUA_6G02800 
FAD dependent oxidoreductase, putative Absent n/a 7 27.2 AFUA_6G04220 
RNA polymerase II Elongator subunit, putative Absent n/a 8 14.4 AFUA_6G05090 
Uncharacterized protein Absent n/a 6 49.4 AFUA_6G08070 
Mitochondrial intermediate peptidase Absent n/a 7 9.6 AFUA_6G08640 
Uncharacterized protein Absent n/a 3 15.2 AFUA_6G09030 
Uncharacterized protein Absent n/a 4 16 AFUA_6G09090 
Gliotoxin oxidoreductase GliT Absent n/a 9 43.4 AFUA_6G09740 
Dynamin GTPase, putative Absent n/a 7 12.4 AFUA_6G11890 
TPR repeat protein Absent n/a 6 22 AFUA_6G13600 
Cystathionine gamma-synthase Absent n/a 7 30.6 AFUA_7G01590 
Nuclear pore complex subunit Nup85, putative Absent n/a 8 10.7 AFUA_7G01940 
Mitochondrial molecular chaperone (Atp12), putative Absent n/a 7 27.2 AFUA_7G02490 
Guanyl-nucleotide exchange factor (Sec7), putative Absent n/a 18 12.6 AFUA_7G05700 
Cytochrome P450 oxidoreductase OrdA-like, putative Absent n/a 5 11.9 AFUA_8G00510 
Mannosyltransferase PMT4 Absent n/a 3 5.4 AFUA_8G04500 
Pirin, putative Absent n/a 6 33.4 AFUA_8G04510 
COP9 signalosome subunit 1 (CsnA), putative Absent n/a 3 12.7 AFUA_8G04880 
Integral membrane protein, putative Absent n/a 2 15.3 AFUA_8G07235 
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9.2  Appendix 2 
Table 9.2. Proteins with significant log2 fold change or unique/absent in A. fumigatus ∆egtA
26933
 compared to ATCC26933 under 
oxidative stress conditions. Data sorted by fold change, in descending order. 
Protein Description 
Present/log2 
(Fold Change) p value Peptides 
Sequence 
coverage [%] Protein IDs 
GrpB domain protein Unique n/a 2 24.2 AFUA_1G01530 
Ubiquitin carboxyl-terminal hydrolase Unique n/a 4 4.9 AFUA_1G07160 
Pre-mRNA-processing ATP-dependent RNA helicase prp5 Unique n/a 2 2.4 AFUA_1G10050 
Transcriptional elongation factor Iws1, putative Unique n/a 4 13 AFUA_1G12260 
37S ribosomal protein Rsm22 Unique n/a 3 4.1 AFUA_2G02290 
Chromosome segregation protein SudA, putative Unique n/a 7 7.9 AFUA_2G14080 
Autophagy protein Atg20, putative Unique n/a 3 7.5 AFUA_2G14160 
Epoxide hydrolase, putative Unique n/a 4 19 AFUA_2G16900 
Uncharacterized protein Unique n/a 5 7.3 AFUA_2G17200 
Septin Unique n/a 4 6.5 AFUA_3G07015 
Uncharacterized protein Unique n/a 3 6.2 AFUA_3G08240 
Protein kinase Yak1, putative Unique n/a 4 5.5 AFUA_4G03850 
Chromatin modification-related protein eaf3 Unique n/a 4 16.1 AFUA_4G10660 
Splicing factor 3a subunit 3, putative Unique n/a 2 2.8 AFUA_5G02420 
DnaJ chaperone (Caj1), putative Unique n/a 1 6.4 AFUA_6G06590 
Actin binding protein, putative Unique n/a 2 9.6 AFUA_6G07150 
Putative uncharacterized protein Unique n/a 3 4.7 AFUA_3G13465 
Zinc-binding oxidoreductase CipB Unique n/a 6 28.8 AFUA_4G00700 
HD superfamily hydrolase, putative Unique n/a 2 11.9 AFUA_1G03035 
BAG domain protein Unique n/a 3 17 AFUA_1G06080 
Golgi phosphoprotein 3 (GPP34) domain containing protein Unique n/a 5 25.8 AFUA_1G06630 
Uncharacterized protein Unique n/a 2 2.9 AFUA_1G16010 
Flavin containing amine oxidase, putative Unique n/a 3 9.3 AFUA_3G12150 
Uncharacterized protein Unique n/a 3 10.4 AFUA_4G09260 
ABC multidrug transporter, putative Unique n/a 1 0.5 AFUA_5G00790 
Nuclear condensin complex subunit 3, putative Unique n/a 1 1.2 AFUA_5G02170 
Pre-mRNA-splicing factor syf1 Unique n/a 4 8.5 AFUA_5G11910 
Putative uncharacterized protein Unique n/a 2 3.5 AFUA_1G16020 
Nuclear export protein Noc3 Unique n/a 2 3.2 AFUA_2G17050 
RNA Polymerase II CTD phosphatase Fcp1, putative Unique n/a 1 1.8 AFUA_3G11410 
Uncharacterized protein Unique n/a 2 2.6 AFUA_3G13300 
Small nucleolar ribonucleoprotein complex subunit, putative Unique n/a 3 6.2 AFUA_4G07500 
Cytochrome P450, putative Unique n/a 1 4 AFUA_5G01360 
Alpha-1,2-mannosyltransferase (Alg2), putative Unique n/a 1 4.3 AFUA_5G13210 
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Mitochondrial intermediate peptidase Unique n/a 3 5.7 AFUA_6G08640 
Noc1p protein, putative Unique n/a 2 4.6 AFUA_8G04660 
IQ and HECT domain protein Unique n/a 4 5 AFUA_1G04210 
TIM-barrel enzyme family protein 5.92033 0.000472 3 18.6 AFUA_1G10110 
Uncharacterized protein 5.87209 0.032885 2 9.1 AFUA_4G06410 
COP9 signalosome complex subunit 5 5.0354 0.001582 4 11.7 AFUA_2G16250 
Steroid alpha reductase family protein 4.61499 0.00464 5 21.2 AFUA_4G10760 
3-ketosteroid reductase 4.49051 0.003899 7 21.6 AFUA_4G11500 
NADPH-dependent FMN reductase Lot6, putative 4.40163 0.00432 8 69.2 AFUA_7G06600 
Small nuclear ribonucleoprotein SmD2, putative 4.21148 0.011957 3 40.2 AFUA_5G12910 
WD repeat protein 4.09183 0.001544 8 12.7 AFUA_5G11870 
Oligosaccharyl transferase subunit (Gamma), putative 4.00277 0.038989 4 22.5 AFUA_2G06280 
Calcium homeostasis protein Regucalcin, putative 3.97213 0.001059 6 20.6 AFUA_4G08610 
Asparaginyl-tRNA synthetase Slm5, putative 3.92433 0.003895 6 18.2 AFUA_3G09630 
Glycogen branching enzyme GbeA, putative 3.86537 0.037875 5 11.2 AFUA_5G10540 
tRNA (adenine(58)-N(1))-methyltransferase non-catalytic subunit trm6 3.77874 0.00946 6 17.7 AFUA_5G01850 
Phenylalanine ammonia-lyase 3.72865 0.020255 26 55.8 AFUA_2G09110 
BET3 family protein 3.71531 0.007944 3 12 AFUA_5G12880 
Mitochondrial ATPase (Afg1), putative 3.67003 0.035905 6 16.2 AFUA_4G04130 
WD repeat-containing protein jip5 3.66549 0.033602 5 18.8 AFUA_6G07080 
Nucleoside-diphosphate-sugar epimerase family protein 3.62394 0.035036 5 24.1 AFUA_6G11740 
Pyridoxal kinase, putative 3.61996 0.007665 7 34.6 AFUA_1G02900 
Translation regulator GCD7 3.55368 0.00112 7 24.6 AFUA_1G09450 
SNARE-dependent exocytosis protein (Sro7), putative 3.4968 0.034112 10 15.6 AFUA_3G11040 
Thiamin pyrophosphokinase, putative 3.43252 0.026301 4 12.2 AFUA_1G01830 
Rho GTPase activator (Rgd1), putative 3.40581 0.023563 6 15.7 AFUA_3G06280 
Kynureninase 1 3.39219 0.004419 12 34 AFUA_2G10360 
Exosome complex subunit Csl4, putative 3.35962 0.016873 4 26.9 AFUA_5G13530 
NmrA-like family protein 3.19014 0.010049 8 44.7 AFUA_6G00280 
Uncharacterized protein 3.17489 0.011677 8 11.1 AFUA_1G14500 
Hexokinase family protein XprF, putative 3.15965 0.008759 7 13 AFUA_2G15700 
Cystathionine beta-lyase MetG 3.09553 0.035534 8 32.5 AFUA_4G03950 
C6 finger domain protein, putative 3.04109 0.039396 5 8.5 AFUA_6G07800 
Uncharacterized protein 3.01403 0.001047 8 26.1 AFUA_4G11990 
PAP2 domain protein 3.00705 0.000123 3 9.7 AFUA_4G08970 
Pre-mRNA splicing factor, putative 2.95321 0.00563 3 7.1 AFUA_3G06440 
RNA polymerase II transcription elongation factor (Ctr9), putative 2.91844 0.009561 10 12.6 AFUA_5G05870 
GDSL Lipase/Acylhydrolase family protein 2.91671 0.020083 3 19.6 AFUA_2G08920 
Hsp70 nucleotide exchange factor fes1 2.91037 0.015253 11 67.1 AFUA_6G04750 
HMG box protein, putative 2.90121 0.004952 7 41.4 AFUA_1G04550 
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Uncharacterized protein 2.89507 0.007283 3 22.9 AFUA_1G00760 
Oxidoreductase, 2OG-Fe(II) oxygenase family 2.88667 0.002938 18 60 AFUA_1G01000 
Ankyrin repeat protein (Yar1), putative 2.8775 0.033214 5 35.7 AFUA_5G09560 
Short chain dehydrogenase family protein 2.87187 0.011169 6 23 AFUA_1G16630 
CsgA-like short chain dehydrogenase/reductase, putative 2.86184 0.046537 6 62.8 AFUB_075540 
Heat shock protein Hsp30-like, putative 2.85856 0.043402 7 52.3 AFUA_6G06470 
Small nuclear ribonucleoprotein SmE, putative 2.85356 0.04101 6 54.7 AFUA_7G05980 
Isoleucyl-tRNA synthetase, putative 2.83275 0.023614 5 8.4 AFUA_7G01420 
DSB repair complex subunit Ku70, putative 2.76057 0.014473 9 17.1 AFUA_5G07740 
50S ribosomal subunit L7, putative 2.75017 0.016585 14 57.2 AFUA_5G06430 
ATP-dependent RNA helicase fal1 2.73637 0.038245 19 40.2 AFUA_5G02410 
Splicing factor 3B subunit 1, putative 2.73212 0.018136 11 14.3 AFUA_2G13780 
Developmental regulator FlbA 2.72199 0.014741 12 21.5 AFUA_2G11180 
uncharacterized protein 2.70833 0.015402 3 3.6 AFUA_2G08660 
U-box domain protein, putative 2.69522 0.00639 9 46.1 AFUA_2G11040 
WW domain protein 2.65057 0.024386 7 9.2 AFUA_6G06520 
O-methyltransferase, putative 2.64354 0.005237 10 53.2 AFUA_6G01830 
NifU-related protein 2.62307 0.048628 7 44.8 AFUA_1G04680 
Aromatic-L-amino-acid decarboxylase, putative 2.60669 0.002154 19 36.3 AFUA_3G02240 
Acid phosphatase, putative 2.60623 0.049938 5 25.3 AFUA_4G01070 
RNA exonuclease Rex2, putative 2.59105 0.000845 5 30.4 AFUA_3G11820 
Transcription initiation factor TFIID, 31kD subunit, putative 2.58688 0.016378 3 17.3 AFUA_1G14600 
Flavin-binding monooxygenase-like protein 2.56424 0.027902 8 21.2 AFUA_6G01900 
Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 
subunit WBP1 2.53911 0.029135 13 32.9 AFUA_5G08970 
Serine/threonine protein kinase, putative 2.53288 0.026905 9 20.2 AFUA_4G11890 
BAR adaptor protein RVS161, putative 2.53092 0.004572 12 49.8 AFUA_5G05950 
DUF567 domain protein 2.51696 0.036334 7 40.1 AFUA_8G05720 
Ortholog(s) have cytochrome-c oxidase activity, role in aerobic 
respiration, mitochondrial electron transport, cytochrome c to oxygen 
and mitochondrial respiratory chain complex IV localization 2.50787 0.028945 5 21.3 AFUA_Mt00120 
Methyltransferase LaeA-like, putative (VipC) 2.49862 0.000127 9 21.5 AFUA_8G01930 
60S ribosomal protein L3 2.48244 0.01963 12 50.4 AFUA_1G12730 
Zinc-binding alcohol dehydrogenase, putative 2.48156 0.001253 21 77.3 AFUA_8G02430 
Uncharacterized protein 2.48149 0.046452 5 8.8 AFUA_5G08450 
Acetyltransferase, GNAT family, putative 2.46315 0.020592 3 20.3 AFUA_4G02980 
Short-chain dehydrogenase, putative 2.45341 0.019904 7 29.3 AFUA_8G00280 
Alpha-amylase, putative 2.45109 0.009808 6 19.8 AFUA_3G00900 
Transcription elongation factor S-II 2.44125 0.005319 3 13.2 AFUA_3G07670 
Vacuolar targeting protein Atg24, putative 2.44043 0.027605 7 19.7 AFUA_4G12950 
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Mitochondrial DnaJ chaperone (Mdj1), putative 2.43118 0.013723 5 16.2 AFUA_2G11750 
Calcineurin binding protein, putative 2.41938 0.010398 5 19.1 AFUA_2G13060 
Nonsense-mediated mRNA decay protein 3 2.37081 0.000358 4 7.3 AFUA_2G16750 
Myo-inositol-1(Or 4)-monophosphatase 2.36977 0.037423 6 29.1 AFUA_4G04200 
O-methyltransferase, putative 2.36381 0.038931 13 66.7 AFUB_096510 
Uncharacterized protein 2.35526 0.000228 7 7.9 AFUA_2G08640 
Alpha-1,3-glucan synthase Ags1 2.32836 0.042328 4 2.6 AFUA_3G00910 
Thioesterase family protein 2.32798 0.030021 5 23.5 AFUA_1G10800 
Kinesin family protein 2.28591 0.031839 8 24.1 AFUA_1G01640 
Golgi to endosome transport protein (Ent3), putative 2.28077 0.016134 10 32 AFUA_2G03650 
Dynein light chain (Tctex1), putative 2.27221 0.014268 7 61.5 AFUA_1G09550 
Uncharacterized protein 2.25293 0.039784 3 12.6 AFUA_4G07030 
Uncharacterized protein 2.23964 0.033311 6 46.7 AFUA_3G07740 
Sulfite reductase, putative 2.22575 0.003046 35 31.2 AFUA_2G15590 
NADH-ubiquinone oxidoreductase subunit GRIM-19, putative 2.20179 0.038593 4 34.6 AFUA_3G08770 
Translation initiation factor IF3, putative 2.17014 0.03893 4 11.2 AFUA_1G12160 
Choline sulfatase, putative 2.16137 0.049261 15 39.4 AFUA_6G13440 
uncharacterized protein 2.12057 0.037434 3 3.9 AFUA_6G03025 
Stomatin family protein 2.07913 0.019136 14 49 AFUA_1G09780 
KH domain RNA binding protein 2.07516 0.026911 16 53.7 AFUA_2G04940 
Mitochondrial carrier protein, putative 2.0702 0.017636 5 31.9 AFUA_6G12550 
Importin beta-3 subunit, putative 2.0596 0.002819 39 54.6 AFUA_1G06790 
Class V chitinase, putative 2.04796 0.025086 14 56.8 AFUA_3G11280 
Proteasome regulatory particle subunit (RpnE), putative 2.04714 0.004918 29 62.4 AFUA_3G06610 
40S ribosomal protein S10a 2.04549 0.016185 7 50 AFUA_2G02150 
Histone H2B 2.02733 0.014674 6 33.6 AFUA_3G05350 
Aflatoxin B1-aldehyde reductase GliO-like, putative 2.01845 0.049263 13 48.3 AFUA_1G13370 
Uridine nucleosidase Urh1, putative 1.97912 0.019106 5 22.9 AFUA_1G05530 
Aspartic protease pep1 1.9734 0.034066 7 26.6 AFUA_5G13300 
T-complex protein 1, zeta subunit, putative 1.94269 0.007998 30 74.1 AFUA_3G09590 
AN1 zinc finger protein 1.91664 0.022847 3 11.2 AFUA_4G04280 
DUF255 domain protein 1.88685 0.041084 12 20.8 AFUA_1G12370 
40S ribosomal protein S13 1.87422 0.009102 5 26.6 AFUA_4G07640 
Cytosine deaminase-uracil phosphoribosyltransferase fusion protein 1.86909 0.009581 11 49.6 AFUA_5G05460 
TAM domain methyltransferase, putative 1.85912 0.018744 4 17.2 AFUA_2G15860 
Polyketide synthase, putative 1.84371 0.002937 60 36.3 AFUA_1G01010 
Glutaryl-CoA dehydrogenase, putative 1.83794 0.007301 10 41.1 AFUA_3G06040 
COP9 signalosome subunit 1 (CsnA), putative 1.82649 0.032548 4 14.7 AFUA_8G04880 
2-dehydropantoate 2-reductase 1.80192 0.041835 4 16.1 AFUA_3G00740 
HAD superfamily hydrolase, putative 1.79199 0.02004 14 73.5 AFUA_6G10760 
338 
 
Heat shock protein Hsp98/Hsp104/ClpA, putative 1.77987 0.004247 54 53 AFUA_1G15270 
Ubiquitin carboxyl-terminal hydrolase 1.76662 0.015637 15 85.2 AFUA_2G05590 
Aspartyl aminopeptidase 1.75773 0.002988 20 56.7 AFUA_3G08290 
General amidase, putative 1.74267 0.026522 9 23.1 AFUA_4G00370 
COP9 signalosome subunit 8 (CsnH), putative 1.73581 0.037207 1 10.2 AFUA_8G04440 
Kynurenine 3-monooxygenase 1.73399 0.029138 12 34.4 AFUA_6G07340 
L-PSP endoribonuclease family protein, putative 1.71522 0.004075 3 22.7 AFUA_2G17470 
Thioesterase family protein 1.68023 0.010773 5 32.2 AFUA_7G03960 
NUDIX domain, putative 1.66635 0.008172 5 32.9 AFUA_5G13840 
Alanine racemase family protein, putative 1.66134 0.020917 13 62.2 AFUA_4G04300 
60S ribosomal protein L25, putative 1.65806 0.015796 7 47.7 AFUA_4G09000 
Vacuolar ATP synthase catalytic subunit A, putative 1.65689 0.018725 40 63.8 AFUA_5G02370 
Uncharacterized protein 1.6496 0.019697 2 7.2 AFUA_6G14120 
Uncharacterized protein 1.64845 0.04011 5 34.4 AFUA_5G06960 
Purple acid phosphatase 1.64701 0.040466 2 5.4 AFUA_5G01330 
Pentafunctional AROM polypeptide 1.63777 9.59E-05 52 49.2 AFUA_1G13740 
Glutamyl-tRNA synthetase 1.63324 0.000912 46 69.4 AFUA_5G03560 
Cell wall integrity signaling protein Lsp1/Pil1, putative 1.63067 0.008446 10 41.5 AFUA_6G07520 
40S ribosomal protein S5, putative 1.62899 0.024461 15 60.2 AFUA_1G15020 
2-oxo acid dehydrogenases acyltransferase, putative 1.62889 0.037992 17 46.3 AFUA_4G12010 
Mitochondrial import inner membrane translocase subunit TIM44 1.61088 0.024164 15 31.9 AFUA_1G09840 
Uncharacterized protein 1.60551 0.022517 8 72.6 AFUA_8G00430 
60S ribosomal protein L35Ae 1.59475 0.040963 6 42 AFUA_3G08460 
Small oligopeptide transporter, OPT family 1.58771 0.02923 1 1.5 AFUA_2G15240 
Phosphoinositide phospholipase C 1.57657 0.016158 8 17.9 AFUA_3G07940 
uncharacterized protein 1.57177 0.041712 11 58 AFUA_2G02490 
uncharacterized protein 1.5613 0.002834 4 43.9 AFUA_5G12325 
Arginyl-tRNA synthetase 1.55487 0.000121 50 72.6 AFUA_2G14030 
Hybrid NRPS/PKS enzyme, putative (PsoA) 1.54538 0.028801 45 16.2 AFUA_8G00540 
Ubiquitin-protein ligase (Tom1), putative 1.54369 0.014006 54 17.3 AFUA_4G10780 
Conserved lysine-rich protein, putative 1.5242 0.001805 33 66 AFUA_4G12450 
Mitochondrial Hsp70 chaperone (Ssc70), putative 1.51405 0.024378 51 64.2 AFUA_2G09960 
NADH-ubiquinone oxidoreductase 304 kDa subunit 1.50531 0.043681 16 52.1 AFUA_6G08810 
Synaptobrevin-like protein Sybl1, putative 1.50039 0.021808 4 29.2 AFUA_6G11270 
Calponin homology domain protein 1.49789 0.006881 6 10.6 AFUA_4G13250 
G-protein complex gamma subunit GpgA 1.48694 0.049955 5 52.2 AFUA_1G05210 
Methyltransferase SirN-like, putative 1.47973 0.022785 21 78.2 AFUA_8G00550 
Sister chromatid separation protein (Src1), putative 1.45998 0.027908 5 9.3 AFUA_6G08530 
AhpC/TSA family protein 1.44847 0.014711 11 54.1 AFUA_6G12500 
Ribose phosphate diphosphokinase Prs1, putative 1.44778 0.038843 9 23.3 AFUA_7G05670 
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NADH-dependent flavin oxidoreductase, putative 1.43235 0.030737 33 76.1 AFUA_7G06420 
Pyridoxal reductase (AKR8), putative 1.42837 0.01439 11 38.6 AFUA_1G10270 
Tubulin subunit TubB 1.41187 0.026163 24 69.8 AFUA_2G14990 
Aldehyde reductase (GliO), putative 1.40263 0.017969 28 84.1 AFUA_5G02020 
WD repeat protein 1.40237 0.038759 8 12.5 AFUA_2G04360 
ATP-dependent RNA helicase dbp2 1.39022 0.006535 20 43.5 AFUA_2G10750 
Uncharacterized protein 1.38839 0.039818 2 11.2 AFUA_2G11650 
Glycerol dehydrogenase (GldB), putative 1.37995 0.019009 30 85.5 AFUA_4G11730 
Pre-mRNA-processing protein 45 1.35882 0.029083 2 5.2 AFUA_5G03050 
Mitochondrial ribosomal protein S19, putative 1.35708 0.004164 6 61.7 AFUB_059030 
OPA3 domain protein 1.35389 0.012597 2 5.8 AFUA_8G05670 
Importin beta-1 subunit 1.35372 0.02131 29 53 AFUA_1G15720 
37S ribosomal protein S25, mitochondrial 1.34439 0.02861 14 48.1 AFUA_4G07250 
NRPS-like enzyme, putative 1.33723 0.041076 41 44.1 AFUA_5G10120 
 Amino acid transporter, putative 1.31178 0.039383 3 5.8 AFUA_4G07760 
TPR domain protein 1.29981 0.017062 2 7.2 AFUA_4G12110 
Arsenate reductase (Arc2), putative 1.27464 0.027714 9 63.3 AFUA_6G13400 
Clathrin heavy chain 1.2721 0.013103 79 63.7 AFUA_4G07700 
SnRNP assembly factor, putative 1.26941 0.013025 7 16.8 AFUA_4G07520 
Amino-acid acetyltransferase, mitochondrial 1.2612 0.025429 3 4.7 AFUA_2G11490 
Methionyl-tRNA synthetase 1.2505 0.017722 29 53.9 AFUA_1G09010 
Ribulose-phosphate 3-epimerase 1.24989 0.043566 5 31.6 AFUA_2G15190 
Metallopeptidase family M24, putative 1.2442 0.008232 6 17.3 AFUA_6G09190 
Uncharacterized protein 1.24148 0.04921 4 9.5 AFUA_5G10850 
2-methylcitrate dehydratase, putative 1.23478 0.009205 38 65.2 AFUA_6G03730 
Uncharacterized protein 1.23095 0.038532 2 9.1 AFUA_4G09670 
Glutathione S-transferase, putative 1.2279 0.045908 13 60.8 AFUA_2G00590 
ATP-dependent RNA helicase mrh4, mitochondrial 1.22367 0.024149 3 5.5 AFUA_2G08480 
DNA damage-inducible protein 1 1.21829 0.034152 24 73.8 AFUA_7G06050 
Uncharacterized protein 1.21237 0.018308 2 17.6 AFUA_1G05350 
Proteasome regulatory particle subunit Rpt5, putative 1.19989 0.031911 29 69 AFUA_1G06170 
Uncharacterized protein 1.19715 0.031891 1 25 AFUA_1G12740 
Short chain dehydrogenase/reductase family protein 1.17302 0.024341 13 80.5 AFUA_1G00990 
Fructosamine-3-kinase, putative 1.16272 0.003539 13 47.4 AFUA_1G07040 
DNA topoisomerase 2 1.15761 0.022823 4 3.5 AFUA_6G13690 
Uncharacterized protein 1.15517 0.043732 9 53.3 AFUA_3G10390 
General amidase, putative 1.14363 0.006564 9 23.5 AFUB_100900 
Actin-related protein 2/3 complex subunit 1A, putative 1.14358 0.043581 18 60.1 AFUA_6G06500 
Pyridoxamine phosphate oxidase, putative 1.13607 0.038128 17 52.4 AFUA_5G10650 
GMC oxidoreductase, putative 1.12674 0.01303 28 56 AFUA_3G01580 
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Imidazole glycerol phosphate synthase subunit hisF 1.10807 0.024405 32 74.4 AFUA_2G06230 
Lon protease homolog, mitochondrial 1.10384 0.039972 29 34.7 AFUA_2G11740 
Alanine--tRNA ligase 1.09797 0.048228 56 66.8 AFUA_8G03880 
Uncharacterized protein 1.09239 0.033914 2 34.8 AFUA_4G12220 
YjgH family protein 1.08735 0.008854 8 59.6 AFUA_3G02253 
Clustered mitochondria protein homolog 1.07508 0.009679 52 52.9 AFUA_3G10800 
40S ribosomal protein S10b 1.06593 0.01039 7 47.1 AFUA_6G12660 
Uncharacterized protein 1.04523 0.022485 14 51.2 AFUA_5G09500 
UBX domain protein 1.03996 0.031287 3 7.2 AFUA_3G06360 
Ribosome associated DnaJ chaperone Zuotin, putative 1.03867 0.040415 18 47.8 AFUA_4G03650 
Uncharacterized protein 1.03697 0.046468 29 60 AFUA_3G12690 
DUF636 domain protein 1.03567 0.025099 10 87.5 AFUA_2G15290 
Nucleoporin SONB, putative 1.03057 0.029446 17 12.7 AFUA_4G11070 
Actin cortical patch component, putative 1.02943 0.020218 26 62.6 AFUA_2G06040 
Phosphatidylserine synthase 1.02661 0.007655 1 4.9 AFUA_4G13680 
RNase III domain protein 1.01868 0.023784 6 23.2 AFUA_5G09670 
Protein transport protein sec24 1.01468 0.001738 29 48.6 AFUA_6G12830 
Ribose 5-phosphate isomerase A 1.00722 0.034898 12 47.8 AFUA_6G10610 
37S ribosomal protein Mrp10, mitochondrial 1.00706 0.011891 2 16.8 AFUA_1G04400 
Aldehyde dehydrogenase, putative -1.07759 0.046538 24 53.7 AFUA_2G00720 
Cytochrome B -1.13698 0.017889 2 4.9 AFUA_Mt00001 
Transcriptional elongation regulator Elc1/Elongin C, putative -1.16689 0.012493 2 17.3 AFUA_6G10530 
Trimethyllysine dioxygenase TmlH, putative -1.27237 0.027847 6 25.2 AFUA_1G06180 
Cyclin Ccl1, putative -1.28282 0.029271 2 4.2 AFUA_5G07030 
GDP-mannose pyrophosphorylase A -1.41181 0.011752 17 49.4 AFUA_6G07620 
uncharacterized protein -1.4512 0.040524 3 13 AFUA_5G04380 
uncharacterized protein -1.59667 0.049842 5 28.6 AFUA_2G12100 
tRNA splicing 2' phosphotransferase 1 -1.60176 0.03059 3 11 AFUA_2G02890 
Peptide methionine sulfoxide reductase -1.65017 0.028258 6 57.6 AFUA_2G03140 
Kelch repeats protein, putative -1.766 0.029777 3 5.5 AFUA_2G04970 
Peptidyl-prolyl cis-trans isomerase -1.82857 0.035488 12 66 AFUB_064740 
Succinyl-CoA:3-ketoacid-coenzyme A transferase -1.93972 0.00699 24 52.9 AFUA_6G12250 
Glycerol kinase, putative -1.99179 0.048473 7 20.7 AFUA_4G11540 
Na/K ATPase alpha 1 subunit, putative -1.9937 0.0284 18 23.4 AFUA_7G04570 
CobW domain protein -2.03634 0.039494 16 35.9 AFUA_8G02620 
Nuclear pore protein (Nic96), putative -2.07972 0.04427 10 16.2 AFUA_4G04720 
DsDNA-binding protein PDCD5, putative -2.12738 0.031351 4 32.5 AFUA_3G06420 
BolA domain protein -2.17693 0.004201 6 51.1 AFUA_7G01520 
Vacuolar protein sorting-associated protein 27 -2.59406 0.000905 6 10.3 AFUA_2G04740 
DnaJ domain protein -2.66553 0.03948 4 25.6 AFUA_8G04610 
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rRNA biogenesis protein RRP5, putative -2.81516 0.040028 12 10.4 AFUA_2G16040 
Endoribonuclease ysh1 -3.13103 0.044313 5 8 AFUA_1G16800 
C2H2 finger domain protein, putative -4.06568 0.007799 3 5.3 AFUA_1G02010 
Ribonuclease T2-like -4.09965 0.004917 3 12.7 AFUA_3G11220 
Extracellular serine-rich protein, putative -4.26486 0.000262 5 9.1 AFUA_3G07870 
Thiamine pyrophosphate enzyme, putative -4.51397 0.002554 3 9.8 AFUA_6G11680 
Uncharacterized protein Absent n/a 1 16.7 AFUA_2G05050 
Uncharacterized protein Absent n/a 2 9.9 AFUA_4G08820 
TRAPP complex component Bet3, putative Absent n/a 2 12.7 AFUA_7G02270 
GABA permease (Uga4), putative Absent n/a 1 3.4 AFUA_4G03370 
Ferrooxidoreductase Fet3, putative Absent n/a 2 5.6 AFUA_5G03790 
Protein bfr2 Absent n/a 3 6.2 AFUA_6G09820 
Oxidoreductase CipA-like, putative Absent n/a 3 13.4 AFUA_1G12460 
Acetyltransferase, GNAT family family Absent n/a 2 12 AFUA_3G01260 
Splicing factor 3b, subunit 2, 145kD Absent n/a 3 8.3 AFUA_5G04420 
TRAPP complex component Bet3, putative Absent n/a 2 5.4 AFUA_5G12350 
Uncharacterized protein Absent n/a 2 21.9 AFUA_5G13100 
Dynamin GTPase, putative Absent n/a 5 8.9 AFUA_6G11890 
rRNA maturation protein (Nop14), putative Absent n/a 2 2 AFUA_8G04220 
 
9.3  Appendix 3 
Table 9.3. Proteins with significant log2 fold change or unique/absent in A. fumigatus ∆egtA
26933
 under oxidative stress conditions 
compared to ∆egtA26933 under basal conditions. Data sorted by fold change, in descending order. 
Protein Description 
Present/log2 
(Fold 
Change) p value Peptides 
Sequence 
coverage [%] Protein IDs 
Glycogen debranching enzyme Gdb1, putative Unique n/a 6 5 AFUA_1G02140 
Uncharacterized protein Unique n/a 3 15.1 AFUA_1G04610 
Protein vts1 Unique n/a 5 11.4 AFUA_1G04990 
Uncharacterized protein Unique n/a 2 17.6 AFUA_1G05350 
Uridine nucleosidase Urh1, putative (EC 3.2.2.-) Unique n/a 5 22.9 AFUA_1G05530 
GTP binding protein, putative Unique n/a 8 27.6 AFUA_1G05560 
Ribosome biogenesis protein Ssf2, putative Unique n/a 2 5.6 AFUA_1G06230 
Protein O-mannosyl transferase Unique n/a 4 5.8 AFUA_1G07690 
50S ribosomal protein L17 Unique n/a 5 34 AFUA_1G09410 
37S ribosomal protein S11, putative Unique n/a 3 18.5 AFUA_1G09850 
Casein kinase 2 beta' regulatory subunit Ckb2, putative (EC 2.7.1.-) Unique n/a 2 8.5 AFUA_1G09950 
TIM-barrel enzyme family protein Unique n/a 3 18.6 AFUA_1G10110 
Pre-mRNA-splicing factor prp46 (Pre-mRNA-processing protein 46) Unique n/a 5 14.3 AFUA_1G10710 
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Prolyl-tRNA synthetase (EC 6.1.1.15) Unique n/a 6 13.5 AFUA_1G10750 
Myosin class II heavy chain (MHC), putative Unique n/a 7 4.4 AFUA_1G11450 
Translation initiation factor IF3, putative Unique n/a 4 13.3 AFUA_1G12160 
ATP-dependent RNA helicase drs1 (EC 3.6.4.13) Unique n/a 4 4.9 AFUA_1G14990 
Uncharacterized protein Unique n/a 5 14.2 AFUA_1G15830 
Probable mitochondrial transport protein (Fungal sideroflexin) Unique n/a 5 16.3 AFUA_1G16750 
Pre-mRNA splicing factor (Prp24), putative Unique n/a 8 7 AFUA_2G01820 
Ubiquinone biosynthesis protein Coq7, putative Unique n/a 4 24.9 AFUA_2G01890 
Mitochondrial import inner membrane translocase subunit tim14 
(Presequence translocated-associated motor subunit pam18) Unique n/a 2 17.1 AFUA_2G02700 
Carboxyphosphonoenolpyruvate phosphonomutase, putative (EC 4.1.3.30) Unique n/a 3 11.1 AFUA_2G03820 
Succinate dehydrogenase assembly factor 3, mitochondrial (SDH assembly 
factor 3) (SDHAF3) Unique n/a 5 38.6 AFUA_2G05090 
NADH-ubiquinone oxidoreductase 64 kDa subunit, putative (EC 1.6.99.3) Unique n/a 4 6.9 AFUA_2G05450 
Pre-mRNA-splicing factor cef1 Unique n/a 7 12.9 AFUA_2G05540 
mRNA decapping hydrolase, putative Unique n/a 8 30.5 AFUA_2G05580 
Autophagy ubiquitin-activating enzyme ApgG, putative Unique n/a 6 9.1 AFUA_2G06250 
Eukaryotic translation initiation factor 5, putative Unique n/a 3 6.2 AFUA_2G08990 
Kynureninase 1 (EC 3.7.1.3) (Biosynthesis of nicotinic acid protein 5-1) (L-
kynurenine hydrolase 1) Unique n/a 10 27.9 AFUA_2G10360 
Nucleolar GTP-binding protein 1 Unique n/a 7 13.7 AFUA_2G11510 
Uncharacterized protein Unique n/a 2 11 AFUA_2G12540 
Translocation protein Sec62, putative Unique n/a 4 12 AFUA_2G12580 
Urease accessory protein UreG, putative Unique n/a 8 36.2 AFUA_2G12900 
Uncharacterized protein Unique n/a 2 6.9 AFUA_2G14070 
Ubiquitin carboxyl-terminal hydrolase (EC 3.4.19.12) Unique n/a 8 6.6 AFUA_2G14130 
Nuclear cohesin complex subunit (Psc3), putative Unique n/a 8 7.6 AFUA_2G16080 
Acyl-CoA dehydrogenase, putative Unique n/a 3 8.4 AFUA_3G01920 
U2 auxiliary factor small subunit, putative Unique n/a 4 36.8 AFUA_3G02380 
Spindle poison sensitivity protein Scp3, putative Unique n/a 3 7.3 AFUA_3G05570 
Uncharacterized protein Unique n/a 2 11 AFUA_3G05980 
Transcription elongation factor S-II Unique n/a 3 13.5 AFUA_3G07670 
Probable dipeptidyl-aminopeptidase B (DPAP B) (EC 3.4.14.5) Unique n/a 6 9.6 AFUA_3G07850 
PX domain protein Unique n/a 6 6.2 AFUA_3G08020 
Uncharacterized protein Unique n/a 3 6.2 AFUA_3G08240 
RNA binding protein, putative Unique n/a 3 5.6 AFUA_3G09620 
Asparaginyl-tRNA synthetase Slm5, putative (EC 6.1.1.22) Unique n/a 2 4.9 AFUA_3G09630 
ADP-ribosylation factor 6, putative Unique n/a 7 65.8 AFUA_3G12080 
Queuine tRNA-ribosyltransferase (EC 2.4.2.29) Unique n/a 7 31.2 AFUA_4G04260 
AN1 zinc finger protein Unique n/a 3 11.2 AFUA_4G04280 
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Uncharacterized protein Unique n/a 2 15.1 AFUA_4G06220 
Ribosome biogenesis protein ytm1 Unique n/a 10 30.3 AFUA_4G07630 
40S ribosomal protein S13 Unique n/a 5 26.6 AFUA_4G07640 
CaaX farnesyltransferase alpha subunit Ram2 (EC 2.5.1.-) Unique n/a 4 15.9 AFUA_4G07800 
Sphinganine-1-phosphate aldolase BST1, putative (EC 4.1.2.27) Unique n/a 3 9.6 AFUA_4G10470 
DlpA domain protein Unique n/a 3 14.9 AFUA_4G10940 
TPR domain protein Unique n/a 2 7.2 AFUA_4G12110 
Calponin homology domain protein Unique n/a 6 10.6 AFUA_4G13250 
DUF455 domain protein Unique n/a 3 5.1 AFUA_5G01840 
Translation initiation factor eIF4E3, putative Unique n/a 3 13.3 AFUA_5G03180 
Pyruvate dehydrogenase kinase, putative (EC 2.7.1.-) Unique n/a 6 14.3 AFUA_5G03240 
Thymidylate kinase (EC 2.7.4.9) Unique n/a 7 36.2 AFUA_5G03460 
Transcription elongation factor spt4 (Chromatin elongation factor spt4) Unique n/a 3 34 AFUA_5G06690 
Uncharacterized protein Unique n/a 5 34.4 AFUA_5G06960 
NADH-ubiquinone oxidoreductase B12 subunit, putative Unique n/a 2 23.2 AFUA_5G07380 
Nuclear migration protein (ApsA), putative Unique n/a 5 3.2 AFUA_5G07710 
MutT/nudix family protein Unique n/a 4 28.2 AFUA_5G08240 
WD repeat protein Unique n/a 4 14.7 AFUA_5G08320 
U1 small nuclear ribonucleoprotein 70 kDa Unique n/a 4 14.2 AFUA_5G13480 
CCCH finger DNA binding protein, putative Unique n/a 5 16.1 AFUA_5G13930 
3' exoribonuclease family protein (EC 3.1.-.-) Unique n/a 2 7.8 AFUA_6G02160 
Aspartate aminotransferase (EC 2.6.1.1) Unique n/a 8 24.3 AFUA_6G02490 
Uncharacterized protein AFUA_6G02800 Unique n/a 3 18.2 AFUA_6G02800 
Probable aspartic-type endopeptidase opsB (EC 3.4.23.-) Unique n/a 6 26.4 AFUA_6G05350 
Endoplasmic reticulum DnaJ domain protein Erj5, putative Unique n/a 3 9.3 AFUA_6G06610 
COPII vesicles protein Yip3, putative Unique n/a 4 27.6 AFUA_6G06620 
WD repeat-containing protein jip5 Unique n/a 5 18.8 AFUA_6G07080 
mRNA splicing factor (Prp17), putative Unique n/a 2 3.8 AFUA_6G07300 
Uncharacterized protein Unique n/a 3 22.5 AFUA_6G07550 
DNA polymerase V, putative (EC 2.7.7.7) Unique n/a 11 13.9 AFUA_6G08170 
Ubiquitin-protein ligase E3 component (UBR1), putative Unique n/a 8 4 AFUA_6G08420 
Uncharacterized protein Unique n/a 3 12.1 AFUA_6G09090 
ABC transporter, putative Unique n/a 8 17.6 AFUA_6G11360 
TPR repeat protein Unique n/a 3 8.2 AFUA_6G13600 
Mitochondrial molecular chaperone (Atp12), putative Unique n/a 6 20.3 AFUA_7G02490 
Amine oxidase (EC 1.4.3.-) Unique n/a 5 10.8 AFUA_7G04180 
Serine/threonine protein kinase, putative (EC 2.7.1.-) Unique n/a 4 11.1 AFUA_7G04550 
Glyoxalase family protein Unique n/a 2 9.3 AFUA_7G05015 
Small nuclear ribonucleoprotein SmE, putative Unique n/a 6 54.7 AFUA_7G05980 
Threonine aldolase, putative (EC 4.1.2.-) Unique n/a 8 32.2 AFUA_7G06540 
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Uncharacterized protein Unique n/a 14 19.2 AFUA_8G00780 
Thioredoxin, putative Unique n/a 2 14.7 AFUA_8G01090 
DNA repair/transcription protein, putative Unique n/a 8 11 AFUA_8G05370 
Dehydrogenase, putative Unique n/a 5 25 AFUA_8G05760 
Alanyl-tRNA synthetase, putative (EC 6.1.1.7) Unique n/a 5 31.9 AFUA_8G07110 
Hybrid PKS/NRPS enzyme EqiS-like, putative Unique n/a 2 0.4 AFUB_045790 
Small nuclear ribonucleoprotein (LSM7), putative 2.53918 0.0447206 4 20.1 AFUA_1G14290 
High expression lethality protein Hel10, putative 2.46315 0.0273076 5 39.6 AFUA_1G06580 
Succinate dehydrogenase subunit CybS, putative 2.38886 0.0316124 4 29.4 AFUA_1G15590 
Isochorismatase family hydrolase, putative 2.08009 0.0234628 6 68 AFUA_6G12220 
Elongation of fatty acids protein (EC 2.3.1.199) (Very-long-chain 3-
oxoacyl-CoA synthase) 2.02084 0.0287129 4 16 AFUA_5G02760 
Small nuclear ribonucleoprotein SmB, putative 1.3701 0.000483799 6 25.2 AFUA_4G07740 
Heat shock protein Hsp30-like, putative 1.33229 0.00951935 7 52.3 AFUA_6G06470 
Translational activator, putative 1.30078 0.0252425 43 25.4 AFUA_2G07960 
Alpha,alpha-trehalose-phosphate synthase (UDP-forming) (EC 2.4.1.15) 
(Trehalose-6-phosphate synthase) 1.29376 0.036481 13 35.1 AFUA_2G04010 
Molybdopterin binding domain protein 1.13164 0.0124949 7 34.7 AFUA_5G11210 
RNA processing protein Emg1, putative 1.11232 0.033944 9 40.9 AFUA_3G06010 
RNase III domain protein 1.08371 0.017722 7 25.9 AFUA_5G09670 
Cyclin dependent kinase inhibitor Pho81, putative 1.06558 0.00839668 15 22.5 AFUA_4G06020 
Small nuclear ribonucleoprotein SmD3, putative 1.02921 0.00392039 5 37.9 AFUA_4G10240 
Hsp70 nucleotide exchange factor fes1 1.0107 0.00151961 11 67.1 AFUA_6G04750 
Uncharacterized protein 1.001 0.0368742 2 10.3 AFUA_3G05670 
Phytanoyl-CoA dioxygenase family protein -1.00669 0.0173754 4 18.4 AFUA_2G01850 
SnRNP and snoRNP protein (Snu13), putative -1.01382 0.0283058 3 52.4 AFUA_2G05950 
Superoxide dismutase copper chaperone Lys7, putative -1.11686 0.0497396 10 54.7 AFUA_2G09700 
Uncharacterized protein -1.13093 0.00676312 6 45.8 AFUA_1G09030 
Uncharacterized protein -1.32621 0.00978505 9 46.7 AFUA_2G04930 
PH domain protein -1.34678 0.000211844 11 27.1 AFUA_6G07910 
MFS peptide transporter Ptr2, putative -1.36993 0.00945255 3 6.9 AFUA_7G01490 
Uncharacterized protein -1.48516 0.0439162 8 72.6 AFUA_8G00430 
Uncharacterized protein -1.61708 0.0410222 7 66.9 AFUA_6G02830 
Mannitol-1-phosphate 5-dehydrogenase (M1PDH) (MPD) (MPDH)  -1.63191 0.0147944 14 54.6 AFUA_2G10660 
Uncharacterized protein -3.13222 0.0487647 2 8.4 AFUA_3G03610 
DNA-directed RNA polymerase I, II, and III subunit Rpb6 (EC 2.7.7.6) Absent n/a 2 13 AFUA_1G05160 
General amidase, putative Absent n/a 5 10.2 AFUA_1G14530 
Phosphoesterase superfamily protein (EC 3.1.4.-) Absent n/a 5 15.4 AFUA_1G17590 
TOR signalling pathway protein TipA, putative Absent n/a 3 9.4 AFUA_2G07540 
NAD(P)H-hydrate epimerase (EC 5.1.99.6) (NAD(P)HX epimerase) Absent n/a 3 28.7 AFUA_5G08360 
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ABC transporter, putative (EC 3.6.3.-) Absent n/a 12 11.2 AFUA_5G10510 
Bis(5'-nucleosyl)-tetraphosphatase, putative Absent n/a 2 7.5 AFUA_8G05000 
TAM domain methyltransferase, putative Absent n/a 3 13.5 AFUA_2G15860 
 
9.4   Appendix 4 
Table 9.4. Proteins with significant log2 fold change or unique/absent in A. fumigatus ATCC26933 under oxidative stress conditions 
compared to ATCC26933 under basal conditions. Data sorted by fold change, in descending order. 
Protein Description 
Present/log2 
(Fold Change) p value Peptides 
Sequence 
coverage [%] Protein IDs 
Probable dipeptidyl-aminopeptidase B (DPAP B) (EC 3.4.14.5) Unique n/a 3 6.6 AFUA_3G07850 
N-acetyltransferase family protein, putative Unique n/a 5 16.1 AFUA_4G10930 
Metallo-beta-lactamase family protein Unique n/a 5 28.9 AFUA_5G12770 
Mitochondrial phosphate carrier protein (Ptp), putative Unique n/a 8 30.2 AFUA_1G02730 
Inosine-5'-monophosphate dehydrogenase (IMP dehydrogenase) (IMPD) 
(IMPDH) (EC 1.1.1.205) Unique n/a 31 76.6 AFUA_2G03610 
Vacuolar protein sorting-associated protein 27 Unique n/a 8 16.2 AFUA_2G04740 
Ribonucleoprotein, putative Unique n/a 4 20.1 AFUA_7G05810 
Uncharacterized protein Unique n/a 3 7 AFUA_1G09570 
Uncharacterized protein Unique n/a 2 27.5 AFUA_3G09870 
Uncharacterized protein Unique n/a 7 22.2 AFUA_4G14050 
Thymidylate kinase (EC 2.7.4.9) Unique n/a 3 22.2 AFUA_5G03460 
HypA-like protein, putative 1.61045 0.00147373 11 27.4 AFUA_5G03330 
Glycine-rich RNA-binding protein, putative 1.58587 0.0280039 3 45.8 AFUA_3G08580 
CHCH domain protein 1.55624 0.0263444 3 12.7 AFUA_3G06370 
Protein arginine methyltransferase RmtB 1.48822 0.0106819 5 11.8 AFUA_3G12490 
GNAT family N-acetyltransferase, putative 1.42225 0.00392018 5 47.8 AFUA_3G00870 
SET domain protein 1.37637 0.0198835 7 20.1 AFUA_6G04520 
Uncharacterized protein 1.33313 0.00935387 4 8.7 AFUA_4G04190 
Branchpoint-bridging protein 1.30618 0.0403665 5 12.9 AFUA_3G10840 
Polyadenylation factor subunit CstF64, putative 1.29843 0.0305713 5 24.3 AFUA_2G09100 
DSB repair complex subunit Ku70, putative 1.20911 0.00753736 5 10.1 AFUA_5G07740 
tRNA-dihydrouridine(47) synthase [NAD(P)(+)] (EC 1.3.1.89) (tRNA-
dihydrouridine synthase 3) 1.17689 0.0207612 9 19.3 AFUA_1G14770 
Ankyrin repeat protein 1.11234 0.0262974 7 53.8 AFUA_1G06370 
Uncharacterized protein 1.10887 0.00174686 4 39.6 AFUA_1G01950 
Ribosome biogenesis GTPase Lsg1, putative 1.08539 0.0381372 8 13.9 AFUA_5G06510 
Guanylate kinase (EC 2.7.4.8) 1.04394 0.00622572 13 64 AFUA_1G08840 
Chromatin remodeling complex subunit (Arp8), putative 1.03054 0.00653048 10 18.1 AFUA_2G10990 
Uncharacterized protein 1.01566 0.0363161 13 20.8 AFUA_1G10440 
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60S ribosomal protein L24a -1.00594 0.0373174 5 23.8 AFUA_6G02440 
Uncharacterized protein -1.03263 0.00254852 10 64.1 AFUA_3G00960 
Riboflavin kinase (EC 2.7.1.26) (Flavin mononucleotide kinase 1) -1.04681 0.0470412 6 63.6 AFUA_2G05820 
Isocitrate dehydrogenase LysB (EC 1.1.1.41) -1.10504 0.00302761 17 50.8 AFUA_6G07390 
Calcium/calmodulin-dependent protein kinase, putative (EC 2.7.11.17) -1.12351 0.0266042 11 36.4 AFUA_2G13680 
Isoflavone reductase family protein (EC 1.3.1.-) -1.15597 0.0206647 12 51.9 AFUA_1G12510 
Zinc-containing alcohol dehydrogenase, putative (EC 1.1.1.1) -1.2389 0.00058003 15 63.5 AFUA_4G08240 
Phosducin family protein -1.27893 0.00735141 6 27.4 AFUA_2G02550 
Electron transfer flavoprotein-ubiquinone oxidoreductase (EC 1.5.5.1) -1.2864 0.0158434 8 20.6 AFUA_3G10110 
CsgA-like short chain dehydrogenase/reductase, putative -1.39785 0.00306685 4 52.1 AFUB_075540 
ABC metal ion transporter, putative -1.48928 0.0421382 10 9.1 AFUA_5G07970 
mRNA decapping hydrolase, putative -1.55983 0.0471714 9 37.2 AFUA_2G05580 
Ribosome biogenesis protein Ria1, putative -1.56757 0.0167107 12 14.9 AFUA_5G13520 
DNA-directed RNA polymerase III RPC4, putative -1.63323 0.0075939 3 6.2 AFUA_2G16170 
Oxidoreductase, zinc-binding dehydrogenase family, putative (EC 1.3.1.-) -1.65097 0.0348013 12 61 AFUA_1G15610 
Transcription elongation factor S-II -1.70446 0.0230974 4 18.4 AFUA_3G07670 
Oxidoreductase, short chain dehydrogenase/reductase family (EC 1.1.1.159) -2.03448 0.000278332 13 86.4 AFUA_5G14000 
SnRNP and snoRNP protein (Snu13), putative -2.60299 0.022395 3 52.4 AFUA_2G05950 
Nucleoporin NUP49/NSP49, putative -4.38796 2.46E-05 4 12.5 AFUA_6G10730 
HD superfamily hydrolase, putative Absent n/a 4 31.3 AFUA_1G03035 
Acetylserotonin methytransferase-like protein (ASMTL), putative Absent n/a 2 9.2 AFUA_1G15580 
Citrate lyase beta subunit, putative (EC 4.1.3.6) Absent n/a 4 18 AFUA_4G13030 
Vacuolar protein sorting/targeting protein 10 (Carboxypeptidase Y receptor) 
(CPY receptor) (Sortilin vps10)  Absent n/a 6 5.3 AFUA_8G02780 
CCAAT-binding factor complex subunit HapC Absent n/a 3 23.8 AFUA_1G03840 
BCAS2 family protein Absent n/a 6 47.7 AFUA_1G06460 
Golgi phosphoprotein 3 (GPP34) domain containing protein Absent n/a 7 35.1 AFUA_1G06630 
Fatty acid hydroxylase, putative (EC 1.14.-.-) Absent n/a 5 14.8 AFUA_1G15820 
Bax Inhibitor family protein Absent n/a 3 12.2 AFUA_2G03220 
NOT2 family protein Absent n/a 4 8.1 AFUA_2G11130 
Amino acid transporter, putative Absent n/a 4 8.2 AFUA_2G17790 
C-4 methyl sterol oxidase Erg25, putative (EC 1.-.-.-) Absent n/a 4 16.9 AFUA_4G04820 
Aldo-keto reductase (AKR), putative Absent n/a 7 28 AFUA_5G01910 
Pheromone-processing carboxypeptidase kex1 (EC 3.4.16.6) 
(Carboxypeptidase D) Absent n/a 3 6.5 AFUA_1G08940 
Pre-mRNA-splicing factor cef1 Absent n/a 7 9.3 AFUA_2G05540 
Deoxycytidylate deaminase, putative (EC 3.5.4.12) Absent n/a 5 22.2 AFUA_2G06240 
Rho GTPase activator (Rgd1), putative Absent n/a 7 15.4 AFUA_3G06280 
COP9 signalosome subunit 2 (CsnB), putative Absent n/a 5 13.7 AFUA_3G06700 
Glutamate carboxypeptidase Tre2, putative Absent n/a 7 12.5 AFUA_3G10650 
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ATP-dependent RNA helicase has1 (EC 3.6.4.13) Absent n/a 8 13.8 AFUA_4G13330 
RNA polymerase II transcription elongation factor (Ctr9), putative Absent n/a 6 5.7 AFUA_5G05870 
Uncharacterized protein Absent n/a 4 14.4 AFUA_5G14865 
Mitochondrial intermediate peptidase (MIP) (EC 3.4.24.59) (Octapeptidyl 
aminopeptidase) Absent n/a 4 6.4 AFUA_6G08640 
Uncharacterized protein Absent n/a 6 13.3 AFUA_6G03460 
 
9.5  Appendix 5 
Table 9.5. Proteins with significant log2 fold change or unique/absent in A. fumigatus ∆vipC
26933
 compared to ATCC26933 under 
basal conditions. Data sorted by fold change, in descending order. 
Protein Description 
Present/log2 Fold 
Change p-value Peptides 
Sequence 
coverage [%] Protein IDs 
CCAAT-binding factor complex subunit HapC Unique n/a 3 23.8 AFUA_1G03840 
Endo-1,3-beta-glucanase Engl1 (EC 3.2.1.6) Unique n/a 6 7.6 AFUA_1G04260 
G-protein complex gamma subunit GpgA Unique n/a 3 34.4 AFUA_1G05210 
Cytochrome c oxidase assembly protein Cox19, putative Unique n/a 2 20.4 AFUA_1G09757 
Ammonium transporter Unique n/a 2 5.2 AFUA_1G10930 
Smr domain protein Unique n/a 2 20.1 AFUA_1G13150 
Uncharacterized protein Unique n/a 4 5.9 AFUA_2G08560 
Uncharacterized protein Unique n/a 5 17.6 AFUA_2G10290 
Uncharacterized protein Unique n/a 3 9.5 AFUA_2G11470 
Zinc/cadmium resistance protein Unique n/a 6 14.3 AFUA_2G14570 
SIR2 family histone deacetylase, putative (EC 3.5.1.-) Unique n/a 4 15.4 AFUA_3G00520 
N2,N2-dimethylguanosine tRNA methyltransferase Unique n/a 2 5.1 AFUA_3G04200 
Rho GTPase Rho3 Unique n/a 3 21.8 AFUA_3G06690 
Structural maintenance of chromosomes protein Unique n/a 5 5.4 AFUA_3G08260 
Endosomal cargo receptor (Erp5), putative Unique n/a 5 34.6 AFUA_4G07390 
Sit4-associated protein (Sap185), putative Unique n/a 2 3.1 AFUA_4G11012 
Arginine biosynthesis bifunctional protein ArgJ Unique n/a 5 15.7 AFUA_5G08120 
U2 small nuclear ribonucleoprotein A' (U2 snRNP A') Unique n/a 4 30 AFUA_5G11000 
Oxidoreductase, 2OG-Fe(II) oxygenase family Unique n/a 6 26.8 AFUA_5G12470 
Synaptobrevin-like protein Sybl1, putative Unique n/a 4 21.3 AFUA_6G11270 
Transcriptional activator soma Unique n/a 2 4.5 AFUA_7G02260 
Protein OS-9 homolog Unique n/a 6 26.9 AFUA_8G04530 
Putative DNA helicase ino80 (EC 3.6.4.12) Unique n/a 6 4.8 AFUA_5G06260 
Amino acid transporter, putative Unique n/a 7 13.3 AFUA_8G00800 
Glucoamylase (EC 3.2.1.3) (1,4-alpha-D-glucan glucohydrolase)  4.69436 0.0248347 17 53.1 AFUA_2G00690 
Tropomyosin, putative 3.01673 0.0106091 30 91.6 AFUA_7G04210 
Small oligopeptide transporter, OPT family 2.9185 0.0144799 10 18.1 AFUA_2G15240 
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Uncharacterized protein 2.84709 0.0142601 5 44.8 AFUA_7G02020 
Uncharacterized protein 2.80325 0.0053967 4 18.2 AFUB_039390 
LipA and NB-ARC domain protein 2.67597 0.0450569 19 45.3 AFUA_3G14650 
H+/nucleoside cotransporter 2.6571 0.0480087 5 11.8 AFUA_6G13190 
Allergen Asp f 4 (allergen Asp f 4) 2.61566 0.0078489 11 55 AFUA_2G03830 
CipC-like antibiotic response protein, putative 2.43259 0.0101168 17 89.2 AFUA_5G09330 
Uncharacterized protein 2.38161 0.0427608 16 25 AFUA_2G12410 
MFS peptide transporter Ptr2, putative 2.17966 0.00657 7 14 AFUA_7G01490 
MFS phospholipid transporter (Git1), putative 2.16428 0.0123344 5 17.6 AFUA_6G07750 
NADH-ubiquinone oxidoreductase 1.94662 0.025202 11 83 AFUA_1G12290 
Thiamine thiazole synthase (Thiazole biosynthetic enzyme) 1.94062 0.045295 10 53.3 AFUA_6G08360 
Uncharacterized protein 1.93594 0.0070151 6 63 AFUA_8G05650 
Thiamine biosynthesis protein (Nmt1), putative 1.92433 0.041293 22 77.5 AFUA_5G02470 
Ribosomal S30/ubiquitin fusion 1.91968 0.0495854 3 19.4 AFUA_6G02450 
NADH-ubiquinone oxidoreductase B18 subunit, putative 1.88806 0.0309145 2 26.9 AFUA_3G13910 
Amino acid permease (Gap1), putative 1.88198 0.0129507 10 19 AFUA_7G04290 
Methylthioribose-1-phosphate isomerase (M1Pi) (MTR-1-P isomerase)  1.77106 0.0415603 20 62.5 AFUA_4G05830 
Aryl-alcohol dehydrogenase, putative (EC 1.1.-.-) 1.743 0.0004814 18 48.1 AFUA_4G00610 
Uncharacterized protein 1.72276 0.0074674 6 31.1 AFUA_8G02800 
Glycogen synthase Gsy1, putative (EC 2.4.1.11) 1.72097 0.0043134 15 30.3 AFUA_5G02480 
Uncharacterized protein 1.70252 0.0241192 8 85.2 AFUA_1G09890 
Uncharacterized protein 1.69953 0.0176889 2 12.1 AFUA_8G01690 
Pathogenesis associated protein Cap20, putative 1.69411 0.0024607 13 79.1 AFUA_1G06350 
Alcohol dehydrogenase, putative (EC 1.1.1.1) 1.66047 0.006741 17 62.9 AFUA_7G01010 
6-phosphofructo-2-kinase 1 1.65222 0.0260854 15 27 AFUA_1G07220 
WW domain protein 1.64097 0.0412963 12 58 AFUA_4G03322 
Structural maintenance of chromosomes protein 1.57865 0.0087512 16 19.4 AFUA_2G14080 
GPR/FUN34 family protein 1.55823 0.0412971 2 13.6 AFUA_2G04080 
Uncharacterized protein 1.54829 0.005589 6 43.1 AFUA_3G00730 
Uncharacterized protein 1.52439 0.0381581 9 85 AFUA_3G00550 
Glycolipid transfer protein HET-C2, putative 1.52004 0.0168031 8 44.8 AFUA_3G13820 
ABC transporter, putative 1.51771 0.0219184 50 45.2 AFUA_1G14330 
SNF7 family protein 1.51372 0.0292409 7 36.1 AFUA_1G06420 
Clathrin light chain 1.51159 0.0361573 10 33.9 AFUA_4G10020 
Uncharacterized protein 1.50097 0.0367368 5 12 AFUA_2G01540 
40S ribosomal protein S15, putative 1.4861 0.0114505 10 76.5 AFUA_2G10090 
ATP synthase subunit E, putative (EC 3.6.3.14) 1.4361 0.0011168 10 47 AFUA_6G02090 
Histone H4 1.43371 0.0417729 10 53.4 AFUA_1G13780 
Phosphoserine phosphatase (EC 3.1.3.3) 1.42824 0.0216512 7 26.7 AFUA_3G06550 
Urease (EC 3.5.1.5) (Urea amidohydrolase) 1.41819 0.039067 15 29.1 AFUA_1G04560 
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Cytochrome c subunit Vb, putative 1.40972 0.0465272 11 67 AFUA_2G03010 
Adenylyl-sulfate kinase (EC 2.7.1.25) 1.40367 0.0296912 7 46.9 AFUA_1G10820 
RNP domain protein 1.36409 0.0064053 3 25.6 AFUA_1G09490 
Malate synthase (EC 2.3.3.9) 1.34951 0.0084706 11 25.8 AFUA_6G03540 
Alpha-1,4 glucan phosphorylase (EC 2.4.1.1) 1.34691 0.0336936 31 45.7 AFUA_1G12920 
NACHT and TPR domain protein 1.34662 0.0215508 11 10.3 AFUA_7G06670 
Phosphoglycerate kinase (EC 2.7.2.3) 1.33227 0.0454454 39 85.9 AFUA_1G10350 
Endosomal cargo receptor (Erp5), putative 1.32874 0.0419246 5 28.1 AFUB_064480 
Calcium/calmodulin-dependent protein kinase, putative (EC 2.7.11.17) 1.2996 0.0283656 9 34.3 AFUA_2G13680 
Uncharacterized protein 1.29389 0.0102144 5 20.2 AFUA_1G04760 
Glycylpeptide N-tetradecanoyltransferase  1.28905 0.0304352 14 37.6 AFUA_4G08070 
Xanthine-guanine phosphoribosyl transferase Xpt1, putative 1.28178 0.0214742 10 75.7 AFUA_4G04550 
Glutamine-serine-proline rich protein, putative 1.28176 0.010393 6 26.4 AFUA_7G04870 
Dynamin GTPase, putative (EC 3.6.5.5) 1.28098 0.0081304 10 17.6 AFUA_6G11890 
Uncharacterized protein 1.2714 0.0093326 18 82.4 AFUA_5G14680 
ATP synthase D chain, mitochondrial, putative (EC 3.6.3.14) 1.26418 0.0291395 9 42.7 AFUA_6G03810 
UPF0136 domain protein 1.26412 0.049667 3 31.4 AFUA_1G03720 
Eukaryotic translation initiation factor 3 subunit J (eIF3j)  1.26255 0.0389505 5 29.6 AFUA_6G06760 
Protein phosphatase PP2A regulatory subunit B 1.24912 0.0080004 10 31.2 AFUA_8G05560 
Uncharacterized protein 1.24551 0.0026272 7 23.6 AFUA_5G02850 
Aminotransferase, putative 1.24488 0.0137447 5 23.5 AFUA_6G02030 
Uncharacterized protein 1.23742 0.0124597 8 12.8 AFUA_2G08090 
ATP synthase delta chain, mitochondrial, putative (EC 3.6.3.14) 1.23138 0.0022145 6 72.7 AFUA_1G03100 
Proteasome regulatory particle subunit (RpnK), putative 1.21836 0.0411085 12 51.3 AFUA_2G03400 
Aflatoxin B1-aldehyde reductase GliO-like, putative (EC 1.1.1.-) 1.2167 0.0011308 8 36.9 AFUA_1G13370 
Glycerol-3-phosphate dehydrogenase [NAD(+)] (EC 1.1.1.8) 1.20969 0.0160771 18 57 AFUA_1G02150 
Uncharacterized protein 1.20528 0.0421702 5 50 AFUA_6G02830 
Proteasome regulatory particle subunit (RpnF), putative 1.20108 0.0483408 13 36.7 AFUA_1G06300 
Extracellular cellulase CelA/allergen Asp F7-like, putative 1.19558 0.0318824 4 25.6 AFUA_5G08030 
Glycerophosphoryl diester phosphodiesterase family protein (EC 
3.1.4.46) 1.19555 0.0346109 5 23.2 AFUA_2G00990 
Indoleamine 2,3-dioxygenase family protein (EC 1.13.11.-) 1.19518 0.0016299 10 36.1 AFUA_7G02010 
Phosphopantothenate-cysteine ligase, putative 1.19441 0.0413487 8 33.9 AFUA_3G07230 
Rho GTPase Rho1 1.19404 0.0317957 10 64 AFUA_6G06900 
Translation initiation factor SUI1, putative 1.19097 0.0365835 7 68.4 AFUA_3G06260 
Succinate-semialdehyde dehydrogenase Uga2, putative (EC 1.2.1.24) 1.18987 0.0316673 9 34.3 AFUA_4G08170 
Mitochondrial tricarboxylate transporter (Ctp), putative 1.18326 0.0325544 6 29.4 AFUA_3G05420 
HAD superfamily hydrolase, putative 1.18276 0.0493669 17 68 AFUA_5G08270 
Small nuclear ribonucleoprotein SmF, putative 1.17408 0.0114853 5 54.5 AFUA_2G15500 
Integral membrane protein 25D9-6 1.16213 0.0173895 4 20.6 AFUA_2G17080 
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60S ribosomal protein L22, putative 1.15504 0.017245 5 44.4 AFUA_3G12300 
Nudix/MutT family protein 1.15135 0.009741 3 30.4 AFUA_2G13080 
Sorting nexin mvp1 1.15114 0.0185654 14 31.8 AFUA_2G17180 
Uncharacterized protein 1.15089 0.0032034 4 38.7 AFUA_1G02290 
DnaJ domain protein 1.14136 0.0386229 20 50 AFUA_7G01230 
T-complex protein 1, beta subunit, putative 1.14097 0.0219699 17 44.5 AFUA_1G01740 
AdoMet-dependent tRNA methyltransferase (MTase) complex subunit 
Trm112, putative 1.13911 0.0087446 5 57.2 AFUA_6G06330 
Ubiquitin C-terminal hydrolase, putative (EC 3.1.2.15) 1.1238 0.0416768 14 38.7 AFUA_6G02380 
Vacuolar ATP synthase catalytic subunit A, putative (EC 3.6.3.14) 1.1222 0.0366562 35 60.3 AFUA_5G02370 
Coproporphyrinogen III oxidase, putative (EC 1.3.3.3) 1.11856 0.0017532 12 40.9 AFUA_1G07480 
Secreted beta-glucosidase sun1 (EC 3.2.1.-) 1.10681 0.0321931 14 53.9 AFUA_7G05450 
Ribosome recycling factor, putative 1.1053 0.0014963 2 7.5 AFUA_8G03940 
CCAAT-binding factor complex subunit HapE 1.09962 0.0205649 5 25.1 AFUA_6G05300 
Vacuolar protein sorting-associated protein VpsB 1.09012 0.0392633 8 22.9 AFUA_6G04870 
Pyruvate dehydrogenase complex component Pdx1, putative 1.07806 0.0246284 5 25.7 AFUA_3G08270 
Nuclear segregation protein (Bfr1), putative 1.07437 0.0252053 17 41.4 AFUA_1G14120 
Phosphoglycerate mutase, 2,3-bisphosphoglycerate-independent 1.07375 0.012372 36 80 AFUA_3G09290 
Histone H2A.Z 1.06943 0.0399999 3 20.3 AFUA_5G01950 
DNA binding protein SART-1, putative 1.06153 0.0446231 6 10.7 AFUA_4G10420 
Uncharacterized protein 1.06148 0.0445837 3 24.7 AFUA_6G07550 
Uncharacterized protein 1.05775 0.0203983 13 27.5 AFUA_5G09270 
Mitogen-activated protein kinase (EC 2.7.11.24) 1.05492 0.0447993 12 35.4 AFUA_4G13720 
Fatty acid activator Faa4, putative (EC 6.2.1.3) 1.04615 0.0414864 25 44.2 AFUA_2G09910 
Sorting nexin-4 (Autophagy-related protein 24) 1.02087 0.0014391 8 27.2 AFUA_4G12950 
Ribose-phosphate pyrophosphokinase (EC 2.7.6.1) 1.01487 0.000887 10 28.7 AFUA_3G13380 
ADP-ribosylation factor 6, putative 1.00644 0.0415546 3 26.1 AFUA_3G12080 
Diphosphomevalonate decarboxylase (EC 4.1.1.33) -1.00043 0.0324085 22 80 AFUA_4G07130 
Small nuclear ribonucleoprotein SmD1, putative -1.00904 0.0378531 3 46.7 AFUA_2G05110 
Uncharacterized protein -1.01386 0.0381539 7 11.7 AFUA_1G13590 
Glyoxylate reductase (EC 1.1.1.95) -1.02229 0.0493176 16 69.8 AFUA_4G11840 
cAMP-dependent protein kinase regulatory subunit  -1.0364 0.0081586 16 56.9 AFUA_3G10000 
RNA binding protein, putative -1.04433 0.0366886 11 20.2 AFUB_039550 
Histone chaperone asf1 (Anti-silencing function protein 1) -1.047 0.0101194 9 64.9 AFUA_3G11030 
Ubiquitin fusion degradation protein Ufd1, putative -1.04765 0.0035942 7 24.5 AFUA_1G02430 
Short chain dehydrogenase/reductase family protein (EC 1.1.1.100) -1.04842 0.0370941 8 56.4 AFUA_4G14010 
Isocitrate dehydrogenase [NADP] (EC 1.1.1.42) -1.05025 0.0075024 38 67.9 AFUA_3G08660 
RNA binding protein (Rbm8A), putative -1.0537 0.0463482 3 29.1 AFUA_2G03260 
Pantetheine-phosphate adenylyltransferase family protein -1.05671 0.0222362 10 44.8 AFUA_4G08550 
Alanyl-tRNA synthetase, putative (EC 6.1.1.7) -1.08222 0.035019 7 42.5 AFUA_8G07110 
351 
 
UV-damaged DNA binding protein, putative -1.08722 0.005705 17 22 AFUA_6G10980 
Glutaminyl-tRNA synthetase (EC 6.1.1.18) -1.09192 0.0269592 28 58.7 AFUA_2G01920 
Tripeptidyl-peptidase sed2 (EC 3.4.14.-) (Sedolisin-B) -1.11798 0.042504 14 36.9 AFUA_4G03490 
NmrA-like family protein (EC 1.3.1.-) -1.12278 0.0374258 8 41.5 AFUA_6G00280 
2-nitropropane dioxygenase family oxidoreductase, putative (EC 
1.3.1.9) -1.12943 0.0140751 9 37.6 AFUA_5G09600 
Profilin -1.13316 0.0499957 6 71.3 AFUA_4G03050 
Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) -1.14477 0.0065496 9 49.3 AFUA_2G03720 
Aspartate-semialdehyde dehydrogenase (EC 1.2.1.11) -1.14656 0.0318739 13 48.2 AFUA_3G06830 
Malate dehydrogenase (EC 1.1.1.37) -1.14731 0.0009595 25 77.9 AFUA_7G05740 
UDP-glucose 4-epimerase (EC 5.1.3.2) -1.14891 0.0264306 25 84.6 AFUA_5G10780 
Aminomethyltransferase (EC 2.1.2.10) -1.1498 0.0365544 14 55.1 AFUA_1G10780 
Threonyl-tRNA synthetase, putative (EC 6.1.1.3) -1.15259 0.0054856 33 58.2 AFUA_4G13700 
DUF866 domain protein -1.1556 0.0120287 11 83.1 AFUA_2G15510 
Fumarylacetoacetate hydrolase family protein -1.16075 0.0145021 8 36.6 AFUA_3G08140 
Gamma-cysteine synthetase regulatory subunit, putative -1.16194 0.0294871 8 46.3 AFUA_3G14280 
Methyltransferase SirN-like, putative -1.17769 0.0140022 29 89.7 AFUA_8G00550 
Branched-chain-amino-acid aminotransferase (EC 2.6.1.42) -1.18114 0.0141411 14 54.2 AFUA_2G10420 
Proline utilization protein PrnX, putative (EC 4.3.1.12) -1.18227 0.0161236 16 61.5 AFUA_6G08780 
Probable cytosolic iron-sulfur protein assembly protein 1 -1.18265 0.0034154 14 49.1 AFUA_1G08930 
Transaldolase (EC 2.2.1.2) -1.20285 0.024829 25 84.6 AFUA_5G09230 
Pyruvate dehydrogenase E1 component subunit alpha (EC 1.2.4.1) -1.20539 0.0006282 21 69.7 AFUA_1G06960 
Nuclear pore complex subunit, putative -1.21763 0.02056 10 41.7 AFUA_6G10620 
Probable D-xylulose kinase A (Xylulokinase A) (EC 2.7.1.17) -1.22422 0.002209 17 39.1 AFUA_5G09840 
Peptidyl-prolyl cis-trans isomerase D (PPIase D) (EC 5.2.1.8) 
(Rotamase D) -1.23241 0.007257 16 68.7 AFUA_2G02050 
Hydroxymethylglutaryl-CoA lyase (EC 4.1.3.4) -1.23855 0.019141 9 49.7 AFUA_2G12450 
CECR1 family adenosine deaminase, putative -1.24283 0.0011191 13 26.5 AFUA_6G13180 
PHD finger domain protein, putative -1.2476 0.0389946 3 6.4 AFUA_7G05250 
Oxidoreductase, short-chain dehydrogenase/reductase family (EC 1.1.-
.-) -1.2485 0.014793 14 76.3 AFUA_5G02870 
DUF636 domain protein -1.25066 0.0170914 5 74.3 AFUA_2G15290 
Cobalamin-independent methionine synthase MetH/D (EC 2.1.1.14) -1.25468 0.0031553 67 73.8 AFUA_4G07360 
Flavin containing amine oxidase, putative (EC 1.4.3.-) -1.25696 0.0265187 12 34.9 AFUA_3G12150 
1,3-beta-glucanosyltransferase (EC 2.4.1.-) -1.26623 0.0025503 8 14 AFUA_8G02130 
NAP family protein -1.27085 0.0024644 14 43.2 AFUA_5G02910 
Uncharacterized protein -1.27124 0.0128833 23 55.1 AFUA_3G12690 
Alanine racemase family protein, putative -1.27143 0.0123628 11 48.3 AFUA_4G04300 
Ran GTPase activating protein 1 (RNA1 protein) -1.28004 0.0301051 14 50 AFUA_3G07680 
Aromatic-L-amino-acid decarboxylase, putative (EC 4.1.1.28) -1.29528 0.0435669 13 34.2 AFUA_3G02240 
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Dienelactone hydrolase family protein (EC 3.1.1.-) -1.29822 0.0091578 12 58.8 AFUA_1G07130 
Pyruvate decarboxylase, putative (EC 4.1.1.1) -1.30638 0.0150329 14 41 AFUA_6G00750 
Poly(A)+ RNA transport protein (UbaA), putative (EC 6.3.2.19) -1.30854 0.0064411 50 75 AFUA_2G15760 
Leukotriene A-4 hydrolase homolog (LTA-4 hydrolase) (EC 3.3.2.6) 
(Leukotriene A(4) hydrolase) -1.30951 0.0199644 28 48.4 AFUA_2G07520 
Alkaline phosphatase (EC 3.1.3.1) -1.31342 0.0323733 15 42.5 AFUA_2G03110 
Kynureninase 1 (EC 3.7.1.3) (Biosynthesis of nicotinic acid protein 5-
1)  -1.3255 0.0133443 14 35.4 AFUA_2G10360 
Fructosyl amino acid oxidase, putative (EC 1.5.3.-) -1.32973 4.95E-06 12 42.4 AFUA_8G06440 
Ornithine carbamoyltransferase (EC 2.1.3.3) -1.33493 0.0201104 15 60.4 AFUA_4G07190 
GNAT family N-acetyltransferase, putative -1.33518 0.0263455 7 47.8 AFUA_3G00870 
FAD dependent oxidoreductase superfamily -1.33639 0.0103546 11 39.2 AFUA_8G05850 
Copper resistance protein Crd2, putative -1.34204 0.0159024 3 41.4 AFUA_4G04318 
Delta-1-pyrroline-5-carboxylate dehydrogenase PrnC (EC 1.2.1.88) -1.34282 0.0111921 19 48.6 AFUA_6G08750 
Aminotransferase family protein (LolT), putative (EgtB) -1.34821 0.0005891 21 74.6 AFUA_2G13295 
Oxidoreductase, putative -1.36883 0.0040351 11 32.9 AFUA_2G14810 
Spermidine synthase (EC 2.5.1.16) -1.37119 0.0276863 20 79.2 AFUA_1G13490 
Dipeptidyl peptidase, putative (EC 3.4.14.4) -1.38226 0.0086309 42 58.3 AFUA_4G06140 
rRNA processing protein Pwp1, putative -1.38229 0.0111472 7 21.4 AFUA_1G02630 
NAD dependent epimerase/dehydratase family protein (EC 1.1.1.133) -1.386 0.026218 11 47 AFUA_5G02240 
Cytosine deaminase, putative (EC 3.5.4.1) -1.39743 0.0311643 9 61.5 AFUA_1G05050 
Saccharopine dehydrogenase Lys9, putative (EC 1.5.1.7) -1.39879 0.0075875 30 80.4 AFUA_4G11340 
Fumarylacetoacetate hydrolase FahA (EC 3.7.1.2) -1.41687 0.0038182 17 59.2 AFUA_2G04230 
Uncharacterized protein -1.42622 0.0211742 8 46.2 AFUA_2G02490 
Haloalkanoic acid dehalogenase, putative (EC 3.8.1.-) -1.44701 0.0031527 12 67.5 AFUA_6G14460 
ThiJ/PfpI family protein -1.44971 0.022028 7 43.6 AFUA_5G01430 
6,7-dimethyl-8-ribityllumazine synthase (DMRL synthase) (EC 
2.5.1.78) -1.4624 0.0217791 10 90.4 AFUA_6G06345 
Uncharacterized protein -1.46339 0.0019636 13 78.7 AFUA_2G04930 
Maleylacetoacetate isomerase MaiA (EC 5.2.1.2) -1.4671 0.0444102 10 56.7 AFUA_2G04240 
Peroxisomal dehydratase, putative -1.47188 0.0238904 7 42.5 AFUA_5G00640 
3-hydroxyisobutyryl-CoA hydrolase, mitochondrial (EC 3.1.2.4) (3-
hydroxyisobutyryl-coenzyme A hydrolase) -1.47736 0.0088731 21 44.4 AFUA_5G12790 
Toxin biosynthesis peroxidase, putative (EC 1.11.-.-) -1.48623 0.0455488 6 31.2 AFUA_4G02780 
Acid phosphatase, putative -1.49047 0.0011107 17 57.7 AFUA_1G16480 
Glutathione S-transferase, putative -1.49575 0.0018108 14 63.3 AFUA_8G00580 
Uncharacterized protein -1.50415 0.0069789 7 31.1 AFUA_6G09090 
Glutathione-specific gamma-glutamylcyclotransferase (EC 2.3.2.-) -1.50449 0.0002845 8 40.3 AFUA_3G08560 
Enoyl-CoA hydratase/isomerase family protein (EC 4.2.-.-) -1.50682 0.0089032 7 42 AFUA_2G14850 
Eukaryotic translation initiation factor 6 (eIF-6) -1.50907 0.0400842 8 48.2 AFUA_5G06010 
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Extracellular phytase, putative (EC 3.1.3.8) -1.5096 0.0455601 10 28.6 AFUA_3G00310 
Pyruvate dehydrogenase E1 beta subunit PdbA, putative (EC 1.2.4.1) -1.51062 0.0055343 15 54.6 AFUA_3G04170 
Ribulose-phosphate 3-epimerase (EC 5.1.3.1) -1.51065 0.0016886 7 36.7 AFUA_2G15190 
Sucrase/ferredoxin-like family protein, putative -1.52074 0.0322815 7 31.5 AFUA_4G11477 
Mitochondrial enoyl reductase, putative -1.52192 0.0064706 18 50.1 AFUA_3G04150 
Adenosine kinase, putative (EC 2.7.1.20) -1.54142 0.004053 22 79 AFUA_5G06390 
Uncharacterized protein -1.54816 0.0475248 26 27.4 AFUA_1G07090 
Cysteine synthase (O-acetylserine (Thiol)-lyase) (Csase) (EC 2.5.1.47) -1.54878 0.0020114 10 42 AFUA_5G02180 
DUF833 domain protein -1.55215 0.0076722 13 61.2 AFUA_2G09530 
Mitochondrial presequence protease (EC 3.4.24.-) -1.55271 0.0071377 32 43.8 AFUA_4G07910 
Putative peroxiredoxin pmp20 (EC 1.11.1.15)  -1.55902 0.0012818 18 91.1 AFUA_6G02280 
RNA binding protein Ligatin/Tma64, putative -1.5596 0.0151092 10 28.1 AFUA_1G12570 
Formyltetrahydrofolate deformylase, putative (EC 3.5.1.10) -1.56986 0.0103306 10 55.1 AFUA_6G11620 
THUMP domain protein -1.57034 0.0430798 7 37.5 AFUA_3G11060 
Uncharacterized protein -1.57288 0.0279353 3 14.8 AFUA_7G02300 
Galactose-1-phosphate uridylyltransferase (EC 2.7.7.12) -1.57647 0.0137686 18 51.4 AFUA_2G11560 
Acyl-CoA:6-aminopenicillanic-acid-acyltransferase, putative -1.57662 0.0099089 15 68.8 AFUA_3G12620 
Nuclear transport factor NTF-2, putative -1.60027 0.0059374 4 40.3 AFUA_3G10460 
Nucleoside-diphosphate-sugar epimerase family protein -1.60144 0.0080693 14 57.5 AFUA_3G02640 
Probable endopolygalacturonase B (EC 3.2.1.15) (Pectinase B) 
(Polygalacturonase B) -1.60304 0.0217355 11 41.5 AFUA_8G01970 
Alpha-1,3-glucan synthase Ags3 (EC 2.4.1.183) -1.61135 0.0242588 34 21.3 AFUA_1G15440 
Uncharacterized protein -1.62161 0.0327148 3 12.8 AFUA_1G11480 
PUA RNA binding domain protein, putative -1.62536 0.0174703 8 59.3 AFUA_1G09810 
Alkaline protease 2 (ALP2) (EC 3.4.21.63)  -1.63035 0.0098581 15 40.6 AFUA_5G09210 
Uncharacterized protein -1.63043 0.0143305 7 43.7 AFUA_3G03610 
Aspartyl aminopeptidase -1.63759 0.0148919 22 60.3 AFUA_3G08290 
DUF967 domain protein -1.65071 0.0027212 7 56.4 AFUA_2G04610 
Cyanate hydratase (Cyanase) (EC 4.2.1.104) (Cyanate hydrolase)  -1.65396 0.0358129 11 85.1 AFUA_2G16530 
Proline iminopeptidase (EC 3.4.11.5) -1.65705 0.0116292 17 48.8 AFUA_2G05000 
Nicotinate phosphoribosyltransferase (EC 6.3.4.21) -1.66553 0.0033016 13 34.3 AFUA_7G01880 
Ubiquitin carboxyl-terminal hydrolase (EC 3.4.19.12) -1.674 0.0239616 10 53.2 AFUA_2G05590 
Thioredoxin Trx1, putative -1.67432 0.0064429 4 35.8 AFUA_3G14970 
Phosphotransferase (EC 2.7.1.-) -1.68779 0.0071848 37 75.5 AFUA_2G05910 
Endo alpha-1,4 polygalactosaminidase, putative -1.68873 0.0087238 5 27 AFUA_3G07890 
Aldo-keto reductase, putative (EC 1.1.1.-) -1.6893 0.0196378 21 71.7 AFUA_4G11260 
Branched-chain-amino-acid aminotransferase (EC 2.6.1.42) -1.69406 0.0093951 13 39.4 AFUA_4G06160 
Iron/copper transporter Atx1, putative -1.70582 0.0282784 4 75.9 AFUA_1G08880 
Oxidoreductase CipA-like, putative (EC 1.3.1.-) -1.71706 0.0153205 17 52.1 AFUA_1G01630 
3-isopropylmalate dehydrogenase (EC 1.1.1.85) -1.72294 0.0395933 16 55.5 AFUA_1G15780 
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Lysophospholipase 3 (EC 3.1.1.5) (Phospholipase B 3) -1.75445 0.0146471 19 33.2 AFUA_3G14680 
FAD/FMN-containing isoamyl alcohol oxidase MreA -1.75912 0.004275 12 37.8 AFUA_6G03620 
Myo-inositol-phosphate synthase, putative (EC 5.5.1.-) -1.78755 0.0034845 25 71.3 AFUA_2G01010 
Probable Xaa-Pro aminopeptidase AFUA_1G14920 (EC 3.4.11.9) 
(Aminoacylproline aminopeptidase) (Prolidase) -1.7877 0.012214 21 48.7 AFUA_1G14920 
Inorganic diphosphatase, putative (EC 3.6.1.1) -1.78805 0.0035457 27 62.9 AFUA_3G08380 
Adenosylhomocysteinase (EC 3.3.1.1) -1.79604 0.0010387 36 74.2 AFUA_1G10130 
Catalase B (EC 1.11.1.6) (Antigenic catalase) (Slow catalase) -1.80239 0.0077993 18 38.6 AFUA_3G02270 
Aconitate hydratase, mitochondrial -1.80632 0.0018982 47 71.5 AFUA_6G12930 
OTU-like cysteine protease, putative -1.80964 0.0071167 6 25.7 AFUA_3G05550 
Mitochondrial dihydroxy acid dehydratase, putative (EC 4.2.1.-) -1.81586 0.0028484 21 70.7 AFUA_1G03550 
CAIB/BAIF family enzyme -1.81747 0.0016485 21 62.6 AFUA_3G09240 
Glyceraldehyde-3-phosphate dehydrogenase -1.83346 0.0157514 32 84.3 AFUB_049500 
S-formylglutathione hydrolase (EC 3.1.2.12) -1.83625 0.0032647 18 79.1 AFUA_5G09860 
Quinone oxidoreductase, putative (EC 1.6.5.5) -1.83926 0.0104127 10 41.6 AFUA_1G02090 
Alcohol dehydrogenase, zinc-containing, putative (EC 1.1.1.1) -1.85088 0.0098128 12 56.6 AFUA_2G00970 
Dihydroxy acid dehydratase Ilv3, putative -1.85153 0.002332 30 71 AFUA_2G14210 
4-aminobutyrate transaminase GatA (EC 2.6.1.19) -1.86949 0.0012947 31 83 AFUA_5G06680 
HypA-like protein, putative -1.87855 0.0223651 14 35.3 AFUA_5G03330 
Aldo-keto reductase (AKR13), puatative (EC 1.1.1.-) -1.8801 0.007858 24 77.1 AFUA_7G00700 
Uncharacterized protein -1.88657 0.0023501 16 72.7 AFUA_6G03100 
Mannosyl-oligosaccharide glucosidase, putative -1.88794 0.0198943 20 35.2 AFUA_6G04210 
Probable Xaa-Pro aminopeptidase pepP (EC 3.4.11.9)  -1.89136 0.0022494 24 62.4 AFUA_2G07500 
Nucleoside diphosphate kinase (NDK) (NDP kinase) (EC 2.7.4.6) -1.89349 0.0037831 11 79.1 AFUA_5G03490 
Glutaryl-CoA dehydrogenase, putative (EC 1.3.8.6) -1.89408 0.0030634 13 52.7 AFUA_3G06040 
Short chain oxidoreductase/dehydrogenase, putative -1.89469 0.0379655 8 56.7 AFUA_1G01770 
Aldo-keto reductase, putative (EC 1.1.1.-) -1.89938 0.027854 21 59.6 AFUA_2G01410 
Glutamine synthetase, putative (EC 6.3.1.2) -1.90463 0.0165266 16 45.1 AFUA_6G03530 
Phosphotransferase (EC 2.7.1.-) -1.91136 0.0053303 39 85.6 AFUA_6G02230 
Glutathione oxidoreductase Glr1, putative (EC 1.8.1.7) -1.91151 0.0093008 25 67.4 AFUA_1G15960 
Oxidoreductase family, NAD-binding Rossmann fold protein -1.92097 0.0119471 13 40.9 AFUA_2G16380 
DSB repair complex subunit Ku70, putative -1.93321 0.0040587 28 51.4 AFUA_5G07740 
Glutamate carboxypeptidase Tre2, putative -1.93664 0.0338926 15 27.5 AFUA_3G10650 
Uncharacterized protein -1.94429 0.006011 19 55.4 AFUA_3G02430 
Phosphoglucomutase (PGM) (EC 5.4.2.2) (Glucose phosphomutase) -1.94759 0.0081111 46 90.5 AFUA_3G11830 
O-acetyltransferase, putative (EC 2.3.1.-) -1.95039 0.0203931 8 46.1 AFUA_3G11510 
Ribose 5-phosphate isomerase A (EC 5.3.1.6) -1.96193 0.0024206 14 48.5 AFUA_6G10610 
Ribonuclease T2-like (RNase T2-like) (EC 3.1.27.1) -1.96521 0.0049226 12 48.2 AFUA_3G11220 
DUF636 domain protein -1.96864 0.0044137 5 46.9 AFUA_1G03180 
F-box domain protein -1.97097 0.0019983 13 42.1 AFUA_4G00200 
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Lysine decarboxylase-like protein -1.97138 0.0003705 4 20.6 AFUA_6G04800 
Peptidyl-prolyl cis-trans isomerase (PPIase) (EC 5.2.1.8) -1.97335 0.0031844 12 74.8 AFUA_3G07430 
Nucleoside-diphosphate-sugar epimerase, putative -1.97395 0.0382535 13 66.3 AFUA_5G07170 
Glutathione synthetase (GSH-S) (EC 6.3.2.3) -1.97585 0.0054128 21 63.8 AFUA_5G06610 
Lactoylglutathione lyase (EC 4.4.1.5) (Glyoxalase I) -1.98281 0.0095249 26 85.5 AFUA_6G07940 
Probable 4-hydroxyphenylpyruvate dioxygenase 1 (4HPPD 1) (HPD 1) 
(HPPDase 1) (EC 1.13.11.27) -1.98312 0.0118759 19 53.8 AFUA_2G04200 
Uncharacterized protein -2.00017 0.0122164 10 42.4 AFUA_4G12880 
GDSL Lipase/Acylhydrolase family protein -2.00165 0.0017301 8 47.7 AFUA_2G08920 
Uncharacterized protein -2.01486 0.0047392 13 57.1 AFUA_3G09110 
Nitrilase family protein (Nit3), putative -2.0271 0.0077196 16 72.3 AFUA_6G13230 
Cystathionine gamma-lyase (EC 4.4.1.8) -2.03402 0.0076254 12 56.8 AFUA_8G04340 
Probable Xaa-Pro aminopeptidase P (AMPP) (Aminopeptidase P)  -2.03436 0.0058493 32 65.3 AFUA_5G08050 
Carnitine acetyl transferase -2.05208 0.001231 34 62 AFUA_2G12530 
Uroporphyrinogen decarboxylase (EC 4.1.1.37) -2.06859 0.0042713 15 49.7 AFUA_1G05060 
Inositol monophosphatase, putative -2.07563 0.0313603 7 36 AFUA_3G04250 
Possible apospory-associated protein c -2.07798 0.0053532 18 89 AFUA_4G08880 
Thioredoxin reductase (EC 1.8.1.9) -2.07939 0.0044825 17 64.5 AFUA_4G12990 
Uncharacterized protein -2.09036 0.0002383 15 58.2 AFUA_4G09240 
Short-chain dehydrogenase, putative (EC 1.-.-.-) -2.095 0.0113509 16 57.8 AFUA_8G00280 
Uncharacterized protein -2.11387 0.0077628 9 60.6 AFUA_3G00960 
ThiJ/PfpI family protein -2.1423 8.65E-05 7 34.3 AFUA_5G02670 
NADH-dependent flavin oxidoreductase, putative (EC 1.-.-.-) -2.16525 0.0384993 16 47.6 AFUA_7G06420 
Porphyromonas-type peptidyl-arginine deiminase superfamily -2.17562 0.0050247 19 69.2 AFUA_3G01850 
Kynurenine aminotransferase, putative (EC 2.6.1.-) -2.18252 0.0033473 18 59.8 AFUA_4G11190 
Uncharacterized protein -2.18469 0.0298192 2 4.4 AFUA_1G09590 
Uncharacterized protein -2.18873 0.0004677 3 14.3 AFUA_5G09380 
Allantoicase Alc, putative (EC 3.5.3.4) -2.20027 0.0039565 16 53.7 AFUA_3G12560 
Dienelactone hydrolase family protein -2.21715 0.004 19 63.4 AFUA_6G01940 
Uncharacterized protein -2.22389 0.03592 10 59.8 AFUA_8G02420 
5-formyltetrahydrofolate cyclo-ligase, putative -2.22677 0.0326988 6 37 AFUA_7G05990 
Zinc-containing alcohol dehydrogenase, putative -2.2391 0.0020093 13 54 AFUA_3G01950 
Mannitol-1-phosphate 5-dehydrogenase (M1PDH) (MPD) (MPDH)  -2.25502 0.0030695 23 69.6 AFUA_2G10660 
Ribokinase (EC 2.7.1.15) -2.29361 0.0029809 8 44 AFUA_5G02530 
Agmatinase, putative (EC 3.5.3.11) -2.29452 0.0111136 14 57.3 AFUA_5G13180 
Allergen, putative (EC 1.-.-.-) -2.30127 0.0018717 11 71.3 AFUA_5G01440 
Succinyl-CoA:3-ketoacid-coenzyme A transferase (EC 2.8.3.5) -2.31709 0.0063545 18 51.9 AFUA_6G12250 
Aldehyde reductase (AKR1), putative (EC 1.1.1.2) -2.32385 0.0043191 22 82 AFUA_6G10260 
Asp-hemolysin (Asp-HS) -2.32658 0.0009185 10 71.9 AFUA_3G00590 
Vacuolar carboxypeptidase Cps1, putative (EC 3.4.17.-) -2.32932 0.0028206 10 27 AFUA_3G07040 
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Acyl-CoA dehydrogenase, putative (EC 1.3.99.-) -2.33151 0.003498 20 60 AFUA_1G14850 
Proliferating cell nuclear antigen -2.33973 0.0024044 13 85.4 AFUA_1G04900 
Formamidase FmdS (EC 3.5.1.49) -2.36059 0.0085728 13 42.6 AFUA_2G02020 
D-amino acid oxidase (EC 1.4.3.3) -2.36282 0.0016141 23 71.2 AFUA_5G11290 
Cell wall biogenesis protein/glutathione transferase (Gto1), putative -2.40308 0.003675 20 52.5 AFUA_2G15770 
S-methyl-5'-thioadenosine phosphorylase  -2.40348 0.004488 15 64.9 AFUA_6G08720 
DUF636 domain protein -2.4095 0.0015275 9 73.3 AFUA_3G01340 
General amidase, putative -2.41743 0.0074634 16 45.5 AFUB_100900 
ATP-dependent (S)-NAD(P)H-hydrate dehydratase  -2.44414 0.0136577 19 78 AFUA_2G10120 
Dienelactone hydrolase family protein (EC 3.1.1.-) -2.44846 0.0064431 19 69.4 AFUA_6G12740 
MutT/nudix family protein -2.45264 0.002231 11 81.8 AFUA_5G08240 
Zinc-binding oxidoreductase ToxD, putative -2.45293 0.0091683 18 74.6 AFUA_6G10120 
Kelch repeat protein -2.46605 0.0066756 17 70.8 AFUA_5G12780 
Oxidoreductase, short chain dehydrogenase/reductase family 
superfamily  -2.47309 0.0019731 10 65.9 AFUA_3G13450 
Alpha-mannosidase (EC 3.2.1.-) -2.48583 0.0021653 41 51.9 AFUA_3G08200 
Oxidoreductase, short-chain dehydrogenase/reductase family, putative  -2.49185 0.0036323 10 49.2 AFUA_5G14340 
Oxidoreductase, short chain dehydrogenase/reductase family -2.49998 0.0127866 14 86.8 AFUA_8G05590 
Epoxide hydrolase, putative -2.50661 0.001963 14 44.1 AFUA_3G08960 
Short chain dehydrogenase/reductase (EC 1.1.-.-) -2.50854 0.0055688 14 45.7 AFUA_2G00830 
Thiamine biosynthetic bifunctional enzyme, putative -2.52849 0.0039941 14 40.7 AFUA_2G08970 
Uncharacterized protein -2.53396 0.0357952 9 71.7 AFUA_2G05720 
Uncharacterized protein -2.5503 0.0133262 3 15.4 AFUA_1G11120 
Endothelin-converting enzyme (EC 3.4.24.-) -2.55051 0.0036315 21 39.9 AFUA_3G12420 
Aldose 1-epimerase, putative (EC 5.1.3.3) -2.56226 0.0149956 9 33.5 AFUA_3G13240 
Vacuolar aspartyl aminopeptidase Lap4, putative -2.57091 0.0022238 18 50.2 AFUA_5G03990 
Isovaleryl-CoA dehydrogenase IvdA, putative (EC 1.3.8.4) -2.57329 0.006896 17 48.3 AFUA_5G08930 
Uncharacterized protein -2.63221 0.0018701 8 47.5 AFUA_5G10990 
TIM-barrel enzyme family protein -2.66703 0.0034144 8 52 AFUA_1G10110 
Beta-hexosaminidase (EC 3.2.1.52) -2.66741 0.0033775 22 57.5 AFUA_8G05020 
Sorbitol/xylulose reductase Sou1-like, putative (EC 1.-.-.-) -2.69917 0.0051158 15 74.1 AFUA_2G15430 
Aminopeptidase (EC 3.4.11.7) -2.71944 0.0029456 64 69.2 AFUA_4G09030 
Glutaminase, putative -2.74585 0.0295248 18 33.6 AFUA_3G10910 
Superoxide dismutase [Cu-Zn] (EC 1.15.1.1) -2.82331 0.0100683 13 82.9 AFUA_5G09240 
Uncharacterized protein -2.84812 0.0011028 13 59.9 AFUA_3G10390 
Uncharacterized protein -2.84887 0.0070039 8 84.4 AFUA_2G00790 
Homogentisate 1,2-dioxygenase (HmgA), putative (EC 1.13.11.5) -2.8556 0.0057077 25 86.9 AFUA_2G04220 
Aldose 1-epimerase, putative (EC 5.1.3.3) -2.85628 0.0027781 22 71 AFUA_3G05740 
Beta-glucosidase, putative -2.90574 0.0023249 27 66.5 AFUA_1G14710 
Endonuclease/exonuclease/phosphatase family protein -2.91538 0.0034253 10 43.3 AFUA_2G16830 
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NmrA-like family protein, putative -2.92523 0.0016372 12 72.6 AFUA_4G02840 
Integral ER membrane protein Scs2, putative -2.94082 0.0074905 9 47 AFUA_4G06950 
3,4-dihydroxy-2-butanone 4-phosphate synthase (DHBP synthase)  -2.94771 0.0146427 10 48.7 AFUA_6G13140 
Ser/Thr protein phosphatase family -2.94997 0.0025816 21 49.5 AFUA_3G04160 
Cytidine deaminase, putative (EC 3.5.4.-) -2.95075 0.0046452 7 74.8 AFUA_8G02770 
Methylmalonate-semialdehyde dehydrogenase, putative (EC 1.2.1.27) -2.9656 0.002058 31 57.6 AFUA_4G12870 
Oxidoreductase, short chain dehydrogenase/reductase family -2.973 0.0051071 13 54.2 AFUA_8G06840 
Probable carboxypeptidase AFUA_6G06800 (EC 3.4.17.-)  -3.00512 0.0028738 9 32 AFUA_6G06800 
Phosphatidylserine decarboxylase family protein (EC 4.1.1.-) -3.03712 0.0247092 8 49.3 AFUA_6G00260 
Uncharacterized protein -3.08088 0.0122566 6 22.4 AFUA_6G02010 
L-PSP endoribonuclease family protein Brt1, putative -3.10319 0.0053939 4 65.6 AFUA_5G03780 
Betaine aldehyde dehydrogenase, putative (EC 1.2.1.8) -3.12066 0.0330817 19 68.7 AFUA_1G00470 
ATP-dependent DNA helicase II subunit 2 (EC 3.6.4.12)  -3.12682 0.0056819 18 35.4 AFUA_2G02620 
Acetyl-coA hydrolase Ach1, putative (EC 2.8.3.8) -3.14153 0.0145817 23 72.4 AFUA_8G05580 
Peptide hydrolase (EC 3.4.-.-) -3.2636 0.0029561 16 57.3 AFUA_2G00220 
Uncharacterized protein -3.30253 0.0146039 14 64.4 AFUA_2G01840 
Glycosyl hydrolase family 75 chitosanase -3.35811 0.0024479 7 35.7 AFUA_4G01290 
Extracelular serine carboxypeptidase, putative (EC 3.4.-.-) -3.41205 0.0162056 11 33.4 AFUA_2G17330 
IgE-binding protein, putative -3.45793 0.0218676 3 39.9 AFUA_6G03560 
Class II aldolase/adducin domain protein -3.47715 0.0036019 9 64.5 AFUA_3G09800 
Kynureninase 2 (EC 3.7.1.3) (Biosynthesis of nicotinic acid protein 5-
2)  -3.60717 0.008983 24 83 AFUA_4G09840 
Uncharacterized protein -3.65234 0.0014706 12 27.8 AFUA_8G01360 
D-arabinitol dehydrogenase ArbD, putative (EC 1.1.1.69) -3.67014 0.0008151 10 40.8 AFUA_5G08900 
Class II aldolase/adducin domain protein -3.73134 0.0116476 14 54.3 AFUA_3G01330 
Fe-containing alcohol dehydrogenase, putative (EC 1.1.1.-) -3.90924 0.0020302 20 55.3 AFUA_2G04520 
Fructosyl amino acid oxidase, putative -4.66424 0.0246961 20 54.7 AFUA_6G03440 
Probable dipeptidyl-aminopeptidase B (DPAP B) (EC 3.4.14.5) -4.71065 0.0035162 17 32.2 AFUA_3G07850 
Phosphatidylglycerol specific phospholipase, putative (EC 3.1.4.-) -5.15335 0.0102591 10 37.6 AFUA_3G01530 
Conidial hydrophobin RodB -5.21637 0.001205 4 61.4 AFUA_1G17250 
Thiamin pyrophosphokinase, putative (EC 2.7.6.-) Absent n/a 9 33.6 AFUA_1G01830 
Cut9 interacting protein Scn1, putative Absent n/a 5 22.3 AFUA_1G03870 
Uncharacterized protein Absent n/a 3 18.8 AFUA_1G05270 
Mandelate racemase/muconate lactonizing enzyme family protein  Absent n/a 3 14.1 AFUA_1G05520 
Histone H2A.Z-specific chaperone chz1 Absent n/a 4 51.2 AFUA_1G07430 
DUF431 domain protein Absent n/a 4 38.5 AFUA_1G08950 
DUF1000 domain protein Absent n/a 4 43.6 AFUA_1G09230 
Probable alpha-L-arabinofuranosidase C (ABF C) (Arabinosidase C) Absent n/a 4 11.6 AFUA_1G09900 
GPI anchored protein, putative Absent n/a 7 28.3 AFUA_1G10590 
Rho GTPase activator Rga, putative Absent n/a 4 5.4 AFUA_1G12680 
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Small nuclear ribonucleoprotein (LSM7), putative Absent n/a 3 19.4 AFUA_1G14290 
Uncharacterized protein Absent n/a 7 13.6 AFUA_1G16430 
Short chain dehydrogenase family protein (EC 1.-.-.-) Absent n/a 9 37.9 AFUA_1G16630 
Uncharacterized protein Absent n/a 2 9.4 AFUA_1G16650 
GNAT family acetyltransferase, putative Absent n/a 3 15.8 AFUA_2G00570 
GAF domain nucleotide-binding protein Absent n/a 3 20.1 AFUA_2G01360 
Signal recognition particle 14kD protein, putative Absent n/a 2 23.7 AFUA_2G01990 
Cell polarity protein (Tea1), putative Absent n/a 4 3.5 AFUA_2G02520 
Aldehyde reductase, putative (EC 1.1.1.-) Absent n/a 7 37.3 AFUA_2G02950 
Uncharacterized protein Absent n/a 2 22.6 AFUA_2G03155 
Asparaginase, putative (EC 3.5.1.1) Absent n/a 3 8.9 AFUA_2G04280 
Sugar hydrolase, putative Absent n/a 9 17 AFUA_2G05400 
IdgA domain protein (EC 2.7.1.-) Absent n/a 8 14.8 AFUA_2G05800 
GYF domain protein Absent n/a 3 2.2 AFUA_2G13290 
Lactoylglutathione lyase (Glo1), putative (EC 4.4.1.5) Absent n/a 5 37.3 AFUA_2G13550 
Thiamine pyrophosphate enzyme, putative (EC 4.1.-.-) Absent n/a 10 32 AFUA_2G13620 
Probable endo-1,3(4)-beta-glucanase AFUA_2G14360 (EC 3.2.1.6) 
(Mixed-linked glucanase AFUA_2G14360) Absent n/a 2 6.6 AFUA_2G14360 
L-PSP endoribonuclease family protein, putative Absent n/a 2 28 AFUA_2G17470 
Uncharacterized protein Absent n/a 2 28.4 AFUA_3G07000 
Uncharacterized protein Absent n/a 3 39.4 AFUA_3G07945 
N,N-dimethylglycine oxidase (EC 1.5.8.3) Absent n/a 7 35.8 AFUA_4G01150 
Protein kinase Scy1, putative Absent n/a 3 7.3 AFUA_4G06150 
Calcium homeostasis protein Regucalcin, putative Absent n/a 9 48.8 AFUA_4G08610 
Uncharacterized protein Absent n/a 2 11.3 AFUA_4G09890 
CaaX farnesyltransferase beta subunit Ram1 (EC 2.5.1.58) Absent n/a 5 19.8 AFUA_4G10330 
N-acetyltransferase family protein, putative Absent n/a 2 5.8 AFUA_4G10930 
DlpA domain protein Absent n/a 5 22 AFUA_4G10940 
Metallo-beta-lactamase domain protein, putative Absent n/a 2 12.2 AFUA_4G13310 
Mannitol 2-dehydrogenase (M2DH) (MDH) (EC 1.1.1.67) Absent n/a 13 36.9 AFUA_4G14450 
Glutathione S-transferase Ure2-like, putative Absent n/a 4 29.8 AFUA_4G14530 
Ribokinase (RK) (EC 2.7.1.15) Absent n/a 6 27.4 AFUA_4G14650 
Uncharacterized protein Absent n/a 3 21.6 AFUA_5G00870 
NADH-dependent flavin oxidoreductase, putative (EC 1.-.-.-) Absent n/a 9 40 AFUA_5G01450 
Amidohydrolase family protein Absent n/a 8 30.4 AFUA_5G01480 
Isopenicillin N-CoA epimerase, putative Absent n/a 11 37.2 AFUA_5G03740 
Oxidoreductase, short-chain dehydrogenase/reductase family  Absent n/a 5 47 AFUA_5G09150 
Beta-lactamase Absent n/a 6 29.2 AFUA_5G09790 
Arsenic methyltransferase Cyt19, putative (EC 2.1.1.137) Absent n/a 11 51.2 AFUA_5G15020 
Probable arabinan endo-1,5-alpha-L-arabinosidase C (EC 3.2.1.99)  Absent n/a 3 14.9 AFUA_6G00770 
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Phenol 2-monooxygenase, putative Absent n/a 15 34.4 AFUA_6G03490 
Sucrase/ferredoxin-like family protein Fmi1, putative Absent n/a 5 30.2 AFUA_6G04900 
Glutaminase, putative Absent n/a 17 28.7 AFUA_6G09910 
Thiamine pyrophosphate enzyme, putative (EC 4.1.-.-) Absent n/a 9 31.1 AFUA_6G11680 
DNA damage-binding protein cmr1 Absent n/a 6 30 AFUA_6G12330 
Putative heme-binding peroxidase (EC 1.11.1.-) Absent n/a 7 35.4 AFUA_6G13570 
Uncharacterized protein Absent n/a 11 38.3 AFUA_6G13900 
Phosphatidylglycerol specific phospholipase C, putative (EC 3.1.4.3) Absent n/a 7 16.7 AFUA_7G04910 
Glyoxalase family protein Absent n/a 5 34.6 AFUA_7G05015 
Uncharacterized protein Absent n/a 2 38.1 AFUA_7G05730 
Probable beta-glucosidase L (EC 3.2.1.21)  Absent n/a 7 18.8 AFUA_7G06140 
Cyanamide hydratase, putative (EC 4.2.1.69) Absent n/a 5 24.7 AFUA_7G06270 
Fumitremorgin biosynthesis protein H Absent n/a 9 36.3 AFUA_8G00250 
Dimethylallyl tryptophan synthase, putative (EC 2.5.1.-) Absent n/a 9 27.3 AFUA_8G00620 
Arylsulfatase (AS) (EC 3.1.6.1) (Aryl-sulfate sulphohydrolase) Absent n/a 2 4 AFUA_8G02520 
AraC-like ligand binding domain protein, putative Absent n/a 4 27.2 AFUA_6G14370 
Fumarylacetoacetate hydrolase family protein Absent n/a 5 31.3 AFUA_1G02370 
Thiamin pyrophosphokinase-related protein Absent n/a 6 33.2 AFUA_5G11110 
Ureidoglycolate hydrolase, putative (EC 3.5.3.19) Absent n/a 10 65.5 AFUA_8G04760 
Uncharacterized protein Absent n/a 4 34.3 AFUB_084960 
Verruculogen synthase (Fumitremorgin biosynthesis protein F) Absent n/a 6 26.5 AFUA_8G00230 
Uncharacterized protein Absent n/a 4 31.2 AFUB_086760 
 
 
 
